{"Title": ["Notable Friday Option Activity: W, TIF, AMGN", "2 Top Small-Cap Stocks to Buy Right Now", "July 31st Options Now Available For Amgen (AMGN)", "Amgen To Present At Goldman Sachs 41st Annual Global Healthcare Conference; Webcast At 1:20 PM ET", "Noteworthy ETF Outflows: IYH, AMGN, MDT, DHR", "Moderna names Amgen executive David Meline as CFO", "3 Top Large-Cap Stocks to Buy in June", "Amgen To Present At The Jefferies 2020 Virtual Healthcare Conference; Webcast At 4:00 PM ET", "Notable Friday Option Activity: W, TIF, AMGN", "Peek Under The Hood: IUS Has 10% Upside", "Is Coherus BioSciences a Buy?", "Is Arrowhead Pharmaceuticals a Buy?", "VTV, T, KO, AMGN: ETF Inflow Alert", "Monday Sector Laggards: Healthcare, Technology & Communications", "Better Buy: Pfizer vs. Bristol Myers Squibb", "Validea's Top Five Healthcare Stocks Based On David Dreman - 5/17/2020", "Nasdaq Today: Why Alexion and Workday Stock Are Soaring", "Ex-Dividend Reminder: AmerisourceBergen, Amgen and Sabra Health Care REIT", "What's Behind Adaptive Biotechnologies' Q1 Earnings Miss", "Is Now Still a Good Time To Buy Amgen?", "Here's Why Cytokinetics Is Skyrocketing 24.5% Today", "Why Amgen Soared in April", "AstraZeneca Completes Recovery Of Global Rights To Brazikumab From Allergan", "Amgen:FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure", "Notable Friday Option Activity: AMGN, UNH, TGT", "Amgen Reports Positive Results For Otezla In Phase 3 Trial", "Why Akebia Therapeutics Stock Is Crushing It Today", "Amgen: Court Ruling Prevents Cipla From Making Generic Version Of KYPROLIS", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Medigus, Aemetis", "Amgen Inc (AMGN) Q1 2020 Earnings Call Transcript", "Amgen studying Otezla for coronavirus, Q1 results beat Street estimates", "Amgen Stock Jumps on Earnings, Covid-19 Trial Announcement", "BUZZ-U.S. STOCKS ON THE MOVE-GM, Axcella, Beyond Meat, SmileDirect", "Here's Why Investors Should Follow Sanofi and GlaxoSmithKline's New Coronavirus Collaboration", "Better Buy: Illumina vs. Adaptive Biotechnologies", "How These 15 Stock Suggestions Fared Against the Market", "IYH, JNJ, ABT, AMGN: ETF Inflow Alert", "Here's Why Verastem Oncology Is Tanking Today", "3 Coronavirus Stocks to Buy Now", "3 Dividend Stocks Weathering the Coronavirus Storm", "Amgen Inc. Q1 adjusted earnings Beat Estimates", "Artificial Intelligence and Drug Discovery: The Companies Leading The Way", "Here's Why Verastem Stock Is Jumping Today", "3 Stocks I'm Buying Right Now", "4 Healthcare Stocks to Buy For Coronavirus Innovation", "ITOT, ABT, COST, AMGN: ETF Outflow Alert", "1 Recent IPO to Add to Your Watch List", "Novartis: Real-world Data Supports Aimovig Clinical Trial Results - Quick Facts", "Better Buy: Amgen vs. Johnson & Johnson", "1 Stock That Crushed the Market During the Last Recession", "AMGN May 29th Options Begin Trading", "Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing", "Why Gilead Sciences Is the Hottest Stock to Buy Today", "Why Amgen Stock Sailed Through March Without a Scratch", "Amgen Teams Up With Adaptive Biotechnologies to Develop COVID-19 Therapy", "Amgen, Adaptive Partner To Find Neutralizing Antibodies For COVID-19", "Noteworthy Tuesday Option Activity: CSTE, TTD, AMGN", "Amgen Pauses Some Clinical Trials to Reduce Coronavirus Transmission Risk", "Notable ETF Inflow Detected - FTCS, PGR, LLY, AMGN", "4 Reasons Drug Stocks Are a Buy Right Now", "Why Amgen is the 'Top Dividend Stock of the Nasdaq 100' With 3.2% Yield (AMGN)", "Health Care Sector Update for 03/26/2020: JNJ, PFE, ABT, MRK, AMGN, HTGM, RKDA, BIOC", "Top Drug Stocks Under $5", "4 Reasons Biotech Stocks Are a Buy Right Now", "Amgen Purchases 49% Of Shares Of Amgen Astellas BioPharma", "Health Care Sector Update for 03/17/2020: JNJ, PFE, ABT, MRK, AMGN, DBVT, AVRO, MRNA", "7 Biotech Stocks to Buy and Hold in 2020", "Better Buy: Biogen vs. Amgen", "Noteworthy ETF Inflows: TQQQ, GOOGL, AMGN, TXN", "Health Care Sector Update for 03/11/2020: JNJ, PFE, ABT, MRK, AMGN, SPHS, CDMO, KALA", "Better Buy: Amgen vs. Gilead Sciences", "Daily Dividend Report: GD,HES,VZ,AMGN,PM", "Notable ETF Inflow Detected - TQQQ, GOOGL, AMGN, TXN", "Health Care Sector Update for 03/04/2020: JNJ, PFE, ABT, MRK, AMGN, MRNA, REPH, CNC, DRRX", "ProShares ProShares UltraPro QQQ Experiences Big Inflow", "Health Care Sector Update for 03/04/2020: JNJ, PFE, ABT, MRK, AMGN, DRRX, VVUS, VYGR", "Thermo Fisher Scientific to Spend $11.5 Billion Upgrading Its DNA Testing Game", "Health Care Sector Update for 03/03/2020: JNJ, PFE, ABT, MRK, AMGN, KMPH, OMER, GNMK", "3 Top Healthcare Stocks to Buy Right Now", "FDA Approves Biohaven's Migraine Treatment Nurtec ODT", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Health Care Sector Update for 02/27/2020: JNJ, PFE, ABT, MRK, AMGN, TDOC, ORMP, LHCG", "Analysts Forecast 11% Upside For The Holdings of FTCS", "Here's Why Karyopharm Therapeutics Has a Unique Growth Opportunity", "Amgen is Oversold", "3 Biotech Stocks That Surged Last Week", "FDA Approves Esperion Therapeutics' New Cholesterol Drug", "A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward", "Amgen Breaks Below 200-Day Moving Average - Notable for AMGN", "IWB, ABT, AMGN, LIN: Large Outflows Detected at ETF", "Health Care Sector Update for 02/19/2020: JNJ, PFE, ABT, MRK, AMGN, MREO, AMED, CTSO", "Notable Thursday Option Activity: ZBRA, AMGN, MMM", "AMGN April 3rd Options Begin Trading", "3 Biotech Stocks That Made Early Shareholders Millionaires", "Bristol-Myers Squibb Stock Is Too Cheap to Ignore", "Is Amgen a Stock to Buy?", "Investors Scrambled to Buy This Biotech IPO", "How Bristol-Myers Squibb Trounced Wall Street's Q4 Estimates", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/6/2020", "Why Amgen Stock Dropped 10.4% in January", "PKW, AMGN, UNP, ORCL: ETF Inflow Alert", "Teva Pharmaceutical Just Got a Little Migraine Relief ", "Amgen a Top Socially Responsible Dividend Stock With 3.0% Yield (AMGN)", "Could Guardant Health Be a Millionaire-Maker Stock?", "Health Care Sector Update for 02/07/2020: JNJ, PFE, ABT, MRK, AMGN, ASRT, ZGNX, MYGN", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Noteworthy Friday Option Activity: AMGN, EXPE, CVS", "Stock Market News: Amazon's Amazing; Amgen Falls Short", "Amgen's Shares Slip on Soft Guidance. Time to Buy?", "Nasdaq 100 Movers: AMGN, AMZN", "Where Will Cara Therapeutics Be in 5 Years?", "Amgen Inc (AMGN) Q4 2019 Earnings Call Transcript", "Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?", "Amgen Issues FY20 Guidance - Quick Facts", "Amgen Inc. Q4 adjusted earnings Beat Estimates", "Amgen Q4 19 Earnings Conference Call At 5:00 PM ET", "Amgen Q4 19 Earnings Conference Call At 5:00 PM ET", "Why Teva Stock Could Be the Next General Electric Stock", "iShares Core Dividend Growth ETF Experiences Big Inflow", "Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences?", "Amgen Revenue Slipped 1% in the Fourth Quarter", "Relative Strength Alert For Amgen", "Better Buy: Amgen vs. Gilead Sciences", "Better Buy: Exact Sciences vs. Qiagen", "3 Attractive Dividend Stocks Whose Dividends Could Double", "2 Biotechs Battling Immune Diseases", "iShares Russell 1000 ETF Experiences Big Outflow", "Noteworthy Thursday Option Activity: MOS, PPG, AMGN", "Is Mylan Stock a Buy?", "Relative Strength Alert For Amgen", "Health Care Sector Update for 01/10/2020: JNJ, PFE, ABT, MRK, AMGN, ACRS, MRNA, PTLA", "Noteworthy ETF Outflows: IWB, AMGN, LLY, QCOM", "These 25 Companies Laid Off Workers in 2019", "Health Care Sector Update for 01/06/2020: JNJ, PFE, ABT, MRK, AMGN, LIFE, LPTX, NOVN", "Amgen a Top 25 Dividend Giant With 2.68% Yield (AMGN)", "Health Care Sector Update for 01/14/2020: JNJ, PFE, ABT, MRK, AMGN, RTIX, TRXC, MREO", "3 of the Best Healthcare Stocks to Buy in 2020", "Amgen Completes Purchase Of About $2.8 Bln Of BeiGene Shares", "Better Buy: Abbott Laboratories vs. Pfizer", "Health Care Sector Update for 01/02/2020: JNJ, PFE, ABT, MRK, AMGN, IPHA, ONTX, AERI", "Breakingviews - A health craze for 2020: Chinese medicine", "Vascepa\u2019s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock", "Noteworthy Monday Option Activity: OKTA, SAVE, AMGN", "AMGN February 14th Options Begin Trading", "The Success of Vascepa Actually Might Be a Problem for Amarin", "3 Biotech Stocks That Crushed It in 2019", "U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020", "3 Blockbuster Cancer Drug Launches to Watch in 2020", "Better Buy: Amgen vs. Johnson & Johnson", "How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition", "FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed", "XLV, JNJ, MRK, AMGN: Large Inflows Detected at ETF", "Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals", "7 Biotech Stocks to Buy and Hold in 2020", "Amarin\u2019s Vascepa Approval Seems Fishy for Patients and AMRN Investors", "Is Amarin a $20 Billion Stock?", "Bristol-Myers Placed A Big Bet On Celgene\u2019s Pipeline. Will It Pay Off For Investors?", "Better Buy: Gilead Sciences vs. Amgen", "3 Reasons This Biotech is a Buy for Risk-Averse Investors", "3 Dividend Stocks That Hiked Their Payouts by More Than 100% in 5 Years", "January 2020 Options Now Available For Amgen (AMGN)", "Here's Why You Should Own Amgen Stock in 2020", "Why BridgeBio Pharma Is Currently Trading At 2x Its IPO Price", "Health Care Sector Update for 12/11/2019: JNJ, PFE, ABT, MRK, AMGN, AQST, RCKT, MRNS", "Is Rigel Pharmaceuticals Stock a Buy?", "Amgen: CANDOR Study Supports Combination Of KYPROLIS, DARZALEX - Quick Facts", "Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, PDLI, TGTX, TVTY, ARQL", "Daily Dividend Report: AMGN, ZTS, PKI, PWR, AXP", "3 Healthcare Stocks to Buy Before the End of 2019", "Better Buy: Biogen vs. Amgen", "4 FDA Dates Biotech Investors Should Circle in December", "Health Care Sector Update for 12/06/2019: JNJ, PFE, ABT, MRK, AMGN, CYAD, SAVA, CRIS", "Health Care Sector Update for 12/06/2019: JNJ, PFE, ABT, MRK, AMGN, CYAD, ONCY, RCKT, SAVA", "Can Cannabis 2.0 Kickstart Marijuana Stocks?", "Save Yourself the Migraine and Buy This 1 Pharma Stock Now", "Health Care Sector Update for 12/09/2019: JNJ, PFE, ABT, MRK, AMGN, ARQL, THOR, MBIO, XBIT", "Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for Amgen", "Notable Monday Option Activity: M, AMGN, IBM", "Biotech Stocks Facing FDA Decision In December 2019", "Health Care Sector Update for 11/29/2019: JNJ, PFE, ABT, MRK, AMGN, CANF, REGN, AZN", "Health Care Sector Update for 11/27/2019: JNJ, PFE, ABT, MRK, AMGN, ARAV, TNXP, VRCA", "Why AbbVie Is a Dividend Growth Stock That's Too Cheap to Ignore", "Health Care Sector Update for 11/26/2019: JNJ, PFE, ABT, MRK, AMGN, CCXI, XFOR, SNOA", "Better Buy: Amgen vs. Pfizer", "Why The Medicines Company Stock Is Soaring Today", "Health Care Sector Update for 11/25/2019: JNJ, PFE, ABT, MRK, AMGN, SRNE, MDCO, NVS, ZIOP", "Healthcare Stocks That Hit New Highs (MTEM, AMGN, AMED...)", "Does Amarin Have a Dark Horse Suitor?", "Why I'm Holding On to My Bristol-Myers Squibb Shares Now That the Celgene Acquisition Has Closed", "2 Stocks to Buy If You're Worried About a Recession", "Health Care Sector Update for 11/22/2019: JNJ, PFE, ABT, MRK, AMGN, SENS, ORGO, HSDT", "A 45% Premium: Here's Why The Medicines Company Is Worth More to Novartis Than It Was to You", "3 Top Healthcare Stocks to Buy in November", "Missed the 310% Rise of Arrowhead Pharmaceuticals? Keep an Eye On This Competitor", "Amgen Boosts FY19 Outlook After Otezla Acquisition - Quick Facts", "Notable ETF Outflow Detected - ITOT, PG, XOM, AMGN", "Health Care Sector Update for 11/20/2019: JNJ, PFE, ABT, MRK, AMGN, ALC, BCRX, CRSP", "Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.", "Here\u2019s Why The Medicines Company Jumped Higher Again Today", "Health Care Sector Update for 11/21/2019: JNJ, PFE, ABT, MRK, AMGN, HARP, ABBV, ENLV, NTGN", "Here's Why The Medicines Company Moved Higher Today", "The Question is Not Why Amarin Stock May Go Up, But Should It?", "Amgen Says New Analysis Shows Benefit Of Repatha In High-Risk Patients", "Noteworthy Thursday Option Activity: AMGN, ROKU, SPLK", "Amarin's Stock Could Reach $50 Per Share Soon", "Ex-Dividend Reminder: Teleflex, Amgen and Sabra Health Care REIT", "Here\u2019s Why FibroGen\u2019s Stock Popped Friday", "If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences", "3 Cancer Treatment Stocks to Buy Right Now", "Here's Why Cytokinetics Stock Tanked on Thursday", "Noteworthy Thursday Option Activity: LH, CSX, AMGN", "Buy These 2 Stocks to Access China's Huge Healthcare Market", "Breakingviews - Biotech upstarts will be Big Pharma's China tonic", "2020 Election Could Hurt Amgen Stock\u2019s Healthy Dividend", "Amgen Reaches Analyst Target Price", "Why Amgen's Stock Soared in October", "Health Care Sector Update for 11/01/2019: BGNE,AMGN,AMED,BLUE", "Health Care Sector Update for 11/01/2019: BGNE,AMGN,AMED,BLUE", "Here's Why Beigene Stock Is Soaring Today", "iShares Russell 3000 ETF Experiences Big Inflow", "BGNE Soars, DRNA Hits New High On Roche Deal, FDA Heeds REPH's Request", "Amgen To Acquire 20.5% Stake In BeiGene For Approx. $2.7 Bln - Quick Facts", "What Should Investors Think of Biogen's Alzheimer's Drug Candidate?", "Better Buy: Mirati Therapeutics vs. Amgen", "Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line", "Can This Tiny Biotech Take Down Amgen?", "Amgen Inc (AMGN) Q3 2019 Earnings Call Transcript", "Amgen Updates Guidance - Quick Facts", "Amgen Inc. Q3 adjusted earnings Beat Estimates", "Here's Why Mirati Therapeutics Stock Is on the Move Again Today", "Is Gossamer Bio a Buy?", "Notable Thursday Option Activity: AMGN, AMD, COST", "Amgen Q3 19 Earnings Conference Call At 5:00 PM ET", "5 Top Healthcare ETFs", "Amgen Decides To Discontinue Original List Price Option For Repatha", "Daily Dividend Report: AEP, LECO, BAC, WFC, AMGN", "ProShares ProShares UltraPro QQQ Experiences Big Outflow", "Amgen Appoints Peter Griffith As CFO, Succeeding David Meline, Effective Jan. 1", "Is Mirati Therapeutics a Good Stock to Buy Now?", "Why Shockwave Medical Is Not a Buy", "Amgen : EVENITY Gets Positive CHMP Opinion For Treatment Of Severe Osteoporosis", "Will The Pace of M&A Pick Up Following The Biotech Sector\u2019s Pounding?", "Noteworthy Monday Option Activity: PD, AMGN, IBM", "Health Care Sector Update for 10/07/2019: JNJ, ABT, PFE, MRK, AMGN, MREO, XENT, CAPR", "How Amazon Is Shaking Up Telemedicine, Plus 1 Winner and 1 Loser Exiting ESMO", "Interesting AMGN Put And Call Options For November 22nd", "2 Great Stocks You Can Buy on Sale", "Amgen: FDA Approves Earlier Use Of Nplate To Treat Immune Thrombocytopenia", "The Medicines Company Surges on Positive Drug Trial Results", "The Medicines Company Is Up 161% Year to Date, but Here's a Better Way to Play the Drugmaker's Success", "Is Amgen Really as Cheap as It Looks?", "Notable Friday Option Activity: AMGN, OKE, AXDX", "Cancer Results to Watch at This Weekend\u2019s European Society of Medical Oncology Congress", "Better Buy: Biogen vs. Amgen", "Interesting AMGN Put And Call Options For November 8th", "Winners and Losers of Europe\u2019s Big Cancer Meeting", "Could Amgen's Latest Bad News Boost the Chances of More Acquisitions?", "Health Care Sector Update for 09/17/2019: IMMP,ABT,ACRS,ADPT,AMGN", "Health Care Sector Update for 09/17/2019: ABT,ACRS,ADPT,AMGN", "Here's Why Alder Biopharmaceuticals Is Rocketing Higher Today", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Amgen's Phase 3 CANDOR Study Meets Primary Endpoint Of PFS - Quick Facts", "TQQQ, ADBE, COST, AMGN: Large Inflows Detected at ETF", "Does Acadia Pharmaceuticals Have More Room to Run?", "Why Amgen Stock Perked Up Last Month", "5 Things You'll Want to Know About Amgen's Future", "Notable ETF Outflow Detected - FBT, AMGN, NBIX, ALNY", "Amgen To Present At The Morgan Stanley Global Conference; Webcast At 9:10 AM ET", "Noteworthy Monday Option Activity: YUM, AMGN, EVRI", "Amarin: Keep Your Dry Powder Ready", "Analysts See 10% Gains Ahead For The Holdings of EQWL", "S&P 500 Movers: AMGN, LB", "Health Care Sector Update for 09/09/2019: ACAD, AXNX, AMGN, JNJ, PFE, ABT, MRK", "Novartis: Aimovig Shows Long-term Efficacy In Treatment Of Episodic Migraine", "Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August", "Amgen Drug Shrinks 54% Of Lung Cancer Tumors In Study", "Better Buy: Amgen vs. Celgene", "Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy", "Nasdaq 100 Movers: AMGN, NFLX", "Here's Why Alexion Pharmaceuticals Dropped 11% in August", "Here's Why The Medicines Company Stock Soared Again on Tuesday", "SPY, BRK.B, NFLX, AMGN: ETF Inflow Alert", "3 Top Biotech Stocks to Buy Right Now", "4 Biotech Stocks to Buy That Are on the Move", "What Happened in the Stock Market Today", "Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win", "4 Biotech Stocks With Big Catalysts in September", "Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen", "Should Amgen Finally Buy Alexion Pharmaceuticals?", "3 Reasons Why Amgen Could Actually Acquire Alexion", "ALXN & Takeover Rumors, AMGN's JASMINE Blooms, CLSD Sees The Writing On The Wall", "SPDR S&P 500 ETF Trust Experiences Big Outflow", "Arrowhead Pharmaceuticals: Buy at the High?", "Is Amgen a Buy?", "5 Top Stock Trades for Tuesday: NFLX, AMGN, ACB, BMY", "Wednesday\u2019s Vital Data: Amgen, American Airlines and Apple", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 14, 2019", "Noteworthy Monday Option Activity: APA, STT, AMGN", "Nasdaq 100 Movers: MELI, AMGN", "Ex-Dividend Reminder: Teleflex, Amgen and U.S. Physical Therapy", "S&P 500 Movers: NKTR, AMGN", "Sandoz To Appeal U.S. Court Ruling In Biosimilar Erelzi U.S. Patent Case", "Notable ETF Outflow Detected - SPYG, AVGO, AMGN, ADP", "5 'Strong Buy' Dividend Stocks With High Upside", "9 Catalysts That Will Drive Chinese Biotech Stocks Much Higher", "Daily Dividend Report: DK, SPNS, SBR, TG, AMGN", "3 Lung Cancer Stocks That Could Soar in September", "iShares U.S. Healthcare ETF Experiences Big Outflow", "Health Care Sector Update for 07/31/2019: DMPI,NUVA,AMGN,ACRS", "Health Care Sector Update for 07/31/2019: NUVA,AMGN,ACRS", "AMGN Named A Top Socially Responsible Dividend Stock", "Amgen Inc (AMGN) Q2 2019 Earnings Call Transcript", "Amgen Manages to Tread Water for Another Quarter", "Amgen Inc. Q2 adjusted earnings Beat Estimates", "Amgen Q2 19 Earnings Conference Call At 5:30 PM ET", "AMGN September 6th Options Begin Trading", "10 Biggest Cancer-Fighting Stocks", "Notable ETF Outflow Detected - TQQQ, NFLX, COST, AMGN", "Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings?", "The Implied Analyst 12-Month Target For EQWL", "ACWI, BABA, KO, AMGN: ETF Inflow Alert", "AMGN August 30th Options Begin Trading", "What Happened in the Stock Market Today", "The 10 Biggest Healthcare Stocks", "Notable Monday Option Activity: STZ, CHGG, AMGN", "Here's Why Coherus BioSciences Is Falling Today", "Health Care Sector Update for 07/23/2019: JNJ, PFE, ABT, MRK, AMGN", "Why Amgen is a Top 25 Dividend Giant (AMGN)", "Here's Why Amgen Stock Gained 10% in June", "How to Invest in Biotech Stocks", "Noteworthy Monday Option Activity: AMP, AVGO, AMGN", "3 Top Biotech Stocks to Buy Right Now", "Where Will Cara Therapeutics Be in 5 Years?", "3 Cancer-Treatment Stocks to Buy", "The Health Care Select Sector SPDR Fund Experiences Big Outflow", "XLV, AMGN, LLY, SYK: ETF Outflow Alert", "The 10 Biggest Biotech Stocks", "Notable Wednesday Option Activity: UNH, RHT, AMGN", "3 Large-Cap Biotech Stocks to Buy for Massive Gains", "IWF, ACN, COST, AMGN: Large Inflows Detected at ETF", "3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal", "3 Stocks to Buy and Hold for the Next 50 Years", "Here's Why Dova Pharmaceuticals Stock Jumped Higher Today", "Health Care Sector Update for 06/07/2019: CRSP,VRTX,LJPC,MRTX,AMGN", "5 Healthcare Stocks to Pick Up From the Wreckage", "5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug", "3 Cancer Stocks Given a Lift by Amgen", "Better Buy: Biogen vs. Amgen", "Here's Why Mirati Therapeutics Is Jumping Today", "Amgen Reports Positive Data From AMG 510 Early Phase 1 Study - Quick Facts", "SSO, MDT, IBM, AMGN: Large Outflows Detected at ETF", "Ranking the Top 10 Stock Buybacks of Last Year", "2 Healthcare Stocks That Doubled Investors' Money in 2019", "3 Charts Every Amgen Investor Needs to See", "Interesting AMGN Put And Call Options For July 5th", "IBB, CELG, GILD, AMGN: ETF Inflow Alert", "Amgen Offers To Buy Nuevolution For SEK 32.50/shr In Cash - Quick Facts", "Notable Friday Option Activity: TMUS, AMGN, ARR", "Health Care Sector Update for 05/16/2019: BLUE,MRTX,AGIO,EDAP,AMGN", "Here's Why Mirati Therapeutics Is Surging Today", "Notable Thursday Option Activity: AGN, DAL, AMGN", "3 Stocks With Big News Coming at ASCO 2019", "Health Care Sector Update for 05/10/2019: JNJ, PFE, ABT, MRK, AMGN, GENE, PIRS, TGTX", "Notable Wednesday Option Activity: EZPW, AMGN, ETSY", "Why Are Investors Passing on Teva Pharmaceutical Industries?", "Who Had the Better Quarter: Gilead Sciences or Amgen?", "5 Top Stock Trades for Thursday: CVS, TWLO, EL, AMGN", "Nasdaq 100 Movers: AMGN, AAPL", "Amgen Inc (AMGN) Q1 2019 Earnings Call Transcript", "Amgen Reports an Unusual Slide Backward", "Amgen Earnings: AMGN Stock Dips Slightly Despite Q1 EPS, Sales Beat", "Amgen Updates Earnings Guidance - Quick Facts", "Amgen Inc. Q1 adjusted earnings Beat Estimates", "June 14th Options Now Available For Amgen (AMGN)", "4 More Healthcare Earnings Reports to Watch This Week", "Noteworthy Friday Option Activity: SAIA, COTY, AMGN", "Notable ETF Outflow Detected - IYH, ABBV, AMGN, MDT", "Pfizer Stock Suffers From an Underappreciated Drugs Pipeline", "Amgen is Oversold", "3 Big Stock Charts for Thursday: Citrix Systems, Goldman Sachs Group and Amgen", "Why Amgen Stock Could Break Out to New Highs", "Amgen Q1 19 Earnings Conference Call At 5:00 PM ET", "Amgen sets $21,900 annual price for new Evenity bone drug", "Better Buy: Amgen vs. Gilead Sciences", "ProShares UltraPro S&P500 Experiences Big Outflow", "FDA Approves Amgen's Osteoporosis Drug Evenity", "Here's Why Novartis Is Sliding Today", "Why Amgen Can Deliver Medical and Financial Miracles", "5 Stocks in the Age of Miracles", "Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales", "Amgen sets $21,900 annual price for new Evenity bone drug", "Here's Why Novartis Is Sliding Today", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Why Amgen's Giving Novartis a Headache", "Why Amgen's Giving Novartis a Headache", "Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig", "Amgen's postmenopausal osteoporosis drug gets FDA greenlight", "Pfizer's New Lung Cancer Drug Vizimpro Gets EU Approval", "Novartis Resubmits BLA to FDA for Biosimilar of Neulasta", "Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN", "Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN", "BMO\u2019s Got A Point About Teva Stock, But Are Investors Willing To Listen?", "BMO\u2019s Got A Point About Teva Stock, But Are Investors Willing To Listen?", "3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop", "Novartis sues Amgen over migraine treatment Aimovig", "Pfizer's New Lung Cancer Drug Vizimpro Gets EU Approval", "Top Research Reports for Apple, Amgen & United Technologies", "QUAL, MO, AMGN, MCO: Large Inflows Detected at ETF", "May 3rd Options Now Available For Amgen (AMGN)", "Biogen Stock Fell Too Far on Unfortunate News", "Here's Why Cytokinetics Stock Jumped Today", "Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down", "The Zacks Analyst Blog Highlights: Apple, Amgen, United Technologies, Travelers and Xilinx", "Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent", "Better Buy: Amgen vs. Gilead Sciences", "iShares Edge MSCI USA Quality Factor ETF Experiences Big Inflow", "Roche Gets Approval for Label Expansion of MabThera in Europe", "Roche Receives EC Approval for Label Expansion of Hemlibra", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2019", "Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval", "Amarin's Vascepa cuts occurrence of serious heart problems 30 pct", "Is Amgen (AMGN) a Profitable Pick ForValue Investors Now?", "AMGN Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 3.2% Yield", "Better Buy: Amgen vs. Biogen", "Daily Dividend Report: MTN, AMT, AMAT, BMY, AMGN", "RSI Alert: Amgen Now Oversold", "Lilly's Emgality Gets FDA Priority Review for Cluster Headache", "Ligand Sells Promacta Rights for $827M, Updates '19 View", "Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer", "U.S. FDA chief tough on e-cigs steps down in surprise resignation", "U.S. FDA chief tough on e-cigarettes steps down abruptly", "US STOCKS-Wall St sinks for 3rd day as healthcare, energy slump", "Wall St sinks for 3rd day as healthcare, energy slump", "Wall St falls for 3rd day as healthcare, energy slump", "US STOCKS-Wall St falls for 3rd day as healthcare, energy slump", "Wall Street eyes third day of losses as healthcare sector weighs", "3 Big Pharmas Trying to Pop the Rebate Bubble", "Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda", "U.S. FDA chief Gottlieb resigns", "U.S. FDA chief Gottlieb resigning", "iShares Russell 1000 Growth ETF Experiences Big Inflow", "AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab", "Spectrum (SPPI) Misses Earnings Estimates in Q4, Tops Sales", "Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales", "US STOCKS-Wall Street eyes third day of losses as healthcare sector weighs", "Notable Tuesday Option Activity: BAC, AMGN, TZOO", "Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion", "Sanofi, Regeneron lose U.S. patent challenge to Amgen cholesterol drug", "Better Buy: Amgen vs. Celgene", "Amgen Starts Phase III Enrollment for Heart Failure Drug", "The Zacks Analyst Blog Highlights: Walmart, Amgen, Honda, TransCanada and TransUnion", "Merck Gets Priority Review for Keytruda in Third-Line SCLC", "Sanofi/Regeneron Disagree With Jury Verdict in Amgen's Favor", "AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review", "Merck's Keytruda Fails to Meet Endpoint in Liver Cancer Study", "Top Analyst Reports for Walmart, Amgen and Honda", "Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review", "Merck Gets Priority Review for Keytruda Combo in Kidney Cancer", "Is Amgen a Buy?", "Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down", "AMGN April 5th Options Begin Trading", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 14, 2019", "Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report", "Merck's Keytruda Gets FDA Priority Review for Head/Neck Cancer", "AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma", "Sanofi/Regeneron Cut Price of PCSK9 Inhibitor Praluent by 60%", "IWV, PEP, ABBV, AMGN: ETF Outflow Alert", "Sanofi and Regeneron cut list price of cholesterol drug by 60 pct", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019", "5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure", "Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down", "Amgen a Top Socially Responsible Dividend Stock With 3.1% Yield (AMGN)", "Facing crackdown in Canada, drugmakers offered billions in price cuts", "Roche Submits sBLA to FDA for Label Expansion of Kadcyla", "After Hours Most Active for Feb 5, 2019 : BRX, SNAP, ET, S, ECA, M, CZR, MSFT, KURA, EA, AMGN, URBN", "Here's Why Coherus BioSciences Rose 48.7% in January", "Pfizer's (PFE) New Lung Cancer Drug Vizimpro Gets CHMP Nod", "A War on High Drug Prices Could Boost Biosimilars", "Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY", "Optum to cover Amgen, Eli Lilly migraine drugs, exclude Teva", "Merck's Keytruda tops $2 billion in quarterly sales, shares rise", "Merck quarterly profit beats estimates on Keytruda strength", "Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance", "Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy", "Novartis (NVS) Q4 Earnings Miss Estimates, Revenues Up Y/Y", "Amgen, Inc (AMGN) Q4 2018 Earnings Conference Call Transcript", "Nasdaq 100 Movers: AMGN, AMD", "Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid", "Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips", "Amgen Leaves Investors With Mixed Emotions", "Amgen Q4 18 Earnings Conference Call At 5:00 PM ET", "Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva", "Amgen quarterly profit tops Street view, 2019 forecast falls short", "After-Hours Earnings Report for January 29, 2019 : AAPL, AMGN, CNI, SYK, ILMN, EBAY, EQR, AMD, BXP, ALGN, TSS, KLAC", "Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?", "Notable Monday Option Activity: GPRE, YUMC, AMGN", "AbbVie (ABBV) Misses on Q4 Earnings & Revenues, Shares Down", "Amgen/Allergan's Rituxan Biosimilar Meets Goal in Phase III", "Health Care Sector Update for 01/25/2019: CHRS,AMGN,RMD,AZN,IDXG,ABBV", "Amgen 2019 forecast falls short of expectations, shares dip", "CVS to cover migraine drugs from Teva, Lilly; excludes Amgen", "Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?", "The Zacks Analyst Blog Highlights: Celgene, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and bluebird bio", "iShares U.S. Healthcare ETF Experiences Big Inflow", "Is a Surprise in the Cards for Novartis (NVS) in Q4 Earnings?", "Biotech Stock Roundup: Amgen, Vertex Get EC Nod for Label Expansion of Drugs", "Better Buy: Amgen vs. Johnson & Johnson", "See Which Of The Latest 13F Filers Holds Amgen", "What's in Store for Bristol-Myers (BMY) in Q4 Earnings?", "Biogen (BIIB) Q4 Earnings Coming Up: What's in the Cards?", "Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?", "Amgen (AMGN) Gains But Lags Market: What You Should Know", "Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod", "Notable ETF Outflow Detected - IBB, AMGN, ILMN, REGN", "Amgen's postmenopausal osteoporosis drug wins FDA panel backing", "Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive?", "What's in Store for Merck in 2019 After a Solid Run in '18?", "Here's Why You Should Invest in Illumina (ILMN) Stock Now", "Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan", "Noteworthy ETF Outflows: XLV, MRK, ABT, AMGN", "U.S. Supreme Court rejects Amgen over cholesterol medication patent fight", "Amgen a Top 25 Dividend Giant With 2.97% Yield (AMGN)", "U.S. top court rejects Amgen over cholesterol medication patent fight", "3 of the Top Big Pharma Stocks to Buy Now", "Here's Why bluebird bio Shares Got Knocked Down 19.3% in December", "Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan", "Teva Pharmaceutical Posting Strong Gain After Resolving Dispute With Amgen", "Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study", "Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019?", "Amgen (AMGN) Stock Moves -1.52%: What You Should Know", "Teva (TEVA) Ends Dispute with Amgen Over Generic Sensipar", "Better Buy: Gilead Sciences vs. Amgen", "Teva, Amgen Settle Dispute Over Teva's Generic Cinacalet HCl Product", "Forget GlaxoSmithKline, Eli Lilly Is a Better Big Pharma Stock", "Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?", "Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis", "QUAL, MA, MO, AMGN: Large Inflows Detected at ETF", "AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV", "3 Pharma Stocks Revving for Growth", "Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review", "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib", "Allergan Drops, Stops Textured Breast Implant Sales in Europe", "Merck's Keytruda Gets FDA Approval for Rare Skin Cancer", "The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte", "3 Top Healthcare Stocks to Buy in December", "Lilly's Shares Rise on Robust 2019 View, Dividend Hike", "Amgen (AMGN) Stock Moves -1%: What You Should Know", "Forget bluebird bio, Amgen Is a Better Biotech Stock", "Amgen And Molecular Partners Collaborate In Immuno-Oncology", "iShares MSCI World ETF Experiences Big Inflow", "Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma", "Teva Reports Positive Top-Line Data for Migraine Candidate", "Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018", "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know", "Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY", "Better Buy: Biogen vs. Amgen", "5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Gilead Sciences a Top Socially Responsible Dividend Stock With 3.4% Yield (GILD)", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018", "Amgen (AMGN) Gains But Lags Market: What You Should Know", "Why Arrowhead Pharmaceuticals Surged 11% Higher Today", "Pfizer's (PFE) Biosimilar of Avastin Gets Positive CHMP Nod", "Wall Street Heads For Higher Open as China's Trade Concessions Trigger Risk Rally", "Health Care Sector Update for 12/11/2018: OPRX,ITCI,ENTX,AMGN,RARX", "Health Care Sector Update for 12/11/2018: ITCI,ENTX,AMGN,RARX", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend", "Daily Dividend Report: AMGN, AES, ERIE, VTR, MRVL", "Noteworthy Friday Option Activity: KODK, AMGN, NYT", "Health Care Sector Update for 12/11/2018: ENTX, AMGN, ITCI, NVS, JNJ, PFE, MRK, ABT", "Wall Street Heads For Higher Open as China's Trade Concessions Trigger Risk Rally", "Health Care Sector Update for 12/11/2018: OPRX,ITCI,ENTX,AMGN,RARX", "FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate", "Amgen Reaches Analyst Target Price", "Monday's ETF Movers: XBI, XLV", "Amgen (AMGN) Gains As Market Dips: What You Should Know", "3 Big Stock Charts for Wednesday: Delta Air Lines, Amgen and Mondelez International", "Can Celgene and bluebird bio Survive a Two-Pronged Attack?", "Noteworthy Wednesday Option Activity: AMGN, V, KO", "5 Biotech Stocks to Scoop Up for Big Dividends", "Notable ETF Inflow Detected - SPYG, ABT, BKNG, AMGN", "4 Reasons Why Lilly is Up More Than 30% This Year So Far", "Roche, AbbVie Get FDA Approval for Venclexta Label Expansion", "Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Novartis (NVS) Receives EC Approval for Neulasta Biosimilar", "Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs", "Amgen (AMGN) Gains As Market Dips: What You Should Know", "Noteworthy ETF Outflows: SPYG, AMGN, TMO, LLY", "Lilly Offers Updates on Progress of Headache Disorder Drugs", "Merck's Keytruda Improves Survival in Esophageal Cancer Study", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018", "Roche's Tecentriq Gets Priority Review for Breast Cancer", "Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension", "Drug Pricing Resurfaces, Pfizer to Raise Cost of 41 Drugs", "Amgen (AMGN) Gains As Market Dips: What You Should Know", "Better Buy: Amgen Inc. vs. Pfizer Inc.", "6 Pharmaceutical Stocks to Buy After the Midterms", "Spectrum (SPPI) Earnings and Sales Beat Estimates in Q3", "Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View", "Stocks Hold Midterm Gains After Fed Statement", "Ex-Dividend Reminder: Aqua America, Amgen and Jones Lang LaSalle", "Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes", "3 Cancer Stocks to Watch in December", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 08, 2018", "The Zacks Analyst Blog Highlights: Amgen, Intercontinental Exchange, TOTAL S.A., Royal Dutch Shell and Williams", "5 Top Stocks to Make the Most of a Divided Congress", "7 Healthcare Stocks Soaring on Election Results", "Election Day 2018: Here Are the Winners & Losers", "Noteworthy ETF Outflows: XLV, AMGN, MDT, LLY", "3 Top Biotech Stocks With P/Es Below 14", "Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO", "Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise", "Radius Health (RDUS) Posts Narrower-Than-Expected Q3 Loss", "Notable Friday Option Activity: AAL, AMGN, QCOM", "The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals", "Biotech ETFs in Focus on String of Q3 Earnings Beat", "Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know", "The Zacks Analyst Blog Highlights: Facebook, Amgen and MGM Resorts International", "Community Health's (CYH) Q3 Loss Widens, Admissions Drop", "Pfizer (PFE) Beats on Q3 Earnings, Meets Sales, Narrows View", "Amgen Inc (AMGN) Q3 2018 Earnings Conference Call Transcript", "Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower", "Facebook Beats Q3 Estimates, Swings to Positive; Plus AMGN, MGM", "Amgen (AMGN) Q3 Earnings and Revenues Beat Estimates", "Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View", "The Zacks Analyst Blog Highlights: Facebook, Amgen and MGM Resorts International", "iShares Russell 1000 Growth ETF Experiences Big Inflow", "The Zacks Analyst Blog Highlights: Allergan, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and AMAG Pharmaceuticals", "This Big Pharma Bet Isn't Paying Off Yet -- and It's Costing You", "Amgen is Oversold", "What's in the Cards for Glaxo (GSK) This Earnings Season?", "Earnings Reaction History: Amgen Inc., 40.0% Follow-Through Indicator, 2.1% Sensitive", "Why Amgen (AMGN) Might Surprise This Earnings Season", "5 Drug/Biotech Stocks Likely to Beat Estimates in Q3 Earnings", "What's in the Cards for HCA Healthcare (HCA) in Q3 Earnings?", "Pfizer (PFE) to Report Q3 Earnings: What's in the Cards?", "Can Amgen (AMGN) Keep the Earnings Streak Alive in Q3?", "Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View", "Sarepta (SRPT) Q3 Earnings & Sales Miss, Exondys 51 Sales Up", "Anthem (ANTM) Q3 Earnings: What's in Store for the Stock?", "Why Amgen (AMGN) Might Surprise This Earnings Season", "Amgen (AMGN) Gains But Lags Market: What You Should Know", "Is a Beat in the Cards for Allergan (AGN) in Q3 Earnings?", "Incyte (INCY) to Report Q3 Earnings: What's in the Cards?", "Notable Wednesday Option Activity: AMTD, LAD, AMGN", "Daily Dividend Report: AMGN, MET, MCO, AMP, NEM", "Amgen (AMGN) Q3 Earnings Preview: What to Look Out For", "Has Amgen (AMGN) Outpaced Other Medical Stocks This Year?", "What's in Store for Celgene Corp. (CELG) Q3 Earnings?", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "What's in Store for Anika Therapeutics (ANIK) in Q3 Earnings?", "Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?", "Alexion (ALXN) to Report Q3 Earnings: What's in the Cards?", "Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates", "Better Buy: Biogen Inc. vs. Amgen Inc.", "4 High Dividend Stocks to Grow Profits", "Notable ETF Inflow Detected - SPYG, INTC, CMCSA, AMGN", "AMGN or ILMN: Which Is the Better Value Stock Right Now?", "Amgen (AMGN) Dips More Than Broader Markets: What You Should Know", "Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?", "Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS", "4 Strong Stocks to Buy That Double As Big Takeover Targets", "Immune Design to Halt Cancer Vaccine Program, Shares Plunge", "3 Dividend Stocks for Income", "AbbVie Settles With Novartis to Delay Humira Biosimilar in US", "Health Care Sector Update for 10/12/2018: APHB, TRVN, NVO, AMGN, MRK, ABT, PFE, JNJ", "Notable Friday Option Activity: WDC, AMGN, AXS", "J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings", "Validea Warren Buffett Strategy Daily Upgrade Report - 10/11/2018", "Validea Peter Lynch Strategy Daily Upgrade Report - 10/11/2018", "Thursday's ETF with Unusual Volume: PBE", "Top Ranked Income Stocks to Buy for October 15th", "Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus", "Bausch's Bryhali Gets Tentative FDA Nod for Plaque Psoriasis", "Kala Pharmaceuticals (KALA) Catches Eye: Stock Jumps 7.4%", "FDA Sets Action Date for Recro's Pain Management Candidate", "10 S&P 500 Stocks to Buy for the Long-Term", "5 Reasons Why Investors Should Bet on Merck (MRK) Stock", "Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?", "Here's Why bluebird bio Dropped 13.3% in September", "Roche (RHHBY) Presents Encouraging Data on SMA Drug Risdiplam", "Amgen Gets FDA Nod for Once-Weekly Regimen of Kyprolis Combo", "Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs", "The Zacks Analyst Blog Highlights: Chevron, Amgen, Thermo Fisher, Estee Lauder and Delta Air Lines", "Dr. Reddy's Sells Antibiotic Production Hub to UAE Drugmaker", "Is Amgen (AMGN) Stock Outpacing Its Medical Peers This Year?", "5 Breakout Stocks to Buy", "Roche's Hemlibra Receives FDA Approval for Label Expansion", "Roche (RHHBY) Presents Encouraging Data on SMA Drug Risdiplam", "Amgen Gets FDA Nod for Once-Weekly Regimen of Kyprolis Combo", "3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph", "Lilly's Migraine Drug Emgality Wins Positive CHMP Opinion", "Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again", "Mylan's Biosimilar of Neulasta Gets Positive CHMP Opinion", "Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status", "Eli Lilly (LLY) Gets FDA Nod for Migraine Drug Emgality", "November 9th Options Now Available For Amgen (AMGN)", "AbbVie Faces California Insurance Department Suit for Humira", "AstraZeneca's Fasenra Long-Term Asthma Study Data Positive", "Notable Wednesday Option Activity: PLAY, AMGN, CRR", "Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?", "The Zacks Analyst Blog Highlights: UnitedHealth, Adobe, Amgen, UPS and Bayer", "Is iShares Nasdaq Biotechnology ETF a Buy?", "Allergan Frown Lines Study Passes Test on Higher Botox Dose", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 9/16/2018", "Is Now a Good Time to Buy Amgen?", "Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Merck Gets Priority Review for Yet Another Keytruda sBLA", "Top Research Reports for UnitedHealth, Adobe & Amgen", "Regeneron/Sanofi's sBLA for Praluent to be Reviewed by FDA", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 13, 2018", "3 Small Biotech Stocks That Almost Doubled in Past Month", "Merck's Keytruda Combo Gets Nod for Lung Cancer in Europe", "3 Top Dividend Stocks to Buy Right Now", "Amgen Reaches Analyst Target Price", "Noteworthy Tuesday Option Activity: AMGN, RLGY, GRUB", "Why Amgen Will Likely Be a Boring Dividend Stock Over the Next Few Years", "AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status", "Pfizer's Skin Disease Drug Gets Breakthrough Therapy Status", "The Zacks Analyst Blog Highlights: Amgen, Puma Biotechnology, MannKind, United Therapeutics and Vertex Pharmaceuticals", "Merck's Keytruda Gets Priority Review for Rare Skin Cancer", "Biotech Stock Roundup: AMGN, PBYI Get EC Nod for Their Drugs, MNKD Soars", "Noteworthy Tuesday Option Activity: GM, AXP, AMGN", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "Noteworthy ETF Inflows: IWF, NVDA, AMGN, MO", "Biotech Stock Roundup: GILD Gets EC Nod for Yescarta, AMGN Submits Kyprolis sNDA", "Pfizer Stock Up This Year So Far: What's Going in its Favor?", "Amgen Files for Once-Weekly Regimen for Myeloma Drug Kyprolis", "5 Reasons Why You Should Add Lilly Stock to Your Portfolio", "Why Is Amgen (AMGN) Up 1.3% Since Last Earnings Report?", "Roche (RHHBY) Gets FDA Approval for Cobas EFGR Mutation Test", "3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them?", "Noteworthy ETF Outflows: IWF, NVDA, AMGN, MO", "Biotech Stock Roundup: GILD Gets EC Nod for Yescarta, AMGN Submits Kyprolis sNDA", "Trade of the Day: Amgen Is a Strong Stock in a Giddy Industry", "Is Amgen Inc. a Buy?", "5 Drug Stocks to Buy While the Pharma Sector Is on Sale", "Merck Gets FDA Nod for Keytruda Lung Cancer Label Expansion", "Amgen Stock Up This Year So Far: Will the Rally Continue?", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 16, 2018", "Notable Friday Option Activity: AMGN, ATVI, DIS", "Noteworthy Wednesday Option Activity: AMGN, TRN, AEO", "Allergan's (AGN) Stock Up 4.2% Since Q2 Earnings: Here's Why", "Top Research Reports: UnitedHealth, PepsiCo, Amgen & More", "Here's Why Merck (MRK) Stock is Up Since Q2 Earnings Release", "Ex-Dividend Reminder: Amgen, Allergan and South State", "Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings", "3 \u201cStrong Buy\u201d Stocks for the Week", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2018", "Why Amgen is a Top Socially Responsible Dividend Stock (AMGN)", "5 Companies Making Giant Buybacks", "Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.", "Radius (RDUS) Q2 Loss Narrower Than Expected, Tymlos Sales Up", "Ligand (LGND) Beats on Q2 Earnings & Revenues, Raises View", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "3 Healthcare Stocks to Buy for the Sector Rebound", "Spectrum (SPPI) Earnings and Sales Miss Estimates in Q2", "Is a Beat in Store for Radius Health (RDUS) in Q2 Earnings?", "Noteworthy Thursday Option Activity: SYNA, AMGN, IPI", "Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit", "Daily Dividend Report: ARCC, LFUS, VNOM, MAIN, AAPL, AMGN, SYK", "Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales", "Two Pharma Giants Successfully Navigate a Challenging Climate", "Amgen Inc.'s Young Lineup Offsets Enbrel Losses With Style", "Earnings Reaction History: Amgen Inc., 45.5% Follow-Through Indicator, 2.2% Sensitive", "After-Hours Earnings Report for July 26, 2018 : AMZN, INTC, AMGN, SBUX, EA, AFL, EW, LRCX, FTV, DFS, DLR, RSG", "Merck's Keytruda Improves Survival in Head/Neck Cancer Study", "Will Pfizer (PFE) Keep the Earnings Streak Alive in Q2?", "Is a Beat in Store for Keryx (KERX) This Earnings Season?", "Amgen (AMGN) to Report Q2 Earnings: Will it Beat Again?", "Amgen (AMGN) Q2 Earnings & Sales Beat Estimates, View Up", "Noteworthy ETF Outflows: IBB, BIIB, GILD, AMGN", "Biogen (BIIB) to Report Q2 Earnings: What's in the Cards?", "Can Eli Lilly (LLY) Keep the Earnings Streak Alive in Q2?", "AbbVie Settles With Mylan to Delay Humira Biosimilar in U.S.", "Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates", "Novartis Q2 Earnings Miss, Sales Top on Cosentyx, Entresto", "Roche's Flu Drug Meets Primary Endpoint in Phase III Study", "AbbVie's Stock Is a Bargain After Falling 8% Last Week", "Is a Surprise in the Cards for Novartis in Q2 Earnings?", "Pacira Focused on Exparel Development Amid Competition", "Better Buy: Biogen Inc. vs. Amgen", "Better Buy: Amgen Inc. vs. Johnson & Johnson", "Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?", "2 Overlooked Biotech Stocks to Buy Now", "Amgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity", "Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population", "Merck's Keytruda Gets FDA's Priority Review for Liver Cancer", "Noteworthy ETF Inflows: IBB, GILD, AMGN, BIIB", "3 Huge Biotech Winners in 2018 (So Far)", "Moving Average Crossover Alert: Amgen (AMGN)", "Amgen Reaches Analyst Target Price", "Why Amgen is a Top 25 Dividend Giant (AMGN)", "Zacks Industry Outlook Highlights: Amgen, ANI and Illumina", "August 31st Options Now Available For Amgen (AMGN)", "Why Biotech Stocks Rallied on Biogen's Alzheimer's Test", "Here's Why AbbVie Stock is Good for Your Portfolio's Health", "Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More", "Biotech Stock Outlook: Short-Term Pricing Pain to Prevail", "IBB, GILD, AMGN, BIIB: Large Outflows Detected at ETF", "Merck's Keytruda Gets Priority Review in Difficult Lung Cancer", "Should Value Investors Consider Amgen (AMGN) Stock Now?", "Notable Friday Option Activity: AMGN, FAST, BGS", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "Better Buy: Amgen Inc. vs. Pfizer Inc.", "4 Biotech Stocks to Bet on in the Second Half of 2018", "5 Cheap Large Cap Stocks to Buy Now", "Mylan, Lupin Collaborate for the Proposed Biosimilar Enbrel", "Amgen Announces Top-Line Data From Remicade Biosimilar Study", "The Zacks Analyst Blog Highlights: Facebook, Amgen, Abbott, Coca-Cola and 3M", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "4 Drug and Biotech Stocks Awaiting FDA Decisions in July", "Merck's Keytruda Under FDA Review for Advanced Melanoma", "Top Stock Reports for Facebook, Amgen & Abbott", "Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes", "Roche's (RHHBY) Study on Tecentriq for Lung Cancer Positive", "Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines", "Merck (MRK) Stock Up So Far This Year on Keytruda Strength", "Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod", "Amgen Gets EU Nod to Add Survival Data on Blincyto's Label", "Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash", "Teva to Discontinue a Fremanezumab Study on Cluster Headache", "10 Top Stock Picks From Wall Street's Best Analysts", "Noteworthy Friday Option Activity: NKE, APC, AMGN", "Roche Announces Positive Data on Gazyva and MS Drug Ocrevus", "Allergan (AGN) Presents Positive Data on Glaucoma Candidate", "XLV, ABBV, AMGN, MDT: ETF Outflow Alert", "Roche's (RHHBY) Avastin Gets Label Expansion Approval by FDA", "Notable ETF Inflow Detected - XLV, ABBV, AMGN, MDT", "Merck's (MRK) Keytruda Gets FDA Approval for Cervical Cancer", "Biotech Stock Roundup: AXON Soars, Amgen Drugs Get FDA, EC Nod", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2018", "Humira's Sales Will Decline -- and It's Fantastic News for AbbVie", "Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study", "Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication", "Roche's (RHHBY) Avastin Gets Label Expansion Approval by FDA", "JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space", "Roche Rituxan Label Expanded by FDA for Pemphigus Vulgaris", "Biotech Stock Roundup: Regeneron, Celgene, Amgen Impress at ASCO", "Merck Presents Positive Melanoma Data on Keytruda at ASCO", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Mylan (MYL) Gets FDA Approval for Biosimilar of Neulasta", "Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label", "Eli Lilly's Olumiant Gets FDA Nod for Rheumatoid Arthritis", "Merck's (MRK) Keytruda Lung Cancer Data in Focus at ASCO", "Biogen Inc Stock Got an Upgrade, but Should You Listen?", "Novartis Announces Positive Data on Kisqali and Tasigna", "Is Amgen Inc. (AMGN) a Buy?", "3 Reasons Gilead Sciences Is a Better Value Stock Than Amgen", "Notable Friday Option Activity: TRIP, MAR, AMGN", "Watch Out Amgen, Here Comes Mylan", "July 6th Options Now Available For Amgen (AMGN)", "Why Is Amgen (AMGN) Up 3.7% Since Its Last Earnings Report?", "Merck's Keytruda Shows Survival Benefit in Squamous NSCLC", "3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More", "Is This Little Biotech the Best Migraine Stock to Buy Now?", "FDA Confirms September Action Date for Teva's Migraine Drug", "Trade of the Day: Amgen, Inc. Clears a Breakout Hurdle", "Allergan Stock Down Since Q1 Earnings Report: Here's Why", "Noteworthy ETF Inflows: DGRO, AMGN, MDT, BMY", "Biotech Stock Roundup: FDA Gives Nod to Amgen's Drugs, EU Approves Exelixis' Cabometyx", "Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN", "Amgen's Label Expansion Application for Prolia Gets FDA Nod", "Company News For May 21, 2018", "Migraine Space in Focus as AMGN/NVS' Aimovig Gets FDA Nod", "Novartis Gets Approval for Remicade Biosimilar in Europe", "Intraday Update: Small Caps Keep the Faith, Blue Chips Blue in the Face", "Amgen's Migraine Drug Aimovig Gets FDA Approval, Shares Up", "Health Care Sector Update for 05/18/2018: AMRX,VLRX,AMGN,NVS,AZN", "Health Care Sector Update for 05/18/2018: VLRX,AMGN,NVS,AZN", "XLV, MRK, AMGN, GILD: ETF Inflow Alert", "Amgen's (AMGN) Repatha Gains EU Nod to Include Outcomes Data", "Why Spectrum Pharmaceuticals, Inc. Is Up Big Today", "Roche (RHHBY) Announces Positive Data on Hemophilia Drug", "Eli Lilly's Cluster Headache Candidate Succeeds in Phase III", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2018", "Better Buy: Amgen Inc. vs. Biogen Inc.", "Ex-Dividend Reminder: Eli Lilly, Amgen and Simon Property Group", "Noteworthy Monday Option Activity: XRX, ALGN, AMGN", "Radius Health (RDUS) Incurs Narrower-Than-Expected Q1 Loss", "Trump Announces Plan to Reign In Drug Prices and Pharma Stocks Rally.", "Pfizer Gets FDA Nod for Amgen, J&J's Anemia Drug Biosimilar", "Eli Lilly's Cluster Headache Candidate Succeeds in Phase III", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2018", "Better Buy: Amgen Inc. vs. Biogen Inc.", "Ex-Dividend Reminder: Eli Lilly, Amgen and Simon Property Group", "Are These Disappointing Drugs Back on Track to Billions?", "Spectrum (SPPI) Earnings and Sales Beat Estimates in Q1", "The Zacks Analyst Blog Highlights: Apple, ExxonMobil, Citigroup and Amgen", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2018", "Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1", "XLV, MRK, AMGN, GILD: Large Outflows Detected at ETF", "Nasdaq 100 Movers: STX, SWKS", "Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Roche (RHHBY) Q1 Earnings: Ocrevus, Perjeta Drive Sales Beat", "This Clinical-Stage Biotech's Tackling a Huge Health Issue, but It Has to Overcome Pessimistic Investors First", "Top Analyst Reports for Apple, ExxonMobil, Citigroup & Amgen", "Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1", "XLV, MRK, AMGN, GILD: Large Outflows Detected at ETF", "Nasdaq 100 Movers: STX, SWKS", "Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat", "Is a Beat in Store for Vertex (VRTX) This Earnings Season?", "Better Buy: Amgen Inc. vs. Celgene", "Company News for Apr 26, 2018", "After-Hours Earnings Report for April 24, 2018 : AMGN, TXN, CB, COF, ILMN, EW, EQR, WYNN, BXP, MKL, TSS, PKG", "Eli Lilly And Co Produced a Monstrous Q1 Beat, But Is It Enough?", "Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN", "Mylan NV Still Undervalued Despite Unveiling of New Products", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Amgen (AMGN) to Report Q1 Earnings: Is a Beat in the Cards?", "What's in Store for Biogen (BIIB) This Earnings Season?", "Amgen, Inc. (AMGN) Beats Q1 Estimates, Posts Weak F18 Guidance", "3 Stocks You Can Safely Own Until 2030", "Mylan NV Could Be Closer to a Breakout Than Most Traders Realize", "Big Biotech ETF Can Bounce Back", "Amgen's Aimovig Reduces Episodic Migraine in 30% Patients", "7 Retirement Stocks for the Coming Correction", "Roche Hemophilia Drug Gets Breakthrough Therapy Designation", "What's in Store for Novartis (NVS) This Earnings Season?", "J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?", "J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store?", "Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar", "Merck's Keytruda Offers Survival Benefit in Lung Cancer Study", "4 Drug/Biotech Stocks to Buy Ahead of World Health Day", "Novartis Announces Data on Cardiovascular Drug Entresto", "Lilly's Cyramza Shows Survival Benefit in Liver Cancer Study", "Biotech Stock Roundup: EDGE Falls, ALKS Down, FDA OK's AMGN Drug Label Expansion", "XLV, PFE, MRK, AMGN: ETF Inflow Alert", "Morning Movers: Tesla---and the Markets---Are Back on Solid Ground", "Amgen's (AMGN) Xgeva Gets EU Approval for Expanded Label", "Better Dividend Stock to Buy: AbbVie Inc. vs. Pfizer Inc.", "Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease", "Peek Under The Hood: RSP Has 14% Upside", "Better Buy: Biogen Inc. vs. Amgen Inc.", "The Zacks Analyst Blog Highlights: Verona, Squibb, Protagonist and Amgen", "Rigel (RIGL) Sinks on Failure of Mid-Stage Study on Lead Drug", "Results Renew Optimism for Esperion Therapeutics", "5 Biotech Stocks With Amazing Pipelines", "Amgen's Repatha Gains CHMP Nod to Include Outcomes Data", "Novartis Gets Positive CHMP Opinion on Biosimilar Remicade", "Merck, Eisai Get Japanese Nod for Lenvima Label Expansion", "iShares Core High Dividend ETF Experiences Big Outflow", "Celgene Corporation Looks Cheap, Considering Its Potential", "Biotech Stock Roundup: PTGX Down, VRNA Up, AMGN's Repatha Gets Positive Opinion", "The Zacks Analyst Blog Highlights: Amgen, FedEx, Thermo Fisher, Sherwin-Williams and Ameriprise", "Stemline Therapeutics Inc Stock Investors Are Betting, Not Investing", "Roche's (RHHBY) Lucentis 0.3 mg PFS Receives FDA Approval", "Notable Two Hundred Day Moving Average Cross - AMGN", "Better Buy: Amgen Inc. vs. Gilead Sciences, Inc.", "Radius Health Announces Positive Data on Lead Drug Tymlos", "Despite Struggles Celgene Corporation Stock Is Still A Buy", "Radius Health Down on Negative CHMP Opinion for Lead Drug", "5 Must-See Quotes From AbbVie's Management", "Merck's Keytruda Gets Priority Review for Cervical Cancer", "IBB, AMGN, GILD, REGN: ETF Outflow Alert", "Is Amgen Inc. (AMGN) a Great Stock for Value Investors?", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 15, 2018", "Bull of the Day: Regeneron (REGN)", "The Amgen, Inc. Stock Spring Is About to Pop", "3 Top Biotech Stocks to Buy Right Now", "Regeneron Takes Aim at Amgen and Esperion Therapeutics", "Regeneron and Sanofi Announce Positive Data on Praluent", "Why Coherus Biosciences Is Skyrocketing Today", "Merck to Pay $300M Upfront to Co-Develop Eisai's Cancer Drug", "Daily Dividend Report: GD, CL, MTN, HMN, PM, AMGN, DVN", "Spectrum (SPPI) Q4 Loss Widens Y/Y, Sales Miss, Stock Falls", "Wednesday\u2019s Vital Data: Alibaba Group Holding Ltd (BABA), Amgen Inc. (AMGN) and Advanced Micro Devices, Inc. (AMD)", "Amgen Stock Split History", "Noteworthy ETF Outflows: IWB, AMGN, GILD, UTX", "3 Top Biotech Stocks to Buy in March", "Notable Tuesday Option Activity: AMGN, NFLX, AMZN", "Interesting AMGN Put And Call Options For May 18th", "10 Companies Making Huge Stock Buybacks in 2018", "Radius (RDUS) Q4 Loss Wider Than Expected on Higher Expenses", "After Hours Most Active for Mar 2, 2018 : F, FE, ORCL, BAC, TEVA, AMGN, FTR, QCOM, GE, QQQ, MSFT, CSX", "Why Esperion Therapeutics' Shares Fell Despite Its Good News", "Biotech ETFs Head to Head: XBI vs. IBB.", "Notable Thursday Option Activity: AMGN, KFY, TAST", "Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo", "3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018", "3 Top Pharma Stocks With Dividend Yields Over 3%", "Radius Health (RDUS) to Disappoint Investors in Q4 Earnings?", "IUSG, MCD, ABT, AMGN: ETF Inflow Alert", "Amgen (AMGN) Gets CHMP Nod to Expand EU Label of Neulasta", "Health Care Sector Update for 02/23/2018: AMGN,PBYI,BLCM,PFE", "Ligand (LGND) Q4 Earnings & Revenues Top, 2018 View Solid", "Is Amgen Inc. a Buy?", "The Zacks Analyst Blog Highlights: Amgen, TOTAL, Marriott, PG&E and Vertex", "Notable Wednesday Option Activity: DDD, ALGN, AMGN", "Novartis Psoriasis Drug Cosentyx Positive in SCALP Study", "Validea's Top Five Healthcare Stocks Based On Benjamin Graham - 2/18/2018", "Health Care Sector Update for 02/23/2018: BLCM, PFE, PBYI, AMGN, 4507:JP", "AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan", "VYM, GE, MCD, AMGN: Large Inflows Detected at ETF", "Did AbbVie, Inc. Just Become the Most Shareholder-Friendly Stock in America?", "3 Tough Questions for Amgen", "Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth?", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2018", "Roche's Rituxan Gets Priority Review for Label Expansion", "Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion", "3 Dividend Stocks for In-the-Know Investors", "Is Agenus Inc. a Buy?", "Trade of the Day: Amgen, Inc. Remains a Promising Biotechnology Play", "Ex-Dividend Reminder: Amgen, Primerica and Monmouth Real Estate Investment", "Better Buy: Amgen Inc. vs. Celgene", "Forget Amgen -- Cara Therapeutics, Inc. Is a Better Growth Stock", "Novartis' Cosentyx Label Expanded to Include Scalp Psoriasis", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2018", "Roche Reports Positive Data From Tecentriq-Avastin Study", "Amgen Breaks Below 200-Day Moving Average - Notable for AMGN", "Noteworthy Tuesday Option Activity: WYN, AMGN, MON", "Amgen Q4 Earnings Results: 2 Things to Hate and 2 Things to Like", "Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft", "Roche (RHHBY) Posts Solid 2017 Sales on Tecentriq & Alecensa", "Amgen Topples After Fourth-Quarter Sales, Earnings Lag", "Spectrum Pharma's Rolontis Positive in Pivotal Cancer Study", "Earnings Reaction History: Amgen Inc., 40.0% Follow-Through Indicator, 2.3% Sensitive", "After-Hours Earnings Report for February 1, 2018 : AAPL, AMZN, GOOGL, V, AMGN, EW, MSI, EMN, FBHS, XL, CPT, AIV", "Amgen Gets CHMP Nod to Add ENDEAVOR Data on Kyprolis Label", "Why Earnings Season Could Be Great for Amgen (AMGN)", "VTV, GE, AMGN, ABT: ETF Inflow Alert", "Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat", "Roche Gets Breakthrough Therapy Designation For ASD Drug", "Validea John Neff Strategy Daily Upgrade Report - 2/1/2018", "AMGN Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 2.7% Yield", "AMGN October 19th Options Begin Trading", "Will Amgen (AMGN) Benefit From Growth Drugs in Q4 Earnings?", "Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors", "Roche Hemophilia Drug Hemlibra Gets Positive CHMP Opinion", "Why Dividend Investors Want to Own AbbVie in 2018", "Novartis Gets Spark Therapeutics' Luxterna License Outside US", "Meredith (MDP) Hikes Dividend 4.8% Just Ahead of Q2 Earnings", "Why Amgen is a Top Socially Responsible Dividend Stock (AMGN)", "Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto", "Amgen's Migraine Drug Hits Primary Endpoint in Phase IIIb", "Amgen Reaches Analyst Target Price", "Biotech M&A Off to a Strong Start in 2018: More Deals to Follow?", "Novartis Announces Positive Results on Migraine Candidate", "Here's Why AbbVie's Stock Is Skyrocketing 12.6% Today", "What's in the Cards for Novartis (NVS) This Earnings Season?", "The Zacks Analyst Blog Highlights: UnitedHealth, Amgen, United Technologies, CSX and General Dynamics", "The Ideal Stock Evaluation System?", "Noteworthy ETF Outflows: IWB, AMGN, GILD, ABT", "What to Expect From Amgen, Inc. in 2018", "Amgen/Allergan's Avastin Biosimilar Secures EU Approval", "Stocks Up, As Shutdown Vote Looms; Halliburton Breaks Out", "Here's Why Nektar Stock Skyrocketed Almost 500% in a Year", "The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis", "Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label", "Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?", "Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock", "Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News", "Will 2018 Be Amgen Inc.'s Best Year Yet?", "Spectrum Pharmaceuticals Up 134% in 6 Months: Here's Why", "Will Amgen (AMGN) Continue to Tread Growth Path This Year?", "Novartis (NVS) Announces Acceptance of Humira BLA by the FDA", "How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines", "XLV, MRK, AMGN, GILD: ETF Outflow Alert", "The Zacks Analyst Blog Highlights: Celgene, Amgen, Exelixis, Alexion and Vertex", "Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?", "Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally", "5 Big Biotech Stocks To Buy In 2018", "Here's What AbbVie's Management Just Said About Its Future", "Here's Why Arrowhead Pharmaceuticals Inc. Is Up Today", "Apple, Microsoft May Get Big Tax Break \u2014 For Having Unusual Calendars", "June 2019 Options Now Available For Amgen (AMGN)", "Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar", "Humana Extends Contract With Tivity Health, Spurs Healthcare", "Merck's Keytruda Combo Gets Breakthrough Therapy Status", "AstraZeneca's Asthma Drug Benralizumab Gets Approval in EU", "Amgen Announces Acceptance of MAA for Evenity in Europe", "Merck's (MRK) Keytruda Succeeds in High-Risk Melanoma Study", "5 Things Amgen's CEO Just Said That Investors Need to Know", "Is AbbVie Stock Still A Strong Buy?", "Amgen's (AMGN) Xgeva Gets FDA Approval for Multiple Myeloma", "2 Top Dividend Stocks to Buy in 2018", "Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ)", "Key Biosimilar Approvals in 2017: Progress Report", "ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632", "XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF", "Can AbbVie (ABBV) Stock Keep the Momentum Alive in 2018?", "3 Large-Cap Pharma Stocks to Watch Out for This New Year", "3 Biotech Stocks to Buy in January", "Why These 2 Biotechs Could Outperform Amid 'Hyper-Competition'", "3 Big Biotech Stocks to Buy in January", "Another Reason 2018 Might Not Be A Banner Year For Biotech Mergers", "iShares Russell 1000 Value ETF Experiences Big Inflow", "Here's How AbbVie Inc. Crushed It in 2017", "Why is Nektar (NKTR) Stock Up More Than 350% This Year?", "Spectrum Pharma Dismisses CEO, Makes Leadership Changes", "The 5 Best-Selling Drugs of 2017", "Radius Health to Get Third Day-180 List of Outstanding Issues", "The One Safe Way to Get a 55.8% Dividend Yield", "3 Top Dividend Aristocrats to Buy for 2018", "3 Attractive Income Stocks Whose Dividends Could Double", "Beware: Price Wars For Big Pharma, Biotech Companies On Horizon", "Merck's Keytruda Misses Primary End Point for Gastric Cancer", "Pfizer's Arthritis Drug Gets FDA Nod for Label Expansion", "How the 10 Top-Yielding Nasdaq Dividend Stocks Can Boost Your Portfolio", "AMGN Dividend Yield Pushes Past 3%", "10 More Retirement Stocks to Buy and Hold for the Rest of Your Life", "3 Top Dividend Aristocrats to Buy for 2018", "3 Attractive Income Stocks Whose Dividends Could Double", "Beware: Price Wars For Big Pharma, Biotech Companies On Horizon", "Roche/AbbVie Report Positive Phase III Results on Venclexta", "Jim Simons: Pioneer Quant Manager", "3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise", "Roche Reports Positive Data from Tecentriq Combination Study", "Daily Dividend Report: AMGN, BEN, WDFC, O, XRAY", "Sanofi Begins Combo Studies on Multiple Myeloma Candidate", "IWD, PM, MDT, AMGN: Large Inflows Detected at ETF", "AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan", "Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data", "Roche's Avastin Gets Full FDA Approval for Brain Cancer", "AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study", "Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest", "Here's Why Radius Health Is Rising Today", "How Biotechs, Drugmakers Would Fare Under The Senate's Tax Bill", "Amgen, Regeneron Prep For Battle In 2018 Over Cholesterol Drugs", "Why Amgen Could Have An Edge Over These Rivals In Preventing Migraines", "AbbVie Stock Up More Than 30% So Far in 2H17: Here's Why", "5 Biotech and Pharma Stocks with FDA Catalysts this December", "Noteworthy Thursday Option Activity: HCA, AMGN, FFIV", "Why Medicines Co. Is Tumbling Despite $270 Million Deal", "Amgen's PCSK9 Inhibitor Gets FDA Nod for Stroke Prevention", "How Biotechs, Drugmakers Would Fare Under The Senate's Tax Bill", "Will New Drug Approvals Boost Novartis (NVS) Portfolio?", "Nektar (NKTR) Stock Up More than 300% This Year: Here's Why", "J&J Seeks Darzalex's Label Expansion in First-Line Setting", "Bet on Biogen Inc for Easy Profits Into the New Year", "Why Coke Could Be the Next GE (and 1 Stock to Buy Instead)", "Bullish Two Hundred Day Moving Average Cross - AMGN", "Marco Investment Management Llc Buys DowDuPont Inc, Apple Inc, JPMorgan Chase, Sells E.I. ...", "AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA", "Two Sigma Advisers, Llc Buys DowDuPont Inc, Pfizer Inc, Caterpillar Inc, Sells E.I. ...", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16, 2017", "Sum Up The Parts: XLV Could Be Worth $90", "Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer", "Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US", "Ex-Dividend Reminder: U.S. Physical Therapy, Allergan and Amgen", "Novartis (NVS) Arm's Biosimilars Study Results Encourage", "Amgen Gets Positive CHMP Opinion to Expand Nplate's Label", "Ligand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised", "XLV, MRK, ABBV, AMGN: ETF Outflow Alert", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 09, 2017", "3 ETFs to Watch on Biotech Earnings", "Amgen is Oversold", "Ex-Dividend Reminder: U.S. Physical Therapy, Allergan and Amgen", "Novartis (NVS) Arm's Biosimilars Study Results Encourage", "Looking For Great Stocks? First Use A Checklist To Identify Great Bases", "IWD, MRK, WMT, AMGN: ETF Inflow Alert", "Biotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts", "Pfizer (PFE) Beats on Q3 Earnings, Raises 2017 EPS View", "Here's Why Insulet Corporation's Investors Are Pumped", "AMGN Named 'Top Dividend Stock of the Nasdaq 100' at Dividend Channel With 2.6% Yield", "The Zacks Analyst Blog Highlights: Amgen, Comcast, McDonald's, Waste Management and BB&T", "A Me-Too Push By Biopharma Is Crowding the Psoriasis Market", "AbbVie (ABBV) Q3 Earnings Top, Revenues In Line, View Up", "BioMarin (BMRN) Q3 Loss Narrows, Profit Guidance Raised", "Will Radius Health (RDUS) Disappoint This Earnings Season?", "AbbVie: The Dividend Does It?", "Pfizer Inc. Stock Is Boring, and That\u2019s Perfect", "Buy the Dip in Amgen, Inc. While Wall Street Fears It", "Amgen (AMGN) Q3 Earnings Top, Sales Decline Y/Y, Stock Falls", "Bristol-Myers: More Bad Medicine for the Market", "Key Predictions for Q3 Earnings Reports of ABBV, MRK", "Futures Trending Higher as Earnings Give Hope, ECB Extends Asset Purchase Program", "Trade of the Day: Amgen, Inc. Nears a Buy Point Again", "3 Value Stocks at 52-Week Highs Still Worth Buying", "What's Behind Amgen's Q3 Revenue Decline", "Three Biotech Firms Top Third-Quarter Views \u2014 But Only One Pops", "Earnings Reaction History: Amgen Inc., 54.5% Follow-Through Indicator, 2.8% Sensitive", "After-Hours Earnings Report for October 25, 2017 : AMGN, SU, LVS, NXPI, VRTX, PSA, AFL, DLR, NOW, WCN, ABX, ORLY", "Notable Wednesday Option Activity: AMGN, LUV, TRIP", "Daily Dividend Report: BAC, WFC, AMGN, MPC, TXT, MET", "Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up", "3 Stocks to Watch on Thursday: Amgen, Inc. (AMGN), Buffalo Wild Wings (BWLD) and Las Vegas Sands Corp. (LVS)", "What's Behind Amgen's Q3 Revenue Decline", "Three Biotech Firms Top Third-Quarter Views \u2014 But Only One Pops", "Earnings Reaction History: Amgen Inc., 54.5% Follow-Through Indicator, 2.8% Sensitive", "Boeing, Grubhub, Nike, Glaxo, Amgen, Visa Lead Investing Action Plan", "Health Care Sector Update for 10/23/2017: JNJ, PFE, ABT, MRK, AMGN, TIG, AZN", "IBD's No. 1 Group Under Pressure; These 6 Key Earnings Loom; S&P 500 Futures", "10 More Retirement Stocks to Buy and Hold for the Rest of Your Life", "IWD, MRK, WMT, AMGN: ETF Inflow Alert", "Oakbrook Investments Llc Buys Starbucks Corp, Biogen Inc, DowDuPont Inc, Sells The Western ...", "Teva Submits BLA to FDA for Migraine Candidate Fremanezumab", "Merriman Wealth Management, LLC Buys Vanguard S&P 500, PowerShares FTSE RAFI US 1500 ...", "3 Top Stocks Billionaires Love", "2 Great Stocks For Retirees", "What's in the Cards for Novartis (NVS) This Earnings Season?", "What's in the Cards for Amgen (AMGN) this Earnings Season?", "Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen", "ImmunoGen to Push Leukemia Candidate into Phase I Trial", "Noteworthy ETF Inflows: IWD, WMT, AMGN, SLB", "Celgene Blood Cancer Treatment: Just The Tip Of Its Disruptive Science?", "Trump Likely To Sign Executive Order On Drug Pricing 'Any Day'", "Edmp, Inc. Buys Tanger Factory Outlet Centers Inc, CVS Health Corp, Penske Automotive Group ...", "Better Buy: AbbVie Inc. vs. Merck", "How Allergan's 'Public Relations Backlash' Deepened This Week", "Dubuque Bank & Trust Co Buys Heartland Financial USA Inc, Vanguard Total Stock Market, ...", "3 Stocks for Baby Boomers to Reach Their Goals", "Mylan Gets Complete Response Letter For Biosimilar Neulasta", "Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit", "How Safe Is AbbVie's Dividend?", "Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down", "Amgen Label Expansion Application for Prolia Accepted by FDA", "Why 2017 Could Be This Stock's Best Year Yet", "Forget Teva (TEVA), Buy These 5 Drug Stocks Instead", "Cancer Space Last Week Update: Pipeline Expansion in Focus", "3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now", "AbbVie's Fast Becoming a Top Stock to Buy Now", "3 Blockbuster Drugs That Still Cost More Than They Should", "This Dirt-Cheap Biotech Stock Is a Bargain to Buy", "Notable ETF Inflow Detected - IWD, MRK, WMT, AMGN", "Amgen Wins Reprieve on Its 2nd-Best-Selling Drug", "Regeneron and Sanofi Get Favorable Ruling Against Amgen", "Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now?", "3 Top Stocks Wall Street Insiders Love", "Marshwinds Advisory Co Buys DowDuPont Inc, BHP Billiton, Enbridge Inc, Sells E.I. ...", "Why Regeneron's Patent Win Is Worse For Amgen Than You Think", "Regeneron Pops After Judge Tosses Ban On Amgen-Rivaling Med", "AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why", "Health Care Sector Update for 10/06/2017: JNJ, PFE, ABT, MRK, AMGN, KDMN", "Stocks With Rising Relative Strength: Amgen", "Amgen Enters Into an Immuno-Oncology Partnership With CytomX", "Wall Street's Winning Streak Pauses; Private Sector Hiring Slows", "Health Care Sector Update for 10/04/2017: CTMX,AMGN,MYL,TEVA,RIGL", "Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation", "Close Update: Wall Street Extends Winning Streak With New Record Highs", "Health Care Sector Update for 10/04/2017: SBBP,CTMX,AMGN,CLSN", "3 Big Pharma Stocks Set to Succeed", "Health Care Sector Update for 10/04/2017: RIGL,CTMX,AMGN,CLSN", "Midday Update: U.S. Stocks Turn Positive After Tillerson Denies Plans to Resign", "CytomX Breaks Out On Mash-Up With Amgen In Immuno-Oncology", "3 Top-Ranked Big Biotech Stocks to Buy Now", "Why Shares in AbbVie Soared 18% in September", "3 Dividend Stocks Should Thrive in a Recession", "Notable Tuesday Option Activity: AMGN, AMD, PAYX", "Amgen, CytomX Join in Immuno-Oncology Collaboration", "AbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk", "AbbVie Stock Upgraded: What You Need to Know", "AbbVie: Better Late Than Never", "Radius (RDUS) Enrols First Patient in Breast Cancer Study", "How Good Is AbbVie's Humira Deal With Amgen?", "How Will Trump\u2019s Proposed Tax Reform Impact Drug Companies?", "AbbVie, Amgen Resolve Humira Patent Dispute", "Why This Biotech Suffered A 2-Day Headache On Rare-Disease Trial", "Why BlackBerry, AbbVie, and bluebird bio Jumped Today", "Biotechs Beating The Market, But Are They In Buy Range?", "Biotech Stocks To Watch And Pharma Industry News", "Why Amgen's Drug Win Sent AbbVie Stock Into The Stratosphere", "Noteworthy ETF Inflows: FVD, BMS, AMGN, CMI", "Trade of the Day: Amgen, Inc. (AMGN) Stock Has Plenty More Upside", "Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues", "Sanofi Rides on Genzyme & Vaccines Unit, Diabetes Sales Weak", "Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake", "Noteworthy Thursday Option Activity: AMGN, FFIV, EBIX", "4 Sell-Ranked Biotech Stocks with Falling Estimates to Avoid", "Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook", "Novartis Poised to Grow on Oncology Portfolio & Biosimilars", "iShares Russell 1000 Value ETF Experiences Big Inflow", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Merck's Keytruda Gets FDA Nod for Advanced Gastric Cancer", "3 Great Income Stocks That Could Double Their Dividends", "SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI", "Amgen/Allergan's Avastin Biosimilar Secures FDA Approval", "3 Reasons Why Gilead Sciences Stock Is a Buy Now", "Top Research Reports for Philip Morris, Amgen & Union Pacific", "A Biosimilar Cure for Sky-High Cancer Drug Prices", "Biosimilar 2017 Progress Report: Stocks in Focus", "Novartis Announces Positive Data on Urticaria Drug Xolair", "4 Biotech Stocks for the Long-Term", "Amgen Reaches Analyst Target Price", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2017", "5 Compelling Reasons Why AbbVie's Dividend Will Keep on Growing", "Novartis' BLA for Biosimilar of Rituxan Accepted by the FDA", "Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock", "AbbVie's RA Candidate Meets Primary Endpoint in Phase III", "Noteworthy Thursday Option Activity: AMGN, RCL, CVX", "3 Things Amgen Inc.'s Management Just Said That You'll Want to Know", "Interesting AMGN Put And Call Options For January 2020", "TQQQ, AMGN, KHC, PCLN: ETF Outflow Alert", "Amgen/AstraZeneca Asthma Candidate Tezepelumab Shows Promise", "AstraZeneca's COPD Candidate Duaklir Reports Positive Data", "Noteworthy Thursday Option Activity: AMGN, CVX, CMCSA", "Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer", "5 Things Regeneron's CEO Said as the Biotech Stock Sank", "Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data", "The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500", "Key FDA Regulatory Events to Watch Out for in Sep 2017", "Amgen Gets EU Nod to Expand Hyperparathyroidism Drug Label", "Noteworthy ETF Outflows: TQQQ, AMGN, KHC, PCLN", "The Smart Money Likes These 5 Stocks", "Immunogen Inks Deal With Jazz Pharma to Develop ADC Molecule", "Ligand (LGND) Diabetes Candidate Positive in Phase II Study", "Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data", "3 Dividend Stocks That Thrive in Market Crashes", "3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock", "Why I Love AbbVie Inc.", "Is the System Rigged Against Biosimilars?", "Biogen's Humira Biosimilar Imraldi Gets Approval in EU", "Amgen (AMGN) Down 6.4% Since Earnings Report: Can It Rebound?", "Why Tiny Organovo Is Giving Money to Huge Biotech Amgen", "Amgen Presents New Repatha Analysis from FOURIER Study", "3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences", "Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe", "4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings", "What Will Drive Regeneron Pharmaceuticals' Growth Higher From Here?", "3 Large-Cap Biotech Stocks to Scrape From the Selloff", "The Netherlands Is Taking Aim at One of America's Fastest-Growing Sectors", "Can Sanofi (SNY) Sustain the Solid 1H Momentum in 2H17?", "Amgen in Collaboration With Humana for Patients' Benefit", "Noteworthy ETF Inflows: TQQQ, GOOG, AMGN, BIIB", "Chiron Investment Management, LLC Buys iShares iBoxx $ Investment Grade Corporate Bond, Gilead ...", "Can Ligand's Captisol Deals Boost Growth in the Long Run?", "Are Amgen's New Drugs Doing Well Enough to Drive Sales?", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 16, 2017", "The Zacks Analyst Blog Highlights: Disney, Amgen, Caterpillar, S&P Global and Emerson Electric", "Add Up The Parts: PWV Could Be Worth $39", "Profund Advisors Llc Buys Baker Hughes Inc, NextEra Energy Inc, Duke Energy Corp, Sells ...", "Schwartz Investment Counsel Inc Buys Hexcel Corp, Cognizant Technology Solutions Corp, ...", "Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Quiet Bull", "Graham Disciple Charles Brandes' 5 Largest 2nd Quarter New Buys", "Here's Why Coherus Biosciences Rose as Much as 22.2% Today", "Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised", "XLV, UNH, MRK, AMGN: ETF Inflow Alert", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2017", "Here's Why Array BioPharma Inc. Fell 13.7% in July", "Radius (RDUS) Q2 Loss Wider than Expected on Higher Expenses", "Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down", "Health Care Sector Update for 08/03/2017: JNJ, PFE, ABT, MRK, AMGN, REGN, TEVA", "Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales", "Noteworthy ETF Outflows: XLV, AMGN, AET, ANTM", "Sanofi (SNY) Q2 Earnings In Line, Sales Lag,'17 View Raised", "Ray Gerald L & Associates Ltd Buys Norfolk Southern Corp, Splunk Inc, ONEOK Inc, Sells ...", "Health Care Sector Update for 07/28/2017: JNJ, PFE, ABT, MRK, AMGN, ABBV, NUVA", "Eliot Finkel Investment Counsel, LLC Buys Extra Space Storage Inc, Bank of Nova Scotia, Chevron ...", "See Which Of The Latest 13F Filers Holds Amgen", "Company News for July 27, 2017", "Arthur M. Cohen & Associates, Llc Buys Brookfield Infrastructure Partners LP, Fortive Corp, ...", "Validea Martin Zweig Strategy Daily Upgrade Report - 7/27/2017", "AMGN Named A Top Socially Responsible Dividend Stock", "Daily Dividend Report: K, CBOE, HTA, AMGN, SYY", "Like Facebook Inc (FB) Stock? Protect Yourself Anyway.", "Nvidia Corporation (NVDA) Stock Isn\u2019t as Attractive as the Company", "Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios", "Amgen (AMGN) Stock Falls Despite Q2 Earnings & Sales Beat", "2 Incredibly Cheap Dividend Stocks", "Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug", "Earnings Reaction History: Amgen Inc., 54.5% Follow-Through Indicator, 3.1% Sensitive", "Argyle Capital Management Inc. Buys DXC Technology Co, CVS Health Corp, C.R. ...", "After-Hours Earnings Report for July 25, 2017 : T, AMGN, TXN, CB, CNI, ESRX, EQR, AMP, WCN, WYNN, AMD, TSS", "Noteworthy Tuesday Option Activity: AMGN, NEM, JPM", "3 Large-Cap Biotech Stocks to Buy Now", "Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN", "3 Stocks That Are Absurdly Cheap Right Now", "XLV, UNH, MRK, AMGN: Large Outflows Detected at ETF", "Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?", "Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up", "Oakbrook Investments Llc Buys Schlumberger, JPMorgan Chase, Visa Inc, Sells W.W. ...", "Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs", "3 Dividend Stocks That Thrive in Both Bull and Bear Markets", "Ligand Signs Agreement with Amgen, Grants Rights to Captisol", "Novartis Tops Q2 Earnings, Sandoz Faces Pricing Pressure", "Why Did Radius Health (RDUS) Stock Plummet Today?", "Mylan's Biosimilar Herceptin Gets FDA Advisory Committee Nod", "3 Dividend Stocks That Thrive in Market Crashes", "Wells Fargo & Co (WFC) Stock Slumps Following Solid Q2 Earnings Report", "Can Novartis (NVS) Spring a Surprise This Earnings Season?", "Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Standout", "Notable Friday Option Activity: REGN, DDD, AMGN", "Amgen Applies to Have Kyprolis' Label Updated", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Amgen's Myeloma Drug Improves Overall Survival in Phase III", "Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA", "Edmp, Inc. Buys Penske Automotive Group Inc, Ventas Inc, STORE Capital Corp, Sells Alphabet ...", "Can ImmunoGen's Lead Pipeline Cancer Candidate Boost Growth?", "Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label", "Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal", "3 Dividend Stocks in Healthcare", "Amgen, Inc. (AMGN) Stock Is the Cure for Ailing Portfolios", "Novartis' Cosentyx Superior to Stelara in Psoriasis Study", "A New Cancer Treatment Is on the Way -- and Cancer Better Be Scared", "Edmp, Inc. Buys Penske Automotive Group Inc, Ventas Inc, STORE Capital Corp, Sells Alphabet ...", "Are Medicines Company's Key Drugs Set for Growth in 2017?", "3 Dividend Stocks You May Be Overlooking", "Better Buy: Amgen Inc. vs. Celgene Corporation", "Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies", "3 Best Fidelity Funds to Finish 2017", "XLV, UNH, MRK, AMGN: Large Inflows Detected at ETF", "Here's What's Behind Amgen, Inc.'s 10.2% Gain in June", "Pfizer's (PFE) Leukemia Candidate Receives Approval in EU", "Key FDA Events to Watch Out for in Jul 2017", "10 Biotech Stocks With Game-Changing Dates in Q3", "3 Charts That Show Why to Buy Gilead Sciences Stock Now", "Teva's (TEVA) Filing for Biosimilar Rituxan Accepted by FDA", "Amgen's Colorectal Cancer Drug Gets FDA Nod to Expand Label", "Dova Pharmaceuticals Targets a 9-Figure Opportunity, but Should You Buy Its IPO?", "Biotech Stock Roundup: Cara Plunges on Study Data, Regulatory Updates & More", "Novartis' Erelzi, Biosimilar of Enbrel Approved In Europe", "AbbVie Has the Most Valuable Late-Stage Pipeline -- But Is Its Stock a Buy?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Amgen Gets Positive CHMP Opinion for Mimpara Label Expansion", "Roche's (RHHBY) Combination Cancer Remedy Wins FDA Approval", "Allergan Continues to Focus on Acquisitions and Branded Unit", "Merck's Keytruda on a Roll: Can it Retain the Momentum?", "Alder's Shares Dip Despite Positive Migraine Trial Results", "Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More", "Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt", "Ligand Gets Milestone Payment on Partner Drug FDA Approval", "5 Biotech Stocks That Are Roaring Back to Life", "Amgen's Xgeva Myeloma Label Expansion sBLA Accepted by FDA", "5 Most Profitable Big Pharma Stocks on the Market Right Now", "If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy", "Noteworthy Tuesday Option Activity: RHT, CTSH, AMGN", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?", "3 Most Wildly Overvalued Stocks in Biotech (At Least on Paper)", "AbbVie Stock Just Hit a 52-Week High: Here's Why It Should Go Even Higher", "The Supreme Court Just Made a Big Opportunity for Biosimilars Even Bigger", "2 Incredibly Cheap Biotech Stocks", "3 Dividend Stocks for Long-Term Investors", "3 Stocks That Could Double Your Money", "Is Amgen (AMGN) a Great Stock for Value Investors?", "Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why", "Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally?", "Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug", "3 Dividend Stocks for Astute Investors", "Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx", "3 Biotech Trades to Diversify Your Portfolio", "Coherus Stock Plummets as FDA Rejects Neulasta Biosimilar", "Merck Stalls Enrolment in Two Myeloma Studies of Keytruda", "Amgen's Multiple Myeloma Drug Receives NICE Recommendation", "Health Care Sector Update for 06/13/2017: JNJ, PFE, ABT, MRK, AMGN, CHRS, IMNP", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2017", "Why Coherus Biosciences Stock Is Getting Hammered Today", "Sanofi/Regeneron's Praluent Cuts Bad Cholesterol in Studies", "Why Is ImmunoGen (IMGN) Stock Up 131% This Year?", "Health Care Sector Update for 06/12/2017: TROV,AZN,GTXI,CHRS,AMGN", "BIB, CELG, AMGN, INCY: ETF Inflow Alert", "AbbVie (ABBV) Announced Positive Phase III RA Candidate Data", "Teva Migraine Candidate Succeeds in Second Phase III Study", "Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit", "Health Care Sector Update for 06/08/2017: JNJ, PRE, ABT, MRK, AMGN, CHRS, TVTY, AXN", "4 Types of Investments to Avoid", "Health Care Sector Update for 06/12/2017: HYH,GTXI,CHRS,AMGN", "3 Value Stocks Perfect for Retirement", "Amgen Files for Repatha in the U.S., EU for Expanded Use", "Amgen (AMGN) Presents Positive Clinical Data on Cancer Drugs", "Noteworthy Monday Option Activity: AMGN, WYN, MNK", "Noteworthy ETF Outflows: XLV, MDT, AMGN, CELG", "How Regeneron Pharmaceuticals, Inc. Makes Most of Its Money", "The 5 Best Dividend Stocks in Cholesterol Drugs", "Merck's Cancer Drug Keytruda Positive in Clinical Studies", "3 Dividend Stocks That Thrive in Market Crashes", "Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote", "3 Top Dividend Stocks in Generic Drugs", "The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene", "Radius Health Osteoporosis Drug Positive in Phase III Study", "Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers", "Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data", "Amgen (AMGN) Down 4.5% Since Earnings Report: Can It Rebound?", "This Stock Turned $1,000 Into $1.53 Million in Less Than 33 Years", "Insider Buying: The Evidence", "Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna", "3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)", "Amgen is Oversold", "Noteworthy Monday Option Activity: AMGN, AFL, NOG", "Amgen, Inc. (AMGN) Stock Dips on Osteoporosis Drug Disappointment", "3 Reasons Gilead Sciences, Inc. Is a Better Dividend Stock Than Amgen, Inc.", "Nasdaq 100 Movers: AMGN, WYNN", "Is the Snap Inc (SNAP) Stock Bounce for Real?", "Why Apple Inc. (AAPL) Stock Is Vulnerable Right Now", "Amgen Evenity Approval Derailed on Cardiovascular Side Effect", "The 3 Best Dividend Stocks in Arthritis Medication", "Starbucks Corporation (SBUX) Stock Is Waking Up. Drink Up!", "These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?", "Notable ETF Outflow Detected - SSO, MRK, MCD, AMGN", "Hbk Investments L P Buys NXP Semiconductors NV, SPDR S&P 500, Amgen Inc, Sells St Jude ...", "Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab", "Amgen (AMGN) Shares Cross 3% Yield Mark", "Health Care Sector Update for 05/22/2017: RDUS,AMGN,EYEG,VRX,BSTG", "Here's Why Radius Health Gained as Much as 20.2% Today", "Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab", "Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications", "3 Stocks to Watch on Monday: Amgen, Inc. (AMGN), Lockheed Martin Corporation (LMT) and Ford Motor Company (F)", "Market Tailwind Has Lifted This Top Fidelity Mutual Fund Manager's Portfolio", "What's Your Flavor? Don't Worry, There's An ETF For That", "AbbVie Down on Humira Patent Loss: Is More Damage in Store?", "Salesforce.com, Inc. (CRM) Stock Roars Into Earnings", "Amgen, Inc. (AMGN) Stock Has the Cure for Boring Portfolios", "Celgene's (CELG) Revlimid Looks Solid on Label Expansion", "Health Care Sector Update for 05/16/2017: MNKD,AKBA,FMS,ETRM", "Implied FMK Analyst Target Price: $32", "Market Tailwind Has Lifted This Top Fidelity Mutual Fund Manager's Portfolio", "Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint", "Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.", "Is Regeneron Pharmaceuticals Stock Still a Buy After Its Big Bounce?", "Noteworthy ETF Inflows: XLV, MRK, UNH, AMGN", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 15, 2017", "Ex-Dividend Reminder: Consolidated Edison, Amgen and Simon Property Group", "3 Best Dividend Stocks in Biotech", "Notable Two Hundred Day Moving Average Cross - AMGN", "Ligand Pharmaceuticals (LGND) Q1 Earnings Miss Estimates", "Notable Wednesday Option Activity: WFM, INGN, AMGN", "Mylan (MYL) Beats on Q1 Earnings, Revenues Miss Estimates", "Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View", "Better Buy: Amgen Inc. vs. Johnson & Johnson", "XLV, UNH, AMGN, MDT: ETF Inflow Alert", "Bellevue Group AG Buys Align Technology Inc, Anthem Inc, Walgreens Boots Alliance Inc, Sells ...", "Notable Two Hundred Day Moving Average Cross - AMGN", "Ligand Pharmaceuticals (LGND) Q1 Earnings Miss Estimates", "Radius Health (RDUS) Posts Wider Q1 Loss, Tymlos Approved", "Is Regeneron (Finally) Getting Back on Track?", "Amgen: The Bear Case From a Bull", "Sanofi (SNY) Q1 Earnings Top, Sales Rise Y/Y, Shares Up", "Biotech Stock Roundup: Amgen, Gilead, Celgene Q1 Earnings, Sunesis Down on Vosaroxin Update", "Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline", "Starbucks Corporation (SBUX) Should Dip After Earnings, And That\u2019s OK", "Amgen's Q1 Results Highlight the Need for an Acquisition", "Will Amazon.com, Inc. (AMZN) Stock Hit $950? It\u2019s Not a Given.", "3 Stocks to Watch on Thursday: Nokia Oyj (ADR) (NOK), Amgen, Inc. (AMGN) and PayPal Holdings Inc (PYPL)", "The 3 Best Long-Term Dividend Stocks To Buy Now (AMGN,HON, CVS)", "What's in Store for Merck (MRK) this Earnings Season?", "These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016", "Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline", "Better Buy: Amgen Inc. vs. Biogen", "5 Fantastic Earnings Charts", "After-Hours Earnings Report for April 26, 2017 : AMGN, PYPL, SU, LVS, PSA, EQIX, AVB, FISV, ORLY, EFX, WCN, NOW", "Earnings Reaction History: Amgen Inc., 60.0% Follow-Through Indicator, 3.2% Sensitive", "Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong", "3 Stocks Could Double Their Dividends -- But Shouldn't", "Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise?", "Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More", "Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?", "Notable Tuesday Option Activity: WDC, THO, AMGN", "Novartis Tops Q1 Earnings: Cosentyx, Entresto Boost Sales", "What Options Traders Expect from Amgen, Inc. (AMGN) Earnings", "What's in Store for Agenus (AGEN) this Earnings Season?", "Better Buy: Amgen Inc. vs. Pfizer", "Why Earnings Season Could Be Great for Amgen (AMGN)", "Read This Before You Buy Biotech Stocks", "Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?", "Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?", "Universal Health (UHS) Q1 Earnings: What's in the Cards?", "Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?", "Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?", "What's in Store for Biogen (BIIB) this Earnings Season?", "Celgene (CELG) to Post Q1 Earnings: What's in the Cards?", "XLV, AMGN, MDT, LLY: Large Inflows Detected at ETF", "The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe's, Bristol-Myers and Priceline", "5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates", "AbbVie Inc.: The Bear Case From a Bull", "Mylan Down on FDA Warning Letter to Manufacturing Facility", "Amgen's Offering a Money Back Guarantee for Repatha. Will It Be Enough?", "ANTH's (ANTH) Blisibimod Completes Dosing in Phase III Study", "What's in the Cards for Centene (CNC) this Earnings Season?", "XLV, AMGN, MDT, LLY: Large Inflows Detected at ETF", "3 Big Drugmakers Most Likely to Buy Incyte", "10 Reasons Amgen Could Be the World's Most Perfect Stock", "3 Big Biotech Stocks With Big-Time Catalysts", "Analysts Release New Health Care Stock Ratings", "Notable ETF Outflow Detected - DGRO, MRK, AMGN, WMT", "3 Top Big Pharma Stocks to Buy Now", "Country Club Trust Company, n.a. Buys WisdomTree Europe Hedged Equity Fund, Vanguard ...", "This Is Why Radius Health Inc. Tumbled 8.6% in March", "Amgen Files for Xgeva Label Expansion, To Include Myeloma", "Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug", "Why Is Amgen (AMGN) Up 12.9% Since the Last Earnings Report?", "Rosenbaum Jay D. Buys Salesforce.com, Newell Brands, General Dynamics, Sells Walt Disney Co, ...", "What's Next for Amgen's Repatha?", "Why Amgen, Inc. Stock (AMGN) Is My Top Buy for Dividend Growth and Upside", "Analysts Anticipate 10% Gains Ahead For XLV", "Healthcare Winners and Losers Following the AHCA's Failure", "Better Buy: Celgene Corporation vs. Amgen Inc.", "Could Pfizer Buy Esperion Therapeutics?", "Mylan Receives CRL for Generic Advair Diskus From the FDA", "FDA Grants Amgen Priority Review for Blincyto sBLA", "Amgen's Leukemia Drug Accepted for Priority Review by FDA", "The 3 Best Cholesterol Drug Stocks to Buy in 2017", "Kite Pharma Completes Filing for CAR-T Therapy with FDA", "Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study", "3 Drugmakers With Boatloads of Cash to Spend", "Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe", "3 Big Stock Charts for Tuesday: Alphabet Inc (GOOGL), Amgen, Inc. (AMGN) and United Parcel Service, Inc. (UPS)", "Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher?", "J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe", "Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma", "Notable ETF Outflow Detected - XLV, MRK, UNH, AMGN", "Amgen's Humira Biosimilar Approved in Europe", "Amgen's (AMGN) Humira Biosimilar Receives Approval in EU", "Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval", "The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General Electric and Carnival", "Why You're Smart to Buy Jazz Pharmaceuticals plc", "How This Company Is Taking on Amgen", "Health ETF Wobbles As Vote On Bill To Replace ObamaCare Nears; Gold Gains", "5 Stocks With Ridiculously Fast-Growing Dividends", "Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results", "Notable ETF Outflow Detected - XLV, UNH, AMGN, MDT", "3 Biotech Stocks That Are Broker Favorites", "Biotech Bull Making a Comeback", "Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop", "Why Biotech Stock Gilead (GILD) Could Be a Value Trap", "Here's What Pushed Esperion Therapeutics Inc Stock Higher Today", "Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen", "Is Trump Bad for Healthcare Stocks? These 4 Winners Don't Think So", "Amgen, Inc. (AMGN) Offers Money-Back Guarantee to Heart Attack Victims on Repatha", "Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher", "Privacy Revamp Makes Facebook Inc (FB) Stock Even More Attractive", "Amgen, Inc. (AMGN) Stock Crashed. Here\u2019s How to Trade It.", "Nasdaq 100 Movers: AMGN, ADBE", "S&P 500 Movers: AMGN, ADBE", "Why Amgen's Success Was a Big Disappointment", "What are Sanofi's (SNY) Strengths and Challenges in 2017?", "Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,901", "Why Amgen, AmTrust Financial Services, and BRF Slumped Today", "Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today", "Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China", "Does Amgen Offer a Great Value Buying Opportunity Right Now?", "Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data", "Stock Market News for March 17, 2017", "Amgen's Repatha Meets Primary Endpoint in Phase III Study", "Noteworthy Tuesday Option Activity: AMGN, ROK, ORCL", "Noteworthy ETF Inflows: XLV, AMGN, MDT, ABBV", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2017", "The 19 Best-Selling Prescription Drugs of All-Time", "Which Biotech Is the Best Dividend Stock?", "Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?", "Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication", "AbbVie Stock Upgraded: What You Need to Know", "AbbVie at the Cowen Healthcare Conference: 4 Things You'll Want to Know", "Daily Dividend Report: PBA, PLCE, AMGN, SPLS, VGR", "J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day", "Novartis (NVS) Reports Positive Data on Biosimilar Humira", "3 Biotech Stocks You Don't Have to Babysit", "5 FDA Decisions to Watch Out for in Mar 2017", "After Hours Most Active for Mar 10, 2017 : DISH, GE, LLTC, FNB, INTC, QQQ, GM, AGN, V, BAC, ABCO, AMGN", "AbbVie Stock Upgraded: What You Need to Know", "Mylan (MYL) Beats on Q4 Earnings, Stock Up on Strong View", "Why Perrigo Company plc Stock Crashed on Tuesday", "Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals", "Here's Why Esperion Therapeutics Inc Stock Popped Today", "Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly", "Amgen Dividend History: What's Ahead for the Biotech Pioneer?", "XLV, AMGN, MDT, ABBV: ETF Inflow Alert", "Here's Why Amgen Stock Rose 10.5% in February", "3 Stocks You Don't Have to Babysit", "Ligand (LGND) Q4 Earnings Down Y/Y, Revenues Miss Estimates", "Notable Friday Option Activity: CELG, AMGN, LMT", "Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems", "Should I Buy Procter & Gamble Co (PG) Stock? 3 Pros, 3 Cons", "Noteworthy ETF Inflows: TQQQ, AMGN, KHC, CHTR", "3 Ways to Play This Biotech Stocks Dip", "Numeric Investors Llc Buys Gilead Sciences, Microsoft, Baxter International, Sells Facebook, ...", "3 Stocks You Don't Have to Babysit", "Study Reveals PCSK9 Drugs Can Save Heart Disease Patients", "Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.", "Pfizer's Xeljanz Combo Comparable to AbbVie's Humira", "Mylan's Proposed Biosimailar for Cancer Under Review in U.S.", "Should You Buy Amgen, Inc. (AMGN) Stock? 3 Pros, 3 Cons", "The Zacks Analyst Blog Highlights: Amgen, Procter & Gamble, Bank of America, Netflix and Honda", "Don't Count on Valeant's New Drug to Save the Day", "Marco Investment Management Llc Buys Johnson Controls International PLC, Amgen, AbbVie, Sells ...", "Stock Index ETFs Nail Another Gain; Health Stocks Lead", "Want to Get In on Biotech? Check Out These 3 Stocks", "Amgen Looking to Broaden Leukemia Drug Blincyto's Label", "Vanguard Growth ETF Experiences Big Inflow", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 15, 2017", "Why Amgen's Becoming One of My Top Dividend Stocks to Buy", "Noteworthy Monday Option Activity: AMGN, AMBA, AXON", "PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union Pacific, ...", "Hunter Associates inc. Buys Pfizer, Procter & Gamble Co, R.R. ...", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 13, 2017", "3 Beaten-Down Stocks Ready to Bounce Back", "Van Strum & Towne Inc. Buys Charles Schwab, Bank of Americaoration, 3M Co, Sells Eaton ...", "Regeneron (REGN) Misses on Q4 Earnings & Sales, View Bleak", "Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma", "Noteworthy Monday Option Activity: AMGN, AMBA, AXON", "PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union Pacific, ...", "Hunter Associates inc. Buys Pfizer, Procter & Gamble Co, R.R. ...", "Better Buy: Amgen Inc. vs. Celgene", "Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib", "Regeneron (REGN) Q4 Earnings: Will the Stock Disappoint?", "Sapphire Star Partners LP Buys Cirrus Logic, Cracker Barrel Old Country Store, Vascular ...", "Sanofi (SNY) Q4 Earnings In Line; Can Sell Praulent for Now", "Company News for February 06, 2017", "Merck???s Keytruda Gets Priority Review for Bladder Cancer", "Trump's Plan to Lower Drug Costs Is a Fairy Tale", "Nasdaq 100 Movers: AMZN, AMGN", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), GoPro Inc (GPRO) and Visa Inc (V)", "Are Options Traders Betting on a Big Move in Amgen (AMGN) Stock?", "Amgen (AMGN) Q4 Earnings Top; Repatha Positive in CV Study", "VUG, AMGN, MMM, ABBV: Large Inflows Detected at ETF", "Company News for February 06, 2017", "Merck???s Keytruda Gets Priority Review for Bladder Cancer", "Why Esperion Therapeutics, Inc. Is Soaring Today", "Health Care Sector Update for 02/03/2017: CBM,CERU,IDXG", "Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data", "After-Hours Earnings Report for February 2, 2017 : AMZN, V, AMGN, HIG, ESS, MSI, CMG, MTD, KIM, HBI, CSC, OTEX", "Amgen, Inc. (AMGN) Q4 Earnings Preview", "Why Morgan Stanley, Amgen, and Tableau Software Jumped Today", "Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN", "Should You Sell Amgen (AMGN) Before Earnings?", "These 3 Biotech Stocks Are Ridiculously Cheap", "Merck Keytruda Gets EU Approval for First-Line Lung Cancer", "Mallinckrodt (MNK) Earnings This Quarter: Stock to Disappoint?", "Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft", "4 FDA Decisions to Watch Out for in Feb 2017", "The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals", "Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN", "Should You Sell Amgen (AMGN) Before Earnings?", "United Bank Buys Fortis, Sells ITC Holdings, Revance Therapeutics, T. Rowe Price Group", "Amgen, Inc.: Capture Stronger Upside in AMGN Stock", "Stock Market News for January 27, 2017", "Health Care Sector Update for 01/27/2017: AMGN", "Will Amgen (AMGN) Keep the Earnings Streak Alive in Q4?", "Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting", "Notable Friday Option Activity: AMGN, NVDA, FNGN", "Biogen (BIIB) Q4 Earnings Top Estimates; '17 Sales View Soft", "Novartis (NVS) Beats Q4 Earnings, Might Spin-Off Alcon", "3 Biotech Stocks to Buy and Hold Stress-Free", "Noteworthy ETF Inflows: VUG, AMGN, MMM, ABBV", "Can Amgen (AMGN) Be a Top Choice for Value Investors?", "Why the Amgen, Inc. (AMGN) Patent Case Is So Important", "Amgen, Inc. (AMGN) Stock Is a Bet on Fatter Yields", "5 Biotech Stocks You'll Want to Watch in the 1st Quarter", "Value Investing 2017: 3 Stocks to Put on Your Radar", "Better Buy: Amgen Inc. vs. Celgene Corporation", "Donald Trump Just Leveled Drug Companies With These 4 Words", "Coherus Offers Positive Phase III Data on Humira Biosimilar", "3 Cheap Value Stocks to Buy Today", "Apple Inc. (AAPL) Stock Cuts Production, But It May Not Be Time to Run", "4 Top Biotech Mutual Funds for 2017", "SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!", "Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short", "Notable Wednesday Option Activity: BIIB, MRK, AMGN", "Stock Market News for January 10, 2017", "Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit", "Kite Pharma Inks Deals for CAR T Cell Drug in Japan, China", "Rosenbaum Jay D. Buys Comcast Corp, Lowe's Companies Inc, The Travelers Companies Inc, Sells ...", "Should You Buy Amgen Inc. (AMGN) Stock? 3 Pros, 3 Cons", "Notable ETF Outflow Detected - TQQQ, AMGN, KHC, GILD", "Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised)", "Why Biotech Titans Are Clashing Over Cholesterol", "Midday Update: Stocks Regain Upward Momentum After Mixed Jobs Report", "AMGN Crosses Above Key Moving Average Level", "Nasdaq 100 Movers: REGN, AMGN", "S&P 500 Movers: REGN, AMGN", "Why Amgen's Stock Slumped in 2016", "Health Care Sector Update for 01/06/2017: MDCO, SNY, REGN, JNJ, PFE, ABT, MRK, AMGN", "Stock Futures Turn Positive on Gains in Hourly Earnings", "Pfizer's Humira Biosimilar Meets Primary Endpoint in Study", "Amgen's Repatha Wins Over Sanofi & Regeneron's Praluent", "Why Regeneron Pharmaceuticals, Sears Holdings, and Shake Shack Slumped Today", "Close Update: Labor Market Report Powers S&P 500 and Nasdaq to Record Highs", "The Zacks Analyst Blog Highlights: Comcast, Amgen, General Mills, Target and Ford", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gap Inc (GPS) and PriceSmart, Inc. (PSMT)", "Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation", "Kite Pharma (KITE) to Move Cancer Candidate into Phase I", "Health Care Sector Update for 01/04/2017: SNY,AMGN,REGN,CBAY,AGRX", "Noteworthy Tuesday Option Activity: M, APA, AMGN", "Biotech Stocks: What to Watch in 2017", "2 Healthcare Stocks With Better Dividends Than HCP, Inc.", "OEF, V, IBM, AMGN: Large Outflows Detected at ETF", "These 3 Dividend Stocks Are Ridiculously Cheap", "Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now", "6 Dividend Stocks Increasing Payouts \u2014 AMGN CVS MCO FITB BXP CHH", "3 Big Pharma Stocks With the Fastest-Growing Dividends", "Ligand (LGND) Signs Licensing Deals with Ono and Novartis", "Noteworthy ETF Outflows: TQQQ, AMGN, KHC, GILD", "Daily Dividend Report: AMGN, FITB, MCO, WOR, WDR", "Bristol-Myers, PsiOxus Ink Deal for Oncolytic Virus Therapy", "Merck (MRK) Does Well in 2016: Reasons for Outperformance", "3 Big Stock Charts for Tuesday: Darden Restaurants, Inc. (DRI), Amgen, Inc. (AMGN) and Caterpillar Inc. (CAT)", "Amgen Files for Approval of Osteoporosis Drug in Japan", "Great News: Clinical Trial Success Rates Are Up for the First Time in More Than a Decade", "Merck Keytruda Gets CHMP Nod for First-Line Lung Cancer", "3 Small Biotech Stocks That Big Biotechs Like", "Stock Exchange: Do Emotions And Symbolism Affect Technical Analysis?", "Is This Gilead Sciences' Biggest Mistake in 2016?", "Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys", "5 Fairly Valued Dividend Growth Stocks In The Healthcare Sector", "Big Pharma Face Off: Is Merck More Attractive than J&J?", "XLV, AMGN, ABBV, GILD: ETF Outflow Alert", "3 Top Biotech Stocks to Buy on Sale", "Better Buy: Gilead Sciences Inc. vs. Amgen Inc.", "Harvard Bioscience's Recent Acquisitions Make A Difference, Initiate With Buy Rating", "YieldBoost Amgen To 4.7% Using Options", "Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study", "Amgen, Inc. (AMGN) Stock Might Be on Santa\u2019s Buy List", "Better Buy: Amgen Inc. vs. Biogen", "Biogen Inc (BIIB) Stock Trade Showcases the \u2018Art of the Steal\u2019", "Stock Market News for December 08, 2016", "Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus", "Better Buy: Amgen Inc. vs. Pfizer", "Global Blood Therapeutics: Short-Sellers Could Be In For A Ride", "Monday\u2019s Vital Data: Bank of America Corp (BAC), Apple Inc. (AAPL) and Seadrill Ltd (SDRL)", "AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH", "Here's Why Arrowhead Pharmaceuticals Inc. Is Being Obliterated Today", "Momenta/Shire's Humira Biosimilar Meets Study Objective", "Better Buy: Biogen Inc. vs. Amgen", "Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab", "Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno", "3 Top Dividend Stocks to Buy in 2017", "Noteworthy ETF Inflows: XLV, MRK, AMGN, GILD", "J&J Immunotherapy Darzalex OK'd for Label Expansion by FDA", "5 Biotech Stocks George Soros Is Buying", "Novartis (NVS) Reports Favorable Data on Enbrel Biosimilar", "The Zacks Analyst Blog Highlights: Amgen, Cisco, NextEra Energy, AbbVie and eBay", "Novartis/Amgen Migraine Drug Positive in Phase III Study", "Regeneron/Sanofi's Praluent CV Outcomes Study to Continue", "Aegerion's Juxtapid Gets Pricing Authorization in Japan", "Merck: Keytruda's Priority Review for New Cancer Indication", "Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study", "3 Stocks to Watch on Wednesday: Amgen, Inc. (AMGN), Cisco Systems, Inc. (CSCO) and NetApp Inc. (NTAP)", "3 Beaten-Down Biotech Stocks to Buy for Huge Gains", "Amgen Files for Avastin Biosimilar; Repatha Data Positive", "Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved", "Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?", "3 Biotech ETFs for Decades of Big Returns", "Top Research Reports for Cisco, Amgen & NextEra Energy", "Amgen Presents Osteoporosis Data; Parsabiv Approved in EU", "Fidelity Healthcare Fund: 5 Things You Should Know", "3 Drugmakers That Probably Have Lower Tax Rates Than You Do", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 14, 2016", "Drug Stocks' Q3 Earnings to Watch on Nov 14: ARGS, AST", "Stock Exchange: Is Post-Election Technical Analysis Useful?", "Kite Pharma Q3 Loss Betters Estimate; KTE-C19 On Track", "How To Invest During The Trump Presidency", "Biotech Stock Roundup: Ionis Soars on Spinraza Data, Regeneron's Q3 Results Mixed", "Better Buy: Amgen Inc. vs. Johnson & Johnson", "IYH, UNH, AMGN, ABBV: ETF Outflow Alert", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for November 09, 2016", "Why Amgen Inc. Shares Nose-Dived 15.4% in October", "Biotech ETFs Slumping on Q3 Results", "5 Top Biotech Stocks to Buy on Trump Victory", "SPXT's Underlying Holdings Imply 14% Gain Potential", "2 Reasons Why the iShares NASDAQ Biotechnology Index (ETF) Tumbled 11% in October", "Is AbbVie's Dividend Worth the Risk?", "Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen", "Why AbbVie Shares Tumbled 11.6% in October", "Biotech Stock Roundup: Amgen Down on Enbrel Sales, Regeneron's Sarilumab Faces Delay", "Allergan (AGN) Lags Q3 Earnings, Cuts View, Ups Buyback", "Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences", "SPXT's Underlying Holdings Imply 14% Gain Potential", "Pfizer (PFE) Q3 Earnings Lag; Cuts View, Sheds Bococizumab", "Drug Stocks to Watch for Earnings on Nov 2; AGN, ZTS & More", "3 Things You Really Need to Know About Pfizer's Q3 Results", "Genetic Stocks to Watch for Earnings on Nov 1: GILD & More", "Will This Trend Cost Biotech Stock Investors Lots of Money?", "Amgen, Inc. (AMGN) Stock Sinks Despite Q3 Earnings Beat", "$10 Billion Flop: Is Amgen Stock Still a Buy?", "Amgen (AMGN) Q3 Earnings & Sales Top; Enbrel Hurts Stock", "Why Amgen, McKesson, and Stonemor Partners Slumped Today", "Market Close Report: NASDAQ Composite index closes at 5,190.10 down -25.87 points", "5 Things Amgen Inc.'s Management Wants You to Know", "Here's Why Amgen (AMGN) Stock Slid Over 10% Today", "Amgen, Inc. Tumbles 11% as Pricing Concerns Mount for Lead Drug Enbrel", "Amgen Inc. Delivers in Q3 Despite Sluggish Revenue", "Nasdaq 100 Movers: AMGN, SRCL", "After-Hours Earnings Report for October 27, 2016 : AMZN, GOOGL, AMGN, BIDU, SYK, MCK, AFL, LNKD, RSG, EXPE, HIG, PFG", "Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates", "Gilead Sciences (GILD) Q3 Earnings: Stock to Disappoint?", "Can Prothena (PRTA) Pull a Surprise This Earnings Season?", "Biogen (BIIB) Beats on Q3 Earnings; Tecfidera Propels Sales", "Is a Surprise Coming for Amgen (AMGN) This Earnings Season?", "Novartis (NVS) Tops Q3 Earnings, Misses Sales Estimates", "Earnings Reaction History: Amgen Inc., 60.0% Follow-Through Indicator, 2.7% Sensitive", "3 Key Questions for Amgen Inc. in Q3", "Agenus (AGEN): What's Ahead for the Stock in Q3 Earnings?", "Can AbbVie (ABBV) Sustain Earnings Beat Trend in Q3?", "Noteworthy Monday Option Activity: AMGN, CEMP, RDUS", "Health Care Sector Update for 10/24/2016: AAC,UNIS,INO", "Will Amgen (AMGN) Sustain its Earnings Beat Trend in Q3?", "Amgen's (AMGN) Xgeva Meets Endpoint in Phase III Study", "Merck Keytruda Gets FDA Approval for First-Line Lung Cancer", "GlaxoSmithKline (GSK) Q3 Earnings: What's in the Cards?", "Bristol-Myers Squibb (BMY) Q3 Earnings: What's in Store?", "Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry", "7 Drug Stocks to Consider as Biosimilars Pick Up Pace", "Can Biogen (BIIB) Keep the Earnings Streak Alive in Q3?", "What's in Store for BioMarin (BMRN) This Earnings Season?", "Alexion (ALXN) Q3 Earnings: Can the Stock Pull a Surprise?", "The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals", "GlaxoSmithKline (GSK) Q3 Earnings: What's in the Cards?", "Can Eli Lilly (LLY) Pull a Surprise this Earnings Season?", "Can Merck (MRK) Keep the Earnings Streak Alive in Q3?", "3 Stocks to Supplement Your Social Security Benefits", "Pfizer to Launch Remicade Biosimilar in U.S. in November", "Daily Dividend Report: AMGN, LLY, WY, HSY, VMC, UNM", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Novartis (NVS) Q3 Earnings: Stock to Beat Estimates Again?", "Abbott Labs (ABT) Q3 Earnings: What's Ahead for the Stock?", "Stock Market News for October 12, 2016", "Better Buy: Regeneron Pharmaceuticals, Inc. vs. Roche Holding AG", "Teva Acquires Rights to Oncology Biosimilar Candidates", "3 Top Biotech Stocks to Buy Right Now", "6 Healthcare Stocks Investors Can't Miss in Q3 Earnings", "Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B", "J&J (JNJ) Likely to Beat Earnings Estimates in Q3 Again", "XLV, AMGN, MDT, ABBV: ETF Outflow Alert", "Amgen Announces Publication of Blincyto Phase I/II Data", "3 Top Biotech Stocks to Buy in October", "Marketplace Roundtable: The State Of Biotech", "3 Healthcare Stocks That Could Raise Their Dividends", "Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint", "Is It Too Late to Get In on This Millionaire-Maker Stock?", "3 Ways Rockwell Medical Inc. Could Turn Things Around", "Why Arrowhead Pharmaceuticals Stock Spiked Today", "Mid-Morning Market Update: Markets Edge Lower; PepsiCo Beats Q3 Expectations", "Health Care Sector Update for 09/29/2016: ARWR,AMGN,AEGR,ITCI", "3 Reasons Not to Lose Faith in Amgen, Inc. (AMGN)", "Momenta to Regain Rights to Humira Biosimilar from Shire", "Biotech Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data", "Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III", "Allergan Focus on Brands, Biosimilar Products & Acquisitions", "Nasdaq 100 Movers: GILD, NCLH", "Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.", "Biosimilars in Limelight on FDA Approval of Amgen Drug", "Here's Why Ligand Pharmaceuticals Inc Is Plunging Today", "Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval", "As Humira Alternative Gets FDA Approval, Is Abbvie in Trouble?", "Amgen (AMGN) Repatha Meets Endpoints in Phase III Study", "XLV, AMGN, MDT, GILD: ETF Inflow Alert", "Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning Things Around", "Biotech ETF At Best Level Since January; Are You Braced For Bumps?", "Know Before You Buy These 85 Blue Chips", "Amgen (AMGN) Parsabiv Gets Positive CHMP Opinion in EU", "Is This New Market the Biggest Investment Idea of the Decade?", "IWF, V, PEP, AMGN: ETF Outflow Alert", "Novartis Reports Positive Phase II Data on Migraine Drug", "Stock Market News for September 21, 2016", "Stock Market News for September 15, 2016", "Third Avenue Fund Comments on Amgen", "The Zacks Analyst Blog Highlights: Spectrum Pharmaceuticals, Amgen, AbbVie and Vertex Pharmaceuticals", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2016", "S&P 500 Movers: AAL, PRGO", "3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016", "Noteworthy Monday Option Activity: AMGN, ULTA, AIG", "SPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin\u2019 on Biotech Stocks", "The Biotech ETF With The Unusual Investment Strategy", "Market Treaded Water In August As Investors Shifted To Growth Stocks -- Before Switching Back", "Merck's Lung Cancer Drug Keytruda Under Priority Review", "3 Attractive Income Stocks Whose Dividends Could Double", "Biotech Stock Roundup: CoLucid Soars on Migraine Data, Dynavax Drug FDA Panel Meeting Cancelled", "Amgen Gets FDA Approval for Label Expansion of Blincyto", "Biotech Stock Roundup: Gilead in Patent Infringement Lawsuit, Enbrel Biosimilar Approved", "Two Things You Must Understand About Biotech Investing", "The Medicines Co. Offers Update on Dyslipidemia Programs", "Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel", "Amgen (AMGN) Reports Positive Data on Prolia and Repatha", "Noteworthy ETF Outflows: TQQQ, AMGN, KHC, GILD", "Regeneron/Sanofi Present Positive Phase III Praluent Data", "These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year", "Amgen Gets CRL for Secondary Hyperparathyroidism Drug", "Why Cytokinetics, Inc. Got Hammered Today", "Commit To Purchase Amgen At $135, Earn 5.5% Using Options", "J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for August 25, 2016", "Noteworthy Monday Option Activity: DVAX, AMGN, NDSN", "3 Reasons Medivation Is the Juiciest Target in Biotech", "3 Cheap Dividend Stocks You Can Buy Right Now", "Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled", "Health Care Sector Update for 08/25/2016: AMGN,PVCT", "Better Buy: Amgen Inc. vs. Biogen", "Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data", "Another Endorsement for Biotech ETFs", "3 Stocks to Watch on Tuesday: Twilio Inc (TWLO), Hain Celestial Group Inc (HAIN) and Wal-Mart Stores, Inc. (WMT)", "Amgen, Inc (AMGN) \u2013 Amgen Stock Is a Powerhouse", "7 Battered Biotech Stocks to Buy", "Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010", "The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen", "Better Buy: Amgen Inc. vs. Biogen", "The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2016", "4 Reasons Amgen, Inc. Shareholders Netted a 13% Gain in July", "Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat", "Stock Market News for August 09, 2016", "Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19", "Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010", "Kite (KITE) Q2 Earnings: What's in Store for the Stock?", "Finding Value In The S&P 500: 9 Healthcare Dividend Growth Stocks: Part 1", "Why Advaxis, Inc. Shares Are Soaring 11% Again Today", "IBB: Significantly Overbought - Sharp Declines Imminent", "Mid-Day Market Update: Dow Drops Over 100 Points; Avon Shares Surge Following Earnings Beat", "Close Update: Stocks Pressured by Earnings, Worries About Economy", "2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?", "Notable ETF Outflow Detected - DGRO, ABBV, AMGN, UPS", "Which Of The Latest 13F Filers Holds Amgen?", "QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To $40", "Noteworthy ETF Outflows: BIB, AMGN, CELG, BIIB", "UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance", "Company News for July 29, 2016", "AMGN Named A Top Socially Responsible Dividend Stock", "The Zacks Analyst Blog Highlights: Facebook, Amgen, Whole Foods and Groupon", "Mid-Afternoon Market Update: Crude Oil Down 1.5%; RetailMeNot Shares Gain On Strong Results", "Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View", "2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK", "Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More", "Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure", "After-Hours Earnings Report for July 27, 2016 : FB, AMGN, MCK, PSA, SU, NXPI, ORLY, PXD, ABX, VRTX, MAR, O", "Earnings Reaction History: Amgen Inc., 63.6% Follow-Through Indicator, 2.7% Sensitive", "5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More", "The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene", "Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View", "2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK", "Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More", "ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise?", "Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2", "Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?", "Outerwall Inc: What the Buyout Means for OUTR Stock", "AbbVie (ABBV) Q2 Earnings: Will the Stock Pull a Surprise?", "Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen", "Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?", "Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?", "Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?", "Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)", "Daily Dividend Report: AMGN, NLSN, MAC, CF, EE, WWD", "3 Top Biotech Stocks to Buy Now", "Amgen, Inc.: AMGN Stock May Be Prepping for a Surge", "The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen", "Eli Lilly (LLY) May Beat Q2 Earnings: Will the Stock Gain?", "Gilead (GILD) Stock Likely to Beat This Earnings Season", "Better Buy: Gilead Sciences Inc. vs. Amgen Inc.", "Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug", "Noteworthy ETF Outflows: SSO, AMGN, MCD, CVS", "Implied MOAT Analyst Target Price: $38", "Health Care Sector Update for 07/22/2016: ABAX, VRX, AMGN, MRK, ABT, PFE, JNJ", "Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.", "3 Biotech Stocks for Conservative Investors", "4 Rock-Solid, Cheap Biotech Stocks", "5 Figures to Look For When Johnson & Johnson Reports Its Second-Quarter Results", "Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation", "Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan", "The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx", "3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG", "Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel Backing", "Amgen's Repatha Gains FDA Approval for New Dosing Option", "Instant Analysis: Amgen's Latest Approval Raises the Bar Yet Again on Regeneron Pharmaceuticals Inc and Sanofi SA (ADR)", "Amgen Humira Biosimilar Briefing Documents Look Good", "Noteworthy ETF Outflows: IWF, GOOGL, GOOG, AMGN", "Zacks.com featured highlights: Wal-Mart Stores, Home Depot, Amgen, United Parcel Service and Intel", "Amgen's Kyprolis Gains Approval in EU for Label Expansion", "Here's Why Regeneron Pharmaceuticals, Inc. Dropped Another 12% in June", "AstraZeneca Skin Drug, Tralokinumab, Rights Licensed to LEO", "5 Dividend Growth Stocks to Excel in Any Market Condition", "3 Top Healthcare Stocks to Buy Now", "3 Healthcare Stocks That Could Raise their Dividends", "Amgen (AMGN) Shares Cross Above 200 DMA", "Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies", "iShares Russell 1000 Growth ETF Experiences Big Inflow", "Should Davita's (DVA) Stock Be in Your Portfolio Now?", "Esperion Therapeutics Inc Sinks After FDA Says, \"Ask Us in 2019\"", "Medtronic PLC: High Dividend Growth Stock With Room to Run (MDT)", "Amgen, Inc. (AMGN) Stock: Good Fundamentals, Good Yield, Good Opportunity", "3 Biotech Stocks to Buy in the Wake of the Brexit Vote", "The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery", "How This Former Market Darling Became an Undervalued Stock", "The 3 Most Important Data Releases and FDA Decisions in the Second Half of 2016", "Xencor Stock Up On Cancer Drugs Partnership with Novartis", "Esperion Therapeutics Inc Sinks After FDA Says, \"Ask Us in 2019\"", "Medtronic PLC: High Dividend Growth Stock With Room to Run (MDT)", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2016", "Tricking the Common Cold Into Destroying Cancer", "Notable ETF Outflow Detected - PJP, AGN, AMGN, LLY", "Novartis (NVS) Announces Positive Results on Migraine Drug", "Biotech Stock Roundup: Biogen Slips on MS Results, ASCO Data in Focus", "IXJ, AMGN, AGN, CELG: Large Inflows Detected at ETF", "Why Kite Pharma Shares Vaulted 10.7% Higher in May", "Better Dividend Stock: Pfizer vs. Amgen", "The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)", "3 Biotechs Expecting Market-Moving Trial Results Soon", "SSO, AMGN, CVS, ABBV: Large Outflows Detected at ETF", "Regeneron Reports Interim Data on Cholesterol Lowering Drug", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016", "IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy", "3 Growth Stocks to Buy in June", "Interested in Medivation? Take a Number!", "YieldBoost AMGN To 6.4% Using Options", "Amgen (AMGN) Shares Cross Above 200 DMA", "Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1", "Here's What Pfizer's Telling Us About Biotech M&A", "XLV, UNH, GILD, AMGN: ETF Outflow Alert", "Merck, AbbVie & Amgen Drugs a Step Closer to EU Approval", "Drug Stocks Reporting Earnings on May 17: AXON & FWP", "The Math Shows EUSA Can Go To $48", "Biotech Stock Roundup: Medivation Buyout Rumors Continue, NewLink Plunges on Late-Stage Data", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 13, 2016", "Bristol-Myers/AbbVie Empliciti Gets Approved in the EU", "Noteworthy ETF Outflows: XLV, UNH, GILD, AMGN", "Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, Trevena", "Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More", "Kite Pharma (KITE) Posts Narrower-than-Expected Loss in Q1", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for May 11, 2016", "Drug Stocks Reporting on May 10: XON, ARIA, CPRX & More", "Drug Stocks' Earnings Previews: FGEN, IRWD, ENTA, FLML", "Biotech Stocks Reporting on May 9: INCY, HZNP, JUNO & More", "The Zacks Analyst Blog Highlights: Amgen, Gilead, Celgene, Medivation and Biogen", "Drug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY", "Kite (KITE) to Report Q1 Earnings: Will the Stock Disappoint?", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Biotech Stock Roundup: Amgen Impresses, Gilead Disappoints in Q1, Biogen to Spin Off Hemophilia", "Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More", "Regeneron Pharmaceuticals Inc Has a Lot to Prove on May 5", "Insulet Pumps Out 69% Revenue Growth in Q1, Reaffirms 2016 Guidance", "The Zacks Analyst Blog Highlights: Amgen, Johnson & Johnson, Pfizer, Mylan and Mallinckrodt", "AMGN Makes Notable Cross Below Critical Moving Average", "Biotech ETFs Sink on Mixed Q1 Results", "Trade of the Day: IBB Breaking Down", "Amgen, Inc. (AMGN) Earnings Prove It Should Be in Your Portfolio", "3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK", "Amgen (AMGN) Tops Q1 Earnings & Revenues, Ups View", "3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Gilead Sciences, Inc. (GILD) and TiVo, Inc. (TIVO)", "Q1 Earnings Reports Continue the Deluge: AMZN, GILD, AMGN", "Aside From 1 Eyesore, Amgen Delivers Another Solid Quarter", "Celgene Corporation Short-Term, Long-Term Guidance Up. Medium-Term? Not So Much", "Earnings Reaction History: Amgen Inc., 70.0% Follow-Through Indicator, 2.8% Sensitive", "After-Hours Earnings Report for April 28, 2016 : AMZN, GILD, AMGN, BIDU, HIG, RSG, EXPE, ESS, BMRN, LNKD, SWKS, DLR", "FVD, LMBS: Big ETF Inflows", "See Which Of The Latest 13F Filers Holds Amgen", "4 Biotech Stocks Reporting on Apr 28: AMGN, GILD, ALXN, CELG", "Aegerion (AEGR): Can the Stock Surprise in Q1 Earnings?", "Amgen (AMGN) Beats Q1 Earnings Estimates, Raises 2016 Outlook", "Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings", "Health Care Select Sector SPDR Fund Experiences Big Inflow", "Celgene (CELG) Q1 Earnings: What's in Store for the Stock?", "Centene (CNC) Q1 Earnings: Surprise in Store for Stock?", "Aetna (AET) Q1 Earnings: Is a Surprise in Store for Stock?", "BioMarin (BMRN) Q1 Earnings: Stock Likely to Beat Estimates", "Anthem (ANTM): Stock Poised to Beat on Q1 Earnings", "Aerie (AERI): Can the Stock Pull a Surprise in Q1 Earnings?", "What to Expect from Hubbell (HUBB) This Earnings Season?", "5 Biotech Stocks to Bet on This Earnings Season", "3 Data Points That Will Likely Define Amgen's First-Quarter Report on April 28", "Does Biotech\u2019s Recent Bounce Have Legs?", "Bristol-Myers (BMY) Q1 Earnings: Can the Stock Surprise?", "Vertex (VRTX) to Report Q1 Earnings: Is a Surprise in Store?", "AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?", "Amgen (AMGN) May Beat Q1 Earnings: Will the Stock Gain?", "Will Currency & Competition Hurt Lilly's (LLY) Q1 Earnings?", "Amgen's (AMGN) Phase III Study Results on Nplate Published", "20 Reasons to Buy Amgen and Never Sell", "Health Care Sector Update for 04/20/2016: CARA, AMGN, MRK, ABT, PFE, JNJ, STJ", "Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal", "Health Care Sector Update for 04/19/2016: SCMP, AMGN, MRK, ABT, PFE, JNJ", "3 Biotech Stocks That Could Endure Hillary Clinton", "Glaxo (GSK) Q1 Earnings: What's in Store for the Stock?", "Health Care Sector Update for 04/15/2016: AMGN, MRK, ABT, PFE, JNJ, VRX, MRNS", "Surprising Analyst 12-Month Target For IWL", "Will Perrigo (PRGO) Surprise Earnings Estimates in Q1?", "IWF, AMGN, UNH, MA: Large Outflows Detected at ETF", "Health Care Sector Update for 04/14/2016: AMGN, MRK, ABT, PFE, JNJ, ABBV, ENTA, SNTA", "Trade of the Day: Pounce on AMGN Stock on a Pullback", "Health Care Sector Update for 04/18/2016: MDVN, BIIB, AMGN, MRK, ABT, PFE, JNJ", "3 Biotech Takeover Targets That Could Get Bought Soon", "Health Care Sector Update for 04/12/2016: AMGN, MRK, ABT, PFE, JNJ, CLVS, CBRP", "Shares of Regeneron Pharmaceuticals, Inc. Struggled in March -- Here's Why", "Novartis Binocrit's Subcutaneous Formula Gets EC Approval", "Notable ETF Outflow Detected - IWB, GILD, AMGN, SBUX", "Pfizer's (PFE) Biosimilar of Remicade Receives FDA Approval", "7 Healthcare Stocks to Buy for Your Retirement", "Health Care Sector Update for 04/13/2016: OCLS, PSTI, AMGN, MRK, ABT, PFE, JNJ", "This Amgen News Could Be a Game-Changer in its Fight Against Sanofi and Regeneron Pharmaceuticals", "Amgen Breaks Above 200-Day Moving Average - Bullish for AMGN", "3 Biotech Stocks on the Verge of an Overdue Run (AMGN, GILD, REGN)", "Better Buy: Regeneron Pharmaceuticals, Inc. vs. Amgen", "Pfizer's PCSK9 Inhibitor Positive in Second Phase III Study", "This Could Be the Next Big Pharma Buyout", "Post Conference Get-Together", "Forget Regeneron Pharmaceuticals, Inc.: These 2 Stocks Are Better Buys", "This Amgen News Could Be a Game-Changer in its Fight Against Sanofi and Regeneron Pharmaceuticals", "Better Buy: Amgen Inc. vs. Celgene Corp.", "Community Banks Can Be the 'Teddy Bears' to Shield Against Market", "Why Fitbit Inc (FIT), Medivation Inc (MDVN) and Tesla Motors Inc (TSLA) Are 3 of Today\u2019s Best Stocks", "Health Care Sector Update for 03/31/2016: MDVN,AZN,GILD,AMGN,SNY,GNVA,LIFE", "3 Biotech Stocks That Make the Grade for Investors", "Opko Health Inc.: FDA Denial Won\u2019t Kill OPK", "4 Best Biotech Stocks of the First Quarter of 2016", "Noteworthy ETF Outflows: SPY, JNJ, UNH, AMGN", "Last Week's Best Healthcare ETF", "The Zacks Analyst Blog Highlights: Gilead, Amgen, Regeneron, Ionis and Biogen", "4 Surging Stocks Brokers Love in the Healthcare Sector", "9 Things You Need to Know About Biosimilar Drugs", "Regeneron/Sanofi Report Positive Phase III Data on Praluent", "Gilead & Biogen's Patent Woes, Amgen Scores Win in Patent Litigation", "3 Biotech Stocks You Don't Have to Babysit", "Stock Market News for March 22, 2012", "Gilead and 4 Other Buy Stocks in the Biotech Industry", "Biogen Inc. vs. Amgen: Which Big Biotech Is the Smarter Buy Today?", "Forget CVS Health Corp.: Here Are 2 Better Dividend Stocks", "UCB and Amgen Report Positive Data on Osteoporosis Drug", "This Big Biotech ETF Faces a Key Technical Test", "Amgen, Inc.: AMGN Stock Looking to Break Out", "J&J, Roche Tie Up to Study Dual Immunotherapy Combination", "Stock Market News for March 22, 2012", "Zacks Industry Outlook Highlights: Valeant, Pfizer, Amgen and Biogen", "Amgen Wins PCSK9 Lawsuit, Sanofi and Regeneron to Appeal", "Why Investors Should Sell These Biotech Stocks & Buy Gilead Instead", "Biotech Investing Guide: 3 Stocks to Buy and 3 to Avoid", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2016", "Better Buy: Amgen Inc. vs. Biogen", "Kite Collaborates with Roche for Immunotherapy Cocktail", "How Risky Is Opko Health Inc. Stock?", "Zacks Industry Outlook Highlights: Valeant, Pfizer, Amgen and Biogen", "What Does Trump's Healthcare Plan Mean for Investors?", "3 Reasons Novartis Stock Could Rise", "Daily Dividend Report: GD, AVGO, AMGN, PXD, HES, HRB", "The Zacks Analyst Blog Highlights: Gilead, Amgen, Baxalta, PTC Therapeutics and Cara Therapeutics", "AbbVie's Boehringer Deal to Boost Immunology Pipeline", "Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in Immuno-Oncology Deal", "Kite Pharma Q4 Loss Wider but Focus Remains on KTE-C19", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 02, 2016", "Did Amgen's Experimental Osteoporosis Drug Just Whiff at the Plate?", "The Zacks Analyst Blog Highlights: Catalyst Pharma, PTC Therapeutics, Radius Health, Amgen and Celgene", "Kite (KITE) to Report 4Q Earnings: What's in Store?", "Biotech Stock Roundup: PTCT Plunges on \"RTF\" from FDA, Radius Shoots Up on Amgen Data", "Amgen Seeks FDA Approval for Blincyto's Label Expansion", "Biotech Stock Roundup: Gilead HIV Drug Approved, Baxalta in Immuno-Oncology Deal", "Kite Pharma Q4 Loss Wider but Focus Remains on KTE-C19", "Health Care Sector Update for 02/22/2016: UNIS,AMGN,TRVN,CMRX", "Midday Update: Oil Lifts Dow to Seven-Week High, Energy Stocks Lead Broad-Based Rally for Markets", "Why Radius Health Inc. is Screaming Higher Today", "5 Beaten Down Stocks with Strong Dividend Yields", "AstraZeneca Zurampic Gets EU Nod, Brilique Label Expanded", "The Zacks Analyst Blog Highlights: Amgen, CVR Refining, Essex Property Trust, Avalonbay Communities and Willis Towers Watson", "IWV, ORCL, AMGN, CVS: Large Outflows Detected at ETF", "Can Biotech Stocks Bounce Back?", "New Strong Buy Stocks for February 18th", "AstraZeneca Cancer Drug Gets Breakthrough Therapy Status", "Health Care Sector Update for 02/16/2016: AMGN, CPHR", "Novartis Acquires Rights to Biosimilar of Remicade from Pfizer", "Amgen's Aranesp Meets Primary Endpoint in Phase III Study", "Better Buy: Gilead Sciences Inc. vs. Amgen Inc.", "Novartis Filing for Neulasta Biosimilar Accepted in the EU", "This FDA Panel Decision Just Changed the Game", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2016", "Pfizer's Biosimilar of Remicade Recommended for Approval", "Bio-Techne Corp (TECH) Ex-Dividend Date Scheduled for February 10, 2016", "Biotech ETFs Slide as Stocks Report Mixed Q4 Results", "Ligand Pharmaceuticals (LGND): Q4 Earnings Preview", "Gilead Sciences Wants to Make Being a Shareholder Worth It", "Amgen's Blincyto and Repatha Positive in Phase III Studies", "Will 2016 Be Amgen Inc.'s Best Year Yet?", "Noteworthy ETF Outflows: IUSG, AMGN, UNP, RAI", "Why NantKwest Shares Fell 41% in January", "Company News for February 01, 2016", "3 Biotech Stocks You Don't Have to Babysit", "Biotech Billionaire Launches His Most Auspicious Project Yet", "Biogen Inc. Takes Aim at Johnson & Johnson", "AbbVie: There Ain't No Stinkin' Biosimilar Threat", "Amgen's Q4 Crushed Estimates and Answered 3 Important Questions in the Process", "The Zacks Analyst Blog Highlights: Amazon.com, Microsoft, Visa, Skyworks Solutions and Amgen", "Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook", "Biotech ETF (IBB) Hits New 52-Week Low", "Top Biotechs for 2016", "Q4 Pedal to the Metal: AMZN, MSFT, V & More", "Where to Invest Money in 2016: 7 Great Ideas", "Celgene Corporation Looks Forward", "Earnings Reaction History: Amgen Inc., 70.0% Follow-Through Indicator, 3.2% Sensitive", "After-Hours Earnings Report for January 28, 2016 : MSFT, AMZN, V, AMGN, EA, SWKS, WDC, KLAC, EMN, CPT, FLEX, N", "3 Key Numbers to Monitor When Amgen Reports Fourth-Quarter Results", "Amgen's Biosimilar of AbbVie's Humira under FDA Review", "3 Healthcare Stocks You Don't Have to Babysit", "Will Amgen (AMGN) Continue with the Earnings Streak in Q4?", "Amgen (AMGN) Beats Q4 Earnings, Revenue Estimates", "3 Reasons to Be Bearish on CVS Health", "Amgen Presents Encouraging Phase III Data on Vectibix", "Novartis (NVS) to Report Q4 Earnings: Will It Disappoint?", "Last Week's Best Healthcare ETF", "Amgen Kyprolis' Label Expanded, Repatha Approved in Japan", "5 Burning Questions We Want Answered When Johnson & Johnson Reports Its Q4 Results", "The Weekly Play: Sell Calls on This Sector (IBB)", "IUSG, GOOGL, GOOG, AMGN: Large Outflows Detected at ETF", "3 Slides That Perfectly Sum Up Where AbbVie Is Headed Next", "Biogen's (BIIB) Biosimilar of Amgen's Enbrel Gets EU Nod", "The Best Healthcare ETF of the Week", "AbbVie's Management Just Made Some Pretty Bold Predictions", "7 Battered Biotech Stocks: Bargains or Busts?", "Was Celgene Corporation's Bad News Really That Bad?", "5 Slides That Tell You Everything You Need to Know About Amgen", "Biotech Stock Roundup: Sarepta Plunges on Briefing Documents, Acorda to Buy Biotie", "Coherus Biosciences and Baxalta Take Aim at Amgen and Pfizer", "4 Great Retirement Stocks to Buy in 2016", "Agree To Buy Amgen At $95, Earn 5.7% Using Options", "The Zacks Analyst Blog Highlights: AbbVie, Amgen, Ligand Pharmaceuticals, Revance Therapeutics and Exelixis", "Stocks, Mutual Funds Rose In Q4 Despite Dec. Woes", "5 Biotech Stocks That Doubled in 2015", "IUSG, AMGN, UNH, CELG: Large Outflows Detected at ETF", "3 Stocks with Better Dividends Than CVS Health Corporation", "Coherus Biosciences and Baxalta Take Aim at Amgen and Pfizer", "Why Amgen is a Top 25 Dividend Giant (AMGN)", "Midday Update: Stocks Unravel on Global Growth Concerns; Mid-East Tensions, Soft U. S. Data Also Weigh on Markets", "Mid-Morning Market Update: Markets Open Lower; Tesla Motors Delivers 17,400 Vehicles in Fourth Quarter", "Stock Futures Fall as Chinese Manufacturing Slows, Mid-East Tensions Escalate", "Health Care Sector Update for 01/04/2016: AMAG,UNIS,MYMX", "Health Care Sector Update for 01/04/2016: RWLK,UNIS,MYMX", "Biotech Stock Roundup: MannKind Tanks on Deal Termination, Speedy Review for Gilead Drug", "Alan Fournier Sells GM, Buys Molson Coors Brewing", "The Biggest Healthcare Headlines of 2015", "Will 2016 Be Johnson & Johnson's Best Year Yet?", "Will Amgen Inc. Raise Its Dividend in 2016?", "AMGN Named A Top Socially Responsible Dividend Stock", "Ligand (LGND) Upgraded to Buy, Perfect for Your Portfolio", "Tuesday's ETF Movers: VPL, ECON", "What Does 2016 Hold for Biotech Stocks?", "Celgene Corporation's Best Drug in 2015", "Enzon Pharmaceuticals, Inc. (ENZN) Ex-Dividend Date Scheduled for December 30, 2015", "What Happened in Biotech in 2015?", "The Worst Regeneron Pharmaceuticals, Inc. Headlines in 2015", "Biotech Industry Could Offer Early Profit in 2016", "The Zacks Analyst Blog Highlights: Actelion, Amgen, Gilead, AbbVie and BioMarin", "Biotech Stock Roundup: KaloBios Removes CEO Shkreli, Actelion PAH Drug Approved", "Notable ETF Outflow Detected - IWB, AMGN, MA, ABBV", "Baxalta/Momenta's Humira Biosimilar Meets Trial Objective", "9 Great Dividend-Paying Stocks for 2016", "Why Aegerion Pharmaceuticals' Stock Bolted Higher Today", "5 Can't-Miss Drug Approvals of 2015", "Stock Market News for December 17, 2015", "Company News for December 17, 2015", "The Best Amgen Inc. Headlines in 2015", "Pfizer Inc.'s Biggest Disappointment in 2015", "4 Top Dividend Plays To Help Cure Stock Price Blues", "Big Biotech Amgen Facing Pivotal Year In 2016", "Instant Analysis: Amgen Cranks Dividend 27% Higher", "Biotech Stock Roundup: Amgen Hikes First Quarter Dividend, ARIAD Lowers Iclusig Outlook", "Amgen Returns More to Shareholders, Hikes Dividend by 27%", "Daily Dividend Report: AMGN, CVS, BEN, MCO, USB, GIS, SRE, O", "Amgen (AMGN) Shares Cross Above 200 DMA", "The Zacks Analyst Blog Highlights: Amgen, ARIAD, Clovis Oncology, Regeneron and Akebia Therapeutics", "Amgen Regains Rights to Prolia, Xgeva & Vectibix from Glaxo", "The Best Johnson & Johnson Headlines in 2015", "Why Akebia Therapeutics Shares Soared 10% Today", "Top FDA Drug Approvals in 2015: High Cholesterol", "IBB, AMGN, REGN, BIIB: Large Outflows Detected at ETF", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2015", "Merck and Eli Lilly Expand Immuno-Oncology Collaboration", "Did CVS Health Just Make a Huge Mistake?", "Aegerion Pharmaceuticals Lost a Third of Its Value in November: Time to Buy?", "Novartis??? Biosimilar for Pfizer???s Enbrel Accepted in the EU", "Health Care Sector Update for 12/09/2015: CHRS,AMGN,AEZS,AEZ.TO", "The Top 3 Drug Approvals of 2015", "Amgen Seeks Kyprolis Label Expansion, Inks Deals with Merck", "Stock Market News for December 04, 2015", "The 3 Most Important Drugs in Amgen's Pipeline", "3 Attractive Income Stocks Whose Dividends Could Double", "PowerShares Dynamic Pharmaceuticals Portfolio Experiences Big Inflow", "The Zacks Analyst Blog Highlights: Repros Therapeutics, AbbVie, Amgen, XOMA and Gilead", "Foamix Pharmaceuticals Ltd Hopes to Profit From Eli Lilly's and Amgen's Side Effect", "Stock Market News for December 02, 2015", "Biotech Stock Roundup: Repros Tanks on CRL, AbbVie Multiple Myeloma Drug Approved", "CVS Health Plays Favorites with New Cholesterol Drugs", "PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 02, 2015", "Health Care Sector Update for 12/04/2015: PTLA, GALE, AMGN", "What Healthcare Dividend Stock Is Best?", "The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros", "Amgen Seeks FDA Approval for First Biosimilar of Humira", "Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Drug", "Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen", "Healthcare's Greatest Dividend Stocks", "Amgen's Repatha Gets Preferred Position on CVS Formularies", "Amgen Inc. Takes Aim at AbbVie Inc.", "What Healthcare Dividend Stock Is Best?", "5 Things Amgen, Inc. Wants You to Know", "The Best Healthcare ETF of the Week", "Better Dividend Stock: Amgen or AstraZeneca PLC?", "Amgen's Multiple Myeloma Drug Kyprolis Gains EU Approval", "Amgen's Repatha Is Too Bloody Pricey for the U.K.", "Novartis: FDA Accepts BLA for Biosimilar Version of Neulasta"], "Elapsed Time": ["19 HOURS AGO", "1 DAY AGO", "1 DAY AGO", "2 DAYS AGO", "5 DAYS AGO", "JUN 4, 2020", "JUN 3, 2020", "JUN 2, 2020", "19 HOURS AGO", "MAY 27, 2020", "MAY 26, 2020", "MAY 24, 2020", "MAY 19, 2020", "MAY 18, 2020", "MAY 17, 2020", "MAY 17, 2020", "MAY 28, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 13, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 11, 2020", "MAY 8, 2020", "MAY 15, 2020", "MAY 6, 2020", "MAY 5, 2020", "MAY 5, 2020", "MAY 1, 2020", "MAY 1, 2020", "APR 30, 2020", "APR 30, 2020", "MAY 6, 2020", "APR 30, 2020", "APR 30, 2020", "APR 28, 2020", "APR 28, 2020", "APR 27, 2020", "APR 26, 2020", "APR 23, 2020", "APR 30, 2020", "APR 22, 2020", "APR 20, 2020", "APR 19, 2020", "APR 17, 2020", "APR 17, 2020", "APR 17, 2020", "APR 16, 2020", "APR 23, 2020", "APR 10, 2020", "APR 9, 2020", "APR 7, 2020", "APR 4, 2020", "APR 2, 2020", "APR 2, 2020", "APR 2, 2020", "APR 14, 2020", "MAR 31, 2020", "MAR 30, 2020", "MAR 30, 2020", "MAR 27, 2020", "MAR 26, 2020", "MAR 26, 2020", "MAR 25, 2020", "MAR 31, 2020", "MAR 17, 2020", "MAR 16, 2020", "MAR 15, 2020", "MAR 12, 2020", "MAR 11, 2020", "MAR 9, 2020", "MAR 5, 2020", "MAR 20, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 4, 2020", "MAR 3, 2020", "MAR 3, 2020", "FEB 28, 2020", "FEB 27, 2020", "MAR 5, 2020", "FEB 27, 2020", "FEB 27, 2020", "FEB 26, 2020", "FEB 25, 2020", "FEB 24, 2020", "FEB 21, 2020", "FEB 21, 2020", "FEB 27, 2020", "FEB 21, 2020", "FEB 19, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 13, 2020", "FEB 10, 2020", "FEB 8, 2020", "FEB 21, 2020", "FEB 6, 2020", "FEB 6, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 4, 2020", "FEB 4, 2020", "FEB 2, 2020", "FEB 7, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 31, 2020", "FEB 2, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 29, 2020", "JAN 28, 2020", "JAN 26, 2020", "JAN 30, 2020", "JAN 24, 2020", "JAN 24, 2020", "JAN 23, 2020", "JAN 19, 2020", "JAN 19, 2020", "JAN 17, 2020", "JAN 16, 2020", "JAN 25, 2020", "JAN 24, 2020", "JAN 10, 2020", "JAN 9, 2020", "JAN 7, 2020", "JAN 6, 2020", "JAN 6, 2020", "JAN 14, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 2, 2020", "JAN 1, 2020", "DEC 31, 2019", "DEC 30, 2019", "JAN 2, 2020", "DEC 30, 2019", "DEC 28, 2019", "DEC 27, 2019", "DEC 24, 2019", "DEC 22, 2019", "DEC 21, 2019", "DEC 19, 2019", "DEC 30, 2019", "DEC 18, 2019", "DEC 17, 2019", "DEC 16, 2019", "DEC 16, 2019", "DEC 16, 2019", "DEC 15, 2019", "DEC 13, 2019", "DEC 19, 2019", "DEC 12, 2019", "DEC 12, 2019", "DEC 12, 2019", "DEC 11, 2019", "DEC 11, 2019", "DEC 10, 2019", "DEC 9, 2019", "DEC 12, 2019", "DEC 9, 2019", "DEC 8, 2019", "DEC 7, 2019", "DEC 6, 2019", "DEC 6, 2019", "DEC 6, 2019", "DEC 6, 2019", "DEC 9, 2019", "DEC 2, 2019", "DEC 2, 2019", "DEC 1, 2019", "NOV 29, 2019", "NOV 27, 2019", "NOV 27, 2019", "NOV 26, 2019", "DEC 4, 2019", "NOV 25, 2019", "NOV 25, 2019", "NOV 25, 2019", "NOV 24, 2019", "NOV 24, 2019", "NOV 22, 2019", "NOV 22, 2019", "NOV 25, 2019", "NOV 21, 2019", "NOV 21, 2019", "NOV 21, 2019", "NOV 20, 2019", "NOV 20, 2019", "NOV 20, 2019", "NOV 19, 2019", "NOV 21, 2019", "NOV 18, 2019", "NOV 18, 2019", "NOV 16, 2019", "NOV 14, 2019", "NOV 13, 2019", "NOV 12, 2019", "NOV 11, 2019", "NOV 19, 2019", "NOV 9, 2019", "NOV 7, 2019", "NOV 7, 2019", "NOV 6, 2019", "NOV 6, 2019", "NOV 5, 2019", "NOV 4, 2019", "NOV 11, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "OCT 31, 2019", "OCT 31, 2019", "NOV 2, 2019", "OCT 31, 2019", "OCT 31, 2019", "OCT 30, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 29, 2019", "OCT 31, 2019", "OCT 29, 2019", "OCT 26, 2019", "OCT 24, 2019", "OCT 23, 2019", "OCT 23, 2019", "OCT 23, 2019", "OCT 20, 2019", "OCT 29, 2019", "OCT 18, 2019", "OCT 11, 2019", "OCT 7, 2019", "OCT 7, 2019", "OCT 4, 2019", "OCT 3, 2019", "OCT 3, 2019", "OCT 18, 2019", "OCT 1, 2019", "OCT 1, 2019", "SEP 28, 2019", "SEP 27, 2019", "SEP 27, 2019", "SEP 27, 2019", "SEP 26, 2019", "OCT 2, 2019", "SEP 18, 2019", "SEP 17, 2019", "SEP 17, 2019", "SEP 16, 2019", "SEP 15, 2019", "SEP 13, 2019", "SEP 26, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 11, 2019", "SEP 10, 2019", "SEP 10, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 12, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 9, 2019", "SEP 8, 2019", "SEP 8, 2019", "SEP 8, 2019", "SEP 6, 2019", "SEP 9, 2019", "SEP 5, 2019", "SEP 3, 2019", "AUG 30, 2019", "AUG 28, 2019", "AUG 27, 2019", "AUG 26, 2019", "AUG 26, 2019", "SEP 5, 2019", "AUG 26, 2019", "AUG 25, 2019", "AUG 24, 2019", "AUG 23, 2019", "AUG 22, 2019", "AUG 21, 2019", "AUG 18, 2019", "AUG 26, 2019", "AUG 14, 2019", "AUG 13, 2019", "AUG 12, 2019", "AUG 12, 2019", "AUG 12, 2019", "AUG 12, 2019", "AUG 11, 2019", "AUG 14, 2019", "AUG 6, 2019", "AUG 5, 2019", "AUG 5, 2019", "AUG 4, 2019", "AUG 2, 2019", "JUL 31, 2019", "JUL 31, 2019", "AUG 7, 2019", "JUL 31, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 29, 2019", "JUL 27, 2019", "JUL 25, 2019", "JUL 31, 2019", "JUL 22, 2019", "JUL 17, 2019", "JUL 15, 2019", "JUL 12, 2019", "JUL 10, 2019", "JUL 8, 2019", "JUL 8, 2019", "JUL 23, 2019", "JUL 8, 2019", "JUL 6, 2019", "JUL 1, 2019", "JUL 1, 2019", "JUN 30, 2019", "JUN 29, 2019", "JUN 29, 2019", "JUL 8, 2019", "JUN 27, 2019", "JUN 25, 2019", "JUN 19, 2019", "JUN 19, 2019", "JUN 18, 2019", "JUN 18, 2019", "JUN 16, 2019", "JUN 27, 2019", "JUN 7, 2019", "JUN 6, 2019", "JUN 6, 2019", "JUN 4, 2019", "JUN 3, 2019", "JUN 3, 2019", "JUN 3, 2019", "JUN 10, 2019", "MAY 30, 2019", "MAY 28, 2019", "MAY 26, 2019", "MAY 23, 2019", "MAY 23, 2019", "MAY 21, 2019", "MAY 31, 2019", "MAY 16, 2019", "MAY 16, 2019", "MAY 16, 2019", "MAY 15, 2019", "MAY 10, 2019", "MAY 8, 2019", "MAY 5, 2019", "MAY 17, 2019", "MAY 1, 2019", "MAY 1, 2019", "APR 30, 2019", "APR 30, 2019", "APR 30, 2019", "APR 30, 2019", "APR 30, 2019", "MAY 2, 2019", "APR 29, 2019", "APR 26, 2019", "APR 22, 2019", "APR 22, 2019", "APR 18, 2019", "APR 18, 2019", "APR 16, 2019", "APR 30, 2019", "APR 15, 2019", "APR 13, 2019", "APR 10, 2019", "APR 9, 2019", "APR 9, 2019", "APR 9, 2019", "APR 9, 2019", "APR 16, 2019", "APR 15, 2019", "APR 9, 2019", "APR 8, 2019", "APR 8, 2019", "APR 7, 2019", "APR 7, 2019", "APR 5, 2019", "APR 9, 2019", "APR 4, 2019", "APR 4, 2019", "APR 2, 2019", "APR 2, 2019", "APR 1, 2019", "APR 1, 2019", "MAR 30, 2019", "APR 4, 2019", "MAR 26, 2019", "MAR 26, 2019", "MAR 25, 2019", "MAR 25, 2019", "MAR 22, 2019", "MAR 20, 2019", "MAR 18, 2019", "MAR 27, 2019", "MAR 18, 2019", "MAR 17, 2019", "MAR 15, 2019", "MAR 15, 2019", "MAR 14, 2019", "MAR 13, 2019", "MAR 12, 2019", "MAR 18, 2019", "MAR 11, 2019", "MAR 11, 2019", "MAR 10, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 12, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 6, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 1, 2019", "MAR 1, 2019", "MAR 6, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 25, 2019", "FEB 24, 2019", "FEB 22, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 26, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 20, 2019", "FEB 19, 2019", "FEB 18, 2019", "FEB 17, 2019", "FEB 14, 2019", "FEB 21, 2019", "FEB 13, 2019", "FEB 13, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 12, 2019", "FEB 11, 2019", "FEB 11, 2019", "FEB 13, 2019", "FEB 7, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 6, 2019", "FEB 5, 2019", "FEB 5, 2019", "FEB 11, 2019", "FEB 4, 2019", "FEB 3, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 1, 2019", "FEB 4, 2019", "JAN 31, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 30, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "FEB 1, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 28, 2019", "JAN 25, 2019", "JAN 25, 2019", "JAN 25, 2019", "JAN 29, 2019", "JAN 25, 2019", "JAN 24, 2019", "JAN 24, 2019", "JAN 24, 2019", "JAN 24, 2019", "JAN 23, 2019", "JAN 23, 2019", "JAN 25, 2019", "JAN 21, 2019", "JAN 21, 2019", "JAN 20, 2019", "JAN 18, 2019", "JAN 17, 2019", "JAN 16, 2019", "JAN 16, 2019", "JAN 21, 2019", "JAN 14, 2019", "JAN 14, 2019", "JAN 9, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 15, 2019", "JAN 4, 2019", "JAN 4, 2019", "JAN 3, 2019", "JAN 3, 2019", "JAN 3, 2019", "JAN 3, 2019", "JAN 3, 2019", "JAN 6, 2019", "JAN 2, 2019", "DEC 29, 2018", "DEC 28, 2018", "DEC 28, 2018", "DEC 27, 2018", "DEC 27, 2018", "JAN 2, 2019", "DEC 21, 2018", "DEC 21, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 20, 2018", "DEC 24, 2018", "DEC 19, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 19, 2018", "DEC 15, 2018", "DEC 14, 2018", "DEC 14, 2018", "DEC 13, 2018", "DEC 12, 2018", "DEC 12, 2018", "DEC 12, 2018", "DEC 17, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 10, 2018", "DEC 10, 2018", "DEC 10, 2018", "DEC 7, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 11, 2018", "DEC 3, 2018", "DEC 3, 2018", "DEC 3, 2018", "NOV 29, 2018", "NOV 28, 2018", "DEC 5, 2018", "NOV 28, 2018", "NOV 27, 2018", "NOV 26, 2018", "NOV 26, 2018", "NOV 22, 2018", "NOV 21, 2018", "NOV 19, 2018", "NOV 28, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 16, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 14, 2018", "NOV 14, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 19, 2018", "NOV 11, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 13, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 7, 2018", "NOV 6, 2018", "NOV 7, 2018", "NOV 3, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 1, 2018", "NOV 1, 2018", "NOV 5, 2018", "OCT 31, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 30, 2018", "OCT 31, 2018", "OCT 31, 2018", "OCT 29, 2018", "OCT 29, 2018", "OCT 28, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 30, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 26, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 26, 2018", "OCT 25, 2018", "OCT 25, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 25, 2018", "OCT 23, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 21, 2018", "OCT 23, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 17, 2018", "OCT 16, 2018", "OCT 15, 2018", "OCT 20, 2018", "OCT 12, 2018", "OCT 12, 2018", "OCT 12, 2018", "OCT 11, 2018", "OCT 11, 2018", "OCT 11, 2018", "OCT 11, 2018", "OCT 15, 2018", "OCT 10, 2018", "OCT 9, 2018", "OCT 9, 2018", "OCT 9, 2018", "OCT 9, 2018", "OCT 8, 2018", "OCT 8, 2018", "OCT 11, 2018", "OCT 4, 2018", "OCT 3, 2018", "OCT 3, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 1, 2018", "SEP 28, 2018", "OCT 5, 2018", "OCT 4, 2018", "SEP 27, 2018", "SEP 26, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 21, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 19, 2018", "SEP 18, 2018", "SEP 18, 2018", "SEP 21, 2018", "SEP 17, 2018", "SEP 16, 2018", "SEP 15, 2018", "SEP 14, 2018", "SEP 14, 2018", "SEP 13, 2018", "SEP 17, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 13, 2018", "SEP 7, 2018", "SEP 6, 2018", "SEP 6, 2018", "SEP 5, 2018", "SEP 5, 2018", "SEP 4, 2018", "SEP 2, 2018", "SEP 10, 2018", "AUG 29, 2018", "AUG 29, 2018", "AUG 28, 2018", "AUG 27, 2018", "AUG 27, 2018", "AUG 24, 2018", "AUG 24, 2018", "AUG 31, 2018", "AUG 29, 2018", "AUG 23, 2018", "AUG 22, 2018", "AUG 22, 2018", "AUG 21, 2018", "AUG 20, 2018", "AUG 15, 2018", "AUG 24, 2018", "AUG 15, 2018", "AUG 14, 2018", "AUG 14, 2018", "AUG 14, 2018", "AUG 14, 2018", "AUG 13, 2018", "AUG 13, 2018", "AUG 15, 2018", "AUG 9, 2018", "AUG 8, 2018", "AUG 8, 2018", "AUG 7, 2018", "AUG 7, 2018", "AUG 6, 2018", "AUG 6, 2018", "AUG 10, 2018", "AUG 2, 2018", "AUG 2, 2018", "AUG 1, 2018", "AUG 1, 2018", "JUL 31, 2018", "JUL 27, 2018", "JUL 27, 2018", "AUG 3, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 24, 2018", "JUL 23, 2018", "JUL 27, 2018", "JUL 19, 2018", "JUL 19, 2018", "JUL 19, 2018", "JUL 18, 2018", "JUL 18, 2018", "JUL 18, 2018", "JUL 17, 2018", "JUL 23, 2018", "JUL 16, 2018", "JUL 16, 2018", "JUL 15, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 16, 2018", "JUL 12, 2018", "JUL 11, 2018", "JUL 11, 2018", "JUL 10, 2018", "JUL 10, 2018", "JUL 9, 2018", "JUL 6, 2018", "JUL 12, 2018", "JUL 6, 2018", "JUL 5, 2018", "JUL 5, 2018", "JUL 5, 2018", "JUL 3, 2018", "JUL 3, 2018", "JUL 2, 2018", "JUL 6, 2018", "JUL 2, 2018", "JUL 1, 2018", "JUN 29, 2018", "JUN 28, 2018", "JUN 28, 2018", "JUN 28, 2018", "JUN 27, 2018", "JUL 2, 2018", "JUL 2, 2018", "JUN 26, 2018", "JUN 26, 2018", "JUN 25, 2018", "JUN 25, 2018", "JUN 24, 2018", "JUN 22, 2018", "JUN 27, 2018", "JUN 20, 2018", "JUN 20, 2018", "JUN 18, 2018", "JUN 18, 2018", "JUN 15, 2018", "JUN 15, 2018", "JUN 14, 2018", "JUN 21, 2018", "JUN 14, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 12, 2018", "JUN 14, 2018", "JUN 11, 2018", "JUN 11, 2018", "JUN 8, 2018", "JUN 6, 2018", "JUN 5, 2018", "JUN 5, 2018", "JUN 5, 2018", "JUN 12, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 3, 2018", "JUN 3, 2018", "JUN 1, 2018", "JUN 5, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 31, 2018", "MAY 23, 2018", "MAY 23, 2018", "MAY 23, 2018", "MAY 22, 2018", "MAY 22, 2018", "MAY 21, 2018", "MAY 21, 2018", "MAY 24, 2018", "MAY 18, 2018", "MAY 18, 2018", "MAY 18, 2018", "MAY 18, 2018", "MAY 17, 2018", "MAY 17, 2018", "MAY 17, 2018", "MAY 21, 2018", "MAY 16, 2018", "MAY 15, 2018", "MAY 15, 2018", "MAY 14, 2018", "MAY 14, 2018", "MAY 11, 2018", "MAY 11, 2018", "MAY 16, 2018", "MAY 16, 2018", "MAY 15, 2018", "MAY 15, 2018", "MAY 14, 2018", "MAY 5, 2018", "MAY 4, 2018", "MAY 4, 2018", "MAY 10, 2018", "MAY 2, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "APR 30, 2018", "APR 27, 2018", "MAY 4, 2018", "MAY 3, 2018", "MAY 2, 2018", "MAY 1, 2018", "MAY 1, 2018", "MAY 1, 2018", "APR 24, 2018", "APR 24, 2018", "APR 26, 2018", "APR 24, 2018", "APR 24, 2018", "APR 23, 2018", "APR 23, 2018", "APR 20, 2018", "APR 20, 2018", "APR 20, 2018", "APR 24, 2018", "APR 20, 2018", "APR 19, 2018", "APR 18, 2018", "APR 18, 2018", "APR 18, 2018", "APR 18, 2018", "APR 17, 2018", "APR 20, 2018", "APR 12, 2018", "APR 12, 2018", "APR 10, 2018", "APR 6, 2018", "APR 5, 2018", "APR 5, 2018", "APR 4, 2018", "APR 12, 2018", "APR 3, 2018", "APR 3, 2018", "APR 3, 2018", "APR 2, 2018", "MAR 30, 2018", "MAR 30, 2018", "MAR 29, 2018", "APR 4, 2018", "MAR 27, 2018", "MAR 27, 2018", "MAR 26, 2018", "MAR 26, 2018", "MAR 26, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 28, 2018", "MAR 23, 2018", "MAR 23, 2018", "MAR 22, 2018", "MAR 22, 2018", "MAR 21, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 23, 2018", "MAR 16, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 19, 2018", "MAR 12, 2018", "MAR 12, 2018", "MAR 9, 2018", "MAR 8, 2018", "MAR 8, 2018", "MAR 7, 2018", "MAR 7, 2018", "MAR 13, 2018", "MAR 6, 2018", "MAR 6, 2018", "MAR 6, 2018", "MAR 5, 2018", "MAR 5, 2018", "MAR 2, 2018", "MAR 2, 2018", "MAR 7, 2018", "MAR 1, 2018", "MAR 1, 2018", "FEB 28, 2018", "FEB 27, 2018", "FEB 27, 2018", "FEB 26, 2018", "FEB 23, 2018", "MAR 1, 2018", "FEB 23, 2018", "FEB 22, 2018", "FEB 21, 2018", "FEB 21, 2018", "FEB 21, 2018", "FEB 20, 2018", "FEB 18, 2018", "FEB 23, 2018", "FEB 16, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 14, 2018", "FEB 14, 2018", "FEB 14, 2018", "FEB 16, 2018", "FEB 13, 2018", "FEB 13, 2018", "FEB 13, 2018", "FEB 12, 2018", "FEB 11, 2018", "FEB 9, 2018", "FEB 8, 2018", "FEB 13, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 6, 2018", "FEB 3, 2018", "FEB 2, 2018", "FEB 1, 2018", "FEB 1, 2018", "FEB 6, 2018", "FEB 1, 2018", "FEB 1, 2018", "JAN 31, 2018", "JAN 31, 2018", "JAN 30, 2018", "JAN 30, 2018", "JAN 30, 2018", "FEB 1, 2018", "JAN 30, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 29, 2018", "JAN 28, 2018", "JAN 26, 2018", "JAN 30, 2018", "JAN 24, 2018", "JAN 24, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 26, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 21, 2018", "JAN 19, 2018", "JAN 22, 2018", "JAN 19, 2018", "JAN 19, 2018", "JAN 18, 2018", "JAN 18, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 17, 2018", "JAN 19, 2018", "JAN 16, 2018", "JAN 16, 2018", "JAN 16, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 12, 2018", "JAN 11, 2018", "JAN 17, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 11, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 10, 2018", "JAN 11, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 9, 2018", "JAN 8, 2018", "JAN 7, 2018", "JAN 10, 2018", "JAN 5, 2018", "JAN 5, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 4, 2018", "JAN 3, 2018", "JAN 2, 2018", "JAN 6, 2018", "DEC 27, 2017", "DEC 27, 2017", "DEC 23, 2017", "DEC 22, 2017", "DEC 18, 2017", "DEC 18, 2017", "DEC 18, 2017", "DEC 29, 2017", "DEC 17, 2017", "DEC 17, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 15, 2017", "DEC 14, 2017", "DEC 14, 2017", "DEC 18, 2017", "DEC 17, 2017", "DEC 17, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 12, 2017", "DEC 11, 2017", "DEC 11, 2017", "DEC 13, 2017", "DEC 8, 2017", "DEC 7, 2017", "DEC 6, 2017", "DEC 6, 2017", "DEC 6, 2017", "DEC 5, 2017", "DEC 4, 2017", "DEC 8, 2017", "DEC 4, 2017", "DEC 4, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 29, 2017", "DEC 4, 2017", "DEC 4, 2017", "NOV 24, 2017", "NOV 24, 2017", "NOV 22, 2017", "NOV 21, 2017", "NOV 20, 2017", "NOV 29, 2017", "NOV 16, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 15, 2017", "NOV 20, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 13, 2017", "NOV 10, 2017", "NOV 9, 2017", "NOV 8, 2017", "NOV 6, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 14, 2017", "NOV 2, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 31, 2017", "NOV 3, 2017", "OCT 31, 2017", "OCT 30, 2017", "OCT 29, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 27, 2017", "OCT 31, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 27, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 24, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 20, 2017", "OCT 24, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 19, 2017", "OCT 18, 2017", "OCT 20, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 14, 2017", "OCT 17, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 11, 2017", "OCT 10, 2017", "OCT 13, 2017", "OCT 9, 2017", "OCT 9, 2017", "OCT 8, 2017", "OCT 8, 2017", "OCT 7, 2017", "OCT 7, 2017", "OCT 6, 2017", "OCT 10, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 6, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 5, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 4, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "SEP 29, 2017", "SEP 29, 2017", "SEP 29, 2017", "OCT 3, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 28, 2017", "SEP 27, 2017", "SEP 27, 2017", "SEP 26, 2017", "SEP 28, 2017", "SEP 21, 2017", "SEP 21, 2017", "SEP 21, 2017", "SEP 20, 2017", "SEP 20, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 25, 2017", "SEP 17, 2017", "SEP 16, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 15, 2017", "SEP 14, 2017", "SEP 14, 2017", "SEP 18, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 12, 2017", "SEP 14, 2017", "SEP 12, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 7, 2017", "SEP 7, 2017", "SEP 7, 2017", "SEP 6, 2017", "SEP 12, 2017", "SEP 6, 2017", "SEP 4, 2017", "SEP 4, 2017", "SEP 1, 2017", "SEP 1, 2017", "AUG 31, 2017", "AUG 30, 2017", "SEP 6, 2017", "SEP 6, 2017", "AUG 29, 2017", "AUG 29, 2017", "AUG 27, 2017", "AUG 26, 2017", "AUG 25, 2017", "AUG 25, 2017", "AUG 30, 2017", "AUG 29, 2017", "AUG 23, 2017", "AUG 23, 2017", "AUG 22, 2017", "AUG 22, 2017", "AUG 21, 2017", "AUG 20, 2017", "AUG 24, 2017", "AUG 18, 2017", "AUG 16, 2017", "AUG 15, 2017", "AUG 15, 2017", "AUG 15, 2017", "AUG 15, 2017", "AUG 14, 2017", "AUG 18, 2017", "AUG 11, 2017", "AUG 11, 2017", "AUG 10, 2017", "AUG 9, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 14, 2017", "AUG 7, 2017", "AUG 4, 2017", "AUG 3, 2017", "AUG 3, 2017", "AUG 1, 2017", "JUL 31, 2017", "JUL 31, 2017", "AUG 8, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 27, 2017", "JUL 31, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 23, 2017", "JUL 21, 2017", "JUL 21, 2017", "JUL 25, 2017", "JUL 20, 2017", "JUL 19, 2017", "JUL 19, 2017", "JUL 18, 2017", "JUL 18, 2017", "JUL 17, 2017", "JUL 17, 2017", "JUL 21, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 14, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 17, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 12, 2017", "JUL 12, 2017", "JUL 11, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 13, 2017", "JUL 13, 2017", "JUL 10, 2017", "JUL 9, 2017", "JUL 8, 2017", "JUL 6, 2017", "JUL 6, 2017", "JUL 5, 2017", "JUL 10, 2017", "JUL 3, 2017", "JUL 3, 2017", "JUL 3, 2017", "JUL 2, 2017", "JUN 30, 2017", "JUN 30, 2017", "JUN 30, 2017", "JUL 5, 2017", "JUN 28, 2017", "JUN 28, 2017", "JUN 27, 2017", "JUN 27, 2017", "JUN 26, 2017", "JUN 26, 2017", "JUN 22, 2017", "JUN 28, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 20, 2017", "JUN 20, 2017", "JUN 22, 2017", "JUN 20, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 19, 2017", "JUN 18, 2017", "JUN 17, 2017", "JUN 16, 2017", "JUN 20, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 15, 2017", "JUN 15, 2017", "JUN 15, 2017", "JUN 15, 2017", "JUN 16, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 13, 2017", "JUN 12, 2017", "JUN 12, 2017", "JUN 15, 2017", "JUN 12, 2017", "JUN 9, 2017", "JUN 8, 2017", "JUN 8, 2017", "JUN 8, 2017", "JUN 8, 2017", "JUN 7, 2017", "JUN 12, 2017", "JUN 6, 2017", "JUN 6, 2017", "JUN 5, 2017", "JUN 5, 2017", "MAY 31, 2017", "MAY 31, 2017", "MAY 30, 2017", "JUN 6, 2017", "MAY 27, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 25, 2017", "MAY 25, 2017", "MAY 24, 2017", "MAY 24, 2017", "MAY 30, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 23, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 24, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 22, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 22, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 18, 2017", "MAY 17, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 16, 2017", "MAY 19, 2017", "MAY 19, 2017", "MAY 15, 2017", "MAY 14, 2017", "MAY 12, 2017", "MAY 12, 2017", "MAY 12, 2017", "MAY 11, 2017", "MAY 16, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 9, 2017", "MAY 7, 2017", "MAY 4, 2017", "MAY 11, 2017", "MAY 10, 2017", "MAY 10, 2017", "MAY 2, 2017", "APR 29, 2017", "APR 29, 2017", "APR 28, 2017", "MAY 3, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 27, 2017", "APR 26, 2017", "APR 26, 2017", "APR 28, 2017", "APR 27, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 26, 2017", "APR 25, 2017", "APR 25, 2017", "APR 26, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 24, 2017", "APR 24, 2017", "APR 25, 2017", "APR 23, 2017", "APR 21, 2017", "APR 21, 2017", "APR 21, 2017", "APR 20, 2017", "APR 20, 2017", "APR 20, 2017", "APR 24, 2017", "APR 18, 2017", "APR 18, 2017", "APR 17, 2017", "APR 14, 2017", "APR 12, 2017", "APR 12, 2017", "APR 11, 2017", "APR 20, 2017", "APR 18, 2017", "APR 11, 2017", "APR 10, 2017", "APR 8, 2017", "APR 7, 2017", "APR 6, 2017", "APR 6, 2017", "APR 11, 2017", "APR 6, 2017", "APR 5, 2017", "APR 5, 2017", "APR 5, 2017", "APR 5, 2017", "APR 4, 2017", "APR 3, 2017", "APR 6, 2017", "APR 2, 2017", "APR 1, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 30, 2017", "MAR 30, 2017", "APR 3, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 28, 2017", "MAR 27, 2017", "MAR 27, 2017", "MAR 29, 2017", "MAR 27, 2017", "MAR 24, 2017", "MAR 24, 2017", "MAR 24, 2017", "MAR 24, 2017", "MAR 23, 2017", "MAR 22, 2017", "MAR 27, 2017", "MAR 22, 2017", "MAR 21, 2017", "MAR 21, 2017", "MAR 21, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 20, 2017", "MAR 22, 2017", "MAR 19, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 20, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 17, 2017", "MAR 14, 2017", "MAR 14, 2017", "MAR 13, 2017", "MAR 13, 2017", "MAR 13, 2017", "MAR 11, 2017", "MAR 10, 2017", "MAR 15, 2017", "MAR 10, 2017", "MAR 9, 2017", "MAR 8, 2017", "MAR 8, 2017", "MAR 7, 2017", "MAR 7, 2017", "MAR 6, 2017", "MAR 10, 2017", "MAR 10, 2017", "MAR 2, 2017", "MAR 1, 2017", "MAR 1, 2017", "MAR 1, 2017", "FEB 28, 2017", "FEB 28, 2017", "MAR 3, 2017", "FEB 27, 2017", "FEB 26, 2017", "FEB 24, 2017", "FEB 24, 2017", "FEB 23, 2017", "FEB 23, 2017", "FEB 22, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 26, 2017", "FEB 21, 2017", "FEB 17, 2017", "FEB 17, 2017", "FEB 17, 2017", "FEB 16, 2017", "FEB 22, 2017", "FEB 16, 2017", "FEB 16, 2017", "FEB 15, 2017", "FEB 15, 2017", "FEB 15, 2017", "FEB 14, 2017", "FEB 14, 2017", "FEB 16, 2017", "FEB 13, 2017", "FEB 13, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 10, 2017", "FEB 9, 2017", "FEB 13, 2017", "FEB 13, 2017", "FEB 13, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 7, 2017", "FEB 9, 2017", "FEB 6, 2017", "FEB 6, 2017", "FEB 5, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 6, 2017", "FEB 6, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 3, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 1, 2017", "FEB 3, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "FEB 1, 2017", "JAN 31, 2017", "JAN 31, 2017", "FEB 1, 2017", "FEB 1, 2017", "JAN 30, 2017", "JAN 30, 2017", "JAN 27, 2017", "JAN 27, 2017", "JAN 27, 2017", "JAN 27, 2017", "JAN 31, 2017", "JAN 27, 2017", "JAN 26, 2017", "JAN 25, 2017", "JAN 24, 2017", "JAN 19, 2017", "JAN 19, 2017", "JAN 18, 2017", "JAN 27, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 17, 2017", "JAN 14, 2017", "JAN 13, 2017", "JAN 12, 2017", "JAN 11, 2017", "JAN 18, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 10, 2017", "JAN 10, 2017", "JAN 10, 2017", "JAN 10, 2017", "JAN 11, 2017", "JAN 9, 2017", "JAN 9, 2017", "JAN 8, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 10, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 5, 2017", "JAN 6, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 3, 2017", "JAN 1, 2017", "DEC 31, 2016", "DEC 30, 2016", "JAN 4, 2017", "DEC 28, 2016", "DEC 27, 2016", "DEC 25, 2016", "DEC 23, 2016", "DEC 22, 2016", "DEC 21, 2016", "DEC 21, 2016", "DEC 30, 2016", "DEC 20, 2016", "DEC 20, 2016", "DEC 19, 2016", "DEC 19, 2016", "DEC 18, 2016", "DEC 16, 2016", "DEC 16, 2016", "DEC 21, 2016", "DEC 15, 2016", "DEC 15, 2016", "DEC 14, 2016", "DEC 13, 2016", "DEC 13, 2016", "DEC 13, 2016", "DEC 12, 2016", "DEC 15, 2016", "DEC 12, 2016", "DEC 11, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 7, 2016", "DEC 7, 2016", "DEC 7, 2016", "DEC 12, 2016", "DEC 6, 2016", "NOV 30, 2016", "NOV 30, 2016", "NOV 30, 2016", "NOV 30, 2016", "NOV 30, 2016", "NOV 29, 2016", "DEC 6, 2016", "NOV 22, 2016", "NOV 22, 2016", "NOV 21, 2016", "NOV 21, 2016", "NOV 18, 2016", "NOV 18, 2016", "NOV 18, 2016", "NOV 29, 2016", "NOV 17, 2016", "NOV 17, 2016", "NOV 17, 2016", "NOV 16, 2016", "NOV 16, 2016", "NOV 16, 2016", "NOV 15, 2016", "NOV 18, 2016", "NOV 14, 2016", "NOV 14, 2016", "NOV 13, 2016", "NOV 11, 2016", "NOV 11, 2016", "NOV 11, 2016", "NOV 10, 2016", "NOV 14, 2016", "NOV 9, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 10, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 6, 2016", "NOV 4, 2016", "NOV 4, 2016", "NOV 3, 2016", "NOV 2, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 1, 2016", "NOV 1, 2016", "NOV 1, 2016", "OCT 31, 2016", "OCT 30, 2016", "OCT 28, 2016", "NOV 2, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 27, 2016", "OCT 28, 2016", "OCT 27, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 25, 2016", "OCT 27, 2016", "OCT 25, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 24, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 25, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 20, 2016", "OCT 21, 2016", "OCT 21, 2016", "OCT 19, 2016", "OCT 19, 2016", "OCT 19, 2016", "OCT 18, 2016", "OCT 17, 2016", "OCT 13, 2016", "OCT 20, 2016", "OCT 13, 2016", "OCT 12, 2016", "OCT 12, 2016", "OCT 11, 2016", "OCT 11, 2016", "OCT 7, 2016", "OCT 7, 2016", "OCT 13, 2016", "OCT 5, 2016", "OCT 4, 2016", "OCT 2, 2016", "OCT 1, 2016", "OCT 1, 2016", "SEP 30, 2016", "SEP 30, 2016", "OCT 7, 2016", "SEP 29, 2016", "SEP 29, 2016", "SEP 29, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 30, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 27, 2016", "SEP 26, 2016", "SEP 26, 2016", "SEP 21, 2016", "SEP 27, 2016", "SEP 21, 2016", "SEP 20, 2016", "SEP 20, 2016", "SEP 19, 2016", "SEP 17, 2016", "SEP 16, 2016", "SEP 16, 2016", "SEP 21, 2016", "SEP 15, 2016", "SEP 14, 2016", "SEP 13, 2016", "SEP 13, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 15, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 8, 2016", "SEP 8, 2016", "SEP 7, 2016", "SEP 2, 2016", "SEP 1, 2016", "SEP 11, 2016", "AUG 31, 2016", "AUG 31, 2016", "AUG 30, 2016", "AUG 29, 2016", "AUG 29, 2016", "AUG 27, 2016", "AUG 25, 2016", "SEP 1, 2016", "AUG 24, 2016", "AUG 24, 2016", "AUG 24, 2016", "AUG 22, 2016", "AUG 21, 2016", "AUG 19, 2016", "AUG 18, 2016", "AUG 25, 2016", "AUG 17, 2016", "AUG 17, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 14, 2016", "AUG 13, 2016", "AUG 18, 2016", "AUG 17, 2016", "AUG 12, 2016", "AUG 12, 2016", "AUG 11, 2016", "AUG 11, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 12, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 3, 2016", "AUG 3, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 8, 2016", "AUG 2, 2016", "AUG 1, 2016", "JUL 29, 2016", "JUL 29, 2016", "JUL 29, 2016", "JUL 29, 2016", "JUL 28, 2016", "AUG 2, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 27, 2016", "JUL 27, 2016", "JUL 27, 2016", "JUL 27, 2016", "JUL 26, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 26, 2016", "JUL 26, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 26, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 20, 2016", "JUL 20, 2016", "JUL 19, 2016", "JUL 18, 2016", "JUL 22, 2016", "JUL 18, 2016", "JUL 17, 2016", "JUL 16, 2016", "JUL 15, 2016", "JUL 14, 2016", "JUL 14, 2016", "JUL 14, 2016", "JUL 18, 2016", "JUL 13, 2016", "JUL 12, 2016", "JUL 12, 2016", "JUL 11, 2016", "JUL 7, 2016", "JUL 7, 2016", "JUL 6, 2016", "JUL 13, 2016", "JUL 6, 2016", "JUL 6, 2016", "JUL 4, 2016", "JUL 2, 2016", "JUL 1, 2016", "JUN 29, 2016", "JUN 29, 2016", "JUL 6, 2016", "JUN 29, 2016", "JUN 27, 2016", "JUN 27, 2016", "JUN 24, 2016", "JUN 24, 2016", "JUN 23, 2016", "JUN 23, 2016", "JUN 29, 2016", "JUN 29, 2016", "JUN 14, 2016", "JUN 13, 2016", "JUN 13, 2016", "JUN 10, 2016", "JUN 9, 2016", "JUN 8, 2016", "JUN 20, 2016", "JUN 6, 2016", "JUN 6, 2016", "JUN 4, 2016", "JUN 4, 2016", "JUN 1, 2016", "JUN 1, 2016", "JUN 1, 2016", "JUN 7, 2016", "MAY 28, 2016", "MAY 27, 2016", "MAY 25, 2016", "MAY 25, 2016", "MAY 24, 2016", "MAY 21, 2016", "MAY 19, 2016", "MAY 31, 2016", "MAY 16, 2016", "MAY 16, 2016", "MAY 12, 2016", "MAY 12, 2016", "MAY 12, 2016", "MAY 11, 2016", "MAY 19, 2016", "MAY 10, 2016", "MAY 10, 2016", "MAY 10, 2016", "MAY 9, 2016", "MAY 6, 2016", "MAY 6, 2016", "MAY 5, 2016", "MAY 11, 2016", "MAY 4, 2016", "MAY 4, 2016", "MAY 4, 2016", "MAY 3, 2016", "MAY 3, 2016", "MAY 3, 2016", "MAY 2, 2016", "MAY 4, 2016", "MAY 2, 2016", "MAY 2, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "APR 28, 2016", "MAY 2, 2016", "APR 28, 2016", "APR 28, 2016", "APR 28, 2016", "APR 27, 2016", "APR 27, 2016", "APR 27, 2016", "APR 27, 2016", "APR 28, 2016", "APR 26, 2016", "APR 26, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 27, 2016", "APR 25, 2016", "APR 25, 2016", "APR 25, 2016", "APR 23, 2016", "APR 22, 2016", "APR 22, 2016", "APR 22, 2016", "APR 25, 2016", "APR 21, 2016", "APR 20, 2016", "APR 20, 2016", "APR 20, 2016", "APR 20, 2016", "APR 19, 2016", "APR 19, 2016", "APR 22, 2016", "APR 15, 2016", "APR 15, 2016", "APR 15, 2016", "APR 14, 2016", "APR 14, 2016", "APR 14, 2016", "APR 18, 2016", "APR 13, 2016", "APR 12, 2016", "APR 11, 2016", "APR 11, 2016", "APR 6, 2016", "APR 6, 2016", "APR 6, 2016", "APR 13, 2016", "APR 5, 2016", "APR 4, 2016", "APR 4, 2016", "APR 4, 2016", "APR 4, 2016", "APR 3, 2016", "APR 2, 2016", "APR 5, 2016", "APR 5, 2016", "APR 1, 2016", "APR 1, 2016", "MAR 31, 2016", "MAR 31, 2016", "MAR 30, 2016", "MAR 30, 2016", "APR 1, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 28, 2016", "MAR 24, 2016", "MAR 24, 2016", "MAR 29, 2016", "MAR 22, 2016", "MAR 22, 2016", "MAR 21, 2016", "MAR 21, 2016", "MAR 21, 2016", "MAR 18, 2016", "MAR 18, 2016", "MAR 23, 2016", "MAR 22, 2016", "MAR 17, 2016", "MAR 17, 2016", "MAR 15, 2016", "MAR 11, 2016", "MAR 11, 2016", "MAR 10, 2016", "MAR 18, 2016", "MAR 18, 2016", "MAR 17, 2016", "MAR 4, 2016", "MAR 4, 2016", "MAR 3, 2016", "MAR 3, 2016", "MAR 8, 2016", "MAR 2, 2016", "MAR 1, 2016", "MAR 1, 2016", "FEB 29, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 25, 2016", "MAR 2, 2016", "MAR 2, 2016", "FEB 23, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 22, 2016", "FEB 23, 2016", "FEB 19, 2016", "FEB 19, 2016", "FEB 18, 2016", "FEB 18, 2016", "FEB 16, 2016", "FEB 16, 2016", "FEB 16, 2016", "FEB 21, 2016", "FEB 12, 2016", "FEB 11, 2016", "FEB 10, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 9, 2016", "FEB 8, 2016", "FEB 13, 2016", "FEB 5, 2016", "FEB 3, 2016", "FEB 2, 2016", "FEB 2, 2016", "FEB 1, 2016", "FEB 1, 2016", "JAN 31, 2016", "FEB 7, 2016", "JAN 30, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 29, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 30, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 28, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 26, 2016", "JAN 28, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 23, 2016", "JAN 22, 2016", "JAN 21, 2016", "JAN 20, 2016", "JAN 25, 2016", "JAN 19, 2016", "JAN 18, 2016", "JAN 17, 2016", "JAN 16, 2016", "JAN 14, 2016", "JAN 14, 2016", "JAN 13, 2016", "JAN 20, 2016", "JAN 12, 2016", "JAN 11, 2016", "JAN 8, 2016", "JAN 8, 2016", "JAN 8, 2016", "JAN 7, 2016", "JAN 7, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 5, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 4, 2016", "JAN 6, 2016", "JAN 3, 2016", "JAN 3, 2016", "JAN 1, 2016", "DEC 31, 2015", "DEC 30, 2015", "DEC 30, 2015", "DEC 29, 2015", "JAN 3, 2016", "DEC 29, 2015", "DEC 29, 2015", "DEC 28, 2015", "DEC 26, 2015", "DEC 24, 2015", "DEC 24, 2015", "DEC 23, 2015", "DEC 29, 2015", "DEC 22, 2015", "DEC 21, 2015", "DEC 21, 2015", "DEC 20, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 22, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 17, 2015", "DEC 16, 2015", "DEC 16, 2015", "DEC 16, 2015", "DEC 15, 2015", "DEC 17, 2015", "DEC 15, 2015", "DEC 14, 2015", "DEC 14, 2015", "DEC 12, 2015", "DEC 11, 2015", "DEC 11, 2015", "DEC 11, 2015", "DEC 15, 2015", "DEC 9, 2015", "DEC 9, 2015", "DEC 9, 2015", "DEC 8, 2015", "DEC 7, 2015", "DEC 4, 2015", "DEC 4, 2015", "DEC 10, 2015", "DEC 3, 2015", "DEC 3, 2015", "DEC 3, 2015", "DEC 2, 2015", "DEC 2, 2015", "DEC 1, 2015", "DEC 1, 2015", "DEC 4, 2015", "NOV 28, 2015", "NOV 27, 2015", "NOV 27, 2015", "NOV 25, 2015", "NOV 25, 2015", "NOV 24, 2015", "NOV 24, 2015", "NOV 28, 2015", "NOV 23, 2015", "NOV 21, 2015", "NOV 20, 2015", "NOV 20, 2015", "NOV 20, 2015", "NOV 19, 2015", "NOV 19, 2015"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/notable-friday-option-activity%3A-w-tif-amgn-2020-06-12", "https://www.nasdaq.com/articles/2-top-small-cap-stocks-to-buy-right-now-2020-06-12", "https://www.nasdaq.com/articles/july-31st-options-now-available-for-amgen-amgn-2020-06-11", "https://www.nasdaq.com/articles/amgen-to-present-at-goldman-sachs-41st-annual-global-healthcare-conference-webcast-at-1%3A20", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-iyh-amgn-mdt-dhr-2020-06-08", "https://www.nasdaq.com/articles/moderna-names-amgen-executive-david-meline-as-cfo-2020-06-04", "https://www.nasdaq.com/articles/3-top-large-cap-stocks-to-buy-in-june-2020-06-03", "https://www.nasdaq.com/articles/amgen-to-present-at-the-jefferies-2020-virtual-healthcare-conference-webcast-at-4%3A00-pm-et", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-w-tif-amgn-2020-06-12", "https://www.nasdaq.com/articles/peek-under-the-hood%3A-ius-has-10-upside-2020-05-27", "https://www.nasdaq.com/articles/is-coherus-biosciences-a-buy-2020-05-26", "https://www.nasdaq.com/articles/is-arrowhead-pharmaceuticals-a-buy-2020-05-24", "https://www.nasdaq.com/articles/vtv-t-ko-amgn%3A-etf-inflow-alert-2020-05-19", "https://www.nasdaq.com/articles/monday-sector-laggards%3A-healthcare-technology-communications-2020-05-18", "https://www.nasdaq.com/articles/better-buy%3A-pfizer-vs.-bristol-myers-squibb-2020-05-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/nasdaq-today%3A-why-alexion-and-workday-stock-are-soaring-2020-05-28", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-amerisourcebergen-amgen-and-sabra-health-care-reit-2020-05-13", "https://www.nasdaq.com/articles/whats-behind-adaptive-biotechnologies-q1-earnings-miss-2020-05-13", "https://www.nasdaq.com/articles/is-now-still-a-good-time-to-buy-amgen-2020-05-13", "https://www.nasdaq.com/articles/heres-why-cytokinetics-is-skyrocketing-24.5-today-2020-05-11", "https://www.nasdaq.com/articles/why-amgen-soared-in-april-2020-05-11", "https://www.nasdaq.com/articles/astrazeneca-completes-recovery-of-global-rights-to-brazikumab-from-allergan-2020-05-11", "https://www.nasdaq.com/articles/amgen%3Afda-grants-fast-track-designation-for-omecamtiv-mecarbil-in-heart-failure-2020-05-08", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-amgn-unh-tgt-2020-05-15", "https://www.nasdaq.com/articles/amgen-reports-positive-results-for-otezla-in-phase-3-trial-2020-05-06", "https://www.nasdaq.com/articles/why-akebia-therapeutics-stock-is-crushing-it-today-2020-05-05", "https://www.nasdaq.com/articles/amgen%3A-court-ruling-prevents-cipla-from-making-generic-version-of-kyprolis-2020-05-05", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-medigus-aemetis-2020-05-01", "https://www.nasdaq.com/articles/amgen-inc-amgn-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/amgen-studying-otezla-for-coronavirus-q1-results-beat-street-estimates-2020-04-30", "https://www.nasdaq.com/articles/amgen-stock-jumps-on-earnings-covid-19-trial-announcement-2020-04-30", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gm-axcella-beyond-meat-smiledirect-2020-05-06", "https://www.nasdaq.com/articles/heres-why-investors-should-follow-sanofi-and-glaxosmithklines-new-coronavirus", "https://www.nasdaq.com/articles/better-buy%3A-illumina-vs.-adaptive-biotechnologies-2020-04-30", "https://www.nasdaq.com/articles/how-these-15-stock-suggestions-fared-against-the-market-2020-04-28", "https://www.nasdaq.com/articles/iyh-jnj-abt-amgn%3A-etf-inflow-alert-2020-04-28", "https://www.nasdaq.com/articles/heres-why-verastem-oncology-is-tanking-today-2020-04-27", "https://www.nasdaq.com/articles/3-coronavirus-stocks-to-buy-now-2020-04-26", "https://www.nasdaq.com/articles/3-dividend-stocks-weathering-the-coronavirus-storm-2020-04-23", "https://www.nasdaq.com/articles/amgen-inc.-q1-adjusted-earnings-beat-estimates-2020-04-30", "https://www.nasdaq.com/articles/artificial-intelligence-and-drug-discovery%3A-the-companies-leading-the-way-2020-04-22", "https://www.nasdaq.com/articles/heres-why-verastem-stock-is-jumping-today-2020-04-20", "https://www.nasdaq.com/articles/3-stocks-im-buying-right-now-2020-04-19", "https://www.nasdaq.com/articles/4-healthcare-stocks-to-buy-for-coronavirus-innovation-2020-04-17", "https://www.nasdaq.com/articles/itot-abt-cost-amgn%3A-etf-outflow-alert-2020-04-17", "https://www.nasdaq.com/articles/1-recent-ipo-to-add-to-your-watch-list-2020-04-17", "https://www.nasdaq.com/articles/novartis%3A-real-world-data-supports-aimovig-clinical-trial-results-quick-facts-2020-04-16", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-johnson-johnson-2020-04-23", "https://www.nasdaq.com/articles/1-stock-that-crushed-the-market-during-the-last-recession-2020-04-10", "https://www.nasdaq.com/articles/amgn-may-29th-options-begin-trading-2020-04-09", "https://www.nasdaq.com/articles/here-are-all-the-companies-working-on-covid-19-vaccines-treatments-and-testing-2020-04-07", "https://www.nasdaq.com/articles/why-gilead-sciences-is-the-hottest-stock-to-buy-today-2020-04-04", "https://www.nasdaq.com/articles/why-amgen-stock-sailed-through-march-without-a-scratch-2020-04-02", "https://www.nasdaq.com/articles/amgen-teams-up-with-adaptive-biotechnologies-to-develop-covid-19-therapy-2020-04-02", "https://www.nasdaq.com/articles/amgen-adaptive-partner-to-find-neutralizing-antibodies-for-covid-19-2020-04-02", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-cste-ttd-amgn-2020-04-14", "https://www.nasdaq.com/articles/amgen-pauses-some-clinical-trials-to-reduce-coronavirus-transmission-risk-2020-03-31", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ftcs-pgr-lly-amgn-2020-03-30", "https://www.nasdaq.com/articles/4-reasons-drug-stocks-are-a-buy-right-now-2020-03-30", "https://www.nasdaq.com/articles/why-amgen-is-the-top-dividend-stock-of-the-nasdaq-100-with-3.2-yield-amgn-2020-03-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-26-2020%3A-jnj-pfe-abt-mrk-amgn-htgm-rkda-bioc-2020-03-26", "https://www.nasdaq.com/articles/top-drug-stocks-under-%245-2020-03-26", "https://www.nasdaq.com/articles/4-reasons-biotech-stocks-are-a-buy-right-now-2020-03-25", "https://www.nasdaq.com/articles/amgen-purchases-49-of-shares-of-amgen-astellas-biopharma-2020-03-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-17-2020%3A-jnj-pfe-abt-mrk-amgn-dbvt-avro-mrna-2020-03-17", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2020-03-16", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2020-03-15", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-tqqq-googl-amgn-txn-2020-03-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-11-2020%3A-jnj-pfe-abt-mrk-amgn-sphs-cdmo-kala-2020-03-11", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-gilead-sciences-2020-03-09", "https://www.nasdaq.com/articles/daily-dividend-report%3A-gdhesvzamgnpm-2020-03-05", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-tqqq-googl-amgn-txn-2020-03-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-04-2020%3A-jnj-pfe-abt-mrk-amgn-mrna-reph-cnc-drrx-2020-03", "https://www.nasdaq.com/articles/proshares-proshares-ultrapro-qqq-experiences-big-inflow-2020-03-04", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-04-2020%3A-jnj-pfe-abt-mrk-amgn-drrx-vvus-vygr-2020-03-04", "https://www.nasdaq.com/articles/thermo-fisher-scientific-to-spend-%2411.5-billion-upgrading-its-dna-testing-game-2020-03-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-03-2020%3A-jnj-pfe-abt-mrk-amgn-kmph-omer-gnmk-2020-03-03", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-right-now-2020-02-28", "https://www.nasdaq.com/articles/fda-approves-biohavens-migraine-treatment-nurtec-odt-2020-02-28", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2020-03-05", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-27-2020%3A-jnj-pfe-abt-mrk-amgn-tdoc-ormp-lhcg-2020-02-27", "https://www.nasdaq.com/articles/analysts-forecast-11-upside-for-the-holdings-of-ftcs-2020-02-27", "https://www.nasdaq.com/articles/heres-why-karyopharm-therapeutics-has-a-unique-growth-opportunity-2020-02-26", "https://www.nasdaq.com/articles/amgen-is-oversold-2020-02-25", "https://www.nasdaq.com/articles/3-biotech-stocks-that-surged-last-week-2020-02-24", "https://www.nasdaq.com/articles/fda-approves-esperion-therapeutics-new-cholesterol-drug-2020-02-21", "https://www.nasdaq.com/articles/a-plan-to-use-blockchain-to-stop-counterfeit-drugs-moves-forward-2020-02-21", "https://www.nasdaq.com/articles/amgen-breaks-below-200-day-moving-average-notable-for-amgn-2020-02-27", "https://www.nasdaq.com/articles/iwb-abt-amgn-lin%3A-large-outflows-detected-at-etf-2020-02-21", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-19-2020%3A-jnj-pfe-abt-mrk-amgn-mreo-amed-ctso-2020-02-19", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-zbra-amgn-mmm-2020-02-13", "https://www.nasdaq.com/articles/amgn-april-3rd-options-begin-trading-2020-02-13", "https://www.nasdaq.com/articles/3-biotech-stocks-that-made-early-shareholders-millionaires-2020-02-13", "https://www.nasdaq.com/articles/bristol-myers-squibb-stock-is-too-cheap-to-ignore-2020-02-10", "https://www.nasdaq.com/articles/is-amgen-a-stock-to-buy-2020-02-08", "https://www.nasdaq.com/articles/investors-scrambled-to-buy-this-biotech-ipo-2020-02-21", "https://www.nasdaq.com/articles/how-bristol-myers-squibb-trounced-wall-streets-q4-estimates-2020-02-06", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-2-6-2020-2020-02-06", "https://www.nasdaq.com/articles/why-amgen-stock-dropped-10.4-in-january-2020-02-05", "https://www.nasdaq.com/articles/pkw-amgn-unp-orcl%3A-etf-inflow-alert-2020-02-05", "https://www.nasdaq.com/articles/teva-pharmaceutical-just-got-a-little-migraine-relief-2020-02-04", "https://www.nasdaq.com/articles/amgen-a-top-socially-responsible-dividend-stock-with-3.0-yield-amgn-2020-02-04", "https://www.nasdaq.com/articles/could-guardant-health-be-a-millionaire-maker-stock-2020-02-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-07-2020%3A-jnj-pfe-abt-mrk-amgn-asrt-zgnx-mygn-2020-02-07", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2020-01-31", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-amgn-expe-cvs-2020-01-31", "https://www.nasdaq.com/articles/stock-market-news%3A-amazons-amazing-amgen-falls-short-2020-01-31", "https://www.nasdaq.com/articles/amgens-shares-slip-on-soft-guidance.-time-to-buy-2020-01-31", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amgn-amzn-2020-01-31", "https://www.nasdaq.com/articles/where-will-cara-therapeutics-be-in-5-years-2020-01-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-q4-2019-earnings-call-transcript-2020-01-31", "https://www.nasdaq.com/articles/amgen-is-making-3-big-bets-will-they-pay-off-for-investors-2020-02-02", "https://www.nasdaq.com/articles/amgen-issues-fy20-guidance-quick-facts-2020-01-30", "https://www.nasdaq.com/articles/amgen-inc.-q4-adjusted-earnings-beat-estimates-2020-01-30", "https://www.nasdaq.com/articles/amgen-q4-19-earnings-conference-call-at-5%3A00-pm-et-2020-01-30-0", "https://www.nasdaq.com/articles/amgen-q4-19-earnings-conference-call-at-5%3A00-pm-et-2020-01-30", "https://www.nasdaq.com/articles/why-teva-stock-could-be-the-next-general-electric-stock-2020-01-29", "https://www.nasdaq.com/articles/ishares-core-dividend-growth-etf-experiences-big-inflow-2020-01-28", "https://www.nasdaq.com/articles/which-big-biotech-has-the-safer-dividend-amgen-or-gilead-sciences-2020-01-26", "https://www.nasdaq.com/articles/amgen-revenue-slipped-1-in-the-fourth-quarter-2020-01-31", "https://www.nasdaq.com/articles/relative-strength-alert-for-amgen-2020-01-24", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-gilead-sciences-2020-01-24", "https://www.nasdaq.com/articles/better-buy%3A-exact-sciences-vs.-qiagen-2020-01-23", "https://www.nasdaq.com/articles/3-attractive-dividend-stocks-whose-dividends-could-double-2020-01-19", "https://www.nasdaq.com/articles/2-biotechs-battling-immune-diseases-2020-01-19", "https://www.nasdaq.com/articles/ishares-russell-1000-etf-experiences-big-outflow-2020-01-17", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-mos-ppg-amgn-2020-01-16", "https://www.nasdaq.com/articles/is-mylan-stock-a-buy-2020-01-25", "https://www.nasdaq.com/articles/relative-strength-alert-for-amgen-2020-01-24", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-10-2020%3A-jnj-pfe-abt-mrk-amgn-acrs-mrna-ptla-2020-01-10", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-iwb-amgn-lly-qcom-2020-01-09", "https://www.nasdaq.com/articles/these-25-companies-laid-off-workers-in-2019-2020-01-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-06-2020%3A-jnj-pfe-abt-mrk-amgn-life-lptx-novn-2020-01-06", "https://www.nasdaq.com/articles/amgen-a-top-25-dividend-giant-with-2.68-yield-amgn-2020-01-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-14-2020%3A-jnj-pfe-abt-mrk-amgn-rtix-trxc-mreo-2020-01-14", "https://www.nasdaq.com/articles/3-of-the-best-healthcare-stocks-to-buy-in-2020-2020-01-02", "https://www.nasdaq.com/articles/amgen-completes-purchase-of-about-%242.8-bln-of-beigene-shares-2020-01-02", "https://www.nasdaq.com/articles/better-buy%3A-abbott-laboratories-vs.-pfizer-2020-01-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-01-02-2020%3A-jnj-pfe-abt-mrk-amgn-ipha-ontx-aeri-2020-01-02", "https://www.nasdaq.com/articles/breakingviews-a-health-craze-for-2020%3A-chinese-medicine-2020-01-02", "https://www.nasdaq.com/articles/vascepas-future-looks-rosy-but-it-could-still-be-fishy-for-amarin-stock-2019-12-31", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-okta-save-amgn-2019-12-30", "https://www.nasdaq.com/articles/amgn-february-14th-options-begin-trading-2020-01-02", "https://www.nasdaq.com/articles/the-success-of-vascepa-actually-might-be-a-problem-for-amarin-2019-12-30", "https://www.nasdaq.com/articles/3-biotech-stocks-that-crushed-it-in-2019-2019-12-28", "https://www.nasdaq.com/articles/u.s.-cannabis-stocks-will-make-cheap-smart-buys-in-2020-2019-12-27", "https://www.nasdaq.com/articles/3-blockbuster-cancer-drug-launches-to-watch-in-2020-2019-12-24", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-johnson-johnson-2019-12-22", "https://www.nasdaq.com/articles/how-gilead-sciences-is-helping-fund-bristol-myers-squibbs-celgene-acquisition-2019-12-21", "https://www.nasdaq.com/articles/fda-nod-for-bhc-third-rituxan-biosim-in-the-offing-cbio-soars-nerv-depressed-2019-12-19", "https://www.nasdaq.com/articles/xlv-jnj-mrk-amgn%3A-large-inflows-detected-at-etf-2019-12-30", "https://www.nasdaq.com/articles/better-buy%3A-vertex-pharmaceuticals-vs.-alexion-pharmaceuticals-2019-12-18", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2019-12-17", "https://www.nasdaq.com/articles/amarins-vascepa-approval-seems-fishy-for-patients-and-amrn-investors-2019-12-16", "https://www.nasdaq.com/articles/is-amarin-a-%2420-billion-stock-2019-12-16", "https://www.nasdaq.com/articles/bristol-myers-placed-a-big-bet-on-celgenes-pipeline.-will-it-pay-off-for-investors-2019-12", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-amgen-2019-12-15", "https://www.nasdaq.com/articles/3-reasons-this-biotech-is-a-buy-for-risk-averse-investors-2019-12-13", "https://www.nasdaq.com/articles/3-dividend-stocks-that-hiked-their-payouts-by-more-than-100-in-5-years-2019-12-19", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-amgen-amgn-2019-12-12", "https://www.nasdaq.com/articles/heres-why-you-should-own-amgen-stock-in-2020-2019-12-12", "https://www.nasdaq.com/articles/why-bridgebio-pharma-is-currently-trading-at-2x-its-ipo-price-2019-12-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-11-2019%3A-jnj-pfe-abt-mrk-amgn-aqst-rckt-mrns-2019-12-11", "https://www.nasdaq.com/articles/is-rigel-pharmaceuticals-stock-a-buy-2019-12-11", "https://www.nasdaq.com/articles/amgen%3A-candor-study-supports-combination-of-kyprolis-darzalex-quick-facts-2019-12-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-09-2019%3A-jnj-pfe-abt-mrk-amgn-pdli-tgtx-tvty-arql-2019-12", "https://www.nasdaq.com/articles/daily-dividend-report%3A-amgn-zts-pki-pwr-axp-2019-12-12", "https://www.nasdaq.com/articles/3-healthcare-stocks-to-buy-before-the-end-of-2019-2019-12-09", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-12-08", "https://www.nasdaq.com/articles/4-fda-dates-biotech-investors-should-circle-in-december-2019-12-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-06-2019%3A-jnj-pfe-abt-mrk-amgn-cyad-sava-cris-2019-12-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-06-2019%3A-jnj-pfe-abt-mrk-amgn-cyad-oncy-rckt-sava-2019-12", "https://www.nasdaq.com/articles/can-cannabis-2.0-kickstart-marijuana-stocks-2019-12-06", "https://www.nasdaq.com/articles/save-yourself-the-migraine-and-buy-this-1-pharma-stock-now-2019-12-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-09-2019%3A-jnj-pfe-abt-mrk-amgn-arql-thor-mbio-xbit-2019-12", "https://www.nasdaq.com/articles/why-novartiss-%249.7-billion-purchase-of-the-medicines-company-is-bad-news-for-amgen-2019-12", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-m-amgn-ibm-2019-12-02", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-december-2019-2019-12-01", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-29-2019%3A-jnj-pfe-abt-mrk-amgn-canf-regn-azn-2019-11-29", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-27-2019%3A-jnj-pfe-abt-mrk-amgn-arav-tnxp-vrca-2019-11-27", "https://www.nasdaq.com/articles/why-abbvie-is-a-dividend-growth-stock-thats-too-cheap-to-ignore-2019-11-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-26-2019%3A-jnj-pfe-abt-mrk-amgn-ccxi-xfor-snoa-2019-11-26", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-pfizer-2019-12-04", "https://www.nasdaq.com/articles/why-the-medicines-company-stock-is-soaring-today-2019-11-25", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-25-2019%3A-jnj-pfe-abt-mrk-amgn-srne-mdco-nvs-ziop-2019-11", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-mtem-amgn-amed...-2019-11-25", "https://www.nasdaq.com/articles/does-amarin-have-a-dark-horse-suitor-2019-11-24", "https://www.nasdaq.com/articles/why-im-holding-on-to-my-bristol-myers-squibb-shares-now-that-the-celgene-acquisition-has", "https://www.nasdaq.com/articles/2-stocks-to-buy-if-youre-worried-about-a-recession-2019-11-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-22-2019%3A-jnj-pfe-abt-mrk-amgn-sens-orgo-hsdt-2019-11-22", "https://www.nasdaq.com/articles/a-45-premium%3A-heres-why-the-medicines-company-is-worth-more-to-novartis-than-it-was-to-you", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-in-november-2019-11-21", "https://www.nasdaq.com/articles/missed-the-310-rise-of-arrowhead-pharmaceuticals-keep-an-eye-on-this-competitor-2019-11-21", "https://www.nasdaq.com/articles/amgen-boosts-fy19-outlook-after-otezla-acquisition-quick-facts-2019-11-21", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-itot-pg-xom-amgn-2019-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-20-2019%3A-jnj-pfe-abt-mrk-amgn-alc-bcrx-crsp-2019-11-20", "https://www.nasdaq.com/articles/looking-for-a-biotech-stock-thats-an-ideal-buyout-candidate-this-is-it.-2019-11-20", "https://www.nasdaq.com/articles/heres-why-the-medicines-company-jumped-higher-again-today-2019-11-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-21-2019%3A-jnj-pfe-abt-mrk-amgn-harp-abbv-enlv-ntgn-2019-11", "https://www.nasdaq.com/articles/heres-why-the-medicines-company-moved-higher-today-2019-11-18", "https://www.nasdaq.com/articles/the-question-is-not-why-amarin-stock-may-go-up-but-should-it-2019-11-18", "https://www.nasdaq.com/articles/amgen-says-new-analysis-shows-benefit-of-repatha-in-high-risk-patients-2019-11-16", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-amgn-roku-splk-2019-11-14", "https://www.nasdaq.com/articles/amarins-stock-could-reach-%2450-per-share-soon-2019-11-13", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-teleflex-amgen-and-sabra-health-care-reit-2019-11-12", "https://www.nasdaq.com/articles/heres-why-fibrogens-stock-popped-friday-2019-11-11", "https://www.nasdaq.com/articles/if-biosimilars-are-struggling-someone-forgot-to-tell-coherus-biosciences-2019-11-19", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-to-buy-right-now-2019-11-09", "https://www.nasdaq.com/articles/heres-why-cytokinetics-stock-tanked-on-thursday-2019-11-07", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-lh-csx-amgn-2019-11-07", "https://www.nasdaq.com/articles/buy-these-2-stocks-to-access-chinas-huge-healthcare-market-2019-11-06", "https://www.nasdaq.com/articles/breakingviews-biotech-upstarts-will-be-big-pharmas-china-tonic-2019-11-06", "https://www.nasdaq.com/articles/2020-election-could-hurt-amgen-stocks-healthy-dividend-2019-11-05", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2019-11-04", "https://www.nasdaq.com/articles/why-amgens-stock-soared-in-october-2019-11-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-01-2019%3A-bgneamgnamedblue-2019-11-01-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-01-2019%3A-bgneamgnamedblue-2019-11-01", "https://www.nasdaq.com/articles/heres-why-beigene-stock-is-soaring-today-2019-11-01", "https://www.nasdaq.com/articles/ishares-russell-3000-etf-experiences-big-inflow-2019-11-01", "https://www.nasdaq.com/articles/bgne-soars-drna-hits-new-high-on-roche-deal-fda-heeds-rephs-request-2019-11-01", "https://www.nasdaq.com/articles/amgen-to-acquire-20.5-stake-in-beigene-for-approx.-%242.7-bln-quick-facts-2019-10-31", "https://www.nasdaq.com/articles/what-should-investors-think-of-biogens-alzheimers-drug-candidate-2019-10-31", "https://www.nasdaq.com/articles/better-buy%3A-mirati-therapeutics-vs.-amgen-2019-11-02", "https://www.nasdaq.com/articles/bristol-myers-squibb-beats-expectations-in-q3-as-its-celgene-acquisition-nears-the-finish", "https://www.nasdaq.com/articles/can-this-tiny-biotech-take-down-amgen-2019-10-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-q3-2019-earnings-call-transcript-2019-10-30", "https://www.nasdaq.com/articles/amgen-updates-guidance-quick-facts-2019-10-29", "https://www.nasdaq.com/articles/amgen-inc.-q3-adjusted-earnings-beat-estimates-2019-10-29", "https://www.nasdaq.com/articles/heres-why-mirati-therapeutics-stock-is-on-the-move-again-today-2019-10-29", "https://www.nasdaq.com/articles/is-gossamer-bio-a-buy-2019-10-29", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-amgn-amd-cost-2019-10-31", "https://www.nasdaq.com/articles/amgen-q3-19-earnings-conference-call-at-5%3A00-pm-et-2019-10-29", "https://www.nasdaq.com/articles/5-top-healthcare-etfs-2019-10-26", "https://www.nasdaq.com/articles/amgen-decides-to-discontinue-original-list-price-option-for-repatha-2019-10-24", "https://www.nasdaq.com/articles/daily-dividend-report%3A-aep-leco-bac-wfc-amgn-2019-10-23", "https://www.nasdaq.com/articles/proshares-proshares-ultrapro-qqq-experiences-big-outflow-2019-10-23", "https://www.nasdaq.com/articles/amgen-appoints-peter-griffith-as-cfo-succeeding-david-meline-effective-jan.-1-2019-10-23", "https://www.nasdaq.com/articles/is-mirati-therapeutics-a-good-stock-to-buy-now-2019-10-20", "https://www.nasdaq.com/articles/why-shockwave-medical-is-not-a-buy-2019-10-29", "https://www.nasdaq.com/articles/amgen-%3A-evenity-gets-positive-chmp-opinion-for-treatment-of-severe-osteoporosis-2019-10-18", "https://www.nasdaq.com/articles/will-the-pace-of-ma-pick-up-following-the-biotech-sectors-pounding-2019-10-11", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-pd-amgn-ibm-2019-10-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-07-2019%3A-jnj-abt-pfe-mrk-amgn-mreo-xent-capr-2019-10-07", "https://www.nasdaq.com/articles/how-amazon-is-shaking-up-telemedicine-plus-1-winner-and-1-loser-exiting-esmo-2019-10-04", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-for-november-22nd-2019-10-03", "https://www.nasdaq.com/articles/2-great-stocks-you-can-buy-on-sale-2019-10-03", "https://www.nasdaq.com/articles/amgen%3A-fda-approves-earlier-use-of-nplate-to-treat-immune-thrombocytopenia-2019-10-18", "https://www.nasdaq.com/articles/the-medicines-company-surges-on-positive-drug-trial-results-2019-10-01", "https://www.nasdaq.com/articles/the-medicines-company-is-up-161-year-to-date-but-heres-a-better-way-to-play-the-drugmakers", "https://www.nasdaq.com/articles/is-amgen-really-as-cheap-as-it-looks-2019-09-28", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-amgn-oke-axdx-2019-09-27", "https://www.nasdaq.com/articles/cancer-results-to-watch-at-this-weekends-european-society-of-medical-oncology-congress", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-09-27", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-for-november-8th-2019-09-26", "https://www.nasdaq.com/articles/winners-and-losers-of-europes-big-cancer-meeting-2019-10-02", "https://www.nasdaq.com/articles/could-amgens-latest-bad-news-boost-the-chances-of-more-acquisitions-2019-09-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-17-2019%3A-immpabtacrsadptamgn-2019-09-17", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-17-2019%3A-abtacrsadptamgn-2019-09-17", "https://www.nasdaq.com/articles/heres-why-alder-biopharmaceuticals-is-rocketing-higher-today-2019-09-16", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2019-09-15", "https://www.nasdaq.com/articles/amgens-phase-3-candor-study-meets-primary-endpoint-of-pfs-quick-facts-2019-09-13", "https://www.nasdaq.com/articles/tqqq-adbe-cost-amgn%3A-large-inflows-detected-at-etf-2019-09-26", "https://www.nasdaq.com/articles/does-acadia-pharmaceuticals-have-more-room-to-run-2019-09-11", "https://www.nasdaq.com/articles/why-amgen-stock-perked-up-last-month-2019-09-11", "https://www.nasdaq.com/articles/5-things-youll-want-to-know-about-amgens-future-2019-09-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-fbt-amgn-nbix-alny-2019-09-10", "https://www.nasdaq.com/articles/amgen-to-present-at-the-morgan-stanley-global-conference-webcast-at-9%3A10-am-et-2019-09-10", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-yum-amgn-evri-2019-09-09", "https://www.nasdaq.com/articles/amarin%3A-keep-your-dry-powder-ready-2019-09-09", "https://www.nasdaq.com/articles/analysts-see-10-gains-ahead-for-the-holdings-of-eqwl-2019-09-12", "https://www.nasdaq.com/articles/sp-500-movers%3A-amgn-lb-2019-09-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-09-2019%3A-acad-axnx-amgn-jnj-pfe-abt-mrk-2019-09-09", "https://www.nasdaq.com/articles/novartis%3A-aimovig-shows-long-term-efficacy-in-treatment-of-episodic-migraine-2019-09-09", "https://www.nasdaq.com/articles/heres-why-arrowhead-pharmaceuticals-rose-17.6-in-august-2019-09-08", "https://www.nasdaq.com/articles/amgen-drug-shrinks-54-of-lung-cancer-tumors-in-study-2019-09-08", "https://www.nasdaq.com/articles/better-buy%3A-amgen-vs.-celgene-2019-09-08", "https://www.nasdaq.com/articles/why-amgens-spending-billions-to-buy-this-1-drug-plus-heart-disease-has-a-new-enemy-2019-09", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amgn-nflx-2019-09-09", "https://www.nasdaq.com/articles/heres-why-alexion-pharmaceuticals-dropped-11-in-august-2019-09-05", "https://www.nasdaq.com/articles/heres-why-the-medicines-company-stock-soared-again-on-tuesday-2019-09-03", "https://www.nasdaq.com/articles/spy-brk.b-nflx-amgn%3A-etf-inflow-alert-2019-08-30", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-08-28", "https://www.nasdaq.com/articles/4-biotech-stocks-to-buy-that-are-on-the-move-2019-08-27", "https://www.nasdaq.com/articles/what-happened-in-the-stock-market-today-2019-08-26", "https://www.nasdaq.com/articles/celgenes-%2413.4-billion-deal-with-amgen-is-a-win-win-win-2019-08-26", "https://www.nasdaq.com/articles/4-biotech-stocks-with-big-catalysts-in-september-2019-09-06", "https://www.nasdaq.com/articles/celgene-news%3A-celg-stock-jumps-on-sale-of-otezla-to-amgen-2019-08-26", "https://www.nasdaq.com/articles/should-amgen-finally-buy-alexion-pharmaceuticals-2019-08-25", "https://www.nasdaq.com/articles/3-reasons-why-amgen-could-actually-acquire-alexion-2019-08-24", "https://www.nasdaq.com/articles/alxn-takeover-rumors-amgns-jasmine-blooms-clsd-sees-the-writing-on-the-wall-2019-08-23", "https://www.nasdaq.com/articles/spdr-sp-500-etf-trust-experiences-big-outflow-2019-08-22", "https://www.nasdaq.com/articles/arrowhead-pharmaceuticals%3A-buy-at-the-high-2019-08-21", "https://www.nasdaq.com/articles/is-amgen-a-buy-2019-08-18", "https://www.nasdaq.com/articles/5-top-stock-trades-for-tuesday%3A-nflx-amgn-acb-bmy-2019-08-26", "https://www.nasdaq.com/articles/wednesdays-vital-data%3A-amgen-american-airlines-and-apple-2019-08-14", "https://www.nasdaq.com/articles/amgen-inc.-amgn-ex-dividend-date-scheduled-for-august-14-2019-2019-08-13", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-apa-stt-amgn-2019-08-12", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-meli-amgn-2019-08-12", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-teleflex-amgen-and-u.s.-physical-therapy-2019-08-12", "https://www.nasdaq.com/articles/sp-500-movers%3A-nktr-amgn-2019-08-12", "https://www.nasdaq.com/articles/sandoz-to-appeal-u.s.-court-ruling-in-biosimilar-erelzi-u.s.-patent-case-2019-08-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-spyg-avgo-amgn-adp-2019-08-14", "https://www.nasdaq.com/articles/5-strong-buy-dividend-stocks-with-high-upside-2019-08-06", "https://www.nasdaq.com/articles/9-catalysts-that-will-drive-chinese-biotech-stocks-much-higher-2019-08-05", "https://www.nasdaq.com/articles/daily-dividend-report%3A-dk-spns-sbr-tg-amgn-2019-08-05", "https://www.nasdaq.com/articles/3-lung-cancer-stocks-that-could-soar-in-september-2019-08-04", "https://www.nasdaq.com/articles/ishares-u.s.-healthcare-etf-experiences-big-outflow-2019-08-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-31-2019%3A-dmpinuvaamgnacrs-2019-07-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-31-2019%3A-nuvaamgnacrs-2019-07-31", "https://www.nasdaq.com/articles/amgn-named-a-top-socially-responsible-dividend-stock-2019-08-07", "https://www.nasdaq.com/articles/amgen-inc-amgn-q2-2019-earnings-call-transcript-2019-07-31", "https://www.nasdaq.com/articles/amgen-manages-to-tread-water-for-another-quarter-2019-07-31", "https://www.nasdaq.com/articles/amgen-inc.-q2-adjusted-earnings-beat-estimates-2019-07-30", "https://www.nasdaq.com/articles/amgen-q2-19-earnings-conference-call-at-5%3A30-pm-et-2019-07-30", "https://www.nasdaq.com/articles/amgn-september-6th-options-begin-trading-2019-07-29", "https://www.nasdaq.com/articles/10-biggest-cancer-fighting-stocks-2019-07-27", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-tqqq-nflx-cost-amgn-2019-07-25", "https://www.nasdaq.com/articles/are-amgen-and-gilead-sciences-better-buys-after-second-quarter-earnings-2019-07-31", "https://www.nasdaq.com/articles/the-implied-analyst-12-month-target-for-eqwl-2019-07-22", "https://www.nasdaq.com/articles/acwi-baba-ko-amgn%3A-etf-inflow-alert-2019-07-17", "https://www.nasdaq.com/articles/amgn-august-30th-options-begin-trading-2019-07-15", "https://www.nasdaq.com/articles/what-happened-in-the-stock-market-today-2019-07-12", "https://www.nasdaq.com/articles/the-10-biggest-healthcare-stocks-2019-07-10", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-stz-chgg-amgn-2019-07-08", "https://www.nasdaq.com/articles/heres-why-coherus-biosciences-is-falling-today-2019-07-08", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-23-2019%3A-jnj-pfe-abt-mrk-amgn-2019-07-23", "https://www.nasdaq.com/articles/why-amgen-is-a-top-25-dividend-giant-amgn-2019-07-08", "https://www.nasdaq.com/articles/heres-why-amgen-stock-gained-10-in-june-2019-07-06", "https://www.nasdaq.com/articles/how-to-invest-in-biotech-stocks-2019-07-02", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-amp-avgo-amgn-2019-07-01", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-06-30", "https://www.nasdaq.com/articles/where-will-cara-therapeutics-be-in-5-years-2019-06-29", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-to-buy-2019-06-29", "https://www.nasdaq.com/articles/the-health-care-select-sector-spdr-fund-experiences-big-outflow-2019-07-08", "https://www.nasdaq.com/articles/xlv-amgn-lly-syk%3A-etf-outflow-alert-2019-06-27", "https://www.nasdaq.com/articles/the-10-biggest-biotech-stocks-2019-06-25", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-unh-rht-amgn-2019-06-19", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-buy-for-massive-gains-2019-06-19", "https://www.nasdaq.com/articles/iwf-acn-cost-amgn%3A-large-inflows-detected-at-etf-2019-06-18", "https://www.nasdaq.com/articles/3-big-drugmakers-most-likely-to-make-acquisitions-after-pfizers-surprise-deal-2019-06-18", "https://www.nasdaq.com/articles/3-stocks-to-buy-and-hold-for-the-next-50-years-2019-06-16", "https://www.nasdaq.com/articles/heres-why-dova-pharmaceuticals-stock-jumped-higher-today-2019-06-27", "https://www.nasdaq.com/articles/health-care-sector-update-for-06-07-2019%3A-crspvrtxljpcmrtxamgn-2019-06-07", "https://www.nasdaq.com/articles/5-healthcare-stocks-to-pick-up-from-the-wreckage-2019-06-06", "https://www.nasdaq.com/articles/5-reasons-pfizer-sat-potential-new-alzheimers-drug-2019-06-06", "https://www.nasdaq.com/articles/3-cancer-stocks-given-lift-amgen-2019-06-04", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-06-03", "https://www.nasdaq.com/articles/heres-why-mirati-therapeutics-jumping-today-2019-06-03", "https://www.nasdaq.com/articles/amgen-reports-positive-data-amg-510-early-phase-1-study-quick-facts-2019-06-03", "https://www.nasdaq.com/articles/sso-mdt-ibm-amgn%3A-large-outflows-detected-etf-2019-06-10", "https://www.nasdaq.com/articles/ranking-the-top-10-stock-buybacks-of-last-year-2019-05-30", "https://www.nasdaq.com/articles/2-healthcare-stocks-doubled-investors-money-2019-2019-05-28", "https://www.nasdaq.com/articles/3-charts-every-amgen-investor-needs-see-2019-05-26", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-july-5th-2019-05-23", "https://www.nasdaq.com/articles/ibb-celg-gild-amgn%3A-etf-inflow-alert-2019-05-23", "https://www.nasdaq.com/articles/amgen-offers-buy-nuevolution-sek-32.50/shr-cash-quick-facts-2019-05-22", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-tmus-amgn-arr-2019-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-16-2019%3A-bluemrtxagioedapamgn-2019-05-16", "https://www.nasdaq.com/articles/heres-why-mirati-therapeutics-surging-today-2019-05-16", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-agn-dal-amgn-2019-05-16", "https://www.nasdaq.com/articles/3-stocks-big-news-coming-asco-2019-2019-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-05/10/2019%3A-jnj-pfe-abt-mrk-amgn-gene-pirs-tgtx-2019-05-10", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-ezpw-amgn-etsy-2019-05-08", "https://www.nasdaq.com/articles/why-are-investors-passing-teva-pharmaceutical-industries-2019-05-05", "https://www.nasdaq.com/articles/who-had-better-quarter%3A-gilead-sciences-or-amgen-2019-05-17", "https://www.nasdaq.com/articles/5-top-stock-trades-thursday%3A-cvs-twlo-el-amgn-2019-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amgn-aapl-2019-05-01", "https://www.nasdaq.com/articles/amgen-inc-amgn-q1-2019-earnings-call-transcript-2019-05-01", "https://www.nasdaq.com/articles/amgen-reports-unusual-slide-backward-2019-04-30", "https://www.nasdaq.com/articles/amgen-earnings%3A-amgn-stock-dips-slightly-despite-q1-eps-sales-beat-2019-04-30", "https://www.nasdaq.com/articles/amgen-updates-earnings-guidance-quick-facts-2019-04-30", "https://www.nasdaq.com/articles/amgen-inc.-q1-adjusted-earnings-beat-estimates-2019-04-30", "https://www.nasdaq.com/articles/june-14th-options-now-available-amgen-amgn-2019-05-02", "https://www.nasdaq.com/articles/4-more-healthcare-earnings-reports-watch-week-2019-04-30", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-saia-coty-amgn-2019-04-26", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iyh-abbv-amgn-mdt-2019-04-22", "https://www.nasdaq.com/articles/pfizer-stock-suffers-underappreciated-drugs-pipeline-2019-04-22", "https://www.nasdaq.com/articles/amgen-oversold-2019-04-18", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-citrix-systems-goldman-sachs-group-and-amgen-2019-04-18", "https://www.nasdaq.com/articles/why-amgen-stock-could-break-out-new-highs-2019-04-16", "https://www.nasdaq.com/articles/amgen-q1-19-earnings-conference-call-5%3A00-pm-et-2019-04-30", "https://www.nasdaq.com/articles/amgen-sets-21900-annual-price-new-evenity-bone-drug-2019-04-15", "https://www.nasdaq.com/articles/better-buy-amgen-vs-gilead-sciences-2019-04-13", "https://www.nasdaq.com/articles/proshares-ultrapro-sp500-experiences-big-outflow-2019-04-10", "https://www.nasdaq.com/articles/fda-approves-amgens-osteoporosis-drug-evenity-2019-04-09", "https://www.nasdaq.com/articles/heres-why-novartis-sliding-today-2019-04-09", "https://www.nasdaq.com/articles/why-amgen-can-deliver-medical-and-financial-miracles-2019-04-09", "https://www.nasdaq.com/articles/5-stocks-age-miracles-2019-04-09", "https://www.nasdaq.com/articles/radius-health-rdus-rallies-33.4-ytd-on-robust-tymlos-sales-2019-04-16-0", "https://www.nasdaq.com/articles/amgen-sets-21900-annual-price-new-evenity-bone-drug-2019-04-15", "https://www.nasdaq.com/articles/heres-why-novartis-sliding-today-2019-04-09-0", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2019-04-08", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2019-04-08-0", "https://www.nasdaq.com/articles/why-amgens-giving-novartis-headache-2019-04-07", "https://www.nasdaq.com/articles/why-amgens-giving-novartis-headache-2019-04-07-0", "https://www.nasdaq.com/articles/novartis-amgen-in-legal-dispute-over-migraine-drug-aimovig-2019-04-05-0", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-gets-fda-greenlight-2019-04-09", "https://www.nasdaq.com/articles/pfizers-new-lung-cancer-drug-vizimpro-gets-eu-approval-2019-04-04-0", "https://www.nasdaq.com/articles/novartis-resubmits-bla-to-fda-for-biosimilar-of-neulasta-2019-04-04-0", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vym-pfe-ibm-amgn-2019-04-02", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vym-pfe-ibm-amgn-2019-04-02-0", "https://www.nasdaq.com/articles/bmos-got-point-about-teva-stock-are-investors-willing-listen-2019-04-01", "https://www.nasdaq.com/articles/bmos-got-point-about-teva-stock-are-investors-willing-listen-2019-04-01-0", "https://www.nasdaq.com/articles/3-leading-alzheimers-disease-drugs-development-after-biogens-aducanumab-flop-2019-03-30", "https://www.nasdaq.com/articles/novartis-sues-amgen-over-migraine-treatment-aimovig-2019-04-04", "https://www.nasdaq.com/articles/abbvies-psoriasis-drug-skyrizi-gets-first-approval-in-japan-2019-03-26", "https://www.nasdaq.com/articles/top-research-reports-apple-amgen-united-technologies-2019-03-26", "https://www.nasdaq.com/articles/qual-mo-amgn-mco-large-inflows-detected-etf-2019-03-25", "https://www.nasdaq.com/articles/may-3rd-options-now-available-amgen-amgn-2019-03-25", "https://www.nasdaq.com/articles/biogen-stock-fell-too-far-unfortunate-news-2019-03-22", "https://www.nasdaq.com/articles/heres-why-cytokinetics-stock-jumped-today-2019-03-20", "https://www.nasdaq.com/articles/spectrum-pharma-sppi-withdraws-rolontis-bla-shares-down-2019-03-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-amgen-united-technologies-travelers-and-xilinx", "https://www.nasdaq.com/articles/regeneron-sanofi-get-ec-nod-for-label-expansion-of-praluent-2019-03-18", "https://www.nasdaq.com/articles/better-buy-amgen-vs-gilead-sciences-2019-03-17", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-quality-factor-etf-experiences-big-inflow-2019-03-15", "https://www.nasdaq.com/articles/roche-gets-approval-for-label-expansion-of-mabthera-in-europe-2019-03-15", "https://www.nasdaq.com/articles/roche-receives-ec-approval-for-label-expansion-of-hemlibra-2019-03-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2019-2019-03-13", "https://www.nasdaq.com/articles/pfizers-herceptin-biosimilar-trazimera-gets-fda-approval-2019-03-12", "https://www.nasdaq.com/articles/amarins-vascepa-cuts-occurrence-serious-heart-problems-30-pct-2019-03-18", "https://www.nasdaq.com/articles/is-amgen-amgn-a-profitable-pick-forvalue-investors-now-2019-03-11", "https://www.nasdaq.com/articles/amgn-named-top-dividend-stock-nasdaq-100-dividend-channel-32-yield-2019-03-11", "https://www.nasdaq.com/articles/better-buy-amgen-vs-biogen-2019-03-10", "https://www.nasdaq.com/articles/daily-dividend-report-mtn-amt-amat-bmy-amgn-2019-03-08", "https://www.nasdaq.com/articles/rsi-alert-amgen-now-oversold-2019-03-07", "https://www.nasdaq.com/articles/lillys-emgality-gets-fda-priority-review-for-cluster-headache-2019-03-06", "https://www.nasdaq.com/articles/ligand-sells-promacta-rights-for-%24827m-updates-19-view-2019-03-06", "https://www.nasdaq.com/articles/roches-rhhby-tecentriq-gets-fda-approval-for-breast-cancer-2019-03-12", "https://www.nasdaq.com/articles/us-fda-chief-tough-e-cigs-steps-down-surprise-resignation-2019-03-06", "https://www.nasdaq.com/articles/us-fda-chief-tough-e-cigarettes-steps-down-abruptly-2019-03-06", "https://www.nasdaq.com/articles/us-stocks-wall-st-sinks-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/wall-st-sinks-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/wall-st-falls-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/us-stocks-wall-st-falls-3rd-day-healthcare-energy-slump-2019-03-06", "https://www.nasdaq.com/articles/wall-street-eyes-third-day-losses-healthcare-sector-weighs-2019-03-06", "https://www.nasdaq.com/articles/3-big-pharmas-trying-pop-rebate-bubble-2019-03-06", "https://www.nasdaq.com/articles/merck-gets-chmp-nod-for-six-week-dosing-option-of-keytruda-2019-03-05", "https://www.nasdaq.com/articles/us-fda-chief-gottlieb-resigns-2019-03-05", "https://www.nasdaq.com/articles/us-fda-chief-gottlieb-resigning-2019-03-05", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-inflow-2019-03-04", "https://www.nasdaq.com/articles/abbvie-gets-chmp-nod-for-psoriasis-candidate-risankizumab-2019-03-04", "https://www.nasdaq.com/articles/spectrum-sppi-misses-earnings-estimates-in-q4-tops-sales-2019-03-01", "https://www.nasdaq.com/articles/radius-rdus-posts-narrower-q4-loss-on-robust-tymlos-sales-2019-03-01", "https://www.nasdaq.com/articles/us-stocks-wall-street-eyes-third-day-losses-healthcare-sector-weighs-2019-03-06", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-bac-amgn-tzoo-2019-02-26", "https://www.nasdaq.com/articles/roche-rhhby-to-acquire-spark-therapeutics-for-%244.8-billion-2019-02-25", "https://www.nasdaq.com/articles/sanofi-regeneron-lose-us-patent-challenge-amgen-cholesterol-drug-2019-02-25", "https://www.nasdaq.com/articles/better-buy-amgen-vs-celgene-2019-02-24", "https://www.nasdaq.com/articles/amgen-starts-phase-iii-enrollment-for-heart-failure-drug-2019-02-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-walmart-amgen-honda-transcanada-and-transunion-2019-02", "https://www.nasdaq.com/articles/merck-gets-priority-review-for-keytruda-in-third-line-sclc-2019-02-21", "https://www.nasdaq.com/articles/sanofi-regeneron-disagree-with-jury-verdict-in-amgens-favor-2019-02-26", "https://www.nasdaq.com/articles/abbvies-ra-candidate-upadacitinib-gets-fda-priority-review-2019-02-20", "https://www.nasdaq.com/articles/mercks-keytruda-fails-to-meet-endpoint-in-liver-cancer-study-2019-02-20", "https://www.nasdaq.com/articles/top-analyst-reports-walmart-amgen-and-honda-2019-02-20", "https://www.nasdaq.com/articles/roches-rhhby-bla-for-lymphoma-drug-gets-priority-review-2019-02-19", "https://www.nasdaq.com/articles/merck-gets-priority-review-for-keytruda-combo-in-kidney-cancer-2019-02-18", "https://www.nasdaq.com/articles/amgen-buy-2019-02-17", "https://www.nasdaq.com/articles/teva-teva-q4-earnings-miss19-view-weak-shares-down-2019-02-14", "https://www.nasdaq.com/articles/amgn-april-5th-options-begin-trading-2019-02-21", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/key-takeaways-from-eli-lillys-lly-q4-earnings-report-2019-02-13", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-priority-review-for-head-neck-cancer-2019-02-12", "https://www.nasdaq.com/articles/abbvie-buys-rights-to-novel-immunotherapy-for-multiple-myeloma-2019-02-12", "https://www.nasdaq.com/articles/sanofi-regeneron-cut-price-of-pcsk9-inhibitor-praluent-by-60-2019-02-12", "https://www.nasdaq.com/articles/iwv-pep-abbv-amgn-etf-outflow-alert-2019-02-11", "https://www.nasdaq.com/articles/sanofi-and-regeneron-cut-list-price-cholesterol-drug-60-pct-2019-02-11", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/5-reasons-eli-lilly-investors-look-can-look-past-lartruvos-failure-2019-02-07", "https://www.nasdaq.com/articles/lilly-lly-lags-q4-earnings-lowers-2019-view-stock-down-2019-02-06", "https://www.nasdaq.com/articles/amgen-top-socially-responsible-dividend-stock-31-yield-amgn-2019-02-06", "https://www.nasdaq.com/articles/facing-crackdown-canada-drugmakers-offered-billions-price-cuts-2019-02-06", "https://www.nasdaq.com/articles/roche-submits-sbla-to-fda-for-label-expansion-of-kadcyla-2019-02-05", "https://www.nasdaq.com/articles/after-hours-most-active-feb-5-2019-brx-snap-et-s-eca-m-czr-msft-kura-ea-amgn-urbn-2019-02", "https://www.nasdaq.com/articles/heres-why-coherus-biosciences-rose-487-january-2019-02-11", "https://www.nasdaq.com/articles/pfizers-pfe-new-lung-cancer-drug-vizimpro-gets-chmp-nod-2019-02-04", "https://www.nasdaq.com/articles/war-high-drug-prices-could-boost-biosimilars-2019-02-03", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-amgn-abbv-lly-2019-02-01", "https://www.nasdaq.com/articles/optum-cover-amgen-eli-lilly-migraine-drugs-exclude-teva-2019-02-01", "https://www.nasdaq.com/articles/mercks-keytruda-tops-2-billion-quarterly-sales-shares-rise-2019-02-01", "https://www.nasdaq.com/articles/merck-quarterly-profit-beats-estimates-keytruda-strength-2019-02-01", "https://www.nasdaq.com/articles/roche-rhhby-2018-sales-up-on-solid-new-drugs-performance-2019-02-01", "https://www.nasdaq.com/articles/teva-gains-positive-chmp-opinion-for-migraine-drug-ajovy-2019-02-04", "https://www.nasdaq.com/articles/novartis-nvs-q4-earnings-miss-estimates-revenues-up-y-y-2019-01-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-q4-2018-earnings-conference-call-transcript-2019-01-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-amd-2019-01-30", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-beat-estimates-2019-guidance-tepid-2019-01-30", "https://www.nasdaq.com/articles/pfizer-pfe-q4-earnings-beat-2019-view-tepid-stock-dips-2019-01-29", "https://www.nasdaq.com/articles/amgen-leaves-investors-mixed-emotions-2019-01-29", "https://www.nasdaq.com/articles/amgen-q4-18-earnings-conference-call-500-pm-et-2019-01-29", "https://www.nasdaq.com/articles/top-us-insurer-cover-amgen-eli-lilly-migraine-drugs-exclude-teva-2019-02-01", "https://www.nasdaq.com/articles/amgen-quarterly-profit-tops-street-view-2019-forecast-falls-short-2019-01-29", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-29-2019-aapl-amgn-cni-syk-ilmn-ebay-eqr-amd-bxp-algn", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q4-earnings%3A-whats-in-the-cards-2019-01-28", "https://www.nasdaq.com/articles/notable-monday-option-activity-gpre-yumc-amgn-2019-01-28", "https://www.nasdaq.com/articles/abbvie-abbv-misses-on-q4-earnings-revenues-shares-down-2019-01-25", "https://www.nasdaq.com/articles/amgen-allergans-rituxan-biosimilar-meets-goal-in-phase-iii-2019-01-25", "https://www.nasdaq.com/articles/health-care-sector-update-01252019-chrsamgnrmdaznidxgabbv-2019-01-25", "https://www.nasdaq.com/articles/amgen-2019-forecast-falls-short-expectations-shares-dip-2019-01-29", "https://www.nasdaq.com/articles/cvs-cover-migraine-drugs-teva-lilly-excludes-amgen-2019-01-25", "https://www.nasdaq.com/articles/pfizer-pfe-to-report-q4-earnings%3A-whats-in-the-cards-2019-01-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-regeneron-pharmaceuticals-amgen-alnylam", "https://www.nasdaq.com/articles/ishares-us-healthcare-etf-experiences-big-inflow-2019-01-24", "https://www.nasdaq.com/articles/is-a-surprise-in-the-cards-for-novartis-nvs-in-q4-earnings-2019-01-24", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgen-vertex-get-ec-nod-for-label-expansion-of-drugs-2019-01-23", "https://www.nasdaq.com/articles/better-buy-amgen-vs-johnson-johnson-2019-01-23", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-amgen-2019-01-25", "https://www.nasdaq.com/articles/whats-in-store-for-bristol-myers-bmy-in-q4-earnings-2019-01-21", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-coming-up%3A-whats-in-the-cards-2019-01-21", "https://www.nasdaq.com/articles/which-big-pharma-stocks-lose-most-war-drug-price-hikes-2019-01-20", "https://www.nasdaq.com/articles/amgen-amgn-gains-but-lags-market%3A-what-you-should-know-2019-01-18", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-gets-fda-panel-nod-2019-01-17", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-amgn-ilmn-regn-2019-01-16", "https://www.nasdaq.com/articles/amgens-postmenopausal-osteoporosis-drug-wins-fda-panel-backing-2019-01-16", "https://www.nasdaq.com/articles/can-amgen-amgn-keep-the-earnings-surprise-streak-alive-2019-01-21", "https://www.nasdaq.com/articles/whats-in-store-for-merck-in-2019-after-a-solid-run-in-18-2019-01-14", "https://www.nasdaq.com/articles/heres-why-you-should-invest-in-illumina-ilmn-stock-now-2019-01-14", "https://www.nasdaq.com/articles/amgens-osteoporosis-candidate-evenity-gets-approval-in-japan-2019-01-09", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-mrk-abt-amgn-2019-01-07", "https://www.nasdaq.com/articles/us-supreme-court-rejects-amgen-over-cholesterol-medication-patent-fight-2019-01-07", "https://www.nasdaq.com/articles/amgen-top-25-dividend-giant-297-yield-amgn-2019-01-07", "https://www.nasdaq.com/articles/us-top-court-rejects-amgen-over-cholesterol-medication-patent-fight-2019-01-07", "https://www.nasdaq.com/articles/3-top-big-pharma-stocks-buy-now-2019-01-15", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-shares-got-knocked-down-193-december-2019-01-04", "https://www.nasdaq.com/articles/merck-buys-nash-candidate-keytruda-wins-5-approvals-in-japan-2019-01-04", "https://www.nasdaq.com/articles/teva-pharmaceutical-posting-strong-gain-after-resolving-dispute-amgen-2019-01-03", "https://www.nasdaq.com/articles/spectrum-pharma-fully-enrolls-1st-cohort-in-poziotinib-study-2019-01-03", "https://www.nasdaq.com/articles/will-pfizers-pfe-stock-keep-up-the-momentum-in-2019-2019-01-03", "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-1.52%3A-what-you-should-know-2019-01-03", "https://www.nasdaq.com/articles/teva-teva-ends-dispute-with-amgen-over-generic-sensipar-2019-01-03", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-amgen-2019-01-06", "https://www.nasdaq.com/articles/teva-amgen-settle-dispute-over-tevas-generic-cinacalet-hcl-product-2019-01-02", "https://www.nasdaq.com/articles/forget-glaxosmithkline-eli-lilly-better-big-pharma-stock-2018-12-29", "https://www.nasdaq.com/articles/will-abbvie-abbv-shares-regain-lost-momentum-in-2019-2018-12-28", "https://www.nasdaq.com/articles/spectrum-pharma-files-bla-for-neutropenia-candidate-rolontis-2018-12-28", "https://www.nasdaq.com/articles/qual-ma-mo-amgn-large-inflows-detected-etf-2018-12-27", "https://www.nasdaq.com/articles/abbvie-stock-3-pros-and-3-cons-consider-investing-abbv-2018-12-27", "https://www.nasdaq.com/articles/3-pharma-stocks-revving-for-growth-2019-01-02", "https://www.nasdaq.com/articles/mercks-sbla-for-keytruda-in-lung-cancer-gets-extended-review-2018-12-21", "https://www.nasdaq.com/articles/abbvie-abbv-seeks-approval-for-ra-candidate-upadacitinib-2018-12-21", "https://www.nasdaq.com/articles/allergan-drops-stops-textured-breast-implant-sales-in-europe-2018-12-20", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-approval-for-rare-skin-cancer-2018-12-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-aduro-vertex-evofem-and-incyte-2018-12-20", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-december-2018-12-20", "https://www.nasdaq.com/articles/lillys-shares-rise-on-robust-2019-view-dividend-hike-2018-12-20", "https://www.nasdaq.com/articles/amgen-amgn-stock-moves-1%3A-what-you-should-know-2018-12-24", "https://www.nasdaq.com/articles/forget-bluebird-bio-amgen-better-biotech-stock-2018-12-19", "https://www.nasdaq.com/articles/amgen-and-molecular-partners-collaborate-immuno-oncology-2018-12-18", "https://www.nasdaq.com/articles/ishares-msci-world-etf-experiences-big-inflow-2018-12-18", "https://www.nasdaq.com/articles/mercks-keytruda-gets-eu-nod-as-adjuvant-therapy-for-melanoma-2018-12-18", "https://www.nasdaq.com/articles/teva-reports-positive-top-line-data-for-migraine-candidate-2018-12-18", "https://www.nasdaq.com/articles/biotech-stocks-made-big-progress-toward-preventing-heart-attacks-2018-2018-12-18", "https://www.nasdaq.com/articles/amgen-amgn-stock-sinks-as-market-gains%3A-what-you-should-know-2018-12-18", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-pipeline-updates-from-vrtx-amgn-adro-teams-up-with-lly-2018-12-19", "https://www.nasdaq.com/articles/better-buy-biogen-vs-amgen-2018-12-15", "https://www.nasdaq.com/articles/5-biotech-stocks-set-bounce-back-19-after-rough-ride-2018-12-14", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2018-12-14", "https://www.nasdaq.com/articles/gilead-sciences-top-socially-responsible-dividend-stock-34-yield-gild-2018-12-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-13-2018-2018-12-12", "https://www.nasdaq.com/articles/amgen-amgn-gains-but-lags-market%3A-what-you-should-know-2018-12-12", "https://www.nasdaq.com/articles/why-arrowhead-pharmaceuticals-surged-11-higher-today-2018-12-12", "https://www.nasdaq.com/articles/pfizers-pfe-biosimilar-of-avastin-gets-positive-chmp-nod-2018-12-17", "https://www.nasdaq.com/articles/wall-street-heads-higher-open-chinas-trade-concessions-trigger-risk-rally-2018-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-oprxitcientxamgnrarx-2018-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-itcientxamgnrarx-2018-12-11", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-12-10", "https://www.nasdaq.com/articles/amgen-amgn-continues-to-reward-shareholders-ups-dividend-2018-12-10", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-aes-erie-vtr-mrvl-2018-12-10", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-kodk-amgn-nyt-2018-12-07", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-entx-amgn-itci-nvs-jnj-pfe-mrk-abt-2018-12-11", "https://www.nasdaq.com/articles/wall-street-heads-higher-open-chinas-trade-concessions-trigger-risk-rally-2018-12-11", "https://www.nasdaq.com/articles/health-care-sector-update-12112018-oprxitcientxamgnrarx-2018-12-11", "https://www.nasdaq.com/articles/fda-committee-to-review-amgens-amgn-osteoporosis-candidate-2018-12-03", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-12-03", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-xlv-2018-12-03", "https://www.nasdaq.com/articles/amgen-amgn-gains-as-market-dips%3A-what-you-should-know-2018-11-29", "https://www.nasdaq.com/articles/3-big-stock-charts-wednesday-delta-air-lines-amgen-and-mondelez-international-2018-11-28", "https://www.nasdaq.com/articles/can-celgene-and-bluebird-bio-survive-two-pronged-attack-2018-12-05", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-amgn-v-ko-2018-11-28", "https://www.nasdaq.com/articles/5-biotech-stocks-scoop-big-dividends-2018-11-27", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-spyg-abt-bkng-amgn-2018-11-26", "https://www.nasdaq.com/articles/4-reasons-why-lilly-is-up-more-than-30-this-year-so-far-2018-11-26", "https://www.nasdaq.com/articles/roche-abbvie-get-fda-approval-for-venclexta-label-expansion-2018-11-22", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-drug-wins-nod-in-china-arena-up-on-licensing-deal-2018-11-21", "https://www.nasdaq.com/articles/amgen-amgn-great-stock-value-investors-2018-11-19", "https://www.nasdaq.com/articles/novartis-nvs-receives-ec-approval-for-neulasta-biosimilar-2018-11-28", "https://www.nasdaq.com/articles/drug-pricing-resurfaces-pfizer-to-raise-cost-of-41-drugs-2018-11-19", "https://www.nasdaq.com/articles/amgen-amgn-gains-as-market-dips%3A-what-you-should-know-2018-11-19", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-spyg-amgn-tmo-lly-2018-11-16", "https://www.nasdaq.com/articles/lilly-offers-updates-on-progress-of-headache-disorder-drugs-2018-11-15", "https://www.nasdaq.com/articles/mercks-keytruda-improves-survival-in-esophageal-cancer-study-2018-11-15", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-15-2018-2018-11-14", "https://www.nasdaq.com/articles/roches-tecentriq-gets-priority-review-for-breast-cancer-2018-11-14", "https://www.nasdaq.com/articles/amgens-blincyto-gets-positive-chmp-opinion-for-line-extension-2018-11-19", "https://www.nasdaq.com/articles/drug-pricing-resurfaces-pfizer-to-raise-cost-of-41-drugs-2018-11-19", "https://www.nasdaq.com/articles/amgen-amgn-gains-as-market-dips%3A-what-you-should-know-2018-11-19", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-inc-2018-11-11", "https://www.nasdaq.com/articles/6-pharmaceutical-stocks-to-buy-after-the-midterms-2018-11-09", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-beat-estimates-in-q3-2018-11-09", "https://www.nasdaq.com/articles/ligand-lgnd-beats-on-q3-earnings-revenues-raises-view-2018-11-09", "https://www.nasdaq.com/articles/stocks-hold-midterm-gains-after-fed-statement-2018-11-09", "https://www.nasdaq.com/articles/ex-dividend-reminder-aqua-america-amgen-and-jones-lang-lasalle-2018-11-13", "https://www.nasdaq.com/articles/amgen-amgn-counts-on-new-drugs-amid-rising-biosimilar-woes-2018-11-07", "https://www.nasdaq.com/articles/3-cancer-stocks-watch-december-2018-11-07", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-08-2018-2018-11-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-intercontinental-exchange-total-s.a.-royal-dutch", "https://www.nasdaq.com/articles/5-top-stocks-make-most-divided-congress-2018-11-07", "https://www.nasdaq.com/articles/7-healthcare-stocks-soaring-election-results-2018-11-07", "https://www.nasdaq.com/articles/election-day-2018-here-are-winners-losers-2018-11-06", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-amgn-mdt-lly-2018-11-07", "https://www.nasdaq.com/articles/3-top-biotech-stocks-pes-below-14-2018-11-03", "https://www.nasdaq.com/articles/drug-stocks-to-post-earnings-on-nov-5%3A-myl-nbix-rare-taro-2018-11-02", "https://www.nasdaq.com/articles/teva-teva-q3-earnings-beat-2018-eps-view-up-shares-rise-2018-11-02", "https://www.nasdaq.com/articles/radius-health-rdus-posts-narrower-than-expected-q3-loss-2018-11-02", "https://www.nasdaq.com/articles/notable-friday-option-activity-aal-amgn-qcom-2018-11-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-amgen-vertex-pharmaceuticals-celgene", "https://www.nasdaq.com/articles/biotech-etfs-in-focus-on-string-of-q3-earnings-beat-2018-11-01", "https://www.nasdaq.com/articles/amgen-amgn-outpaces-stock-market-gains%3A-what-you-should-know-2018-11-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-facebook-amgen-and-mgm-resorts-international-2018-10-31", "https://www.nasdaq.com/articles/community-healths-cyh-q3-loss-widens-admissions-drop-2018-10-30", "https://www.nasdaq.com/articles/pfizer-pfe-beats-on-q3-earnings-meets-sales-narrows-view-2018-10-30", "https://www.nasdaq.com/articles/amgen-inc-amgn-q3-2018-earnings-conference-call-transcript-2018-10-30", "https://www.nasdaq.com/articles/aging-blockbusters-send-amgen-incs-bottom-line-lower-2018-10-30", "https://www.nasdaq.com/articles/facebook-beats-q3-estimates-swings-positive-plus-amgn-mgm-2018-10-30", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-and-revenues-beat-estimates-2018-10-30", "https://www.nasdaq.com/articles/amgen-amgn-beats-on-earnings-sales-in-q3-raises-view-2018-10-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-facebook-amgen-and-mgm-resorts-international-2018-10-31", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-inflow-2018-10-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-allergan-regeneron-pharmaceuticals-amgen-alnylam", "https://www.nasdaq.com/articles/big-pharma-bet-isnt-paying-yet-and-its-costing-you-2018-10-28", "https://www.nasdaq.com/articles/amgen-oversold-2018-10-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-glaxo-gsk-this-earnings-season-2018-10-26", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-400-follow-through-indicator-21-sensitive-2018-10-30", "https://www.nasdaq.com/articles/why-amgen-amgn-might-surprise-this-earnings-season-2018-10-26", "https://www.nasdaq.com/articles/5-drug-biotech-stocks-likely-to-beat-estimates-in-q3-earnings-2018-10-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-hca-healthcare-hca-in-q3-earnings-2018-10-26", "https://www.nasdaq.com/articles/pfizer-pfe-to-report-q3-earnings%3A-whats-in-the-cards-2018-10-25", "https://www.nasdaq.com/articles/can-amgen-amgn-keep-the-earnings-streak-alive-in-q3-2018-10-25", "https://www.nasdaq.com/articles/bristol-myers-bmy-beats-on-q3-earnings-raises-eps-view-2018-10-25", "https://www.nasdaq.com/articles/sarepta-srpt-q3-earnings-sales-miss-exondys-51-sales-up-2018-10-25", "https://www.nasdaq.com/articles/anthem-antm-q3-earnings%3A-whats-in-store-for-the-stock-2018-10-26", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-zoetis-zts-this-earnings-season-2018-10-25", "https://www.nasdaq.com/articles/amgen-amgn-gains-but-lags-market%3A-what-you-should-know-2018-10-25", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-allergan-agn-in-q3-earnings-2018-10-24", "https://www.nasdaq.com/articles/incyte-incy-to-report-q3-earnings%3A-whats-in-the-cards-2018-10-24", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-amtd-lad-amgn-2018-10-24", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-met-mco-amp-nem-2018-10-24", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-preview%3A-what-to-look-out-for-2018-10-23", "https://www.nasdaq.com/articles/has-amgen-amgn-outpaced-other-medical-stocks-this-year-2018-10-25", "https://www.nasdaq.com/articles/whats-in-store-for-celgene-corp.-celg-q3-earnings-2018-10-23", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-10-22", "https://www.nasdaq.com/articles/whats-in-store-for-anika-therapeutics-anik-in-q3-earnings-2018-10-22", "https://www.nasdaq.com/articles/will-gilead-gild-hiv-sales-offset-hcv-sales-decline-in-q3-2018-10-22", "https://www.nasdaq.com/articles/alexion-alxn-to-report-q3-earnings%3A-whats-in-the-cards-2018-10-22", "https://www.nasdaq.com/articles/novartis-nvs-q3-earnings-in-line-revenues-beat-estimates-2018-10-22", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-10-21", "https://www.nasdaq.com/articles/4-high-dividend-stocks-to-grow-profits-2018-10-23", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-spyg-intc-cmcsa-amgn-2018-10-19", "https://www.nasdaq.com/articles/amgn-or-ilmn%3A-which-is-the-better-value-stock-right-now-2018-10-19", "https://www.nasdaq.com/articles/amgen-amgn-dips-more-than-broader-markets%3A-what-you-should-know-2018-10-19", "https://www.nasdaq.com/articles/biogen-biib-q3-earnings-coming-up%3A-whats-in-the-cards-2018-10-19", "https://www.nasdaq.com/articles/health-care-sector-update-10172018-tevaesrxamgnnvwllyvtvtkdmnfms-2018-10-17", "https://www.nasdaq.com/articles/4-strong-stocks-buy-double-big-takeover-targets-2018-10-16", "https://www.nasdaq.com/articles/immune-design-to-halt-cancer-vaccine-program-shares-plunge-2018-10-15", "https://www.nasdaq.com/articles/3-dividend-stocks-income-2018-10-20", "https://www.nasdaq.com/articles/abbvie-settles-with-novartis-to-delay-humira-biosimilar-in-us-2018-10-12", "https://www.nasdaq.com/articles/health-care-sector-update-10122018-aphb-trvn-nvo-amgn-mrk-abt-pfe-jnj-2018-10-12", "https://www.nasdaq.com/articles/notable-friday-option-activity-wdc-amgn-axs-2018-10-12", "https://www.nasdaq.com/articles/jj-jnj-to-set-the-ball-rolling-for-pharma-q3-earnings-2018-10-11", "https://www.nasdaq.com/articles/validea-warren-buffett-strategy-daily-upgrade-report-10112018-2018-10-11", "https://www.nasdaq.com/articles/validea-peter-lynch-strategy-daily-upgrade-report-10112018-2018-10-11", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-pbe-2018-10-11", "https://www.nasdaq.com/articles/top-ranked-income-stocks-to-buy-for-october-15th-2018-10-15", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-ms-drug-ocrevus-2018-10-10", "https://www.nasdaq.com/articles/bauschs-bryhali-gets-tentative-fda-nod-for-plaque-psoriasis-2018-10-09", "https://www.nasdaq.com/articles/kala-pharmaceuticals-kala-catches-eye%3A-stock-jumps-7.4-2018-10-09", "https://www.nasdaq.com/articles/fda-sets-action-date-for-recros-pain-management-candidate-2018-10-09", "https://www.nasdaq.com/articles/10-sp-500-stocks-to-buy-for-the-long-term-2018-10-09", "https://www.nasdaq.com/articles/5-reasons-why-investors-should-bet-on-merck-mrk-stock-2018-10-08", "https://www.nasdaq.com/articles/arrowhead-pharmaceuticals-inc-buy-dip-2018-10-08", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-dropped-133-september-2018-10-11", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-sma-drug-risdiplam-2018-10-04", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-for-once-weekly-regimen-of-kyprolis-combo-2018-10-03", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-on-acquisition-spree-fda-nod-for-regn-amgn-drugs-2018-10-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-chevron-amgen-thermo-fisher-estee-lauder-and-delta-air", "https://www.nasdaq.com/articles/dr.-reddys-sells-antibiotic-production-hub-to-uae-drugmaker-2018-10-02", "https://www.nasdaq.com/articles/is-amgen-amgn-stock-outpacing-its-medical-peers-this-year-2018-10-01", "https://www.nasdaq.com/articles/5-breakout-stocks-to-buy-2018-09-28", "https://www.nasdaq.com/articles/roches-hemlibra-receives-fda-approval-for-label-expansion-2018-10-05", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-sma-drug-risdiplam-2018-10-04", "https://www.nasdaq.com/articles/amarins-stock-soars-as-fish-oil-drug-lowers-heart-risks-2018-09-27", "https://www.nasdaq.com/articles/3-drugmakers-not-pleased-amarins-fish-oil-triumph-2018-09-26", "https://www.nasdaq.com/articles/lillys-migraine-drug-emgality-wins-positive-chmp-opinion-2018-09-24", "https://www.nasdaq.com/articles/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again-2018-09-24", "https://www.nasdaq.com/articles/mylans-biosimilar-of-neulasta-gets-positive-chmp-opinion-2018-09-24", "https://www.nasdaq.com/articles/pfizers-pneumococcal-vaccine-gets-breakthrough-therapy-status-2018-09-21", "https://www.nasdaq.com/articles/eli-lilly-lly-gets-fda-nod-for-migraine-drug-emgality-2018-09-28", "https://www.nasdaq.com/articles/november-9th-options-now-available-amgen-amgn-2018-09-27", "https://www.nasdaq.com/articles/abbvie-faces-california-insurance-department-suit-for-humira-2018-09-19", "https://www.nasdaq.com/articles/astrazenecas-fasenra-long-term-asthma-study-data-positive-2018-09-19", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-play-amgn-crr-2018-09-19", "https://www.nasdaq.com/articles/does-ajovys-approval-make-teva-pain-free-stock-buy-2018-09-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-unitedhealth-adobe-amgen-ups-and-bayer-2018-09-18", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-buy-2018-09-21", "https://www.nasdaq.com/articles/allergan-frown-lines-study-passes-test-on-higher-botox-dose-2018-09-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-martin-zweig-9162018-2018-09-16", "https://www.nasdaq.com/articles/now-good-time-buy-amgen-2018-09-15", "https://www.nasdaq.com/articles/why-bluebird-and-celgene-should-worry-about-amgens-latest-clinical-victory-2018-09-14", "https://www.nasdaq.com/articles/is-amgen-amgn-a-great-stock-for-value-investors-2018-09-14", "https://www.nasdaq.com/articles/merck-gets-priority-review-for-yet-another-keytruda-sbla-2018-09-13", "https://www.nasdaq.com/articles/top-research-reports-unitedhealth-adobe-amgen-2018-09-17", "https://www.nasdaq.com/articles/regeneron-sanofis-sbla-for-praluent-to-be-reviewed-by-fda-2018-09-12", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-13-2018-2018-09-12", "https://www.nasdaq.com/articles/3-small-biotech-stocks-that-almost-doubled-in-past-month-2018-09-11", "https://www.nasdaq.com/articles/mercks-keytruda-combo-gets-nod-for-lung-cancer-in-europe-2018-09-11", "https://www.nasdaq.com/articles/3-top-dividend-stocks-buy-right-now-2018-09-11", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-09-11", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-amgn-rlgy-grub-2018-09-11", "https://www.nasdaq.com/articles/why-amgen-will-likely-be-boring-dividend-stock-over-next-few-years-2018-09-13", "https://www.nasdaq.com/articles/astrazenecas-asthma-drug-gets-breakthrough-therapy-status-2018-09-07", "https://www.nasdaq.com/articles/pfizers-skin-disease-drug-gets-breakthrough-therapy-status-2018-09-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-puma-biotechnology-mannkind-united-therapeutics", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-for-rare-skin-cancer-2018-09-05", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgn-pbyi-get-ec-nod-for-their-drugs-mnkd-soars-2018-09-05", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-gm-axp-amgn-2018-09-04", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-09-02", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iwf-nvda-amgn-mo-2018-09-10", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-gets-ec-nod-for-yescarta-amgn-submits-kyprolis-snda-2018-08-29", "https://www.nasdaq.com/articles/pfizer-stock-up-this-year-so-far%3A-whats-going-in-its-favor-2018-08-29", "https://www.nasdaq.com/articles/amgen-files-for-once-weekly-regimen-for-myeloma-drug-kyprolis-2018-08-28", "https://www.nasdaq.com/articles/5-reasons-why-you-should-add-lilly-stock-to-your-portfolio-2018-08-27", "https://www.nasdaq.com/articles/why-is-amgen-amgn-up-1.3-since-last-earnings-report-2018-08-27", "https://www.nasdaq.com/articles/roche-rhhby-gets-fda-approval-for-cobas-efgr-mutation-test-2018-08-24", "https://www.nasdaq.com/articles/3-big-drug-stocks-big-cash-stockpiles-should-you-spend-your-cash-buying-them-2018-08-24", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwf-nvda-amgn-mo-2018-08-31", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-gets-ec-nod-for-yescarta-amgn-submits-kyprolis-snda-2018-08-29", "https://www.nasdaq.com/articles/trade-day-amgen-strong-stock-giddy-industry-2018-08-23", "https://www.nasdaq.com/articles/amgen-inc-buy-2018-08-22", "https://www.nasdaq.com/articles/5-drug-stocks-to-buy-while-the-pharma-sector-is-on-sale-2018-08-22", "https://www.nasdaq.com/articles/merck-gets-fda-nod-for-keytruda-lung-cancer-label-expansion-2018-08-21", "https://www.nasdaq.com/articles/amgen-stock-up-this-year-so-far%3A-will-the-rally-continue-2018-08-20", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/notable-friday-option-activity-amgn-atvi-dis-2018-08-24", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-amgn-trn-aeo-2018-08-15", "https://www.nasdaq.com/articles/allergans-agn-stock-up-4.2-since-q2-earnings%3A-heres-why-2018-08-14", "https://www.nasdaq.com/articles/top-research-reports-unitedhealth-pepsico-amgen-more-2018-08-14", "https://www.nasdaq.com/articles/heres-why-merck-mrk-stock-is-up-since-q2-earnings-release-2018-08-14", "https://www.nasdaq.com/articles/ex-dividend-reminder-amgen-allergan-and-south-state-2018-08-14", "https://www.nasdaq.com/articles/heres-why-lilly-lly-stock-is-up-15-since-q2-earnings-2018-08-13", "https://www.nasdaq.com/articles/3-strong-buy-stocks-for-the-week-2018-08-13", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/why-amgen-top-socially-responsible-dividend-stock-amgn-2018-08-09", "https://www.nasdaq.com/articles/5-companies-making-giant-buybacks-2018-08-08", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2018-08-08", "https://www.nasdaq.com/articles/radius-rdus-q2-loss-narrower-than-expected-tymlos-sales-up-2018-08-07", "https://www.nasdaq.com/articles/ligand-lgnd-beats-on-q2-earnings-revenues-raises-view-2018-08-07", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-08-06", "https://www.nasdaq.com/articles/3-healthcare-stocks-to-buy-for-the-sector-rebound-2018-08-06", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-miss-estimates-in-q2-2018-08-10", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-radius-health-rdus-in-q2-earnings-2018-08-02", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-syna-amgn-ipi-2018-08-02", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-amgen-vertex-impress-in-q2-gileads-ceo-to-exit-2018-08-01", "https://www.nasdaq.com/articles/daily-dividend-report-arcc-lfus-vnom-main-aapl-amgn-syk-2018-08-01", "https://www.nasdaq.com/articles/pfizer-pfe-beats-on-q2-earnings-sales-ups-profit-view-2018-07-31", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-07-27", "https://www.nasdaq.com/articles/roche-rhhby-1h18-revenues-up-y-y-on-solid-new-drug-sales-2018-07-27", "https://www.nasdaq.com/articles/two-pharma-giants-successfully-navigate-challenging-climate-2018-08-03", "https://www.nasdaq.com/articles/amgen-incs-young-lineup-offsets-enbrel-losses-style-2018-07-26", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-455-follow-through-indicator-22-sensitive-2018-07-26", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-26-2018-amzn-intc-amgn-sbux-ea-afl-ew-lrcx-ftv-dfs-dlr", "https://www.nasdaq.com/articles/mercks-keytruda-improves-survival-in-head-neck-cancer-study-2018-07-25", "https://www.nasdaq.com/articles/will-pfizer-pfe-keep-the-earnings-streak-alive-in-q2-2018-07-25", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-keryx-kerx-this-earnings-season-2018-07-24", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-will-it-beat-again-2018-07-23", "https://www.nasdaq.com/articles/amgen-amgn-q2-earnings-sales-beat-estimates-view-up-2018-07-27", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-gild-amgn-2018-07-19", "https://www.nasdaq.com/articles/biogen-biib-to-report-q2-earnings%3A-whats-in-the-cards-2018-07-19", "https://www.nasdaq.com/articles/can-eli-lilly-lly-keep-the-earnings-streak-alive-in-q2-2018-07-19", "https://www.nasdaq.com/articles/abbvie-settles-with-mylan-to-delay-humira-biosimilar-in-u.s.-2018-07-18", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-amgn-resubmits-evenity-bla-advaxis-soars-regulatory-updates-2018-07", "https://www.nasdaq.com/articles/novartis-q2-earnings-miss-sales-top-on-cosentyx-entresto-2018-07-18", "https://www.nasdaq.com/articles/roches-flu-drug-meets-primary-endpoint-in-phase-iii-study-2018-07-17", "https://www.nasdaq.com/articles/abbvies-stock-bargain-after-falling-8-last-week-2018-07-23", "https://www.nasdaq.com/articles/is-a-surprise-in-the-cards-for-novartis-in-q2-earnings-2018-07-16", "https://www.nasdaq.com/articles/pacira-focused-on-exparel-development-amid-competition-2018-07-16", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-2018-07-15", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-johnson-johnson-2018-07-13", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-amgen-amgn-stock-2018-07-13", "https://www.nasdaq.com/articles/2-overlooked-biotech-stocks-buy-now-2018-07-13", "https://www.nasdaq.com/articles/amgen-resubmits-bla-to-fda-for-osteoporosis-candidate-evenity-2018-07-13", "https://www.nasdaq.com/articles/pfizers-xtandi-gets-fda-nod-for-expanded-patient-population-2018-07-16", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fdas-priority-review-for-liver-cancer-2018-07-12", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-gild-amgn-biib-2018-07-11", "https://www.nasdaq.com/articles/3-huge-biotech-winners-2018-so-far-2018-07-11", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-amgen-amgn-2018-07-10", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-07-10", "https://www.nasdaq.com/articles/why-amgen-top-25-dividend-giant-amgn-2018-07-09", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-amgen-ani-and-illumina-2018-07-06", "https://www.nasdaq.com/articles/august-31st-options-now-available-amgen-amgn-2018-07-12", "https://www.nasdaq.com/articles/why-biotech-stocks-rallied-biogens-alzheimers-test-2018-07-06", "https://www.nasdaq.com/articles/heres-why-abbvie-stock-is-good-for-your-portfolios-health-2018-07-05", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilds-positive-chmp-nod-regulatory-updates-more-2018-07-05", "https://www.nasdaq.com/articles/biotech-stock-outlook%3A-short-term-pricing-pain-to-prevail-2018-07-05", "https://www.nasdaq.com/articles/ibb-gild-amgn-biib-large-outflows-detected-etf-2018-07-03", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-in-difficult-lung-cancer-2018-07-03", "https://www.nasdaq.com/articles/should-value-investors-consider-amgen-amgn-stock-now-2018-07-02", "https://www.nasdaq.com/articles/notable-friday-option-activity-amgn-fast-bgs-2018-07-06", "https://www.nasdaq.com/articles/4-drug-and-biotech-stocks-awaiting-fda-decisions-in-july-2018-07-02", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-inc-2018-07-01", "https://www.nasdaq.com/articles/4-biotech-stocks-bet-second-half-2018-2018-06-29", "https://www.nasdaq.com/articles/5-cheap-large-cap-stocks-buy-now-2018-06-28", "https://www.nasdaq.com/articles/mylan-lupin-collaborate-for-the-proposed-biosimilar-enbrel-2018-06-28", "https://www.nasdaq.com/articles/amgen-announces-top-line-data-from-remicade-biosimilar-study-2018-06-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-facebook-amgen-abbott-coca-cola-and-3m-2018-06-27", "https://www.nasdaq.com/articles/4-drug-and-biotech-stocks-awaiting-fda-decisions-july-2018-07-02", "https://www.nasdaq.com/articles/5-cheap-large-cap-stocks-buy-now-2018-06-27", "https://www.nasdaq.com/articles/mercks-keytruda-under-fda-review-for-advanced-melanoma-2018-06-26", "https://www.nasdaq.com/articles/top-stock-reports-facebook-amgen-abbott-2018-06-26", "https://www.nasdaq.com/articles/amgens-repatha-reduces-bad-cholestrol-in-type-ii-diabetes-2018-06-25", "https://www.nasdaq.com/articles/roches-rhhby-study-on-tecentriq-for-lung-cancer-positive-2018-06-25", "https://www.nasdaq.com/articles/long-term-investors-take-note-these-5-big-pharma-companies-have-best-pipelines-2018-06-24", "https://www.nasdaq.com/articles/merck-mrk-stock-up-so-far-this-year-on-keytruda-strength-2018-06-22", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-pbyi-soars-mack-crashes-gilds-biktarvy-gets-ec-nod-2018-06-27", "https://www.nasdaq.com/articles/amgen-gets-eu-nod-to-add-survival-data-on-blincytos-label-2018-06-20", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-srpt-sldb-soar-on-positive-data-anik-ziop-crash-2018-06-20", "https://www.nasdaq.com/articles/teva-to-discontinue-a-fremanezumab-study-on-cluster-headache-2018-06-18", "https://www.nasdaq.com/articles/10-top-stock-picks-wall-streets-best-analysts-2018-06-18", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-nke-apc-amgn-2018-06-15", "https://www.nasdaq.com/articles/roche-announces-positive-data-on-gazyva-and-ms-drug-ocrevus-2018-06-15", "https://www.nasdaq.com/articles/allergan-agn-presents-positive-data-on-glaucoma-candidate-2018-06-14", "https://www.nasdaq.com/articles/xlv-abbv-amgn-mdt-etf-outflow-alert-2018-06-21", "https://www.nasdaq.com/articles/roches-rhhby-avastin-gets-label-expansion-approval-by-fda-2018-06-14", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-abbv-amgn-mdt-2018-06-13", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-approval-for-cervical-cancer-2018-06-13", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-axon-soars-amgen-drugs-get-fda-ec-nod-2018-06-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2018-2018-06-13", "https://www.nasdaq.com/articles/humiras-sales-will-decline-and-its-fantastic-news-abbvie-2018-06-13", "https://www.nasdaq.com/articles/allergans-second-anti-cgrp-drug-positive-in-mid-stage-study-2018-06-12", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-nod-for-2nd-lymphoma-indication-2018-06-14", "https://www.nasdaq.com/articles/amgens-amgn-prolia-gets-label-expansion-approval-in-europe-2018-06-11", "https://www.nasdaq.com/articles/jak-inhibitors-prospects-strong-4-stocks-ruling-space-2018-06-11", "https://www.nasdaq.com/articles/roche-rituxan-label-expanded-by-fda-for-pemphigus-vulgaris-2018-06-08", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regeneron-celgene-amgen-impress-at-asco-2018-06-06", "https://www.nasdaq.com/articles/merck-presents-positive-melanoma-data-on-keytruda-at-asco-2018-06-05", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2018-06-05", "https://www.nasdaq.com/articles/mylan-myl-gets-fda-approval-for-biosimilar-of-neulasta-2018-06-05", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-add-aspire-data-on-kyprolis-label-2018-06-12", "https://www.nasdaq.com/articles/eli-lillys-olumiant-gets-fda-nod-for-rheumatoid-arthritis-2018-06-04", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-lung-cancer-data-in-focus-at-asco-2018-06-04", "https://www.nasdaq.com/articles/biogen-inc-stock-got-an-upgrade-but-should-you-listen-2018-06-04", "https://www.nasdaq.com/articles/novartis-announces-positive-data-on-kisqali-and-tasigna-2018-06-04", "https://www.nasdaq.com/articles/amgen-inc-amgn-buy-2018-06-03", "https://www.nasdaq.com/articles/3-reasons-gilead-sciences-better-value-stock-amgen-2018-06-03", "https://www.nasdaq.com/articles/notable-friday-option-activity-trip-mar-amgn-2018-06-01", "https://www.nasdaq.com/articles/watch-out-amgen-here-comes-mylan-2018-06-05", "https://www.nasdaq.com/articles/july-6th-options-now-available-amgen-amgn-2018-05-24", "https://www.nasdaq.com/articles/why-is-amgen-amgn-up-3.7-since-its-last-earnings-report-2018-05-24", "https://www.nasdaq.com/articles/mercks-keytruda-shows-survival-benefit-in-squamous-nsclc-2018-05-24", "https://www.nasdaq.com/articles/3-top-biosimilars-will-lift-pfizer-inc-stock-even-more-2018-05-24", "https://www.nasdaq.com/articles/little-biotech-best-migraine-stock-buy-now-2018-05-24", "https://www.nasdaq.com/articles/fda-confirms-september-action-date-for-tevas-migraine-drug-2018-05-24", "https://www.nasdaq.com/articles/trade-day-amgen-inc-clears-breakout-hurdle-2018-05-31", "https://www.nasdaq.com/articles/allergan-stock-down-since-q1-earnings-report%3A-heres-why-2018-05-23", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-dgro-amgn-mdt-bmy-2018-05-23", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-fda-gives-nod-to-amgens-drugs-eu-approves-exelixis-cabometyx-2018", "https://www.nasdaq.com/articles/amgen-breaks-above-200-day-moving-average-bullish-amgn-2018-05-22", "https://www.nasdaq.com/articles/amgens-label-expansion-application-for-prolia-gets-fda-nod-2018-05-22", "https://www.nasdaq.com/articles/company-news-for-may-21-2018-2018-05-21", "https://www.nasdaq.com/articles/migraine-space-in-focus-as-amgn-nvs-aimovig-gets-fda-nod-2018-05-21", "https://www.nasdaq.com/articles/novartis-gets-approval-for-remicade-biosimilar-in-europe-2018-05-24", "https://www.nasdaq.com/articles/intraday-update-small-caps-keep-faith-blue-chips-blue-face-2018-05-18", "https://www.nasdaq.com/articles/amgens-migraine-drug-aimovig-gets-fda-approval-shares-up-2018-05-18", "https://www.nasdaq.com/articles/health-care-sector-update-05182018-amrxvlrxamgnnvsazn-2018-05-18", "https://www.nasdaq.com/articles/health-care-sector-update-05182018-vlrxamgnnvsazn-2018-05-18", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-etf-inflow-alert-2018-05-17", "https://www.nasdaq.com/articles/amgens-amgn-repatha-gains-eu-nod-to-include-outcomes-data-2018-05-17", "https://www.nasdaq.com/articles/why-spectrum-pharmaceuticals-inc-big-today-2018-05-17", "https://www.nasdaq.com/articles/roche-rhhby-announces-positive-data-on-hemophilia-drug-2018-05-21", "https://www.nasdaq.com/articles/eli-lillys-cluster-headache-candidate-succeeds-in-phase-iii-2018-05-16", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-16-2018-2018-05-15", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-inc-2018-05-15", "https://www.nasdaq.com/articles/ex-dividend-reminder-eli-lilly-amgen-and-simon-property-group-2018-05-14", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-xrx-algn-amgn-2018-05-14", "https://www.nasdaq.com/articles/radius-health-rdus-incurs-narrower-than-expected-q1-loss-2018-05-11", "https://www.nasdaq.com/articles/trump-announces-plan-reign-drug-prices-and-pharma-stocks-rally-2018-05-11", "https://www.nasdaq.com/articles/pfizer-gets-fda-nod-for-amgen-jjs-anemia-drug-biosimilar-2018-05-16", "https://www.nasdaq.com/articles/eli-lillys-cluster-headache-candidate-succeeds-in-phase-iii-2018-05-16", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-16-2018-2018-05-15", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-inc-2018-05-15", "https://www.nasdaq.com/articles/ex-dividend-reminder-eli-lilly-amgen-and-simon-property-group-2018-05-14", "https://www.nasdaq.com/articles/are-these-disappointing-drugs-back-track-billions-2018-05-05", "https://www.nasdaq.com/articles/spectrum-sppi-earnings-and-sales-beat-estimates-in-q1-2018-05-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-apple-exxonmobil-citigroup-and-amgen-2018-05-04", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-may-11-2018-2018-05-10", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-vrtx-post-solid-results-gild-disappoints-in-q1-2018-05-02", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-large-outflows-detected-etf-2018-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-stx-swks-2018-05-01", "https://www.nasdaq.com/articles/pfizer-pfe-stock-falls-on-q1-sales-miss-earnings-beat-2018-05-01", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2018-04-30", "https://www.nasdaq.com/articles/roche-rhhby-q1-earnings%3A-ocrevus-perjeta-drive-sales-beat-2018-04-27", "https://www.nasdaq.com/articles/clinical-stage-biotechs-tackling-huge-health-issue-it-has-overcome-pessimistic-investors", "https://www.nasdaq.com/articles/top-analyst-reports-apple-exxonmobil-citigroup-amgen-2018-05-03", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-vrtx-post-solid-results-gild-disappoints-in-q1-2018-05-02", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-large-outflows-detected-etf-2018-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-stx-swks-2018-05-01", "https://www.nasdaq.com/articles/whats-in-the-cards-for-biomarin-bmrn-in-q1-earnings-2018-04-24", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-vertex-vrtx-this-earnings-season-2018-04-24", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-2018-04-24", "https://www.nasdaq.com/articles/company-news-for-apr-26-2018-2018-04-26", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-24-2018-amgn-txn-cb-cof-ilmn-ew-eqr-wynn-bxp-mkl-tss-pkg", "https://www.nasdaq.com/articles/eli-lilly-and-co-produced-monstrous-q1-beat-it-enough-2018-04-24", "https://www.nasdaq.com/articles/drug-biotech-stock-q1-earnings-due-on-apr-24%3A-lly-biib-amgn-2018-04-23", "https://www.nasdaq.com/articles/mylan-nv-still-undervalued-despite-unveiling-new-products-2018-04-23", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-04-20", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q1-earnings%3A-is-a-beat-in-the-cards-2018-04-20", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2018-04-20", "https://www.nasdaq.com/articles/amgen-inc-amgn-beats-q1-estimates-posts-weak-f18-guidance-2018-04-24", "https://www.nasdaq.com/articles/3-stocks-you-can-safely-own-until-2030-2018-04-20", "https://www.nasdaq.com/articles/mylan-nv-could-be-closer-breakout-most-traders-realize-2018-04-19", "https://www.nasdaq.com/articles/big-biotech-etf-can-bounce-back-2018-04-18", "https://www.nasdaq.com/articles/amgens-aimovig-reduces-episodic-migraine-in-30-patients-2018-04-18", "https://www.nasdaq.com/articles/7-retirement-stocks-coming-correction-2018-04-18", "https://www.nasdaq.com/articles/roche-hemophilia-drug-gets-breakthrough-therapy-designation-2018-04-18", "https://www.nasdaq.com/articles/whats-in-store-for-novartis-nvs-this-earnings-season-2018-04-17", "https://www.nasdaq.com/articles/jj-novartis-q1-earnings-impress%3A-will-others-follow-suit-2018-04-20", "https://www.nasdaq.com/articles/jj-jnj-to-begin-pharma-q1-earnings%3A-whats-in-store-2018-04-12", "https://www.nasdaq.com/articles/mylan-fujifilm-kyowa-team-up-to-market-humira-biosimilar-2018-04-12", "https://www.nasdaq.com/articles/mercks-keytruda-offers-survival-benefit-in-lung-cancer-study-2018-04-10", "https://www.nasdaq.com/articles/4-drugbiotech-stocks-buy-ahead-world-health-day-2018-04-06", "https://www.nasdaq.com/articles/novartis-announces-data-on-cardiovascular-drug-entresto-2018-04-05", "https://www.nasdaq.com/articles/lillys-cyramza-shows-survival-benefit-in-liver-cancer-study-2018-04-05", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-edge-falls-alks-down-fda-oks-amgn-drug-label-expansion-2018-04-04", "https://www.nasdaq.com/articles/xlv-pfe-mrk-amgn-etf-inflow-alert-2018-04-12", "https://www.nasdaq.com/articles/morning-movers-tesla-and-markets-are-back-solid-ground-2018-04-03", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-gets-eu-approval-for-expanded-label-2018-04-03", "https://www.nasdaq.com/articles/better-dividend-stock-buy-abbvie-inc-vs-pfizer-inc-2018-04-03", "https://www.nasdaq.com/articles/amgens-blincyto-gets-fda-nod-for-minimum-residual-disease-2018-04-02", "https://www.nasdaq.com/articles/peek-under-hood-rsp-has-14-upside-2018-03-30", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-03-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-verona-squibb-protagonist-and-amgen-2018-03-29", "https://www.nasdaq.com/articles/rigel-rigl-sinks-on-failure-of-mid-stage-study-on-lead-drug-2018-04-04", "https://www.nasdaq.com/articles/results-renew-optimism-esperion-therapeutics-2018-03-27", "https://www.nasdaq.com/articles/5-biotech-stocks-amazing-pipelines-2018-03-27", "https://www.nasdaq.com/articles/amgens-repatha-gains-chmp-nod-to-include-outcomes-data-2018-03-26", "https://www.nasdaq.com/articles/novartis-gets-positive-chmp-opinion-on-biosimilar-remicade-2018-03-26", "https://www.nasdaq.com/articles/merck-eisai-get-japanese-nod-for-lenvima-label-expansion-2018-03-26", "https://www.nasdaq.com/articles/ishares-core-high-dividend-etf-experiences-big-outflow-2018-03-23", "https://www.nasdaq.com/articles/celgene-corporation-looks-cheap-considering-its-potential-2018-03-23", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-ptgx-down-vrna-up-amgns-repatha-gets-positive-opinion-2018-03-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-fedex-thermo-fisher-sherwin-williams-and", "https://www.nasdaq.com/articles/stemline-therapeutics-inc-stock-investors-are-betting-not-investing-2018-03-23", "https://www.nasdaq.com/articles/roches-rhhby-lucentis-0.3-mg-pfs-receives-fda-approval-2018-03-22", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amgn-2018-03-22", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-gilead-sciences-inc-2018-03-21", "https://www.nasdaq.com/articles/radius-health-announces-positive-data-on-lead-drug-tymlos-2018-03-19", "https://www.nasdaq.com/articles/despite-struggles-celgene-corporation-stock-still-buy-2018-03-19", "https://www.nasdaq.com/articles/radius-health-down-on-negative-chmp-opinion-for-lead-drug-2018-03-23", "https://www.nasdaq.com/articles/5-must-see-quotes-abbvies-management-2018-03-16", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-for-cervical-cancer-2018-03-14", "https://www.nasdaq.com/articles/ibb-amgn-gild-regn-etf-outflow-alert-2018-03-14", "https://www.nasdaq.com/articles/is-amgen-inc.-amgn-a-great-stock-for-value-investors-2018-03-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-15-2018-2018-03-14", "https://www.nasdaq.com/articles/bull-day-regeneron-regn-2018-03-14", "https://www.nasdaq.com/articles/amgen-inc-stock-spring-about-pop-2018-03-13", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2018-03-19", "https://www.nasdaq.com/articles/regeneron-takes-aim-amgen-and-esperion-therapeutics-2018-03-12", "https://www.nasdaq.com/articles/regeneron-and-sanofi-announce-positive-data-on-praluent-2018-03-12", "https://www.nasdaq.com/articles/why-coherus-biosciences-skyrocketing-today-2018-03-09", "https://www.nasdaq.com/articles/merck-to-pay-%24300m-upfront-to-co-develop-eisais-cancer-drug-2018-03-08", "https://www.nasdaq.com/articles/daily-dividend-report-gd-cl-mtn-hmn-pm-amgn-dvn-2018-03-08", "https://www.nasdaq.com/articles/spectrum-sppi-q4-loss-widens-y-y-sales-miss-stock-falls-2018-03-07", "https://www.nasdaq.com/articles/wednesdays-vital-data-alibaba-group-holding-ltd-baba-amgen-inc-amgn-and-advanced-micro", "https://www.nasdaq.com/articles/amgen-stock-split-history-2018-03-13", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwb-amgn-gild-utx-2018-03-06", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-march-2018-03-06", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-amgn-nflx-amzn-2018-03-06", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-may-18th-2018-03-05", "https://www.nasdaq.com/articles/10-companies-making-huge-stock-buybacks-2018-2018-03-05", "https://www.nasdaq.com/articles/radius-rdus-q4-loss-wider-than-expected-on-higher-expenses-2018-03-02", "https://www.nasdaq.com/articles/after-hours-most-active-mar-2-2018-f-fe-orcl-bac-teva-amgn-ftr-qcom-ge-qqq-msft-csx-2018", "https://www.nasdaq.com/articles/why-esperion-therapeutics-shares-fell-despite-its-good-news-2018-03-07", "https://www.nasdaq.com/articles/biotech-etfs-head-to-head%3A-xbi-vs.-ibb.-2018-03-01", "https://www.nasdaq.com/articles/notable-thursday-option-activity-amgn-kfy-tast-2018-03-01", "https://www.nasdaq.com/articles/biotech-stock-round-up%3A-celgene-suffers-setback-gilead-teams-up-with-sangamo-2018-02-28", "https://www.nasdaq.com/articles/3-reasons-abbvie-inc-stock-could-keep-soaring-2018-2018-02-27", "https://www.nasdaq.com/articles/3-top-pharma-stocks-dividend-yields-over-3-2018-02-27", "https://www.nasdaq.com/articles/radius-health-rdus-to-disappoint-investors-in-q4-earnings-2018-02-26", "https://www.nasdaq.com/articles/iusg-mcd-abt-amgn-etf-inflow-alert-2018-02-23", "https://www.nasdaq.com/articles/amgen-amgn-gets-chmp-nod-to-expand-eu-label-of-neulasta-2018-03-01", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-amgnpbyiblcmpfe-2018-02-23", "https://www.nasdaq.com/articles/ligand-lgnd-q4-earnings-revenues-top-2018-view-solid-2018-02-22", "https://www.nasdaq.com/articles/amgen-inc-buy-2018-02-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-total-marriott-pge-and-vertex-2018-02-21", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-ddd-algn-amgn-2018-02-21", "https://www.nasdaq.com/articles/novartis-psoriasis-drug-cosentyx-positive-in-scalp-study-2018-02-20", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-benjamin-graham-2182018-2018-02-18", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-blcm-pfe-pbyi-amgn-4507jp-2018-02-23", "https://www.nasdaq.com/articles/abbvie-hikes-dividend-by-35-launches-%2410b-buyback-plan-2018-02-16", "https://www.nasdaq.com/articles/vym-ge-mcd-amgn-large-inflows-detected-etf-2018-02-15", "https://www.nasdaq.com/articles/did-abbvie-inc-just-become-most-shareholder-friendly-stock-america-2018-02-15", "https://www.nasdaq.com/articles/3-tough-questions-amgen-2018-02-15", "https://www.nasdaq.com/articles/can-immunogens-key-ovarian-cancer-candidate-drive-growth-2018-02-14", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-15-2018-2018-02-14", "https://www.nasdaq.com/articles/roches-rituxan-gets-priority-review-for-label-expansion-2018-02-14", "https://www.nasdaq.com/articles/roche-rhhby-to-acquire-flatiron-health-for-%241.9-billion-2018-02-16", "https://www.nasdaq.com/articles/3-dividend-stocks-know-investors-2018-02-13", "https://www.nasdaq.com/articles/agenus-inc-buy-2018-02-13", "https://www.nasdaq.com/articles/trade-day-amgen-inc-remains-promising-biotechnology-play-2018-02-13", "https://www.nasdaq.com/articles/ex-dividend-reminder-amgen-primerica-and-monmouth-real-estate-investment-2018-02-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-2018-02-11", "https://www.nasdaq.com/articles/forget-amgen-cara-therapeutics-inc-better-growth-stock-2018-02-09", "https://www.nasdaq.com/articles/novartis-cosentyx-label-expanded-to-include-scalp-psoriasis-2018-02-08", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2018-2018-02-13", "https://www.nasdaq.com/articles/roche-reports-positive-data-from-tecentriq-avastin-study-2018-02-06", "https://www.nasdaq.com/articles/amgen-breaks-below-200-day-moving-average-notable-amgn-2018-02-06", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-wyn-amgn-mon-2018-02-06", "https://www.nasdaq.com/articles/amgen-q4-earnings-results-2-things-hate-and-2-things-2018-02-03", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-sales-lag-2018-sales-view-soft-2018-02-02", "https://www.nasdaq.com/articles/roche-rhhby-posts-solid-2017-sales-on-tecentriq-alecensa-2018-02-01", "https://www.nasdaq.com/articles/amgen-topples-after-fourth-quarter-sales-earnings-lag-2018-02-01", "https://www.nasdaq.com/articles/spectrum-pharmas-rolontis-positive-in-pivotal-cancer-study-2018-02-06", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-400-follow-through-indicator-23-sensitive-2018-02-01", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-1-2018-aapl-amzn-googl-v-amgn-ew-msi-emn-fbhs-xl-cpt", "https://www.nasdaq.com/articles/amgen-gets-chmp-nod-to-add-endeavor-data-on-kyprolis-label-2018-01-31", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-amgen-amgn-2018-01-31", "https://www.nasdaq.com/articles/vtv-ge-amgn-abt-etf-inflow-alert-2018-01-30", "https://www.nasdaq.com/articles/pfizer-pfe-stock-falls-despite-q4-earnings-sales-beat-2018-01-30", "https://www.nasdaq.com/articles/roche-gets-breakthrough-therapy-designation-for-asd-drug-2018-01-30", "https://www.nasdaq.com/articles/validea-john-neff-strategy-daily-upgrade-report-212018-2018-02-01", "https://www.nasdaq.com/articles/amgn-named-top-dividend-stock-nasdaq-100-dividend-channel-27-yield-2018-01-30", "https://www.nasdaq.com/articles/amgn-october-19th-options-begin-trading-2018-01-29", "https://www.nasdaq.com/articles/will-amgen-amgn-benefit-from-growth-drugs-in-q4-earnings-2018-01-29", "https://www.nasdaq.com/articles/novartis-lutathera-gets-fda-approval-for-pancreatic-tumors-2018-01-29", "https://www.nasdaq.com/articles/roche-hemophilia-drug-hemlibra-gets-positive-chmp-opinion-2018-01-29", "https://www.nasdaq.com/articles/why-dividend-investors-want-own-abbvie-2018-2018-01-28", "https://www.nasdaq.com/articles/novartis-gets-spark-therapeutics-luxterna-license-outside-us-2018-01-26", "https://www.nasdaq.com/articles/meredith-mdp-hikes-dividend-4.8-just-ahead-of-q2-earnings-2018-01-30", "https://www.nasdaq.com/articles/why-amgen-top-socially-responsible-dividend-stock-amgn-2018-01-24", "https://www.nasdaq.com/articles/novartis-nvs-q4-earnings-sales-top-on-cosentyx-entresto-2018-01-24", "https://www.nasdaq.com/articles/amgens-migraine-drug-hits-primary-endpoint-in-phase-iiib-2018-01-23", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2018-01-23", "https://www.nasdaq.com/articles/biotech-ma-strong-start-2018-more-deals-follow-2018-01-23", "https://www.nasdaq.com/articles/novartis-announces-positive-results-on-migraine-candidate-2018-01-23", "https://www.nasdaq.com/articles/heres-why-abbvies-stock-skyrocketing-126-today-2018-01-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-novartis-nvs-this-earnings-season-2018-01-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-unitedhealth-amgen-united-technologies-csx-and-general", "https://www.nasdaq.com/articles/ideal-stock-evaluation-system-2018-01-22", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwb-amgn-gild-abt-2018-01-22", "https://www.nasdaq.com/articles/what-expect-amgen-inc-2018-2018-01-21", "https://www.nasdaq.com/articles/amgen-allergans-avastin-biosimilar-secures-eu-approval-2018-01-19", "https://www.nasdaq.com/articles/stocks-shutdown-vote-looms-halliburton-breaks-out-2018-01-22", "https://www.nasdaq.com/articles/heres-why-nektar-stock-skyrocketed-almost-500-in-a-year-2018-01-19", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-johnson-johnson-abbvie-amgen-novo-nordisk-and-zoetis", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-add-endeavor-data-on-kyprolis-label-2018-01-18", "https://www.nasdaq.com/articles/can-these-4-large-cap-drug-stocks-deliver-an-encore-in-18-2018-01-18", "https://www.nasdaq.com/articles/best-etfs-2018-spdr-sp-biotech-etf-xbi-will-continue-rock-2018-01-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-surges-acquisition-rumor-concert-down-patent-news-2018-01-17", "https://www.nasdaq.com/articles/will-2018-be-amgen-incs-best-year-yet-2018-01-17", "https://www.nasdaq.com/articles/spectrum-pharmaceuticals-up-134-in-6-months%3A-heres-why-2018-01-19", "https://www.nasdaq.com/articles/will-amgen-amgn-continue-to-tread-growth-path-this-year-2018-01-16", "https://www.nasdaq.com/articles/novartis-nvs-announces-acceptance-of-humira-bla-by-the-fda-2018-01-16", "https://www.nasdaq.com/articles/how-biotech-stock-could-top-bigger-rivals-preventing-migraines-2018-01-16", "https://www.nasdaq.com/articles/xlv-mrk-amgn-gild-etf-outflow-alert-2018-01-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celgene-amgen-exelixis-alexion-and-vertex-2018-01-12", "https://www.nasdaq.com/articles/mercks-keytruda-on-a-roll%3A-can-it-retain-the-spark-in-2018-2018-01-12", "https://www.nasdaq.com/articles/jeff-sessions-taking-some-steam-out-marijuana-stocks-rally-2018-01-11", "https://www.nasdaq.com/articles/5-big-biotech-stocks-buy-2018-2018-01-17", "https://www.nasdaq.com/articles/heres-what-abbvies-management-just-said-about-its-future-2018-01-11", "https://www.nasdaq.com/articles/heres-why-arrowhead-pharmaceuticals-inc-today-2018-01-11", "https://www.nasdaq.com/articles/apple-microsoft-may-get-big-tax-break-having-unusual-calendars-2018-01-11", "https://www.nasdaq.com/articles/june-2019-options-now-available-amgen-amgn-2018-01-10", "https://www.nasdaq.com/articles/novartis-starts-trial-on-psoriasis-drug-cosentyx-biosoimilar-2018-01-10", "https://www.nasdaq.com/articles/humana-extends-contract-with-tivity-health-spurs-healthcare-2018-01-10", "https://www.nasdaq.com/articles/mercks-keytruda-combo-gets-breakthrough-therapy-status-2018-01-10", "https://www.nasdaq.com/articles/astrazenecas-asthma-drug-benralizumab-gets-approval-in-eu-2018-01-11", "https://www.nasdaq.com/articles/amgen-announces-acceptance-of-maa-for-evenity-in-europe-2018-01-09", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-succeeds-in-high-risk-melanoma-study-2018-01-09", "https://www.nasdaq.com/articles/5-things-amgens-ceo-just-said-investors-need-know-2018-01-09", "https://www.nasdaq.com/articles/abbvie-stock-still-strong-buy-2018-01-09", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-gets-fda-approval-for-multiple-myeloma-2018-01-08", "https://www.nasdaq.com/articles/2-top-dividend-stocks-buy-2018-2018-01-07", "https://www.nasdaq.com/articles/better-stock-abbvie-inc-abbv-vs-johnson-johnson-jnj-2018-01-10", "https://www.nasdaq.com/articles/key-biosimilar-approvals-in-2017%3A-progress-report-2018-01-05", "https://www.nasdaq.com/articles/immunogen-starts-phase-i-study-on-leukemia-candidate-imgn632-2018-01-05", "https://www.nasdaq.com/articles/xlv-amgn-gild-lly-large-outflows-detected-etf-2018-01-04", "https://www.nasdaq.com/articles/can-abbvie-abbv-stock-keep-the-momentum-alive-in-2018-2018-01-04", "https://www.nasdaq.com/articles/3-large-cap-pharma-stocks-to-watch-out-for-this-new-year-2018-01-04", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-january-2018-01-03", "https://www.nasdaq.com/articles/why-these-2-biotechs-could-outperform-amid-hyper-competition-2018-01-02", "https://www.nasdaq.com/articles/3-big-biotech-stocks-buy-january-2018-01-06", "https://www.nasdaq.com/articles/another-reason-2018-might-not-be-banner-year-biotech-mergers-2017-12-27", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-inflow-2017-12-27", "https://www.nasdaq.com/articles/heres-how-abbvie-inc-crushed-it-2017-2017-12-23", "https://www.nasdaq.com/articles/why-is-nektar-nktr-stock-up-more-than-350-this-year-2017-12-22", "https://www.nasdaq.com/articles/spectrum-pharma-dismisses-ceo-makes-leadership-changes-2017-12-18", "https://www.nasdaq.com/articles/5-best-selling-drugs-2017-2017-12-18", "https://www.nasdaq.com/articles/radius-health-to-get-third-day-180-list-of-outstanding-issues-2017-12-18", "https://www.nasdaq.com/articles/one-safe-way-get-558-dividend-yield-2017-12-29", "https://www.nasdaq.com/articles/3-top-dividend-aristocrats-buy-2018-2017-12-17", "https://www.nasdaq.com/articles/3-attractive-income-stocks-whose-dividends-could-double-2017-12-17", "https://www.nasdaq.com/articles/beware-price-wars-big-pharma-biotech-companies-horizon-2017-12-15", "https://www.nasdaq.com/articles/mercks-keytruda-misses-primary-end-point-for-gastric-cancer-2017-12-15", "https://www.nasdaq.com/articles/pfizers-arthritis-drug-gets-fda-nod-for-label-expansion-2017-12-15", "https://www.nasdaq.com/articles/how-10-top-yielding-nasdaq-dividend-stocks-can-boost-your-portfolio-2017-12-14", "https://www.nasdaq.com/articles/amgn-dividend-yield-pushes-past-3-2017-12-14", "https://www.nasdaq.com/articles/10-more-retirement-stocks-to-buy-and-hold-for-the-rest-of-your-life-2017-12-18", "https://www.nasdaq.com/articles/3-top-dividend-aristocrats-buy-2018-2017-12-17", "https://www.nasdaq.com/articles/3-attractive-income-stocks-whose-dividends-could-double-2017-12-17", "https://www.nasdaq.com/articles/heres-why-everyones-so-excited-about-bluebird-bio-2017-12-13", "https://www.nasdaq.com/articles/roche-abbvie-report-positive-phase-iii-results-on-venclexta-2017-12-13", "https://www.nasdaq.com/articles/jim-simons-pioneer-quant-manager-2017-12-12", "https://www.nasdaq.com/articles/3-stocks-focus-biotech-ma-hopes-2018-rise-2017-12-11", "https://www.nasdaq.com/articles/roche-reports-positive-data-from-tecentriq-combination-study-2017-12-11", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-ben-wdfc-o-xray-2017-12-13", "https://www.nasdaq.com/articles/sanofi-begins-combo-studies-on-multiple-myeloma-candidate-2017-12-08", "https://www.nasdaq.com/articles/iwd-pm-mdt-amgn-large-inflows-detected-etf-2017-12-07", "https://www.nasdaq.com/articles/abbvie-jjs-imbruvica-succeeds-in-combo-study-with-rituxan-2017-12-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-amgen-pcsk9-inhibitor-revance-rt002-data-2017-12-06", "https://www.nasdaq.com/articles/roches-avastin-gets-full-fda-approval-for-brain-cancer-2017-12-06", "https://www.nasdaq.com/articles/abbvie-psoriasis-candidate-succeeds-in-4th-phase-iii-study-2017-12-05", "https://www.nasdaq.com/articles/mylan-up-on-fda-approval-amazons-rumored-pharmacy-interest-2017-12-04", "https://www.nasdaq.com/articles/heres-why-radius-health-rising-today-2017-12-08", "https://www.nasdaq.com/articles/how-biotechs-drugmakers-would-fare-under-senates-tax-bill-2017-12-04", "https://www.nasdaq.com/articles/amgen-regeneron-prep-battle-2018-over-cholesterol-drugs-2017-12-04", "https://www.nasdaq.com/articles/why-amgen-could-have-edge-over-these-rivals-preventing-migraines-2017-11-30", "https://www.nasdaq.com/articles/abbvie-stock-up-more-than-30-so-far-in-2h17%3A-heres-why-2017-11-30", "https://www.nasdaq.com/articles/5-biotech-and-pharma-stocks-fda-catalysts-december-2017-11-30", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-hca-amgn-ffiv-2017-11-30", "https://www.nasdaq.com/articles/why-medicines-co-tumbling-despite-270-million-deal-2017-11-29", "https://www.nasdaq.com/articles/amgens-pcsk9-inhibitor-gets-fda-nod-for-stroke-prevention-2017-12-04", "https://www.nasdaq.com/articles/how-biotechs-drugmakers-would-fare-under-senates-tax-bill-2017-12-04", "https://www.nasdaq.com/articles/will-new-drug-approvals-boost-novartis-nvs-portfolio-2017-11-24", "https://www.nasdaq.com/articles/nektar-nktr-stock-up-more-than-300-this-year%3A-heres-why-2017-11-24", "https://www.nasdaq.com/articles/jj-seeks-darzalexs-label-expansion-in-first-line-setting-2017-11-22", "https://www.nasdaq.com/articles/bet-biogen-inc-easy-profits-new-year-2017-11-21", "https://www.nasdaq.com/articles/why-coke-could-be-next-ge-and-1-stock-buy-instead-2017-11-20", "https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-amgn-2017-11-29", "https://www.nasdaq.com/articles/marco-investment-management-llc-buys-dowdupont-inc-apple-inc-jpmorgan-chase-sells-ei-2017", "https://www.nasdaq.com/articles/astrazenecas-azn-asthma-drug-benralizumab-approved-by-fda-2017-11-15", "https://www.nasdaq.com/articles/two-sigma-advisers-llc-buys-dowdupont-inc-pfizer-inc-caterpillar-inc-sells-ei-2017-11-15", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-16-2017-2017-11-15", "https://www.nasdaq.com/articles/sum-parts-xlv-could-be-worth-90-2017-11-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-dynavax-vaccine-gets-fda-nod-loxo-inks-deal-bayer-2017-11-15", "https://www.nasdaq.com/articles/amgen-amgn-unveils-auto-injector-device-for-enbrel-in-us-2017-11-20", "https://www.nasdaq.com/articles/ex-dividend-reminder-us-physical-therapy-allergan-and-amgen-2017-11-14", "https://www.nasdaq.com/articles/novartis-nvs-arms-biosimilars-study-results-encourage-2017-11-14", "https://www.nasdaq.com/articles/amgen-gets-positive-chmp-opinion-to-expand-nplates-label-2017-11-13", "https://www.nasdaq.com/articles/ligand-lgnd-q3-earnings-revenues-top-2017-view-raised-2017-11-10", "https://www.nasdaq.com/articles/xlv-mrk-abbv-amgn-etf-outflow-alert-2017-11-09", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-09-2017-2017-11-08", "https://www.nasdaq.com/articles/3-etfs-watch-biotech-earnings-2017-11-06", "https://www.nasdaq.com/articles/amgen-oversold-2017-11-14", "https://www.nasdaq.com/articles/ex-dividend-reminder-us-physical-therapy-allergan-and-amgen-2017-11-14", "https://www.nasdaq.com/articles/novartis-nvs-arms-biosimilars-study-results-encourage-2017-11-14", "https://www.nasdaq.com/articles/looking-great-stocks-first-use-checklist-identify-great-bases-2017-11-02", "https://www.nasdaq.com/articles/iwd-mrk-wmt-amgn-etf-inflow-alert-2017-11-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-amgen-gilead-hit-q3-results-vertex-beats-all-fronts-2017-11", "https://www.nasdaq.com/articles/pfizer-pfe-beats-on-q3-earnings-raises-2017-eps-view-2017-10-31", "https://www.nasdaq.com/articles/heres-why-insulet-corporations-investors-are-pumped-2017-11-03", "https://www.nasdaq.com/articles/amgn-named-top-dividend-stock-nasdaq-100-dividend-channel-26-yield-2017-10-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-comcast-mcdonalds-waste-management-and-bbt-2017", "https://www.nasdaq.com/articles/me-too-push-biopharma-crowding-psoriasis-market-2017-10-29", "https://www.nasdaq.com/articles/abbvie-abbv-q3-earnings-top-revenues-in-line-view-up-2017-10-27", "https://www.nasdaq.com/articles/biomarin-bmrn-q3-loss-narrows-profit-guidance-raised-2017-10-27", "https://www.nasdaq.com/articles/will-radius-health-rdus-disappoint-this-earnings-season-2017-10-27", "https://www.nasdaq.com/articles/abbvie-dividend-does-it-2017-10-27", "https://www.nasdaq.com/articles/pfizer-inc-stock-boring-and-thats-perfect-2017-10-31", "https://www.nasdaq.com/articles/buy-dip-amgen-inc-while-wall-street-fears-it-2017-10-26", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-top-sales-decline-y-y-stock-falls-2017-10-26", "https://www.nasdaq.com/articles/bristol-myers-more-bad-medicine-market-2017-10-26", "https://www.nasdaq.com/articles/key-predictions-for-q3-earnings-reports-of-abbv-mrk-2017-10-26", "https://www.nasdaq.com/articles/futures-trending-higher-earnings-give-hope-ecb-extends-asset-purchase-program-2017-10-26", "https://www.nasdaq.com/articles/trade-day-amgen-inc-nears-buy-point-again-2017-10-26", "https://www.nasdaq.com/articles/3-value-stocks-52-week-highs-still-worth-buying-2017-10-27", "https://www.nasdaq.com/articles/whats-behind-amgens-q3-revenue-decline-2017-10-25", "https://www.nasdaq.com/articles/three-biotech-firms-top-third-quarter-views-only-one-pops-2017-10-25", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-545-follow-through-indicator-28-sensitive-2017-10-25", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-25-2017-amgn-su-lvs-nxpi-vrtx-psa-afl-dlr-now-wcn-abx", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-amgn-luv-trip-2017-10-25", "https://www.nasdaq.com/articles/daily-dividend-report-bac-wfc-amgn-mpc-txt-met-2017-10-25", "https://www.nasdaq.com/articles/biogen-biib-tops-q3-earnings-sales-spinraza-sales-up-2017-10-24", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-thursday%3A-amgen-inc.-amgn-buffalo-wild-wings-bwld-and-las-vegas-sands", "https://www.nasdaq.com/articles/whats-behind-amgens-q3-revenue-decline-2017-10-25", "https://www.nasdaq.com/articles/three-biotech-firms-top-third-quarter-views-only-one-pops-2017-10-25", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-2017-10-24", "https://www.nasdaq.com/articles/boeing-grubhub-nike-glaxo-amgen-visa-lead-investing-action-plan-2017-10-24", "https://www.nasdaq.com/articles/health-care-sector-update-10232017-jnj-pfe-abt-mrk-amgn-tig-azn-2017-10-23", "https://www.nasdaq.com/articles/ibds-no-1-group-under-pressure-these-6-key-earnings-loom-sp-500-futures-2017-10-23", "https://www.nasdaq.com/articles/10-more-retirement-stocks-to-buy-and-hold-for-the-rest-of-your-life-2017-10-20", "https://www.nasdaq.com/articles/iwd-mrk-wmt-amgn-etf-inflow-alert-2017-10-24", "https://www.nasdaq.com/articles/oakbrook-investments-llc-buys-starbucks-corp-biogen-inc-dowdupont-inc-sells-western-2017", "https://www.nasdaq.com/articles/teva-submits-bla-to-fda-for-migraine-candidate-fremanezumab-2017-10-19", "https://www.nasdaq.com/articles/merriman-wealth-management-llc-buys-vanguard-sp-500-powershares-ftse-rafi-us-1500-2017-10", "https://www.nasdaq.com/articles/3-top-stocks-billionaires-love-2017-10-19", "https://www.nasdaq.com/articles/2-great-stocks-retirees-2017-10-19", "https://www.nasdaq.com/articles/whats-in-the-cards-for-novartis-nvs-this-earnings-season-2017-10-18", "https://www.nasdaq.com/articles/whats-in-the-cards-for-amgen-amgn-this-earnings-season-2017-10-20", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-gilead-teva-pfizer-and-amgen-2017-10-17", "https://www.nasdaq.com/articles/immunogen-to-push-leukemia-candidate-into-phase-i-trial-2017-10-17", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iwd-wmt-amgn-slb-2017-10-16", "https://www.nasdaq.com/articles/celgene-blood-cancer-treatment-just-tip-its-disruptive-science-2017-10-16", "https://www.nasdaq.com/articles/trump-likely-sign-executive-order-drug-pricing-any-day-2017-10-16", "https://www.nasdaq.com/articles/edmp-inc-buys-tanger-factory-outlet-centers-inc-cvs-health-corp-penske-automotive-group", "https://www.nasdaq.com/articles/better-buy-abbvie-inc-vs-merck-2017-10-14", "https://www.nasdaq.com/articles/how-allergans-public-relations-backlash-deepened-week-2017-10-17", "https://www.nasdaq.com/articles/dubuque-bank-trust-co-buys-heartland-financial-usa-inc-vanguard-total-stock-market-2017-10", "https://www.nasdaq.com/articles/3-stocks-baby-boomers-reach-their-goals-2017-10-12", "https://www.nasdaq.com/articles/mylan-gets-complete-response-letter-for-biosimilar-neulasta-2017-10-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-imlygic-data-promising-regeneron-scores-win-pcsk9-lawsuit", "https://www.nasdaq.com/articles/how-safe-abbvies-dividend-2017-10-11", "https://www.nasdaq.com/articles/dows-merck-bails-cholesterol-drug-prodding-shares-down-2017-10-11", "https://www.nasdaq.com/articles/amgen-label-expansion-application-for-prolia-accepted-by-fda-2017-10-10", "https://www.nasdaq.com/articles/why-2017-could-be-stocks-best-year-yet-2017-10-13", "https://www.nasdaq.com/articles/forget-teva-teva-buy-these-5-drug-stocks-instead-2017-10-09", "https://www.nasdaq.com/articles/cancer-space-last-week-update%3A-pipeline-expansion-in-focus-2017-10-09", "https://www.nasdaq.com/articles/3-best-healthcare-dividend-aristocrat-stocks-you-can-buy-right-now-2017-10-08", "https://www.nasdaq.com/articles/abbvies-fast-becoming-top-stock-buy-now-2017-10-08", "https://www.nasdaq.com/articles/3-blockbuster-drugs-still-cost-more-they-should-2017-10-07", "https://www.nasdaq.com/articles/dirt-cheap-biotech-stock-bargain-buy-2017-10-07", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-iwd-mrk-wmt-amgn-2017-10-06", "https://www.nasdaq.com/articles/amgen-wins-reprieve-its-2nd-best-selling-drug-2017-10-10", "https://www.nasdaq.com/articles/regeneron-and-sanofi-get-favorable-ruling-against-amgen-2017-10-06", "https://www.nasdaq.com/articles/everything-going-right-abbvie-it-best-biotech-stock-buy-right-now-2017-10-06", "https://www.nasdaq.com/articles/3-top-stocks-wall-street-insiders-love-2017-10-06", "https://www.nasdaq.com/articles/marshwinds-advisory-co-buys-dowdupont-inc-bhp-billiton-enbridge-inc-sells-ei-2017-10-06", "https://www.nasdaq.com/articles/why-regenerons-patent-win-worse-amgen-you-think-2017-10-06", "https://www.nasdaq.com/articles/regeneron-pops-after-judge-tosses-ban-amgen-rivaling-med-2017-10-05", "https://www.nasdaq.com/articles/abbvie-abbv-stock-up-almost-17-in-one-month%3A-heres-why-2017-10-05", "https://www.nasdaq.com/articles/health-care-sector-update-10062017-jnj-pfe-abt-mrk-amgn-kdmn-2017-10-06", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-amgen-2017-10-05", "https://www.nasdaq.com/articles/amgen-enters-into-an-immuno-oncology-partnership-with-cytomx-2017-10-04", "https://www.nasdaq.com/articles/wall-streets-winning-streak-pauses-private-sector-hiring-slows-2017-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-10042017-ctmxamgnmyltevarigl-2017-10-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-endocyte-shoots-deal-amgen-abbvie-settle-humira-litigation-2017-10", "https://www.nasdaq.com/articles/close-update-wall-street-extends-winning-streak-new-record-highs-2017-10-04", "https://www.nasdaq.com/articles/health-care-sector-update-10042017-sbbpctmxamgnclsn-2017-10-04", "https://www.nasdaq.com/articles/3-big-pharma-stocks-set-succeed-2017-10-05", "https://www.nasdaq.com/articles/health-care-sector-update-10042017-riglctmxamgnclsn-2017-10-04", "https://www.nasdaq.com/articles/midday-update-us-stocks-turn-positive-after-tillerson-denies-plans-resign-2017-10-04", "https://www.nasdaq.com/articles/cytomx-breaks-out-mash-amgen-immuno-oncology-2017-10-04", "https://www.nasdaq.com/articles/3-top-ranked-big-biotech-stocks-to-buy-now-2017-10-03", "https://www.nasdaq.com/articles/why-shares-abbvie-soared-18-september-2017-10-03", "https://www.nasdaq.com/articles/3-dividend-stocks-should-thrive-recession-2017-10-03", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-amgn-amd-payx-2017-10-03", "https://www.nasdaq.com/articles/amgen-cytomx-join-immuno-oncology-collaboration-2017-10-04", "https://www.nasdaq.com/articles/abbvie-patent-deal-staves-amgen-competition-others-lurk-2017-10-02", "https://www.nasdaq.com/articles/abbvie-stock-upgraded-what-you-need-know-2017-10-02", "https://www.nasdaq.com/articles/abbvie-better-late-never-2017-10-02", "https://www.nasdaq.com/articles/radius-rdus-enrols-first-patient-in-breast-cancer-study-2017-10-02", "https://www.nasdaq.com/articles/how-good-abbvies-humira-deal-amgen-2017-09-29", "https://www.nasdaq.com/articles/how-will-trumps-proposed-tax-reform-impact-drug-companies-2017-09-29", "https://www.nasdaq.com/articles/abbvie-amgen-resolve-humira-patent-dispute-2017-09-29", "https://www.nasdaq.com/articles/why-biotech-suffered-2-day-headache-rare-disease-trial-2017-10-03", "https://www.nasdaq.com/articles/why-blackberry-abbvie-and-bluebird-bio-jumped-today-2017-09-28", "https://www.nasdaq.com/articles/biotechs-beating-market-are-they-buy-range-2017-09-28", "https://www.nasdaq.com/articles/biotech-stocks-watch-and-pharma-industry-news-2017-09-28", "https://www.nasdaq.com/articles/why-amgens-drug-win-sent-abbvie-stock-stratosphere-2017-09-28", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-fvd-bms-amgn-cmi-2017-09-27", "https://www.nasdaq.com/articles/trade-of-the-day%3A-amgen-inc.-amgn-stock-has-plenty-more-upside-2017-09-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-ocaliva-safety-issues", "https://www.nasdaq.com/articles/sanofi-rides-on-genzyme-vaccines-unit-diabetes-sales-weak-2017-09-28", "https://www.nasdaq.com/articles/pfizer-sues-jj-accuses-it-of-preventing-inflectra-uptake-2017-09-21", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-amgn-ffiv-ebix-2017-09-21", "https://www.nasdaq.com/articles/4-sell-ranked-biotech-stocks-with-falling-estimates-to-avoid-2017-09-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-first-cancer-biosimilar-halo-deals-raised-outlook-2017-09-20", "https://www.nasdaq.com/articles/novartis-poised-to-grow-on-oncology-portfolio-biosimilars-2017-09-20", "https://www.nasdaq.com/articles/ishares-russell-1000-value-etf-experiences-big-inflow-2017-09-19", "https://www.nasdaq.com/articles/is-amgen-amgn-a-great-stock-for-value-investors-2017-09-19", "https://www.nasdaq.com/articles/mercks-keytruda-gets-fda-nod-for-advanced-gastric-cancer-2017-09-25", "https://www.nasdaq.com/articles/3-great-income-stocks-could-double-their-dividends-2017-09-17", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-the-quick-guide-to-xbi-2017-09-16", "https://www.nasdaq.com/articles/amgen-allergans-avastin-biosimilar-secures-fda-approval-2017-09-15", "https://www.nasdaq.com/articles/3-reasons-why-gilead-sciences-stock-buy-now-2017-09-15", "https://www.nasdaq.com/articles/top-research-reports-philip-morris-amgen-union-pacific-2017-09-15", "https://www.nasdaq.com/articles/biosimilar-cure-sky-high-cancer-drug-prices-2017-09-14", "https://www.nasdaq.com/articles/biosimilar-2017-progress-report%3A-stocks-in-focus-2017-09-14", "https://www.nasdaq.com/articles/novartis-announces-positive-data-on-urticaria-drug-xolair-2017-09-18", "https://www.nasdaq.com/articles/4-biotech-stocks-for-the-long-term-2017-09-13", "https://www.nasdaq.com/articles/amgen-reaches-analyst-target-price-2017-09-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2017-2017-09-13", "https://www.nasdaq.com/articles/5-compelling-reasons-why-abbvies-dividend-will-keep-growing-2017-09-13", "https://www.nasdaq.com/articles/novartis-bla-for-biosimilar-of-rituxan-accepted-by-the-fda-2017-09-12", "https://www.nasdaq.com/articles/supercharge-your-portfolio-with-amgen-inc.-amgn-stock-2017-09-12", "https://www.nasdaq.com/articles/abbvies-ra-candidate-meets-primary-endpoint-in-phase-iii-2017-09-12", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-amgn-rcl-cvx-2017-09-14", "https://www.nasdaq.com/articles/3-things-amgen-incs-management-just-said-youll-want-know-2017-09-12", "https://www.nasdaq.com/articles/interesting-amgn-put-and-call-options-january-2020-2017-09-11", "https://www.nasdaq.com/articles/tqqq-amgn-khc-pcln-etf-outflow-alert-2017-09-11", "https://www.nasdaq.com/articles/amgen-astrazeneca-asthma-candidate-tezepelumab-shows-promise-2017-09-07", "https://www.nasdaq.com/articles/astrazenecas-copd-candidate-duaklir-reports-positive-data-2017-09-07", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-amgn-cvx-cmcsa-2017-09-07", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-eu-approval-for-bladder-cancer-2017-09-06", "https://www.nasdaq.com/articles/5-things-regenerons-ceo-said-biotech-stock-sank-2017-09-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-cellectis-down-clinical-hold-insmed-soars-positive-data-2017-09-06", "https://www.nasdaq.com/articles/only-2-biotech-stocks-higher-dividend-yield-sp-500-2017-09-04", "https://www.nasdaq.com/articles/key-fda-regulatory-events-watch-out-sep-2017-2017-09-04", "https://www.nasdaq.com/articles/amgen-gets-eu-nod-to-expand-hyperparathyroidism-drug-label-2017-09-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-tqqq-amgn-khc-pcln-2017-09-01", "https://www.nasdaq.com/articles/smart-money-likes-these-5-stocks-2017-08-31", "https://www.nasdaq.com/articles/immunogen-inks-deal-with-jazz-pharma-to-develop-adc-molecule-2017-08-30", "https://www.nasdaq.com/articles/ligand-lgnd-diabetes-candidate-positive-in-phase-ii-study-2017-09-06", "https://www.nasdaq.com/articles/amgen-presents-new-repatha-analysis-from-fourier-study-2017-08-29", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-market-crashes-2017-08-29", "https://www.nasdaq.com/articles/3-reasons-to-be-cautious-on-vertex-pharmaceuticals-incorporated-vrtx-stock-2017-08-29", "https://www.nasdaq.com/articles/why-i-love-abbvie-inc-2017-08-27", "https://www.nasdaq.com/articles/system-rigged-against-biosimilars-2017-08-26", "https://www.nasdaq.com/articles/biogens-humira-biosimilar-imraldi-gets-approval-in-eu-2017-08-25", "https://www.nasdaq.com/articles/amgen-amgn-down-6.4-since-earnings-report%3A-can-it-rebound-2017-08-25", "https://www.nasdaq.com/articles/why-tiny-organovo-giving-money-huge-biotech-amgen-2017-08-30", "https://www.nasdaq.com/articles/proshares-ultrapro-qqq-experiences-big-inflow-2017-08-24", "https://www.nasdaq.com/articles/3-reasons-abbvie-better-dividend-stock-gilead-sciences-2017-08-23", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-label-expansion-alexion-biib-facing-drug-price-probe-2017-08-23", "https://www.nasdaq.com/articles/4-biotech-stocks-add-your-portfolio-post-q2-earnings-2017-08-22", "https://www.nasdaq.com/articles/what-will-drive-regeneron-pharmaceuticals-growth-higher-here-2017-08-22", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-scrape-from-the-selloff-2017-08-21", "https://www.nasdaq.com/articles/netherlands-taking-aim-one-americas-fastest-growing-sectors-2017-08-20", "https://www.nasdaq.com/articles/can-sanofi-sny-sustain-the-solid-1h-momentum-in-2h17-2017-08-24", "https://www.nasdaq.com/articles/amgen-collaboration-humana-patients-benefit-2017-08-18", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-goog-amgn-biib-2017-08-16", "https://www.nasdaq.com/articles/chiron-investment-management-llc-buys-ishares-iboxx-investment-grade-corporate-bond-gilead", "https://www.nasdaq.com/articles/can-ligands-captisol-deals-boost-growth-in-the-long-run-2017-08-15", "https://www.nasdaq.com/articles/are-amgens-new-drugs-doing-well-enough-to-drive-sales-2017-08-15", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-16-2017-2017-08-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-disney-amgen-caterpillar-sp-global-and-emerson-electric", "https://www.nasdaq.com/articles/add-parts-pwv-could-be-worth-39-2017-08-18", "https://www.nasdaq.com/articles/profund-advisors-llc-buys-baker-hughes-inc-nextera-energy-inc-duke-energy-corp-sells-2017", "https://www.nasdaq.com/articles/schwartz-investment-counsel-inc-buys-hexcel-corp-cognizant-technology-solutions-corp-2017", "https://www.nasdaq.com/articles/trade-of-the-day%3A-amgen-inc.-amgn-stock-is-a-quiet-bull-2017-08-10", "https://www.nasdaq.com/articles/graham-disciple-charles-brandes-5-largest-2nd-quarter-new-buys-2017-08-09", "https://www.nasdaq.com/articles/heres-why-coherus-biosciences-rose-much-222-today-2017-08-08", "https://www.nasdaq.com/articles/ligand-lgnd-q2-earnings-revenues-top-2017-view-raised-2017-08-08", "https://www.nasdaq.com/articles/xlv-unh-mrk-amgn-etf-inflow-alert-2017-08-08", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-15-2017-2017-08-14", "https://www.nasdaq.com/articles/heres-why-array-biopharma-inc-fell-137-july-2017-08-07", "https://www.nasdaq.com/articles/radius-rdus-q2-loss-wider-than-expected-on-higher-expenses-2017-08-04", "https://www.nasdaq.com/articles/allergan-agn-q2-earnings-sales-top-restasis-sales-down-2017-08-03", "https://www.nasdaq.com/articles/health-care-sector-update-08032017-jnj-pfe-abt-mrk-amgn-regn-teva-2017-08-03", "https://www.nasdaq.com/articles/pfizer-pfe-surpasses-q2-earnings-estimates-misses-sales-2017-08-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-amgn-aet-antm-2017-07-31", "https://www.nasdaq.com/articles/sanofi-sny-q2-earnings-in-line-sales-lag17-view-raised-2017-07-31", "https://www.nasdaq.com/articles/ray-gerald-l-associates-ltd-buys-norfolk-southern-corp-splunk-inc-oneok-inc-sells-2017-08", "https://www.nasdaq.com/articles/health-care-sector-update-07282017-jnj-pfe-abt-mrk-amgn-abbv-nuva-2017-07-28", "https://www.nasdaq.com/articles/eliot-finkel-investment-counsel-llc-buys-extra-space-storage-inc-bank-nova-scotia-chevron", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-amgen-2017-07-27", "https://www.nasdaq.com/articles/company-news-for-july-27-2017-2017-07-27", "https://www.nasdaq.com/articles/arthur-m-cohen-associates-llc-buys-brookfield-infrastructure-partners-lp-fortive-corp-2017", "https://www.nasdaq.com/articles/validea-martin-zweig-strategy-daily-upgrade-report-7272017-2017-07-27", "https://www.nasdaq.com/articles/amgn-named-top-socially-responsible-dividend-stock-2017-07-27", "https://www.nasdaq.com/articles/daily-dividend-report-k-cboe-hta-amgn-syy-2017-07-31", "https://www.nasdaq.com/articles/like-facebook-inc-fb-stock-protect-yourself-anyway.-2017-07-26", "https://www.nasdaq.com/articles/nvidia-corporation-nvda-stock-isnt-as-attractive-as-the-company-2017-07-26", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-is-a-trade-for-ailing-portfolios-2017-07-26", "https://www.nasdaq.com/articles/amgen-amgn-stock-falls-despite-q2-earnings-sales-beat-2017-07-26", "https://www.nasdaq.com/articles/2-incredibly-cheap-dividend-stocks-2017-07-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-biogen-top-q2-estimates-update-incyte-ra-drug-2017-07-26", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-545-follow-through-indicator-31-sensitive-2017-07-25", "https://www.nasdaq.com/articles/argyle-capital-management-inc-buys-dxc-technology-co-cvs-health-corp-cr-2017-07-26", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-25-2017-t-amgn-txn-cb-cni-esrx-eqr-amp-wcn-wynn-amd-tss", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-amgn-nem-jpm-2017-07-25", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-buy-now-2017-07-24", "https://www.nasdaq.com/articles/big-pharma-q2-earnings-releases-on-jul-25%3A-lly-biib-amgn-2017-07-24", "https://www.nasdaq.com/articles/3-stocks-are-absurdly-cheap-right-now-2017-07-23", "https://www.nasdaq.com/articles/xlv-unh-mrk-amgn-large-outflows-detected-etf-2017-07-21", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q2-earnings%3A-whats-in-the-cards-2017-07-21", "https://www.nasdaq.com/articles/biogen-biib-tops-q2-earnings-sales-spinraza-sales-up-2017-07-25", "https://www.nasdaq.com/articles/oakbrook-investments-llc-buys-schlumberger-jpmorgan-chase-visa-inc-sells-ww-2017-07-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-boosted-cf-data-fda-nod-gilead-puma-drugs-2017-07-19", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-both-bull-and-bear-markets-2017-07-19", "https://www.nasdaq.com/articles/ligand-signs-agreement-with-amgen-grants-rights-to-captisol-2017-07-18", "https://www.nasdaq.com/articles/novartis-tops-q2-earnings-sandoz-faces-pricing-pressure-2017-07-18", "https://www.nasdaq.com/articles/why-did-radius-health-rdus-stock-plummet-today-2017-07-17", "https://www.nasdaq.com/articles/mylans-biosimilar-herceptin-gets-fda-advisory-committee-nod-2017-07-17", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-market-crashes-2017-07-21", "https://www.nasdaq.com/articles/wells-fargo-co-wfc-stock-slumps-following-solid-q2-earnings-report-2017-07-14", "https://www.nasdaq.com/articles/can-novartis-nvs-spring-a-surprise-this-earnings-season-2017-07-14", "https://www.nasdaq.com/articles/trade-of-the-day%3A-amgen-inc.-amgn-stock-is-a-standout-2017-07-14", "https://www.nasdaq.com/articles/notable-friday-option-activity-regn-ddd-amgn-2017-07-14", "https://www.nasdaq.com/articles/amgen-applies-have-kyprolis-label-updated-2017-07-14", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2017-07-13", "https://www.nasdaq.com/articles/amgens-myeloma-drug-improves-overall-survival-in-phase-iii-2017-07-13", "https://www.nasdaq.com/articles/amgen-amgn-gets-crl-for-osteoporosis-drug-evenitys-bla-2017-07-17", "https://www.nasdaq.com/articles/edmp-inc-buys-penske-automotive-group-inc-ventas-inc-store-capital-corp-sells-alphabet", "https://www.nasdaq.com/articles/can-immunogens-lead-pipeline-cancer-candidate-boost-growth-2017-07-13", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-to-broaden-leukemia-drug-blincytos-label-2017-07-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-arena-shoots-study-data-celg-inks-immuno-oncology-deal-2017-07-12", "https://www.nasdaq.com/articles/3-dividend-stocks-healthcare-2017-07-11", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-is-the-cure-for-ailing-portfolios-2017-07-10", "https://www.nasdaq.com/articles/novartis-cosentyx-superior-to-stelara-in-psoriasis-study-2017-07-10", "https://www.nasdaq.com/articles/new-cancer-treatment-way-and-cancer-better-be-scared-2017-07-13", "https://www.nasdaq.com/articles/country-club-trust-company-na-buys-ishares-msci-eafe-macquarie-infrastructure-corp-royal", "https://www.nasdaq.com/articles/are-medicines-companys-key-drugs-set-for-growth-in-2017-2017-07-10", "https://www.nasdaq.com/articles/3-dividend-stocks-you-may-be-overlooking-2017-07-09", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-corporation-2017-07-08", "https://www.nasdaq.com/articles/merck-falls-as-fda-puts-hold-on-3-keytruda-myeloma-studies-2017-07-06", "https://www.nasdaq.com/articles/3-best-fidelity-funds-to-finish-2017-2017-07-06", "https://www.nasdaq.com/articles/xlv-unh-mrk-amgn-large-inflows-detected-etf-2017-07-05", "https://www.nasdaq.com/articles/heres-whats-behind-amgen-incs-102-gain-june-2017-07-10", "https://www.nasdaq.com/articles/pfizers-pfe-leukemia-candidate-receives-approval-in-eu-2017-07-03", "https://www.nasdaq.com/articles/key-fda-events-watch-out-jul-2017-2017-07-03", "https://www.nasdaq.com/articles/10-biotech-stocks-with-game-changing-dates-in-q3-2017-07-03", "https://www.nasdaq.com/articles/3-charts-show-why-buy-gilead-sciences-stock-now-2017-07-02", "https://www.nasdaq.com/articles/tevas-teva-filing-for-biosimilar-rituxan-accepted-by-fda-2017-06-30", "https://www.nasdaq.com/articles/amgens-colorectal-cancer-drug-gets-fda-nod-to-expand-label-2017-06-30", "https://www.nasdaq.com/articles/dova-pharmaceuticals-targets-9-figure-opportunity-should-you-buy-its-ipo-2017-06-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-cara-plunges-study-data-regulatory-updates-more-2017-07-05", "https://www.nasdaq.com/articles/novartis-erelzi-biosimilar-of-enbrel-approved-in-europe-2017-06-28", "https://www.nasdaq.com/articles/abbvie-has-most-valuable-late-stage-pipeline-its-stock-buy-2017-06-28", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2017-06-27", "https://www.nasdaq.com/articles/amgen-gets-positive-chmp-opinion-for-mimpara-label-expansion-2017-06-27", "https://www.nasdaq.com/articles/roches-rhhby-combination-cancer-remedy-wins-fda-approval-2017-06-26", "https://www.nasdaq.com/articles/allergan-continues-to-focus-on-acquisitions-and-branded-unit-2017-06-26", "https://www.nasdaq.com/articles/mercks-keytruda-on-a-roll%3A-can-it-retain-the-momentum-2017-06-22", "https://www.nasdaq.com/articles/alders-shares-dip-despite-positive-migraine-trial-results-2017-06-28", "https://www.nasdaq.com/articles/small-cancer-biotech-space-in-focus-3-stocks-up-100-more-2017-06-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-clovis-soars-rubraca-data-seattle-hit-study-halt-2017-06-21", "https://www.nasdaq.com/articles/ligand-gets-milestone-payment-on-partner-drug-fda-approval-2017-06-21", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-roaring-back-to-life-2017-06-21", "https://www.nasdaq.com/articles/amgens-xgeva-myeloma-label-expansion-sbla-accepted-by-fda-2017-06-20", "https://www.nasdaq.com/articles/5-most-profitable-big-pharma-stocks-market-right-now-2017-06-20", "https://www.nasdaq.com/articles/if-esperion-wants-market-next-big-cholesterol-drug-it-will-take-strategy-2017-06-22", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-rht-ctsh-amgn-2017-06-20", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2017-06-19", "https://www.nasdaq.com/articles/abbvie-abbv-stock-hits-52-week-high%3A-more-room-to-run-2017-06-19", "https://www.nasdaq.com/articles/3-most-wildly-overvalued-stocks-biotech-least-paper-2017-06-19", "https://www.nasdaq.com/articles/abbvie-stock-just-hit-52-week-high-heres-why-it-should-go-even-higher-2017-06-18", "https://www.nasdaq.com/articles/supreme-court-just-made-big-opportunity-biosimilars-even-bigger-2017-06-17", "https://www.nasdaq.com/articles/2-incredibly-cheap-biotech-stocks-2017-06-16", "https://www.nasdaq.com/articles/3-dividend-stocks-long-term-investors-2017-06-20", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2017-06-16", "https://www.nasdaq.com/articles/is-amgen-amgn-a-great-stock-for-value-investors-2017-06-16", "https://www.nasdaq.com/articles/nektar-nktr-stock-rallied-almost-50-this-year%3A-heres-why-2017-06-16", "https://www.nasdaq.com/articles/will-these-cutting-edge-cancer-killers-reignite-biotech-rally-2017-06-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-management-changes-biogen-alexion-gild-files-hiv-drug-2017-06-15", "https://www.nasdaq.com/articles/3-dividend-stocks-astute-investors-2017-06-15", "https://www.nasdaq.com/articles/novartis-nvs-announced-positive-data-on-psoriasis-cosentyx-2017-06-15", "https://www.nasdaq.com/articles/3-biotech-trades-to-diversify-your-portfolio-2017-06-16", "https://www.nasdaq.com/articles/coherus-stock-plummets-as-fda-rejects-neulasta-biosimilar-2017-06-13", "https://www.nasdaq.com/articles/merck-stalls-enrolment-in-two-myeloma-studies-of-keytruda-2017-06-13", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-receives-nice-recommendation-2017-06-13", "https://www.nasdaq.com/articles/health-care-sector-update-06132017-jnj-pfe-abt-mrk-amgn-chrs-imnp-2017-06-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2017-2017-06-13", "https://www.nasdaq.com/articles/why-coherus-biosciences-stock-getting-hammered-today-2017-06-12", "https://www.nasdaq.com/articles/sanofi-regenerons-praluent-cuts-bad-cholesterol-in-studies-2017-06-12", "https://www.nasdaq.com/articles/why-is-immunogen-imgn-stock-up-131-this-year-2017-06-15", "https://www.nasdaq.com/articles/health-care-sector-update-06122017-trovazngtxichrsamgn-2017-06-12", "https://www.nasdaq.com/articles/bib-celg-amgn-incy-etf-inflow-alert-2017-06-09", "https://www.nasdaq.com/articles/abbvie-abbv-announced-positive-phase-iii-ra-candidate-data-2017-06-08", "https://www.nasdaq.com/articles/teva-migraine-candidate-succeeds-in-second-phase-iii-study-2017-06-08", "https://www.nasdaq.com/articles/allergan-to-buy-keller-funnel-boost-plastic-surgery-unit-2017-06-08", "https://www.nasdaq.com/articles/health-care-sector-update-06082017-jnj-pre-abt-mrk-amgn-chrs-tvty-axn-2017-06-08", "https://www.nasdaq.com/articles/4-types-investments-avoid-2017-06-07", "https://www.nasdaq.com/articles/health-care-sector-update-06122017-hyhgtxichrsamgn-2017-06-12", "https://www.nasdaq.com/articles/3-value-stocks-perfect-retirement-2017-06-06", "https://www.nasdaq.com/articles/amgen-files-for-repatha-in-the-u.s.-eu-for-expanded-use-2017-06-06", "https://www.nasdaq.com/articles/amgen-amgn-presents-positive-clinical-data-on-cancer-drugs-2017-06-05", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-wyn-mnk-2017-06-05", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-mdt-amgn-celg-2017-05-31", "https://www.nasdaq.com/articles/how-regeneron-pharmaceuticals-inc-makes-most-its-money-2017-05-31", "https://www.nasdaq.com/articles/5-best-dividend-stocks-cholesterol-drugs-2017-05-30", "https://www.nasdaq.com/articles/mercks-cancer-drug-keytruda-positive-in-clinical-studies-2017-06-06", "https://www.nasdaq.com/articles/3-dividend-stocks-thrive-market-crashes-2017-05-27", "https://www.nasdaq.com/articles/pfizers-epogen-biosimilar-gets-positive-fda-committee-vote-2017-05-26", "https://www.nasdaq.com/articles/3-top-dividend-stocks-generic-drugs-2017-05-26", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-amgen-and-celgene-2017-05-25", "https://www.nasdaq.com/articles/radius-health-osteoporosis-drug-positive-in-phase-iii-study-2017-05-25", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-nod-for-solid-tumor-cancers-2017-05-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-regeneron-ra-drug-amgen-hit-study-data-2017-05-24", "https://www.nasdaq.com/articles/amgen-amgn-down-4.5-since-earnings-report%3A-can-it-rebound-2017-05-30", "https://www.nasdaq.com/articles/stock-turned-1000-153-million-less-33-years-2017-05-23", "https://www.nasdaq.com/articles/insider-buying-evidence-2017-05-23", "https://www.nasdaq.com/articles/edward-owens-buys-abbott-labs-sells-allergan-amgen-aetna-2017-05-23", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-bristol-myers-squibb-co-bmy-pfizer-inc.-pfe-and-amgen-inc.", "https://www.nasdaq.com/articles/amgen-oversold-2017-05-22", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-afl-nog-2017-05-22", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-dips-osteoporosis-drug-disappointment-2017-05-22", "https://www.nasdaq.com/articles/3-reasons-gilead-sciences-inc-better-dividend-stock-amgen-inc-2017-05-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-wynn-2017-05-22", "https://www.nasdaq.com/articles/is-the-snap-inc-snap-stock-bounce-for-real-2017-05-22", "https://www.nasdaq.com/articles/why-apple-inc.-aapl-stock-is-vulnerable-right-now-2017-05-22", "https://www.nasdaq.com/articles/amgen-evenity-approval-derailed-on-cardiovascular-side-effect-2017-05-22", "https://www.nasdaq.com/articles/3-best-dividend-stocks-arthritis-medication-2017-05-22", "https://www.nasdaq.com/articles/starbucks-corporation-sbux-stock-is-waking-up.-drink-up-2017-05-22", "https://www.nasdaq.com/articles/these-3-biotech-stocks-have-ballooned-2017-will-they-pop-2017-05-22", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-sso-mrk-mcd-amgn-2017-05-22", "https://www.nasdaq.com/articles/hbk-investments-l-p-buys-nxp-semiconductors-nv-spdr-sp-500-amgen-inc-sells-st-jude-2017-05", "https://www.nasdaq.com/articles/astrazeneca-azn-gets-positive-chmp-opinion-for-brodalumab-2017-05-22", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-3-yield-mark-2017-05-22", "https://www.nasdaq.com/articles/health-care-sector-update-05222017-rdusamgneyegvrxbstg-2017-05-22", "https://www.nasdaq.com/articles/heres-why-radius-health-gained-much-202-today-2017-05-22", "https://www.nasdaq.com/articles/amgen-amgn-submits-bla-to-fda-for-migraine-drug-erenumab-2017-05-19", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-nod-for-two-new-indications-2017-05-19", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-monday%3A-amgen-inc.-amgn-lockheed-martin-corporation-lmt-and-ford", "https://www.nasdaq.com/articles/market-tailwind-has-lifted-top-fidelity-mutual-fund-managers-portfolio-2017-05-19", "https://www.nasdaq.com/articles/whats-your-flavor-dont-worry-theres-etf-2017-05-19", "https://www.nasdaq.com/articles/abbvie-down-on-humira-patent-loss%3A-is-more-damage-in-store-2017-05-18", "https://www.nasdaq.com/articles/salesforce.com-inc.-crm-stock-roars-into-earnings-2017-05-17", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-has-the-cure-for-boring-portfolios-2017-05-17", "https://www.nasdaq.com/articles/celgenes-celg-revlimid-looks-solid-on-label-expansion-2017-05-16", "https://www.nasdaq.com/articles/health-care-sector-update-05162017-mnkdakbafmsetrm-2017-05-16", "https://www.nasdaq.com/articles/implied-fmk-analyst-target-price-32-2017-05-19", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-j.c.-penney-amazon-verizon-citigroup-and-amgen-2017-05", "https://www.nasdaq.com/articles/lillys-migraine-drug-phase-iii-trials-meet-primary-endpoint-2017-05-15", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2017-05-14", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-stock-still-buy-after-its-big-bounce-2017-05-12", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xlv-mrk-unh-amgn-2017-05-12", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-15-2017-2017-05-12", "https://www.nasdaq.com/articles/ex-dividend-reminder-consolidated-edison-amgen-and-simon-property-group-2017-05-11", "https://www.nasdaq.com/articles/3-best-dividend-stocks-biotech-2017-05-16", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amgn-2017-05-10", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-lgnd-q1-earnings-miss-estimates-2017-05-10", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-wfm-ingn-amgn-2017-05-10", "https://www.nasdaq.com/articles/mylan-myl-beats-on-q1-earnings-revenues-miss-estimates-2017-05-10", "https://www.nasdaq.com/articles/allergan-agn-beats-q1-earnings-estimates-ups-2017-view-2017-05-09", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-johnson-johnson-2017-05-07", "https://www.nasdaq.com/articles/xlv-unh-amgn-mdt-etf-inflow-alert-2017-05-04", "https://www.nasdaq.com/articles/bellevue-group-ag-buys-align-technology-inc-anthem-inc-walgreens-boots-alliance-inc-sells", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amgn-2017-05-10", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-lgnd-q1-earnings-miss-estimates-2017-05-10", "https://www.nasdaq.com/articles/radius-health-rdus-posts-wider-q1-loss-tymlos-approved-2017-05-02", "https://www.nasdaq.com/articles/regeneron-finally-getting-back-track-2017-04-29", "https://www.nasdaq.com/articles/amgen-bear-case-bull-2017-04-29", "https://www.nasdaq.com/articles/sanofi-sny-q1-earnings-top-sales-rise-y-y-shares-up-2017-04-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-gilead-celgene-q1-earnings-sunesis-down-vosaroxin-update-2017", "https://www.nasdaq.com/articles/amgen-amgn-q1-earnings-top-sales-miss-shares-decline-2017-04-27", "https://www.nasdaq.com/articles/starbucks-corporation-sbux-should-dip-after-earnings-and-thats-ok-2017-04-27", "https://www.nasdaq.com/articles/amgens-q1-results-highlight-need-acquisition-2017-04-27", "https://www.nasdaq.com/articles/will-amazon.com-inc.-amzn-stock-hit-%24950-its-not-a-given.-2017-04-27", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-thursday%3A-nokia-oyj-adr-nok-amgen-inc.-amgn-and-paypal-holdings-inc", "https://www.nasdaq.com/articles/3-best-long-term-dividend-stocks-buy-now-amgnhon-cvs-2017-04-26", "https://www.nasdaq.com/articles/whats-in-store-for-merck-mrk-this-earnings-season-2017-04-26", "https://www.nasdaq.com/articles/these-7-drugmakers-relied-price-hikes-100-their-earnings-growth-2016-2017-04-28", "https://www.nasdaq.com/articles/amgen-amgn-q1-earnings-top-sales-miss-shares-decline-2017-04-27", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2017-04-26", "https://www.nasdaq.com/articles/5-fantastic-earnings-charts-2017-04-26", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-26-2017-amgn-pypl-su-lvs-psa-eqix-avb-fisv-orly-efx-wcn", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-600-follow-through-indicator-32-sensitive-2017-04-26", "https://www.nasdaq.com/articles/biogen-biib-q1-earnings-sales-top-spinraza-sales-strong-2017-04-25", "https://www.nasdaq.com/articles/3-stocks-could-double-their-dividends-shouldnt-2017-04-25", "https://www.nasdaq.com/articles/pfizer-pfe-q1-earnings%3A-will-it-pull-off-a-surprise-2017-04-26", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-releases-on-apr-26%3A-amgn-gsk-more-2017-04-25", "https://www.nasdaq.com/articles/gilead-gild-q1-earnings%3A-stock-likely-to-beat-estimates-2017-04-25", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-wdc-tho-amgn-2017-04-25", "https://www.nasdaq.com/articles/novartis-tops-q1-earnings%3A-cosentyx-entresto-boost-sales-2017-04-25", "https://www.nasdaq.com/articles/what-options-traders-expect-from-amgen-inc.-amgn-earnings-2017-04-25", "https://www.nasdaq.com/articles/whats-in-store-for-agenus-agen-this-earnings-season-2017-04-24", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-2017-04-24", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-amgen-amgn-2017-04-25", "https://www.nasdaq.com/articles/read-you-buy-biotech-stocks-2017-04-23", "https://www.nasdaq.com/articles/amgen-amgn-to-report-q1-earnings%3A-will-it-beat-again-2017-04-21", "https://www.nasdaq.com/articles/alexion-alxn-q1-earnings%3A-can-the-stock-pull-a-surprise-2017-04-21", "https://www.nasdaq.com/articles/universal-health-uhs-q1-earnings%3A-whats-in-the-cards-2017-04-21", "https://www.nasdaq.com/articles/eli-lilly-lly-to-report-q1-earnings%3A-whats-in-the-cards-2017-04-20", "https://www.nasdaq.com/articles/novartis-nvs-q1-earnings%3A-will-the-stock-disappoint-2017-04-20", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2017-04-20", "https://www.nasdaq.com/articles/celgene-celg-to-post-q1-earnings%3A-whats-in-the-cards-2017-04-24", "https://www.nasdaq.com/articles/xlv-amgn-mdt-lly-large-inflows-detected-etf-2017-04-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-alphabet-amgen-lowes-bristol-myers-and-priceline-2017", "https://www.nasdaq.com/articles/5-major-drug-stocks-likely-to-beat-q1-earnings-estimates-2017-04-17", "https://www.nasdaq.com/articles/abbvie-inc-bear-case-bull-2017-04-14", "https://www.nasdaq.com/articles/mylan-down-on-fda-warning-letter-to-manufacturing-facility-2017-04-12", "https://www.nasdaq.com/articles/amgens-offering-money-back-guarantee-repatha-will-it-be-enough-2017-04-12", "https://www.nasdaq.com/articles/anths-anth-blisibimod-completes-dosing-in-phase-iii-study-2017-04-11", "https://www.nasdaq.com/articles/whats-in-the-cards-for-centene-cnc-this-earnings-season-2017-04-20", "https://www.nasdaq.com/articles/xlv-amgn-mdt-lly-large-inflows-detected-etf-2017-04-18", "https://www.nasdaq.com/articles/3-big-drugmakers-most-likely-buy-incyte-2017-04-11", "https://www.nasdaq.com/articles/10-reasons-amgen-could-be-worlds-most-perfect-stock-2017-04-10", "https://www.nasdaq.com/articles/3-big-biotech-stocks-big-time-catalysts-2017-04-08", "https://www.nasdaq.com/articles/analysts-release-new-health-care-stock-ratings-2017-04-07", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-dgro-mrk-amgn-wmt-2017-04-06", "https://www.nasdaq.com/articles/3-top-big-pharma-stocks-buy-now-2017-04-06", "https://www.nasdaq.com/articles/country-club-trust-company-na-buys-wisdomtree-europe-hedged-equity-fund-vanguard-2017-04", "https://www.nasdaq.com/articles/why-radius-health-inc-tumbled-86-march-2017-04-06", "https://www.nasdaq.com/articles/amgen-files-for-xgeva-label-expansion-to-include-myeloma-2017-04-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-acorda-down-court-ruling-patent-challenge-celg-drug-2017-04-05", "https://www.nasdaq.com/articles/why-is-amgen-amgn-up-12.9-since-the-last-earnings-report-2017-04-05", "https://www.nasdaq.com/articles/rosenbaum-jay-d-buys-salesforcecom-newell-brands-general-dynamics-sells-walt-disney-co", "https://www.nasdaq.com/articles/whats-next-amgens-repatha-2017-04-04", "https://www.nasdaq.com/articles/why-amgen-inc.-stock-amgn-is-my-top-buy-for-dividend-growth-and-upside-2017-04-03", "https://www.nasdaq.com/articles/analysts-anticipate-10-gains-ahead-xlv-2017-04-06", "https://www.nasdaq.com/articles/healthcare-winners-and-losers-following-ahcas-failure-2017-04-02", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-amgen-inc-2017-04-01", "https://www.nasdaq.com/articles/could-pfizer-buy-esperion-therapeutics-2017-03-31", "https://www.nasdaq.com/articles/mylan-receives-crl-for-generic-advair-diskus-from-the-fda-2017-03-31", "https://www.nasdaq.com/articles/fda-grants-amgen-priority-review-blincyto-sbla-2017-03-31", "https://www.nasdaq.com/articles/amgens-leukemia-drug-accepted-for-priority-review-by-fda-2017-03-30", "https://www.nasdaq.com/articles/3-best-cholesterol-drug-stocks-buy-2017-2017-03-30", "https://www.nasdaq.com/articles/kite-pharma-completes-filing-for-car-t-therapy-with-fda-2017-04-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-tesaro-drugs-approved-vertex-scores-big-study-2017-03-29", "https://www.nasdaq.com/articles/3-drugmakers-boatloads-cash-spend-2017-03-29", "https://www.nasdaq.com/articles/pfizers-arthritis-drug-xeljanz-gets-marketing-nod-in-europe-2017-03-28", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-alphabet-inc-googl-amgen-inc.-amgn-and-united-parcel", "https://www.nasdaq.com/articles/biotech-etfs-defy-trump-tweets-rally-what-can-send-them-higher-2017-03-28", "https://www.nasdaq.com/articles/jj-jnj-anaemia-drug-marketing-label-expanded-in-europe-2017-03-27", "https://www.nasdaq.com/articles/mercks-ketruda-gets-positive-chmp-opinion-for-lymphoma-2017-03-27", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-mrk-unh-amgn-2017-03-29", "https://www.nasdaq.com/articles/amgens-humira-biosimilar-approved-europe-2017-03-27", "https://www.nasdaq.com/articles/amgens-amgn-humira-biosimilar-receives-approval-in-eu-2017-03-24", "https://www.nasdaq.com/articles/pfizers-immunotherapy-for-skin-cancer-gets-fda-approval-2017-03-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-berkshire-hathaway-amgen-walgreens-boots-alliance", "https://www.nasdaq.com/articles/why-youre-smart-buy-jazz-pharmaceuticals-plc-2017-03-24", "https://www.nasdaq.com/articles/how-company-taking-amgen-2017-03-23", "https://www.nasdaq.com/articles/health-etf-wobbles-vote-bill-replace-obamacare-nears-gold-gains-2017-03-22", "https://www.nasdaq.com/articles/5-stocks-ridiculously-fast-growing-dividends-2017-03-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-down-repatha-data-nektar-surges-pain-results-2017-03-22", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-unh-amgn-mdt-2017-03-21", "https://www.nasdaq.com/articles/3-biotech-stocks-are-broker-favorites-2017-03-21", "https://www.nasdaq.com/articles/biotech-bull-making-comeback-2017-03-21", "https://www.nasdaq.com/articles/amgen-amgn%3A-repatha-outcomes-data-disappoint-shares-drop-2017-03-20", "https://www.nasdaq.com/articles/why-biotech-stock-gilead-gild-could-be-value-trap-2017-03-20", "https://www.nasdaq.com/articles/heres-what-pushed-esperion-therapeutics-inc-stock-higher-today-2017-03-20", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-nasdaq-biotechnology-index-gilead-valeant", "https://www.nasdaq.com/articles/trump-bad-healthcare-stocks-these-4-winners-dont-think-so-2017-03-19", "https://www.nasdaq.com/articles/amgen-inc-amgn-offers-money-back-guarantee-heart-attack-victims-repatha-2017-03-17", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-negative-avexis-shares-spike-higher-2017-03-17", "https://www.nasdaq.com/articles/privacy-revamp-makes-facebook-inc-fb-stock-even-more-attractive-2017-03-17", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-crashed.-heres-how-to-trade-it.-2017-03-17", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-adbe-2017-03-17", "https://www.nasdaq.com/articles/sp-500-movers-amgn-adbe-2017-03-17", "https://www.nasdaq.com/articles/why-amgens-success-was-big-disappointment-2017-03-20", "https://www.nasdaq.com/articles/what-are-sanofis-sny-strengths-and-challenges-in-2017-2017-03-17", "https://www.nasdaq.com/articles/market-close-report-nasdaq-trading-volume-joins-top-ten-ranking-year-nasdaq-composite-26", "https://www.nasdaq.com/articles/why-amgen-amtrust-financial-services-and-brf-slumped-today-2017-03-17", "https://www.nasdaq.com/articles/heres-why-amgen-medicines-company-and-esperion-therapeutics-are-all-tanking-today-2017-03", "https://www.nasdaq.com/articles/pfizers-arthritis-drug-xeljanz-gets-marketing-nod-in-china-2017-03-16", "https://www.nasdaq.com/articles/does-amgen-offer-a-great-value-buying-opportunity-right-now-2017-03-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-data-repatha-catalyst-soars-firdapse-data-2017-03-16", "https://www.nasdaq.com/articles/stock-market-news-for-march-17-2017-2017-03-17", "https://www.nasdaq.com/articles/amgens-repatha-meets-primary-endpoint-in-phase-iii-study-2017-03-14", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-amgn-rok-orcl-2017-03-14", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xlv-amgn-mdt-abbv-2017-03-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2017-2017-03-13", "https://www.nasdaq.com/articles/19-best-selling-prescription-drugs-all-time-2017-03-13", "https://www.nasdaq.com/articles/which-biotech-best-dividend-stock-2017-03-11", "https://www.nasdaq.com/articles/why-amgen-amgn-stock-rallied-after-q4-earnings-release-2017-03-10", "https://www.nasdaq.com/articles/mercks-mrk-keytruda-gets-fda-nod-for-lymphoma-indication-2017-03-15", "https://www.nasdaq.com/articles/abbvie-stock-upgraded-what-you-need-know-2017-03-10", "https://www.nasdaq.com/articles/abbvie-cowen-healthcare-conference-4-things-youll-want-know-2017-03-09", "https://www.nasdaq.com/articles/daily-dividend-report-pba-plce-amgn-spls-vgr-2017-03-08", "https://www.nasdaq.com/articles/j2-global-ehealth-pfizer-amgen-and-mylan-highlighted-as-zacks-bull-and-bear-of-the-day", "https://www.nasdaq.com/articles/novartis-nvs-reports-positive-data-on-biosimilar-humira-2017-03-07", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2017-03-07", "https://www.nasdaq.com/articles/5-fda-decisions-watch-out-mar-2017-2017-03-06", "https://www.nasdaq.com/articles/after-hours-most-active-mar-10-2017-dish-ge-lltc-fnb-intc-qqq-gm-agn-v-bac-abco-amgn-2017", "https://www.nasdaq.com/articles/abbvie-stock-upgraded-what-you-need-know-2017-03-10", "https://www.nasdaq.com/articles/mylan-myl-beats-on-q4-earnings-stock-up-on-strong-view-2017-03-02", "https://www.nasdaq.com/articles/why-perrigo-company-plc-stock-crashed-tuesday-2017-03-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-kite-soars-car-t-data-exel-immuno-oncology-deals-2017-03-01", "https://www.nasdaq.com/articles/heres-why-esperion-therapeutics-inc-stock-popped-today-2017-03-01", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-johnson-johnson-pfizer-glaxo-amgens-and-lilly-2017-02", "https://www.nasdaq.com/articles/amgen-dividend-history-whats-ahead-biotech-pioneer-2017-02-28", "https://www.nasdaq.com/articles/xlv-amgn-mdt-abbv-etf-inflow-alert-2017-03-03", "https://www.nasdaq.com/articles/numeric-investors-llc-buys-gilead-sciences-microsoft-baxter-international-sells-facebook", "https://www.nasdaq.com/articles/3-stocks-you-dont-have-babysit-2017-02-26", "https://www.nasdaq.com/articles/ligand-lgnd-q4-earnings-down-y-y-revenues-miss-estimates-2017-02-24", "https://www.nasdaq.com/articles/notable-friday-option-activity-celg-amgn-lmt-2017-02-24", "https://www.nasdaq.com/articles/better-cloud-growth-stock-twilio-inc-vs-veeva-systems-2017-02-23", "https://www.nasdaq.com/articles/should-i-buy-procter-gamble-co-pg-stock-3-pros-3-cons-2017-02-23", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-amgn-khc-chtr-2017-02-22", "https://www.nasdaq.com/articles/3-ways-to-play-this-biotech-stocks-dip-2017-02-27", "https://www.nasdaq.com/articles/numeric-investors-llc-buys-gilead-sciences-microsoft-baxter-international-sells-facebook", "https://www.nasdaq.com/articles/who-could-buy-bristol-myers-squibb-2017-02-22", "https://www.nasdaq.com/articles/study-reveals-pcsk9-drugs-can-save-heart-disease-patients-2017-02-21", "https://www.nasdaq.com/articles/valeants-vrx-plaque-psoriasis-drug-approved-in-the-u.s.-2017-02-17", "https://www.nasdaq.com/articles/pfizers-xeljanz-combo-comparable-to-abbvies-humira-2017-02-17", "https://www.nasdaq.com/articles/mylans-proposed-biosimailar-for-cancer-under-review-in-u.s.-2017-02-17", "https://www.nasdaq.com/articles/should-you-buy-amgen-inc.-amgn-stock-3-pros-3-cons-2017-02-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-procter-gamble-bank-of-america-netflix-and-honda", "https://www.nasdaq.com/articles/dont-count-valeants-new-drug-save-day-2017-02-16", "https://www.nasdaq.com/articles/marco-investment-management-llc-buys-johnson-controls-international-plc-amgen-abbvie-sells", "https://www.nasdaq.com/articles/stock-index-etfs-nail-another-gain-health-stocks-lead-2017-02-15", "https://www.nasdaq.com/articles/want-get-biotech-check-out-these-3-stocks-2017-02-15", "https://www.nasdaq.com/articles/amgen-looking-to-broaden-leukemia-drug-blincytos-label-2017-02-15", "https://www.nasdaq.com/articles/vanguard-growth-etf-experiences-big-inflow-2017-02-14", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-15-2017-2017-02-14", "https://www.nasdaq.com/articles/why-amgens-becoming-one-my-top-dividend-stocks-buy-2017-02-16", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-amba-axon-2017-02-13", "https://www.nasdaq.com/articles/primecap-management-buys-astrazeneca-plc-alkermes-plc-whirlpool-sells-union-pacific-2017", "https://www.nasdaq.com/articles/hunter-associates-inc-buys-pfizer-procter-gamble-co-rr-2017-02-10", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-13-2017-2017-02-10", "https://www.nasdaq.com/articles/3-beaten-down-stocks-ready-bounce-back-2017-02-10", "https://www.nasdaq.com/articles/van-strum-towne-inc-buys-charles-schwab-bank-americaoration-3m-co-sells-eaton-2017-02-10", "https://www.nasdaq.com/articles/regeneron-regn-misses-on-q4-earnings-sales-view-bleak-2017-02-09", "https://www.nasdaq.com/articles/daniel-loeb-picks-rate-sensitive-financials-drops-pharma-2017-02-13", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-amba-axon-2017-02-13", "https://www.nasdaq.com/articles/primecap-management-buys-astrazeneca-plc-alkermes-plc-whirlpool-sells-union-pacific-2017", "https://www.nasdaq.com/articles/amgens-secondary-hyperparathyroidism-drug-approved-in-u.s.-2017-02-08", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-2017-02-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-gilead-report-4q-results-ariad-seeks-eu-nod-brigatinib-2017-02", "https://www.nasdaq.com/articles/regeneron-regn-q4-earnings%3A-will-the-stock-disappoint-2017-02-08", "https://www.nasdaq.com/articles/sapphire-star-partners-lp-buys-cirrus-logic-cracker-barrel-old-country-store-vascular-2017", "https://www.nasdaq.com/articles/sanofi-sny-q4-earnings-in-line-can-sell-praulent-for-now-2017-02-09", "https://www.nasdaq.com/articles/company-news-for-february-06-2017-2017-02-06", "https://www.nasdaq.com/articles/mercks-keytruda-gets-priority-review-for-bladder-cancer-2017-02-06", "https://www.nasdaq.com/articles/trumps-plan-lower-drug-costs-fairy-tale-2017-02-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-amzn-amgn-2017-02-03", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gopro-inc-gpro-and-visa-inc-v-2017-02-03", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amgen-amgn-stock-2017-02-03", "https://www.nasdaq.com/articles/amgen-amgn-q4-earnings-top-repatha-positive-in-cv-study-2017-02-03", "https://www.nasdaq.com/articles/vug-amgn-mmm-abbv-large-inflows-detected-etf-2017-02-06", "https://www.nasdaq.com/articles/company-news-for-february-06-2017-2017-02-06", "https://www.nasdaq.com/articles/why-medicines-company-rocketed-higher-today-2017-02-03", "https://www.nasdaq.com/articles/why-esperion-therapeutics-inc-soaring-today-2017-02-03", "https://www.nasdaq.com/articles/health-care-sector-update-02032017-cbmceruidxg-2017-02-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-biogen-abbv-post-q4-results-catabasis-falls-dmd-data-2017-02", "https://www.nasdaq.com/articles/after-hours-earnings-report-february-2-2017-amzn-v-amgn-hig-ess-msi-cmg-mtd-kim-hbi-csc", "https://www.nasdaq.com/articles/amgen-inc.-amgn-q4-earnings-preview-2017-02-01", "https://www.nasdaq.com/articles/why-morgan-stanley-amgen-and-tableau-software-jumped-today-2017-02-03", "https://www.nasdaq.com/articles/drug-stocks-to-report-q4-earnings-on-feb-2%3A-mrk-amgn-2017-02-01", "https://www.nasdaq.com/articles/should-you-sell-amgen-amgn-before-earnings-2017-02-01", "https://www.nasdaq.com/articles/these-3-biotech-stocks-are-ridiculously-cheap-2017-02-01", "https://www.nasdaq.com/articles/merck-keytruda-gets-eu-approval-for-first-line-lung-cancer-2017-02-01", "https://www.nasdaq.com/articles/mallinckrodt-mnk-earnings-this-quarter%3A-stock-to-disappoint-2017-02-01", "https://www.nasdaq.com/articles/pfizer-pfe-q4-earnings-lag-sales-top-17-sales-view-soft-2017-01-31", "https://www.nasdaq.com/articles/4-fda-decisions-watch-out-feb-2017-2017-01-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-synergy-pharmaceuticals-amgen-valeant-pharmaceuticals", "https://www.nasdaq.com/articles/drug-stocks-to-report-q4-earnings-on-feb-2%3A-mrk-amgn-2017-02-01", "https://www.nasdaq.com/articles/amgen-wins-favorable-chmp-opinion-for-humira-biosimilar-2017-01-30", "https://www.nasdaq.com/articles/united-bank-buys-fortis-sells-itc-holdings-revance-therapeutics-t-rowe-price-group-2017-01", "https://www.nasdaq.com/articles/amgen-inc.%3A-capture-stronger-upside-in-amgn-stock-2017-01-27", "https://www.nasdaq.com/articles/stock-market-news-for-january-27-2017-2017-01-27", "https://www.nasdaq.com/articles/health-care-sector-update-01272017-amgn-2017-01-27", "https://www.nasdaq.com/articles/will-amgen-amgn-keep-the-earnings-streak-alive-in-q4-2017-01-27", "https://www.nasdaq.com/articles/stock-market-roundup-jan-31-nasdaq-rebounds-amid-trump-biotech-meeting-2017-01-31", "https://www.nasdaq.com/articles/notable-friday-option-activity-amgn-nvda-fngn-2017-01-27", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-top-estimates-17-sales-view-soft-2017-01-26", "https://www.nasdaq.com/articles/novartis-nvs-beats-q4-earnings-might-spin-off-alcon-2017-01-25", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-and-hold-stress-free-2017-01-24", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vug-amgn-mmm-abbv-2017-01-19", "https://www.nasdaq.com/articles/can-amgen-amgn-be-a-top-choice-for-value-investors-2017-01-19", "https://www.nasdaq.com/articles/why-the-amgen-inc.-amgn-patent-case-is-so-important-2017-01-18", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-is-a-bet-on-fatter-yields-2017-01-27", "https://www.nasdaq.com/articles/5-biotech-stocks-youll-want-watch-1st-quarter-2017-01-18", "https://www.nasdaq.com/articles/value-investing-2017-3-stocks-put-your-radar-2017-01-18", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-corporation-2017-01-17", "https://www.nasdaq.com/articles/donald-trump-just-leveled-drug-companies-these-4-words-2017-01-14", "https://www.nasdaq.com/articles/coherus-offers-positive-phase-iii-data-on-humira-biosimilar-2017-01-13", "https://www.nasdaq.com/articles/3-cheap-value-stocks-buy-today-2017-01-12", "https://www.nasdaq.com/articles/apple-inc.-aapl-stock-cuts-production-but-it-may-not-be-time-to-run-2017-01-11", "https://www.nasdaq.com/articles/4-top-biotech-mutual-funds-for-2017-2017-01-18", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-get-on-board-the-biotech-train-2017-01-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-ariad-be-acquired-52b-vertex-outlook-falls-short-2017-01-11", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-biib-mrk-amgn-2017-01-11", "https://www.nasdaq.com/articles/stock-market-news-for-january-10-2017-2017-01-10", "https://www.nasdaq.com/articles/amgen-inks-multiple-deals-offers-update-on-repatha-lawsuit-2017-01-10", "https://www.nasdaq.com/articles/kite-pharma-inks-deals-for-car-t-cell-drug-in-japan-china-2017-01-10", "https://www.nasdaq.com/articles/rosenbaum-jay-d-buys-comcast-corp-lowes-companies-inc-travelers-companies-inc-sells-2017", "https://www.nasdaq.com/articles/should-you-buy-amgen-inc.-amgn-stock-3-pros-3-cons-2017-01-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-tqqq-amgn-khc-gild-2017-01-09", "https://www.nasdaq.com/articles/pfizers-humira-biosimilar-meets-primary-endpoint-in-study-revised-2017-01-09", "https://www.nasdaq.com/articles/why-biotech-titans-are-clashing-over-cholesterol-2017-01-08", "https://www.nasdaq.com/articles/midday-update-stocks-regain-upward-momentum-after-mixed-jobs-report-2017-01-06", "https://www.nasdaq.com/articles/amgn-crosses-above-key-moving-average-level-2017-01-06", "https://www.nasdaq.com/articles/nasdaq-100-movers-regn-amgn-2017-01-06", "https://www.nasdaq.com/articles/sp-500-movers-regn-amgn-2017-01-06", "https://www.nasdaq.com/articles/why-amgens-stock-slumped-2016-2017-01-10", "https://www.nasdaq.com/articles/health-care-sector-update-01062017-mdco-sny-regn-jnj-pfe-abt-mrk-amgn-2017-01-06", "https://www.nasdaq.com/articles/stock-futures-turn-positive-gains-hourly-earnings-2017-01-06", "https://www.nasdaq.com/articles/pfizers-humira-biosimilar-meets-primary-endpoint-in-study-2017-01-06", "https://www.nasdaq.com/articles/amgens-repatha-wins-over-sanofi-regenerons-praluent-2017-01-06", "https://www.nasdaq.com/articles/why-regeneron-pharmaceuticals-sears-holdings-and-shake-shack-slumped-today-2017-01-06", "https://www.nasdaq.com/articles/close-update-labor-market-report-powers-sp-500-and-nasdaq-record-highs-2017-01-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-comcast-amgen-general-mills-target-and-ford-2017-01-05", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gap-inc-gps-and-pricesmart-inc.-psmt-2017-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-inotek-plunges-pipeline-setback-kite-files-ind-study-initiation-2017", "https://www.nasdaq.com/articles/kite-pharma-kite-to-move-cancer-candidate-into-phase-i-2017-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-01042017-snyamgnregncbayagrx-2017-01-04", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-m-apa-amgn-2017-01-03", "https://www.nasdaq.com/articles/biotech-stocks-what-watch-2017-2017-01-01", "https://www.nasdaq.com/articles/2-healthcare-stocks-better-dividends-hcp-inc-2016-12-31", "https://www.nasdaq.com/articles/oef-v-ibm-amgn-large-outflows-detected-etf-2016-12-30", "https://www.nasdaq.com/articles/these-3-dividend-stocks-are-ridiculously-cheap-2017-01-04", "https://www.nasdaq.com/articles/zacks-podcast-highlights-immunotherapy-stocks-101-what-biotech-investors-need-know-now", "https://www.nasdaq.com/articles/6-dividend-stocks-increasing-payouts-amgn-cvs-mco-fitb-bxp-chh-2016-12-27", "https://www.nasdaq.com/articles/3-big-pharma-stocks-fastest-growing-dividends-2016-12-25", "https://www.nasdaq.com/articles/ligand-lgnd-signs-licensing-deals-with-ono-and-novartis-2016-12-23", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-tqqq-amgn-khc-gild-2016-12-22", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-fitb-mco-wor-wdr-2016-12-21", "https://www.nasdaq.com/articles/bristol-myers-psioxus-ink-deal-for-oncolytic-virus-therapy-2016-12-21", "https://www.nasdaq.com/articles/merck-mrk-does-well-in-2016%3A-reasons-for-outperformance-2016-12-30", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-darden-restaurants-inc.-dri-amgen-inc.-amgn-and", "https://www.nasdaq.com/articles/amgen-files-for-approval-of-osteoporosis-drug-in-japan-2016-12-20", "https://www.nasdaq.com/articles/great-news-clinical-trial-success-rates-are-first-time-more-decade-2016-12-19", "https://www.nasdaq.com/articles/merck-keytruda-gets-chmp-nod-for-first-line-lung-cancer-2016-12-19", "https://www.nasdaq.com/articles/3-small-biotech-stocks-big-biotechs-2016-12-18", "https://www.nasdaq.com/articles/stock-exchange-do-emotions-and-symbolism-affect-technical-analysis-2016-12-16", "https://www.nasdaq.com/articles/gilead-sciences-biggest-mistake-2016-2016-12-16", "https://www.nasdaq.com/articles/forget-gilead-sciences-inc-these-3-stocks-are-better-buys-2016-12-21", "https://www.nasdaq.com/articles/5-fairly-valued-dividend-growth-stocks-healthcare-sector-2016-12-15", "https://www.nasdaq.com/articles/big-pharma-face-off%3A-is-merck-more-attractive-than-jj-2016-12-15", "https://www.nasdaq.com/articles/xlv-amgn-abbv-gild-etf-outflow-alert-2016-12-14", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-sale-2016-12-13", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2016-12-13", "https://www.nasdaq.com/articles/harvard-biosciences-recent-acquisitions-make-difference-initiate-buy-rating-2016-12-13", "https://www.nasdaq.com/articles/yieldboost-amgen-47-using-options-2016-12-12", "https://www.nasdaq.com/articles/pfizer%3A-fda-approves-eczema-ointment-xtandi-fails-study-2016-12-15", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-might-be-on-santas-buy-list-2016-12-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-12-11", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-trade-showcases-the-art-of-the-steal-2016-12-08", "https://www.nasdaq.com/articles/stock-market-news-for-december-08-2016-2016-12-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-actelion-remains-ma-spotlight-ash-data-focus-2016-12-07", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-pfizer-2016-12-07", "https://www.nasdaq.com/articles/global-blood-therapeutics-short-sellers-could-be-ride-2016-12-07", "https://www.nasdaq.com/articles/mondays-vital-data%3A-bank-of-america-corp-bac-apple-inc.-aapl-and-seadrill-ltd-sdrl-2016-12", "https://www.nasdaq.com/articles/abbvie-abbv-presents-impressive-imbruvica-data-at-ash-2016-12-06", "https://www.nasdaq.com/articles/heres-why-arrowhead-pharmaceuticals-inc-being-obliterated-today-2016-11-30", "https://www.nasdaq.com/articles/momenta-shires-humira-biosimilar-meets-study-objective-2016-11-30", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-2016-11-30", "https://www.nasdaq.com/articles/pfizer-merck-kgaa%3A-priority-review-for-cancer-drug-avelumab-2016-11-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-actelion-soars-acquisition-talks-another-clinical-hold-juno-2016-11", "https://www.nasdaq.com/articles/3-top-dividend-stocks-buy-2017-2016-11-29", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-xlv-mrk-amgn-gild-2016-12-06", "https://www.nasdaq.com/articles/jj-immunotherapy-darzalex-okd-for-label-expansion-by-fda-2016-11-22", "https://www.nasdaq.com/articles/5-biotech-stocks-george-soros-buying-2016-11-22", "https://www.nasdaq.com/articles/novartis-nvs-reports-favorable-data-on-enbrel-biosimilar-2016-11-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-cisco-nextera-energy-abbvie-and-ebay-2016-11-21", "https://www.nasdaq.com/articles/novartis-amgen-migraine-drug-positive-in-phase-iii-study-2016-11-18", "https://www.nasdaq.com/articles/regeneron-sanofis-praluent-cv-outcomes-study-to-continue-2016-11-18", "https://www.nasdaq.com/articles/aegerions-juxtapid-gets-pricing-authorization-in-japan-2016-11-18", "https://www.nasdaq.com/articles/merck%3A-keytrudas-priority-review-for-new-cancer-indication-2016-11-29", "https://www.nasdaq.com/articles/amgens-migraine-drug-hits-primary-endpoint-in-strive-study-2016-11-17", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-amgen-inc.-amgn-cisco-systems-inc.-csco-and-netapp-inc.", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-to-buy-for-huge-gains-2016-11-17", "https://www.nasdaq.com/articles/amgen-files-for-avastin-biosimilar-repatha-data-positive-2016-11-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-biotech-stocks-soar-election-results-gilead-hbv-drug-approved-2016", "https://www.nasdaq.com/articles/immunotherapy-next-hot-industry-biotech-stock-investors-2016-11-16", "https://www.nasdaq.com/articles/3-biotech-etfs-for-decades-of-big-returns-2016-11-15", "https://www.nasdaq.com/articles/top-research-reports-cisco-amgen-nextera-energy-2016-11-18", "https://www.nasdaq.com/articles/amgen-presents-osteoporosis-data-parsabiv-approved-in-eu-2016-11-14", "https://www.nasdaq.com/articles/fidelity-healthcare-fund-5-things-you-should-know-2016-11-14", "https://www.nasdaq.com/articles/3-drugmakers-probably-have-lower-tax-rates-you-do-2016-11-13", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-14-2016-2016-11-11", "https://www.nasdaq.com/articles/drug-stocks-q3-earnings-to-watch-on-nov-14%3A-args-ast-2016-11-11", "https://www.nasdaq.com/articles/stock-exchange-post-election-technical-analysis-useful-2016-11-11", "https://www.nasdaq.com/articles/kite-pharma-q3-loss-betters-estimate-kte-c19-on-track-2016-11-10", "https://www.nasdaq.com/articles/how-invest-during-trump-presidency-2016-11-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-ionis-soars-spinraza-data-regenerons-q3-results-mixed-2016-11-09", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-johnson-johnson-2016-11-08", "https://www.nasdaq.com/articles/iyh-unh-amgn-abbv-etf-outflow-alert-2016-11-08", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-november-09-2016-2016-11-08", "https://www.nasdaq.com/articles/why-amgen-inc-shares-nose-dived-154-october-2016-11-08", "https://www.nasdaq.com/articles/biotech-etfs-slumping-on-q3-results-2016-11-08", "https://www.nasdaq.com/articles/5-top-biotech-stocks-buy-trump-victory-2016-11-10", "https://www.nasdaq.com/articles/spxts-underlying-holdings-imply-14-gain-potential-2016-11-07", "https://www.nasdaq.com/articles/2-reasons-why-ishares-nasdaq-biotechnology-index-etf-tumbled-11-october-2016-11-07", "https://www.nasdaq.com/articles/abbvies-dividend-worth-risk-2016-11-06", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-mylan-lilly-pfizer-novartis-and-amgen-2016-11-04", "https://www.nasdaq.com/articles/why-abbvie-shares-tumbled-116-october-2016-11-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-down-enbrel-sales-regenerons-sarilumab-faces-delay-2016-11-03", "https://www.nasdaq.com/articles/allergan-agn-lags-q3-earnings-cuts-view-ups-buyback-2016-11-02", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-amgen-vertex-valeant-pharmaceuticals-international", "https://www.nasdaq.com/articles/pfizers-surprising-news-upends-market-next-gen-cholesterol-busters-2016-11-01", "https://www.nasdaq.com/articles/pfizer-pfe-q3-earnings-lag-cuts-view-sheds-bococizumab-2016-11-01", "https://www.nasdaq.com/articles/drug-stocks-to-watch-for-earnings-on-nov-2-agn-zts-more-2016-11-01", "https://www.nasdaq.com/articles/3-things-you-really-need-know-about-pfizers-q3-results-2016-11-01", "https://www.nasdaq.com/articles/genetic-stocks-to-watch-for-earnings-on-nov-1%3A-gild-more-2016-10-31", "https://www.nasdaq.com/articles/will-trend-cost-biotech-stock-investors-lots-money-2016-10-30", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-sinks-despite-q3-earnings-beat-2016-10-28", "https://www.nasdaq.com/articles/10-billion-flop-amgen-stock-still-buy-2016-11-02", "https://www.nasdaq.com/articles/amgen-amgn-q3-earnings-sales-top-enbrel-hurts-stock-2016-10-28", "https://www.nasdaq.com/articles/why-amgen-mckesson-and-stonemor-partners-slumped-today-2016-10-28", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-519010-down-2587-points-2016-10-28", "https://www.nasdaq.com/articles/5-things-amgen-incs-management-wants-you-know-2016-10-28", "https://www.nasdaq.com/articles/heres-why-amgen-amgn-stock-slid-over-10-today-2016-10-28", "https://www.nasdaq.com/articles/amgen-inc-tumbles-11-pricing-concerns-mount-lead-drug-enbrel-2016-10-28", "https://www.nasdaq.com/articles/amgen-inc-delivers-q3-despite-sluggish-revenue-2016-10-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-amgn-srcl-2016-10-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-october-27-2016-amzn-googl-amgn-bidu-syk-mck-afl-lnkd-rsg-expe", "https://www.nasdaq.com/articles/biotech-stock-roundup-clinical-holds-hit-inovio-aduro-vertex-q3-results-miss-estimates", "https://www.nasdaq.com/articles/gilead-sciences-gild-q3-earnings%3A-stock-to-disappoint-2016-10-26", "https://www.nasdaq.com/articles/can-prothena-prta-pull-a-surprise-this-earnings-season-2016-10-26", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q3-earnings-tecfidera-propels-sales-2016-10-26", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-amgen-amgn-this-earnings-season-2016-10-26", "https://www.nasdaq.com/articles/novartis-nvs-tops-q3-earnings-misses-sales-estimates-2016-10-25", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-600-follow-through-indicator-27-sensitive-2016-10-27", "https://www.nasdaq.com/articles/3-key-questions-amgen-inc-q3-2016-10-25", "https://www.nasdaq.com/articles/agenus-agen%3A-whats-ahead-for-the-stock-in-q3-earnings-2016-10-24", "https://www.nasdaq.com/articles/can-abbvie-abbv-sustain-earnings-beat-trend-in-q3-2016-10-24", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-cemp-rdus-2016-10-24", "https://www.nasdaq.com/articles/health-care-sector-update-10242016-aacunisino-2016-10-24", "https://www.nasdaq.com/articles/will-amgen-amgn-sustain-its-earnings-beat-trend-in-q3-2016-10-21", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-meets-endpoint-in-phase-iii-study-2016-10-21", "https://www.nasdaq.com/articles/merck-keytruda-gets-fda-approval-for-first-line-lung-cancer-2016-10-25", "https://www.nasdaq.com/articles/glaxosmithkline-gsk-q3-earnings%3A-whats-in-the-cards-2016-10-21", "https://www.nasdaq.com/articles/bristol-myers-squibb-bmy-q3-earnings%3A-whats-in-store-2016-10-21", "https://www.nasdaq.com/articles/best-and-worst-biotech-etfs-2016-tell-tale-about-industry-2016-10-21", "https://www.nasdaq.com/articles/7-drug-stocks-consider-biosimilars-pick-pace-2016-10-20", "https://www.nasdaq.com/articles/can-biogen-biib-keep-the-earnings-streak-alive-in-q3-2016-10-20", "https://www.nasdaq.com/articles/whats-in-store-for-biomarin-bmrn-this-earnings-season-2016-10-20", "https://www.nasdaq.com/articles/alexion-alxn-q3-earnings%3A-can-the-stock-pull-a-surprise-2016-10-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-pfizer-novartis-ag-amgen-merck-and-momenta", "https://www.nasdaq.com/articles/celgene-celg-q3-earnings%3A-whats-in-store-for-the-stock-2016-10-20", "https://www.nasdaq.com/articles/can-eli-lilly-lly-pull-a-surprise-this-earnings-season-2016-10-19", "https://www.nasdaq.com/articles/can-merck-mrk-keep-the-earnings-streak-alive-in-q3-2016-10-19", "https://www.nasdaq.com/articles/3-stocks-supplement-your-social-security-benefits-2016-10-19", "https://www.nasdaq.com/articles/pfizer-to-launch-remicade-biosimilar-in-u.s.-in-november-2016-10-18", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-lly-wy-hsy-vmc-unm-2016-10-17", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2016-10-13", "https://www.nasdaq.com/articles/novartis-nvs-q3-earnings%3A-stock-to-beat-estimates-again-2016-10-20", "https://www.nasdaq.com/articles/abbott-labs-abt-q3-earnings%3A-whats-ahead-for-the-stock-2016-10-13", "https://www.nasdaq.com/articles/stock-market-news-for-october-12-2016-2016-10-12", "https://www.nasdaq.com/articles/better-buy-regeneron-pharmaceuticals-inc-vs-roche-holding-ag-2016-10-12", "https://www.nasdaq.com/articles/teva-acquires-rights-to-oncology-biosimilar-candidates-2016-10-11", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2016-10-11", "https://www.nasdaq.com/articles/6-healthcare-stocks-investors-cant-miss-in-q3-earnings-2016-10-07", "https://www.nasdaq.com/articles/pfizer-to-sell-hospira-infusion-unit-to-icu-medical-for-%241b-2016-10-07", "https://www.nasdaq.com/articles/jj-jnj-likely-to-beat-earnings-estimates-in-q3-again-2016-10-13", "https://www.nasdaq.com/articles/xlv-amgn-mdt-abbv-etf-outflow-alert-2016-10-05", "https://www.nasdaq.com/articles/amgen-announces-publication-of-blincyto-phase-i-ii-data-2016-10-04", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-october-2016-10-02", "https://www.nasdaq.com/articles/marketplace-roundtable-state-biotech-2016-10-01", "https://www.nasdaq.com/articles/3-healthcare-stocks-could-raise-their-dividends-2016-10-01", "https://www.nasdaq.com/articles/amgen-amgn-migraine-drug-hits-phase-iii-primary-endpoint-2016-09-30", "https://www.nasdaq.com/articles/it-too-late-get-millionaire-maker-stock-2016-09-30", "https://www.nasdaq.com/articles/3-ways-rockwell-medical-inc-could-turn-things-around-2016-10-07", "https://www.nasdaq.com/articles/why-arrowhead-pharmaceuticals-stock-spiked-today-2016-09-29", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-pepsico-beats-q3-expectations-2016-09-29", "https://www.nasdaq.com/articles/health-care-sector-update-09292016-arwramgnaegritci-2016-09-29", "https://www.nasdaq.com/articles/3-reasons-not-to-lose-faith-in-amgen-inc.-amgn-2016-09-28", "https://www.nasdaq.com/articles/momenta-to-regain-rights-to-humira-biosimilar-from-shire-2016-09-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgens-kyprolis-disappoints-array-cancer-data-2016-09-28", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-kyprolis-fails-in-phase-iii-2016-09-28", "https://www.nasdaq.com/articles/allergan-focus-on-brands-biosimilar-products-acquisitions-2016-09-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-gild-nclh-2016-09-27", "https://www.nasdaq.com/articles/amgen-ucbs-bla-for-osteoporosis-drug-accepted-in-the-u.s.-2016-09-27", "https://www.nasdaq.com/articles/biosimilars-limelight-fda-approval-amgen-drug-2016-09-27", "https://www.nasdaq.com/articles/heres-why-ligand-pharmaceuticals-inc-plunging-today-2016-09-27", "https://www.nasdaq.com/articles/amgens-biosimilar-of-abbvies-humira-gets-fda-approval-2016-09-26", "https://www.nasdaq.com/articles/humira-alternative-gets-fda-approval-abbvie-trouble-2016-09-26", "https://www.nasdaq.com/articles/amgen-amgn-repatha-meets-endpoints-in-phase-iii-study-2016-09-21", "https://www.nasdaq.com/articles/xlv-amgn-mdt-gild-etf-inflow-alert-2016-09-27", "https://www.nasdaq.com/articles/trade-of-the-day%3A-ishares-nasdaq-biotechnology-index-etf-ibb-is-turning-things-around-2016", "https://www.nasdaq.com/articles/biotech-etf-best-level-january-are-you-braced-bumps-2016-09-20", "https://www.nasdaq.com/articles/know-you-buy-these-85-blue-chips-2016-09-20", "https://www.nasdaq.com/articles/amgen-amgn-parsabiv-gets-positive-chmp-opinion-in-eu-2016-09-19", "https://www.nasdaq.com/articles/new-market-biggest-investment-idea-decade-2016-09-17", "https://www.nasdaq.com/articles/iwf-v-pep-amgn-etf-outflow-alert-2016-09-16", "https://www.nasdaq.com/articles/novartis-reports-positive-phase-ii-data-on-migraine-drug-2016-09-16", "https://www.nasdaq.com/articles/stock-market-news-for-september-21-2016-2016-09-21", "https://www.nasdaq.com/articles/stock-market-news-for-september-15-2016-2016-09-15", "https://www.nasdaq.com/articles/third-avenue-fund-comments-amgen-2016-09-14", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-spectrum-pharmaceuticals-amgen-abbvie-and-vertex", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2016-2016-09-13", "https://www.nasdaq.com/articles/sp-500-movers-aal-prgo-2016-09-12", "https://www.nasdaq.com/articles/3-drug-stocks-could-benefit-key-fda-events-sep-2016-2016-09-12", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-amgn-ulta-aig-2016-09-12", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-the-bears-got-nothin-on-biotech-stocks-2016-09-15", "https://www.nasdaq.com/articles/biotech-etf-unusual-investment-strategy-2016-09-09", "https://www.nasdaq.com/articles/market-treaded-water-august-investors-shifted-growth-stocks-switching-back-2016-09-09", "https://www.nasdaq.com/articles/mercks-lung-cancer-drug-keytruda-under-priority-review-2016-09-08", "https://www.nasdaq.com/articles/3-attractive-income-stocks-whose-dividends-could-double-2016-09-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-colucid-soars-migraine-data-dynavax-drug-fda-panel-meeting-cancelled", "https://www.nasdaq.com/articles/amgen-gets-fda-approval-for-label-expansion-of-blincyto-2016-09-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-patent-infringement-lawsuit-enbrel-biosimilar-approved-2016", "https://www.nasdaq.com/articles/two-things-you-must-understand-about-biotech-investing-2016-09-11", "https://www.nasdaq.com/articles/the-medicines-co.-offers-update-on-dyslipidemia-programs-2016-08-31", "https://www.nasdaq.com/articles/novartis-nvs-gets-fda-nod-for-biosimilar-version-of-enbrel-2016-08-31", "https://www.nasdaq.com/articles/amgen-amgn-reports-positive-data-on-prolia-and-repatha-2016-08-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-tqqq-amgn-khc-gild-2016-08-29", "https://www.nasdaq.com/articles/regeneron-sanofi-present-positive-phase-iii-praluent-data-2016-08-29", "https://www.nasdaq.com/articles/these-next-generation-cholesterol-drugs-could-raise-us-healthcare-costs-119-billion-year", "https://www.nasdaq.com/articles/amgen-gets-crl-for-secondary-hyperparathyroidism-drug-2016-08-25", "https://www.nasdaq.com/articles/why-cytokinetics-inc-got-hammered-today-2016-09-01", "https://www.nasdaq.com/articles/commit-purchase-amgen-135-earn-55-using-options-2016-08-24", "https://www.nasdaq.com/articles/jj-jnj-seeks-eu-approval-for-darzalexs-expanded-use-2016-08-24", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-august-25-2016-2016-08-24", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-dvax-amgn-ndsn-2016-08-22", "https://www.nasdaq.com/articles/3-reasons-medivation-juiciest-target-biotech-2016-08-21", "https://www.nasdaq.com/articles/3-cheap-dividend-stocks-you-can-buy-right-now-2016-08-19", "https://www.nasdaq.com/articles/cytokinetics-amyotrophic-lateral-sclerosis-study-enrolled-2016-08-18", "https://www.nasdaq.com/articles/health-care-sector-update-08252016-amgnpvct-2016-08-25", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-08-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-slips-study-halt-aurinia-plunges-lupus-data-2016-08-17", "https://www.nasdaq.com/articles/another-endorsement-biotech-etfs-2016-08-16", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-twilio-inc-twlo-hain-celestial-group-inc-hain-and-wal-mart", "https://www.nasdaq.com/articles/amgen-inc-amgn-amgen-stock-is-a-powerhouse-2016-08-16", "https://www.nasdaq.com/articles/7-battered-biotech-stocks-buy-2016-08-14", "https://www.nasdaq.com/articles/prices-these-4-top-selling-prescription-drugs-have-more-doubled-2010-2016-08-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-aurinia-aveo-and-amgen-2016-08-18", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-08-17", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-biomarin-abbvie-amgen-and-biogen-2016-08-12", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-15-2016-2016-08-12", "https://www.nasdaq.com/articles/4-reasons-amgen-inc-shareholders-netted-13-gain-july-2016-08-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-earnings-focus-abbvie-takes-steps-block-humira-copycat-2016-08-11", "https://www.nasdaq.com/articles/stock-market-news-for-august-09-2016-2016-08-09", "https://www.nasdaq.com/articles/kite-pharma-kite-q2-loss-wider-focus-kte-c19-2016-08-09", "https://www.nasdaq.com/articles/prices-these-4-top-selling-prescription-drugs-have-more-doubled-2010-2016-08-12", "https://www.nasdaq.com/articles/kite-kite-q2-earnings-whats-store-stock-2016-08-04", "https://www.nasdaq.com/articles/finding-value-sp-500-9-healthcare-dividend-growth-stocks-part-1-2016-08-04", "https://www.nasdaq.com/articles/why-advaxis-inc-shares-are-soaring-11-again-today-2016-08-03", "https://www.nasdaq.com/articles/ibb-significantly-overbought-sharp-declines-imminent-2016-08-03", "https://www.nasdaq.com/articles/mid-day-market-update-dow-drops-over-100-points-avon-shares-surge-following-earnings-beat", "https://www.nasdaq.com/articles/close-update-stocks-pressured-earnings-worries-about-economy-2016-08-02", "https://www.nasdaq.com/articles/2-biotech-funds-leading-nascent-bull-market-which-right-you-2016-08-02", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-dgro-abbv-amgn-ups-2016-08-08", "https://www.nasdaq.com/articles/which-latest-13f-filers-holds-amgen-2016-08-02", "https://www.nasdaq.com/articles/qqq-etf-posts-52-week-high-energy-stocks-sag-oil-drops-40-2016-08-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-bib-amgn-celg-biib-2016-07-29", "https://www.nasdaq.com/articles/ucb-ucbjf-posts-1h16-results-reaffirms-2016-guidance-2016-07-29", "https://www.nasdaq.com/articles/company-news-for-july-29-2016-2016-07-29", "https://www.nasdaq.com/articles/amgn-named-top-socially-responsible-dividend-stock-2016-07-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-facebook-amgen-whole-foods-and-groupon-2016-07-28", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-15-retailmenot-shares-gain-strong-results-2016", "https://www.nasdaq.com/articles/amgen-amgn-tops-q2-earnings-revenues-raises-view-2016-07-28", "https://www.nasdaq.com/articles/2-large-cap-drug-stocks-watch-earnings-abbv-mrk-2016-07-28", "https://www.nasdaq.com/articles/facebook-fb-owns-q2-earnings-huge-beat-plus-grpn-gpro-and-more-2016-07-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-q2-results-impress-gilead-hcv-franchise-under-pressure-2016", "https://www.nasdaq.com/articles/after-hours-earnings-report-july-27-2016-fb-amgn-mck-psa-su-nxpi-orly-pxd-abx-vrtx-mar-o", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-636-follow-through-indicator-27-sensitive-2016-07-27", "https://www.nasdaq.com/articles/5-drug-stocks-earnings-on-jul-27%3A-amgn-vrtx-more-2016-07-26", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-gilead-abbvie-amgen-and-celgene-2016-07-28", "https://www.nasdaq.com/articles/amgen-amgn-tops-q2-earnings-revenues-raises-view-2016-07-28", "https://www.nasdaq.com/articles/2-large-cap-drug-stocks-watch-earnings-abbv-mrk-2016-07-28", "https://www.nasdaq.com/articles/merck-mrk-q2-earnings-will-stock-pull-surprise-2016-07-26", "https://www.nasdaq.com/articles/ariad-aria-report-q2-earnings-will-stock-surprise-2016-07-26", "https://www.nasdaq.com/articles/bristol-myers-bmy%3A-stock-to-beat-earnings-again-in-q2-2016-07-25", "https://www.nasdaq.com/articles/celgene-celg-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-07-25", "https://www.nasdaq.com/articles/outerwall-inc%3A-what-the-buyout-means-for-outr-stock-2016-07-25", "https://www.nasdaq.com/articles/abbvie-abbv-q2-earnings-will-stock-pull-surprise-2016-07-26", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-bristol-myers-pfizer-sanofi-amgen-and-biogen-2016-07-25", "https://www.nasdaq.com/articles/glaxo-gsk-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-07-25", "https://www.nasdaq.com/articles/vertex-vrtx-report-q2-earnings-surprise-store-2016-07-25", "https://www.nasdaq.com/articles/amgen-amgn-may-beat-q2-earnings-will-stock-gain-2016-07-25", "https://www.nasdaq.com/articles/biotech-earnings-battle-gilead-gild-vs-amgen-amgn-2016-07-25", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-nlsn-mac-cf-ee-wwd-2016-07-25", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-now-2016-07-25", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-may-be-prepping-surge-2016-07-25", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-zafgen-celgene-amgen-abbvie-and-biogen-2016-07-21", "https://www.nasdaq.com/articles/eli-lilly-lly-may-beat-q2-earnings-will-stock-gain-2016-07-21", "https://www.nasdaq.com/articles/gilead-gild-stock-likely-to-beat-this-earnings-season-2016-07-21", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2016-07-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-immuno-oncology-deal-zafgen-drops-lead-drug-2016-07-20", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-sso-amgn-mcd-cvs-2016-07-19", "https://www.nasdaq.com/articles/implied-moat-analyst-target-price-38-2016-07-18", "https://www.nasdaq.com/articles/health-care-sector-update-07222016-abax-vrx-amgn-mrk-abt-pfe-jnj-2016-07-22", "https://www.nasdaq.com/articles/valeants-vrx-brodalumab-bla-up-for-review-in-the-u.s.-2016-07-18", "https://www.nasdaq.com/articles/3-biotech-stocks-conservative-investors-2016-07-17", "https://www.nasdaq.com/articles/4-rock-solid-cheap-biotech-stocks-2016-07-16", "https://www.nasdaq.com/articles/5-figures-look-when-johnson-johnson-reports-its-second-quarter-results-2016-07-15", "https://www.nasdaq.com/articles/novartis-enbrel-biosimilar-gets-fda-panel-recommendation-2016-07-14", "https://www.nasdaq.com/articles/amgen-and-daiichi-sankyo-team-up-for-biosimilars-in-japan-2016-07-14", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-juno-amgen-abbvie-gilead-and-cytrx-2016-07-14", "https://www.nasdaq.com/articles/3-drug-stocks-report-earnings-jul-19-jnj-nvs-neog-2016-07-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-and-out-clinical-hold-amgen-biosimilar-gets-panel-backing-2016", "https://www.nasdaq.com/articles/amgens-repatha-gains-fda-approval-for-new-dosing-option-2016-07-12", "https://www.nasdaq.com/articles/instant-analysis-amgens-latest-approval-raises-bar-yet-again-regeneron-pharmaceuticals-inc", "https://www.nasdaq.com/articles/amgen-humira-biosimilar-briefing-documents-look-good-2016-07-11", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iwf-googl-goog-amgn-2016-07-07", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-wal-mart-stores-home-depot-amgen-united-parcel-service-and", "https://www.nasdaq.com/articles/amgens-kyprolis-gains-approval-in-eu-for-label-expansion-2016-07-06", "https://www.nasdaq.com/articles/heres-why-regeneron-pharmaceuticals-inc-dropped-another-12-june-2016-07-13", "https://www.nasdaq.com/articles/astrazeneca-skin-drug-tralokinumab-rights-licensed-leo-2016-07-06", "https://www.nasdaq.com/articles/5-dividend-growth-stocks-to-excel-in-any-market-condition-2016-07-06", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-now-2016-07-04", "https://www.nasdaq.com/articles/3-healthcare-stocks-could-raise-their-dividends-2016-07-02", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-above-200-dma-2016-07-01", "https://www.nasdaq.com/articles/pfizers-pcsk9-inhibitor-tops-two-additional-phase-iii-studies-2016-06-29", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-inflow-2016-06-29", "https://www.nasdaq.com/articles/should-davitas-dva-stock-be-in-your-portfolio-now-2016-07-06", "https://www.nasdaq.com/articles/esperion-therapeutics-inc-sinks-after-fda-says-ask-us-2019-2016-06-29", "https://www.nasdaq.com/articles/medtronic-plc%3A-high-dividend-growth-stock-with-room-to-run-mdt-2016-06-27", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-good-fundamentals-good-yield-good-opportunity-2016-06-27", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-wake-brexit-vote-2016-06-24", "https://www.nasdaq.com/articles/the-ishares-nasdaq-biotechnology-index-ibb%3A-biotech-stocks-are-pushing-for-recovery-2016", "https://www.nasdaq.com/articles/how-former-market-darling-became-undervalued-stock-2016-06-23", "https://www.nasdaq.com/articles/3-most-important-data-releases-and-fda-decisions-second-half-2016-2016-06-23", "https://www.nasdaq.com/articles/xencor-stock-up-on-cancer-drugs-partnership-with-novartis-2016-06-29", "https://www.nasdaq.com/articles/esperion-therapeutics-inc-sinks-after-fda-says-ask-us-2019-2016-06-29", "https://www.nasdaq.com/articles/amgens-biosimilar-of-abbvies-humira-to-face-fda-panel-2016-06-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2016-2016-06-13", "https://www.nasdaq.com/articles/tricking-common-cold-destroying-cancer-2016-06-13", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-pjp-agn-amgn-lly-2016-06-10", "https://www.nasdaq.com/articles/novartis-nvs-announces-positive-results-on-migraine-drug-2016-06-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-slips-ms-results-asco-data-focus-2016-06-08", "https://www.nasdaq.com/articles/ixj-amgn-agn-celg-large-inflows-detected-etf-2016-06-20", "https://www.nasdaq.com/articles/why-kite-pharma-shares-vaulted-107-higher-may-2016-06-06", "https://www.nasdaq.com/articles/better-dividend-stock-pfizer-vs-amgen-2016-06-06", "https://www.nasdaq.com/articles/new-17-billion-market-youve-probably-never-heard-and-3-stocks-poised-profit-2016-06-04", "https://www.nasdaq.com/articles/3-biotechs-expecting-market-moving-trial-results-soon-2016-06-04", "https://www.nasdaq.com/articles/sso-amgn-cvs-abbv-large-outflows-detected-etf-2016-06-01", "https://www.nasdaq.com/articles/regeneron-reports-interim-data-on-cholesterol-lowering-drug-2016-06-01", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-june-02-2016-2016-06-01", "https://www.nasdaq.com/articles/ibb-ishares-nasdaq-biotechnology-index-etf-still-buy-2016-06-07", "https://www.nasdaq.com/articles/3-growth-stocks-buy-june-2016-05-28", "https://www.nasdaq.com/articles/interested-medivation-take-number-2016-05-27", "https://www.nasdaq.com/articles/yieldboost-amgn-64-using-options-2016-05-25", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-above-200-dma-2016-05-25", "https://www.nasdaq.com/articles/billionaires-lightened-their-load-these-3-widely-held-stocks-q1-2016-05-24", "https://www.nasdaq.com/articles/heres-what-pfizers-telling-us-about-biotech-ma-2016-05-21", "https://www.nasdaq.com/articles/xlv-unh-gild-amgn-etf-outflow-alert-2016-05-19", "https://www.nasdaq.com/articles/merck-abbvie-amgen-drugs-step-closer-eu-approval-2016-05-31", "https://www.nasdaq.com/articles/drug-stocks-reporting-earnings-on-may-17%3A-axon-fwp-2016-05-16", "https://www.nasdaq.com/articles/math-shows-eusa-can-go-48-2016-05-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-medivation-buyout-rumors-continue-newlink-plunges-late-stage-data", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-13-2016-2016-05-12", "https://www.nasdaq.com/articles/bristol-myers-abbvie-empliciti-gets-approved-in-the-eu-2016-05-12", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-unh-gild-amgn-2016-05-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-pfizer-buy-anacor-52b-pipeline-setbacks-aduro-trevena-2016-05-19", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-slated-on-may-11%3A-acrs-ears-more-2016-05-10", "https://www.nasdaq.com/articles/kite-pharma-kite-posts-narrower-expected-loss-q1-2016-05-10", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-may-11-2016-2016-05-10", "https://www.nasdaq.com/articles/drug-stocks-reporting-on-may-10%3A-xon-aria-cprx-more-2016-05-09", "https://www.nasdaq.com/articles/drug-stocks-earnings-previews%3A-fgen-irwd-enta-flml-2016-05-06", "https://www.nasdaq.com/articles/biotech-stocks-reporting-may-9-incy-hznp-juno-more-2016-05-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-gilead-celgene-medivation-and-biogen-2016-05-05", "https://www.nasdaq.com/articles/drug-stocks-earnings-slated-for-this-week%3A-rdy-avxs-esaly-2016-05-11", "https://www.nasdaq.com/articles/kite-kite-report-q1-earnings-will-stock-disappoint-2016-05-04", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2016-05-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-impresses-gilead-disappoints-q1-biogen-spin-hemophilia-2016-05", "https://www.nasdaq.com/articles/biotech-stocks-earnings-preview%3A-regn-lgnd-ecyt-more-2016-05-03", "https://www.nasdaq.com/articles/regeneron-pharmaceuticals-inc-has-lot-prove-may-5-2016-05-03", "https://www.nasdaq.com/articles/insulet-pumps-out-69-revenue-growth-q1-reaffirms-2016-guidance-2016-05-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-johnson-johnson-pfizer-mylan-and-mallinckrodt", "https://www.nasdaq.com/articles/amgn-makes-notable-cross-below-critical-moving-average-2016-05-04", "https://www.nasdaq.com/articles/biotech-etfs-sink-on-mixed-q1-results-2016-05-02", "https://www.nasdaq.com/articles/trade-day-ibb-breaking-down-2016-05-02", "https://www.nasdaq.com/articles/amgen-inc-amgn-earnings-prove-it-should-be-your-portfolio-2016-04-29", "https://www.nasdaq.com/articles/3-drug-stocks-reporting-early-next-week%3A-pfe-myl-mnk-2016-04-29", "https://www.nasdaq.com/articles/amgen-amgn-tops-q1-earnings-revenues-ups-view-2016-04-29", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-friday%3A-amgen-inc.-amgn-gilead-sciences-inc.-gild-and-tivo-inc.-tivo", "https://www.nasdaq.com/articles/q1-earnings-reports-continue-deluge-amzn-gild-amgn-2016-04-28", "https://www.nasdaq.com/articles/aside-1-eyesore-amgen-delivers-another-solid-quarter-2016-05-02", "https://www.nasdaq.com/articles/celgene-corporation-short-term-long-term-guidance-medium-term-not-so-much-2016-04-28", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-700-follow-through-indicator-28-sensitive-2016-04-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-april-28-2016-amzn-gild-amgn-bidu-hig-rsg-expe-ess-bmrn-lnkd", "https://www.nasdaq.com/articles/fvd-lmbs-big-etf-inflows-2016-04-27", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-amgen-2016-04-27", "https://www.nasdaq.com/articles/4-biotech-stocks-reporting-apr-28-amgn-gild-alxn-celg-2016-04-27", "https://www.nasdaq.com/articles/aegerion-aegr%3A-can-the-stock-surprise-in-q1-earnings-2016-04-27", "https://www.nasdaq.com/articles/amgen-amgn-beats-q1-earnings-estimates-raises-2016-outlook-2016-04-28", "https://www.nasdaq.com/articles/biotech-stock-gilead-gild-likely-to-beat-in-q1-earnings-2016-04-26", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-inflow-2016-04-26", "https://www.nasdaq.com/articles/celgene-celg-q1-earnings%3A-whats-in-store-for-the-stock-2016-04-25", "https://www.nasdaq.com/articles/centene-cnc-q1-earnings%3A-surprise-in-store-for-stock-2016-04-25", "https://www.nasdaq.com/articles/aetna-aet-q1-earnings%3A-is-a-surprise-in-store-for-stock-2016-04-25", "https://www.nasdaq.com/articles/biomarin-bmrn-q1-earnings%3A-stock-likely-to-beat-estimates-2016-04-25", "https://www.nasdaq.com/articles/anthem-antm%3A-stock-poised-to-beat-on-q1-earnings-2016-04-25", "https://www.nasdaq.com/articles/aerie-aeri%3A-can-the-stock-pull-a-surprise-in-q1-earnings-2016-04-27", "https://www.nasdaq.com/articles/what-to-expect-from-hubbell-hubb-this-earnings-season-2016-04-25", "https://www.nasdaq.com/articles/5-biotech-stocks-to-bet-on-this-earnings-season-2016-04-25", "https://www.nasdaq.com/articles/3-data-points-will-likely-define-amgens-first-quarter-report-april-28-2016-04-25", "https://www.nasdaq.com/articles/does-biotechs-recent-bounce-have-legs-2016-04-23", "https://www.nasdaq.com/articles/bristol-myers-bmy-q1-earnings%3A-can-the-stock-surprise-2016-04-22", "https://www.nasdaq.com/articles/vertex-vrtx-report-q1-earnings-surprise-store-2016-04-22", "https://www.nasdaq.com/articles/abbvie-abbv-likely-beat-q1-earnings-stock-gain-2016-04-22", "https://www.nasdaq.com/articles/amgen-amgn-may-beat-q1-earnings-will-stock-gain-2016-04-25", "https://www.nasdaq.com/articles/will-currency-competition-hurt-lillys-lly-q1-earnings-2016-04-21", "https://www.nasdaq.com/articles/amgens-amgn-phase-iii-study-results-on-nplate-published-2016-04-20", "https://www.nasdaq.com/articles/20-reasons-buy-amgen-and-never-sell-2016-04-20", "https://www.nasdaq.com/articles/health-care-sector-update-04202016-cara-amgn-mrk-abt-pfe-jnj-stj-2016-04-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-medivation-buyout-rumors-resurface-synta-merger-deal-2016-04-20", "https://www.nasdaq.com/articles/health-care-sector-update-04192016-scmp-amgn-mrk-abt-pfe-jnj-2016-04-19", "https://www.nasdaq.com/articles/3-biotech-stocks-that-could-endure-hillary-clinton-2016-04-19", "https://www.nasdaq.com/articles/glaxo-gsk-q1-earnings%3A-whats-in-store-for-the-stock-2016-04-22", "https://www.nasdaq.com/articles/health-care-sector-update-04152016-amgn-mrk-abt-pfe-jnj-vrx-mrns-2016-04-15", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-iwl-2016-04-15", "https://www.nasdaq.com/articles/will-perrigo-prgo-surprise-earnings-estimates-in-q1-2016-04-15", "https://www.nasdaq.com/articles/iwf-amgn-unh-ma-large-outflows-detected-etf-2016-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-04142016-amgn-mrk-abt-pfe-jnj-abbv-enta-snta-2016-04-14", "https://www.nasdaq.com/articles/trade-day-pounce-amgn-stock-pullback-2016-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-04182016-mdvn-biib-amgn-mrk-abt-pfe-jnj-2016-04-18", "https://www.nasdaq.com/articles/3-biotech-takeover-targets-could-get-bought-soon-2016-04-13", "https://www.nasdaq.com/articles/health-care-sector-update-04122016-amgn-mrk-abt-pfe-jnj-clvs-cbrp-2016-04-12", "https://www.nasdaq.com/articles/shares-regeneron-pharmaceuticals-inc-struggled-march-heres-why-2016-04-11", "https://www.nasdaq.com/articles/novartis-binocrits-subcutaneous-formula-gets-ec-approval-2016-04-11", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwb-gild-amgn-sbux-2016-04-06", "https://www.nasdaq.com/articles/pfizers-pfe-biosimilar-of-remicade-receives-fda-approval-2016-04-06", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-for-your-retirement-2016-04-06", "https://www.nasdaq.com/articles/health-care-sector-update-04132016-ocls-psti-amgn-mrk-abt-pfe-jnj-2016-04-13", "https://www.nasdaq.com/articles/amgen-news-could-be-game-changer-its-fight-against-sanofi-and-regeneron-pharmaceuticals", "https://www.nasdaq.com/articles/amgen-breaks-above-200-day-moving-average-bullish-amgn-2016-04-04", "https://www.nasdaq.com/articles/3-biotech-stocks-on-the-verge-of-an-overdue-run-amgn-gild-regn-2016-04-04", "https://www.nasdaq.com/articles/better-buy-regeneron-pharmaceuticals-inc-vs-amgen-2016-04-04", "https://www.nasdaq.com/articles/pfizers-pcsk9-inhibitor-positive-second-phase-iii-study-2016-04-04", "https://www.nasdaq.com/articles/could-be-next-big-pharma-buyout-2016-04-03", "https://www.nasdaq.com/articles/post-conference-get-together-2016-04-02", "https://www.nasdaq.com/articles/forget-regeneron-pharmaceuticals-inc-these-2-stocks-are-better-buys-2016-04-05", "https://www.nasdaq.com/articles/amgen-news-could-be-game-changer-its-fight-against-sanofi-and-regeneron-pharmaceuticals", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-celgene-corp-2016-04-01", "https://www.nasdaq.com/articles/community-banks-can-be-teddy-bears-shield-against-market-2016-04-01", "https://www.nasdaq.com/articles/why-fitbit-inc-fit-medivation-inc-mdvn-and-tesla-motors-inc-tsla-are-3-of-todays-best", "https://www.nasdaq.com/articles/health-care-sector-update-03312016-mdvnazngildamgnsnygnvalife-2016-03-31", "https://www.nasdaq.com/articles/3-biotech-stocks-that-make-the-grade-for-investors-2016-03-30", "https://www.nasdaq.com/articles/opko-health-inc-fda-denial-wont-kill-opk-2016-03-30", "https://www.nasdaq.com/articles/4-best-biotech-stocks-of-the-first-quarter-of-2016-2016-04-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-spy-jnj-unh-amgn-2016-03-28", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-03-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-amgen-regeneron-ionis-and-biogen-2016-03-28", "https://www.nasdaq.com/articles/4-surging-stocks-brokers-love-healthcare-sector-2016-03-28", "https://www.nasdaq.com/articles/9-things-you-need-know-about-biosimilar-drugs-2016-03-28", "https://www.nasdaq.com/articles/regeneron-sanofi-report-positive-phase-iii-data-on-praluent-2016-03-24", "https://www.nasdaq.com/articles/gilead-biogens-patent-woes-amgen-scores-win-patent-litigation-2016-03-24", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2016-03-29", "https://www.nasdaq.com/articles/stock-market-news-for-march-22-2012-2016-03-22", "https://www.nasdaq.com/articles/gilead-and-4-other-buy-stocks-biotech-industry-2016-03-22", "https://www.nasdaq.com/articles/biogen-inc-vs-amgen-which-big-biotech-smarter-buy-today-2016-03-21", "https://www.nasdaq.com/articles/forget-cvs-health-corp-here-are-2-better-dividend-stocks-2016-03-21", "https://www.nasdaq.com/articles/ucb-and-amgen-report-positive-data-on-osteoporosis-drug-2016-03-21", "https://www.nasdaq.com/articles/big-biotech-etf-faces-key-technical-test-2016-03-18", "https://www.nasdaq.com/articles/amgen-inc-amgn-stock-looking-break-out-2016-03-18", "https://www.nasdaq.com/articles/jj-roche-tie-up-to-study-dual-immunotherapy-combination-2016-03-23", "https://www.nasdaq.com/articles/how-risky-opko-health-inc-stock-2016-03-18", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-valeant-pfizer-amgen-and-biogen-2016-03-17", "https://www.nasdaq.com/articles/amgen-wins-pcsk9-lawsuit-sanofi-and-regeneron-to-appeal-2016-03-17", "https://www.nasdaq.com/articles/why-investors-should-sell-these-biotech-stocks-buy-gilead-instead-2016-03-15", "https://www.nasdaq.com/articles/biotech-investing-guide-3-stocks-buy-and-3-avoid-2016-03-11", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2016-2016-03-11", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-03-10", "https://www.nasdaq.com/articles/kite-collaborates-with-roche-for-immunotherapy-cocktail-2016-03-18", "https://www.nasdaq.com/articles/how-risky-opko-health-inc-stock-2016-03-18", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-valeant-pfizer-amgen-and-biogen-2016-03-17", "https://www.nasdaq.com/articles/what-does-trumps-healthcare-plan-mean-investors-2016-03-04", "https://www.nasdaq.com/articles/3-reasons-novartis-stock-could-rise-2016-03-04", "https://www.nasdaq.com/articles/daily-dividend-report-gd-avgo-amgn-pxd-hes-hrb-2016-03-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-amgen-baxalta-ptc-therapeutics-and-cara", "https://www.nasdaq.com/articles/abbvies-boehringer-deal-boost-immunology-pipeline-2016-03-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-hiv-drug-approved-baxalta-immuno-oncology-deal-2016-03-02", "https://www.nasdaq.com/articles/kite-pharma-q4-loss-wider-focus-remains-kte-c19-2016-03-01", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-march-02-2016-2016-03-01", "https://www.nasdaq.com/articles/did-amgens-experimental-osteoporosis-drug-just-whiff-plate-2016-02-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-catalyst-pharma-ptc-therapeutics-radius-health-amgen", "https://www.nasdaq.com/articles/kite-kite-report-4q-earnings-whats-store-2016-02-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-ptct-plunges-rtf-fda-radius-shoots-amgen-data-2016-02-25", "https://www.nasdaq.com/articles/amgen-seeks-fda-approval-for-blincytos-label-expansion-2016-03-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-gilead-hiv-drug-approved-baxalta-immuno-oncology-deal-2016-03-02", "https://www.nasdaq.com/articles/amgen-ucbs-romosozumab-positive-late-stage-study-2016-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02222016-unisamgntrvncmrx-2016-02-22", "https://www.nasdaq.com/articles/midday-update-oil-lifts-dow-seven-week-high-energy-stocks-lead-broad-based-rally-markets", "https://www.nasdaq.com/articles/why-radius-health-inc-screaming-higher-today-2016-02-22", "https://www.nasdaq.com/articles/5-beaten-down-stocks-strong-dividend-yields-2016-02-22", "https://www.nasdaq.com/articles/astrazeneca-zurampic-gets-eu-nod-brilique-label-expanded-2016-02-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-cvr-refining-essex-property-trust-avalonbay", "https://www.nasdaq.com/articles/iwv-orcl-amgn-cvs-large-outflows-detected-etf-2016-02-19", "https://www.nasdaq.com/articles/can-biotech-stocks-bounce-back-2016-02-19", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-february-18th-2016-02-18", "https://www.nasdaq.com/articles/astrazeneca-cancer-drug-gets-breakthrough-therapy-status-2016-02-18", "https://www.nasdaq.com/articles/health-care-sector-update-02162016-amgn-cphr-2016-02-16", "https://www.nasdaq.com/articles/novartis-acquires-rights-to-biosimilar-of-remicade-from-pfizer-2016-02-16", "https://www.nasdaq.com/articles/amgens-aranesp-meets-primary-endpoint-in-phase-iii-study-2016-02-16", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-amgen-inc-2016-02-21", "https://www.nasdaq.com/articles/novartis-filing-for-neulasta-biosimilar-accepted-in-the-eu-2016-02-12", "https://www.nasdaq.com/articles/fda-panel-decision-just-changed-game-2016-02-11", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-11-2016-2016-02-10", "https://www.nasdaq.com/articles/pfizers-biosimilar-of-remicade-recommended-for-approval-2016-02-10", "https://www.nasdaq.com/articles/bio-techne-corp-tech-ex-dividend-date-scheduled-february-10-2016-2016-02-09", "https://www.nasdaq.com/articles/biotech-etfs-slide-as-stocks-report-mixed-q4-results-2016-02-09", "https://www.nasdaq.com/articles/ligand-pharmaceuticals-lgnd%3A-q4-earnings-preview-2016-02-08", "https://www.nasdaq.com/articles/gilead-sciences-wants-make-being-shareholder-worth-it-2016-02-13", "https://www.nasdaq.com/articles/amgens-blincyto-and-repatha-positive-in-phase-iii-studies-2016-02-05", "https://www.nasdaq.com/articles/will-2016-be-amgen-incs-best-year-yet-2016-02-03", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iusg-amgn-unp-rai-2016-02-02", "https://www.nasdaq.com/articles/why-nantkwest-shares-fell-41-january-2016-02-02", "https://www.nasdaq.com/articles/company-news-for-february-01-2016-2016-02-01", "https://www.nasdaq.com/articles/3-biotech-stocks-you-dont-have-babysit-2016-02-01", "https://www.nasdaq.com/articles/biotech-billionaire-launches-his-most-auspicious-project-yet-2016-01-31", "https://www.nasdaq.com/articles/biogen-inc-takes-aim-johnson-johnson-2016-02-07", "https://www.nasdaq.com/articles/abbvie-there-aint-no-stinkin-biosimilar-threat-2016-01-30", "https://www.nasdaq.com/articles/amgens-q4-crushed-estimates-and-answered-3-important-questions-process-2016-01-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amazon.com-microsoft-visa-skyworks-solutions-and-amgen", "https://www.nasdaq.com/articles/amgen-tops-q4-earnings-revenues-ups-2016-outlook-2016-01-29", "https://www.nasdaq.com/articles/biotech-etf-ibb-hits-new-52-week-low-2016-01-29", "https://www.nasdaq.com/articles/top-biotechs-2016-2016-01-28", "https://www.nasdaq.com/articles/q4-pedal-metal-amzn-msft-v-more-2016-01-28", "https://www.nasdaq.com/articles/where-invest-money-2016-7-great-ideas-2016-01-30", "https://www.nasdaq.com/articles/celgene-corporation-looks-forward-2016-01-28", "https://www.nasdaq.com/articles/earnings-reaction-history-amgen-inc-700-follow-through-indicator-32-sensitive-2016-01-28", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-28-2016-msft-amzn-v-amgn-ea-swks-wdc-klac-emn-cpt-flex", "https://www.nasdaq.com/articles/3-key-numbers-monitor-when-amgen-reports-fourth-quarter-results-2016-01-27", "https://www.nasdaq.com/articles/amgens-biosimilar-of-abbvies-humira-under-fda-review-2016-01-27", "https://www.nasdaq.com/articles/3-healthcare-stocks-you-dont-have-babysit-2016-01-27", "https://www.nasdaq.com/articles/will-amgen-amgn-continue-earnings-streak-q4-2016-01-26", "https://www.nasdaq.com/articles/amgen-amgn-beats-q4-earnings-revenue-estimates-2016-01-28", "https://www.nasdaq.com/articles/3-reasons-be-bearish-cvs-health-2016-01-25", "https://www.nasdaq.com/articles/amgen-presents-encouraging-phase-iii-data-on-vectibix-2016-01-25", "https://www.nasdaq.com/articles/novartis-nvs-to-report-q4-earnings%3A-will-it-disappoint-2016-01-25", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-01-23", "https://www.nasdaq.com/articles/amgen-kyprolis-label-expanded-repatha-approved-in-japan-2016-01-22", "https://www.nasdaq.com/articles/5-burning-questions-we-want-answered-when-johnson-johnson-reports-its-q4-results-2016-01", "https://www.nasdaq.com/articles/weekly-play-sell-calls-sector-ibb-2016-01-20", "https://www.nasdaq.com/articles/iusg-googl-goog-amgn-large-outflows-detected-etf-2016-01-25", "https://www.nasdaq.com/articles/3-slides-perfectly-sum-where-abbvie-headed-next-2016-01-19", "https://www.nasdaq.com/articles/biogens-biib-biosimilar-of-amgens-enbrel-gets-eu-nod-2016-01-18", "https://www.nasdaq.com/articles/best-healthcare-etf-week-2016-01-17", "https://www.nasdaq.com/articles/abbvies-management-just-made-some-pretty-bold-predictions-2016-01-16", "https://www.nasdaq.com/articles/7-battered-biotech-stocks-bargains-or-busts-2016-01-14", "https://www.nasdaq.com/articles/was-celgene-corporations-bad-news-really-bad-2016-01-14", "https://www.nasdaq.com/articles/5-slides-tell-you-everything-you-need-know-about-amgen-2016-01-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-plunges-briefing-documents-acorda-buy-biotie-2016-01-20", "https://www.nasdaq.com/articles/coherus-biosciences-and-baxalta-take-aim-amgen-and-pfizer-2016-01-12", "https://www.nasdaq.com/articles/4-great-retirement-stocks-buy-2016-2016-01-11", "https://www.nasdaq.com/articles/agree-buy-amgen-95-earn-57-using-options-2016-01-08", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-abbvie-amgen-ligand-pharmaceuticals-revance", "https://www.nasdaq.com/articles/stocks-mutual-funds-rose-q4-despite-dec-woes-2016-01-08", "https://www.nasdaq.com/articles/5-biotech-stocks-doubled-2015-2016-01-07", "https://www.nasdaq.com/articles/iusg-amgn-unh-celg-large-outflows-detected-etf-2016-01-07", "https://www.nasdaq.com/articles/3-stocks-better-dividends-cvs-health-corporation-2016-01-13", "https://www.nasdaq.com/articles/doctorx-positions-2016-my-no-1-risk-factor-flood-money-biotech-2016-01-06", "https://www.nasdaq.com/articles/why-amgen-top-25-dividend-giant-amgn-2016-01-05", "https://www.nasdaq.com/articles/midday-update-stocks-unravel-global-growth-concerns-mid-east-tensions-soft-u-s-data-also", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-tesla-motors-delivers-17400-vehicles-fourth", "https://www.nasdaq.com/articles/stock-futures-fall-chinese-manufacturing-slows-mid-east-tensions-escalate-2016-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-01042016-amagunismymx-2016-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-01042016-rwlkunismymx-2016-01-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-mannkind-tanks-deal-termination-speedy-review-gilead-drug-2016-01-06", "https://www.nasdaq.com/articles/alan-fournier-sells-gm-buys-molson-coors-brewing-2016-01-03", "https://www.nasdaq.com/articles/biggest-healthcare-headlines-2015-2016-01-03", "https://www.nasdaq.com/articles/will-2016-be-johnson-johnsons-best-year-yet-2016-01-01", "https://www.nasdaq.com/articles/will-amgen-inc-raise-its-dividend-2016-2015-12-31", "https://www.nasdaq.com/articles/amgn-named-top-socially-responsible-dividend-stock-2015-12-30", "https://www.nasdaq.com/articles/ligand-lgnd-upgraded-to-buy-perfect-for-your-portfolio-2015-12-30", "https://www.nasdaq.com/articles/tuesdays-etf-movers-vpl-econ-2015-12-29", "https://www.nasdaq.com/articles/what-does-2016-hold-biotech-stocks-2016-01-03", "https://www.nasdaq.com/articles/celgene-corporations-best-drug-2015-2015-12-29", "https://www.nasdaq.com/articles/enzon-pharmaceuticals-inc-enzn-ex-dividend-date-scheduled-december-30-2015-2015-12-29", "https://www.nasdaq.com/articles/what-happened-biotech-2015-2015-12-28", "https://www.nasdaq.com/articles/worst-regeneron-pharmaceuticals-inc-headlines-2015-2015-12-26", "https://www.nasdaq.com/articles/biotech-industry-could-offer-early-profit-2016-2015-12-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-actelion-amgen-gilead-abbvie-and-biomarin-2015-12-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-removes-ceo-shkreli-actelion-pah-drug-approved-2015-12-23", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwb-amgn-ma-abbv-2015-12-29", "https://www.nasdaq.com/articles/baxalta-momentas-humira-biosimilar-meets-trial-objective-2015-12-22", "https://www.nasdaq.com/articles/9-great-dividend-paying-stocks-2016-2015-12-21", "https://www.nasdaq.com/articles/why-aegerion-pharmaceuticals-stock-bolted-higher-today-2015-12-21", "https://www.nasdaq.com/articles/5-cant-miss-drug-approvals-2015-2015-12-20", "https://www.nasdaq.com/articles/stock-market-news-for-december-17-2015-2015-12-17", "https://www.nasdaq.com/articles/company-news-for-december-17-2015-2015-12-17", "https://www.nasdaq.com/articles/best-amgen-inc-headlines-2015-2015-12-17", "https://www.nasdaq.com/articles/pfizer-incs-biggest-disappointment-2015-2015-12-22", "https://www.nasdaq.com/articles/4-top-dividend-plays-help-cure-stock-price-blues-2015-12-17", "https://www.nasdaq.com/articles/big-biotech-amgen-facing-pivotal-year-2016-2015-12-17", "https://www.nasdaq.com/articles/instant-analysis-amgen-cranks-dividend-27-higher-2015-12-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-hikes-first-quarter-dividend-ariad-lowers-iclusig-outlook-2015", "https://www.nasdaq.com/articles/amgen-returns-more-to-shareholders-hikes-dividend-by-27-2015-12-16", "https://www.nasdaq.com/articles/daily-dividend-report-amgn-cvs-ben-mco-usb-gis-sre-o-2015-12-16", "https://www.nasdaq.com/articles/amgen-amgn-shares-cross-above-200-dma-2015-12-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-ariad-clovis-oncology-regeneron-and-akebia", "https://www.nasdaq.com/articles/amgen-regains-rights-to-prolia-xgeva-vectibix-from-glaxo-2015-12-15", "https://www.nasdaq.com/articles/best-johnson-johnson-headlines-2015-2015-12-14", "https://www.nasdaq.com/articles/why-akebia-therapeutics-shares-soared-10-today-2015-12-14", "https://www.nasdaq.com/articles/top-fda-drug-approvals-2015-high-cholesterol-2015-12-12", "https://www.nasdaq.com/articles/ibb-amgn-regn-biib-large-outflows-detected-etf-2015-12-11", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-14-2015-2015-12-11", "https://www.nasdaq.com/articles/merck-and-eli-lilly-expand-immuno-oncology-collaboration-2015-12-11", "https://www.nasdaq.com/articles/did-cvs-health-just-make-huge-mistake-2015-12-15", "https://www.nasdaq.com/articles/aegerion-pharmaceuticals-lost-third-its-value-november-time-buy-2015-12-09", "https://www.nasdaq.com/articles/novartis-biosimilar-for-pfizers-enbrel-accepted-in-the-eu-2015-12-09", "https://www.nasdaq.com/articles/health-care-sector-update-12092015-chrsamgnaezsaezto-2015-12-09", "https://www.nasdaq.com/articles/top-3-drug-approvals-2015-2015-12-08", "https://www.nasdaq.com/articles/amgen-seeks-kyprolis-label-expansion-inks-deals-with-merck-2015-12-07", "https://www.nasdaq.com/articles/stock-market-news-for-december-04-2015-2015-12-04", "https://www.nasdaq.com/articles/3-most-important-drugs-amgens-pipeline-2015-12-04", "https://www.nasdaq.com/articles/3-attractive-income-stocks-whose-dividends-could-double-2015-12-10", "https://www.nasdaq.com/articles/powershares-dynamic-pharmaceuticals-portfolio-experiences-big-inflow-2015-12-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-repros-therapeutics-abbvie-amgen-xoma-and-gilead-2015", "https://www.nasdaq.com/articles/foamix-pharmaceuticals-ltd-hopes-profit-eli-lillys-and-amgens-side-effect-2015-12-03", "https://www.nasdaq.com/articles/stock-market-news-for-december-02-2015-2015-12-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-repros-tanks-crl-abbvie-multiple-myeloma-drug-approved-2015-12-02", "https://www.nasdaq.com/articles/cvs-health-plays-favorites-new-cholesterol-drugs-2015-12-01", "https://www.nasdaq.com/articles/pdl-biopharma-inc-pdli-ex-dividend-date-scheduled-december-02-2015-2015-12-01", "https://www.nasdaq.com/articles/health-care-sector-update-12042015-ptla-gale-amgn-2015-12-04", "https://www.nasdaq.com/articles/what-healthcare-dividend-stock-best-2015-11-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biomarin-amgen-vertex-gilead-biogen-and-repros-2015-11", "https://www.nasdaq.com/articles/amgen-seeks-fda-approval-for-first-biosimilar-of-humira-2015-11-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-soars-shkreli-steps-fda-panel-not-convinced-about-biomarin", "https://www.nasdaq.com/articles/johnson-johnsons-latest-fda-approval-could-spell-problems-amgen-2015-11-25", "https://www.nasdaq.com/articles/healthcares-greatest-dividend-stocks-2015-11-24", "https://www.nasdaq.com/articles/amgens-repatha-gets-preferred-position-cvs-formularies-2015-11-24", "https://www.nasdaq.com/articles/amgen-inc-takes-aim-abbvie-inc-2015-11-28", "https://www.nasdaq.com/articles/relevance-portfolio-holdings-3-concentrated-funds-buy-sell-2015-11-23", "https://www.nasdaq.com/articles/5-things-amgen-inc-wants-you-know-2015-11-21", "https://www.nasdaq.com/articles/best-healthcare-etf-week-2015-11-20", "https://www.nasdaq.com/articles/better-dividend-stock-amgen-or-astrazeneca-plc-2015-11-20", "https://www.nasdaq.com/articles/amgens-multiple-myeloma-drug-kyprolis-gains-eu-approval-2015-11-20", "https://www.nasdaq.com/articles/amgens-repatha-too-bloody-pricey-uk-2015-11-19", "https://www.nasdaq.com/articles/novartis%3A-fda-accepts-bla-for-biosimilar-version-of-neulasta-2015-11-19"], "Content": []}